data_2mhl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mhl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.754 0.312 . . . . 62.11 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.15 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 71.53 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.52 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 61.11 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.859 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.121 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 64.32 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 64.33 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.22 111.092 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.43 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 73.12 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.22 112.324 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.821 0.343 . . . . 72.14 111.062 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.934 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 74.03 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.1 111.182 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.45 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 75.25 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.04 111.12 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.15 111.161 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.21 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 72.35 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 74.24 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.41 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.52 111.157 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 72.12 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 73.32 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 62.33 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 73.11 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 65.23 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 75.13 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.03 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.52 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 75.51 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.786 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.907 0.384 . . . . 73.01 111.066 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.54 111.09 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 72.53 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.33 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.823 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.31 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.44 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 65.33 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.44 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 64.53 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 73.15 110.941 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.4 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.41 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 71.44 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.42 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.43 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.52 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.13 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.127 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 72.21 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.1 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 70.32 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.33 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 71.01 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.21 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.31 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 74.4 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 75.41 110.911 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.42 112.56 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 73.23 110.901 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.9 0.381 . . . . 74.1 110.842 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.21 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.21 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 74.24 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.43 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 71.44 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.03 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 139' ' ' VAL . 1.6 mm100 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.32 110.982 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.502 ' H ' ' NE2' ' A' ' 138' ' ' GLN . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.11 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.21 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.99 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.45 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.22 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 75.35 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.01 110.938 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.32 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.33 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.21 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.21 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.819 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 74.34 111.133 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 75.51 110.818 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.44 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.1 111.176 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.46 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.05 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.405 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 75.42 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.886 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.924 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.33 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.11 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 73.33 111.076 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.2 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.2 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.04 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.43 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.959 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.928 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.41 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.34 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.41 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 71.03 110.815 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 75.03 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 71.11 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 74.34 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.607 0.241 . . . . 75.12 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 64.13 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.33 111.052 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 65.21 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.34 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 73.23 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 63.14 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' NE ' ' H ' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.44 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.04 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.12 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.15 111.065 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 72.11 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.3 111.187 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 75.14 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 74.54 112.371 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.844 0.354 . . . . 71.02 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 74.2 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.096 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 73.21 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.24 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 73.24 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 74.43 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.211 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.4 111.095 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 73.3 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.12 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.22 111.211 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 61.42 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.51 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.841 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.53 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.929 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 72.42 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.44 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.54 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 73.22 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.862 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.853 0.359 . . . . 72.31 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.44 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 75.14 111.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.22 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.05 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 54.25 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.44 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.14 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.54 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 74.21 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 70.44 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 72.23 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.31 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.33 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.41 111.233 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.45 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 73.44 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 75.02 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.11 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.13 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 73.52 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 75.03 110.879 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.748 0.309 . . . . 75.21 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 73.24 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.854 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 72.43 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 73.43 110.851 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 74.13 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 75.05 112.591 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 75.44 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.097 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 62.11 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.12 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 63.13 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.42 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.32 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.52 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.844 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.15 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.88 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.03 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.213 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 72.31 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.14 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 168' ' ' LEU . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 71.3 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.2 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 71.15 111.025 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 75.42 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 63.31 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 74.11 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 71.2 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.43 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 75.32 111.167 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.461 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 74.4 112.542 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 75.33 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 75.24 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 72.43 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.748 0.309 . . . . 71.43 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.081 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.12 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.34 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.746 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 71.0 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.54 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 71.01 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.35 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.31 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.45 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 72.33 111.161 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.45 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 75.33 112.36 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.78 0.324 . . . . 74.42 111.084 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.02 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.55 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.33 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 75.01 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.34 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 73.11 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.24 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.25 111.222 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.32 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.55 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 75.04 111.071 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 72.2 111.157 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.2 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.23 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 72.03 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 73.14 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.3 111.147 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.11 112.332 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 74.0 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.43 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.814 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.793 0.33 . . . . 72.14 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 73.42 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.31 111.13 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.22 110.843 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 75.4 110.739 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 63.04 112.385 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 71.43 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.914 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.89 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.44 110.859 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.34 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.42 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.51 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 71.03 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.54 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.23 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.41 112.361 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.45 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 62.15 111.076 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.41 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.3 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 73.41 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.973 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.12 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.33 111.116 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.54 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.988 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.983 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 70.3 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.02 110.821 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 71.42 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.24 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.919 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 70.04 110.824 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 71.42 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 71.04 110.792 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.962 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.23 112.36 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 70.44 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.31 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 51.12 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.31 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 73.43 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.2 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 71.31 111.195 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.01 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.15 110.971 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.03 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.44 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 64.23 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 71.43 110.938 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 71.03 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 71.32 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.2 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.52 110.972 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 75.04 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.31 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 72.34 111.067 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.54 111.182 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.05 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.03 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.52 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 72.31 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.53 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.55 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 72.01 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 71.4 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.911 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 64.54 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.34 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.01 111.091 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 70.41 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.43 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.51 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.53 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.51 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 61.13 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 65.34 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.55 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.787 0.327 . . . . 72.2 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.3 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.53 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.11 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.722 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 75.11 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.959 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.8 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.814 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.41 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.54 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 55.2 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 74.41 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.12 111.156 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.02 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.12 112.297 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.788 0.328 . . . . 63.51 111.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.45 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.43 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.12 111.014 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.51 110.94 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 72.22 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.838 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.51 111.176 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.722 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.436 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.2 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 74.2 111.098 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 72.31 111.085 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 71.21 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 64.43 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.526 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 73.3 111.198 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.1 110.803 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.35 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.12 111.064 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 71.31 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 74.15 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 72.22 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.841 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.947 0.403 . . . . 74.4 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.215 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 75.25 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.42 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 71.24 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' N ' ' HG ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.33 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 71.21 112.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 75.21 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.32 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 74.34 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 64.42 111.173 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.55 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.42 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 63.54 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.23 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 74.15 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.35 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 75.4 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.35 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.02 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 74.55 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 70.22 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.55 111.049 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 73.54 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.55 110.826 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 73.43 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.43 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.21 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.978 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 74.3 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 53.42 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.52 110.919 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.851 0.358 . . . . 73.53 110.942 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 65.41 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.44 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.917 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.876 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.05 110.926 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 72.54 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.12 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 72.2 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 75.13 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.33 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.04 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 72.12 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 74.04 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.15 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 74.24 110.823 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.23 111.051 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 71.43 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.53 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 74.15 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.916 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.138 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.13 111.069 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 65.22 111.126 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.32 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 74.44 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.04 110.906 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 62.44 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.53 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 50.54 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.44 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.03 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.44 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.04 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.42 111.193 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 73.51 110.872 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 74.43 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.02 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.13 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 75.44 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 74.21 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.33 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.1 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.834 0.349 . . . . 74.44 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.33 111.158 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.22 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.34 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.581 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.581 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.35 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 72.35 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 74.35 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.4 111.096 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 72.24 111.179 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.42 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.3 112.381 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.818 0.342 . . . . 75.12 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.24 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.34 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 73.21 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.2 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 75.53 111.172 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 75.11 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.23 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 74.04 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.134 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.03 110.893 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.24 111.12 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.31 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 75.32 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.3 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.23 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 65.23 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.868 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.801 0.334 . . . . 74.33 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.092 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.52 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.41 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.828 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 73.52 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.22 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.21 111.216 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.51 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.33 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.995 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.1 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.14 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.42 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.13 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.015 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 61.13 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 65.32 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.42 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 71.05 110.969 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 75.32 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.33 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HA ' ' HA2' ' A' ' 137' ' ' GLY . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.52 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.43 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.24 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.915 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 75.55 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.129 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 63.13 110.83 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.01 110.922 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.871 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.953 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 73.45 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.44 110.803 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.34 110.861 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 70.23 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.804 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.12 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.833 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 73.21 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 71.15 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 75.13 110.834 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 74.52 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.31 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.02 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 74.02 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.24 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.33 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 62.22 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 74.53 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.898 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.24 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 71.43 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.02 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.53 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.12 111.158 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.41 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 73.23 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 74.43 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.2 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.55 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 73.53 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 74.03 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.44 111.223 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.51 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 71.22 110.815 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 74.14 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.41 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.31 111.135 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.44 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 74.15 110.901 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.55 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 73.24 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.23 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.51 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.31 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.3 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 72.41 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 70.51 111.158 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.21 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.23 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 74.4 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.54 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.696 0.284 . . . . 73.52 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 65.02 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.42 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.52 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.45 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.12 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.43 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.835 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 70.25 111.029 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.31 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.34 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 71.53 111.189 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.175 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 74.32 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.12 112.355 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.814 0.34 . . . . 75.12 111.142 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.02 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.51 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 70.11 110.95 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.4 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.049 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.32 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.131 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.117 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m120 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.21 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.33 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 74.42 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.904 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 53.23 111.099 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.13 111.101 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.4 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.24 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.53 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.332 . . . . 72.32 111.208 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.4 111.14 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.176 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 74.25 110.87 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.2 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.02 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.831 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 62.53 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.24 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.1 111.121 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.12 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 65.05 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 72.42 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.02 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 73.22 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.4 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.23 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.14 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.32 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.4 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.41 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 70.42 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.01 111.123 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 75.13 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 72.23 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 75.12 110.997 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.44 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 73.0 111.052 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.03 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.33 112.508 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 2.6 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.12 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 115' ' ' PHE . 4.0 mm? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.859 0.361 . . . . 74.45 110.974 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.41 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.14 110.774 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.35 110.863 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.31 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 74.34 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.44 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.12 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 65.1 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.21 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.43 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.14 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.4 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 71.02 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.4 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.42 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.956 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 72.02 111.156 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.777 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.2 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.879 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.45 111.119 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 186' ' ' PHE . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.42 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 73.13 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.44 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 75.21 111.126 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 75.31 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.12 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.44 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.01 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.03 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.34 110.937 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 70.44 110.867 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.44 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 63.12 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.43 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 73.12 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.43 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 70.14 111.166 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 74.35 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.3 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.21 112.336 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.34 111.162 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.32 110.824 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 65.32 111.126 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 74.54 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.22 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 71.25 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.321 . . . . 74.14 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.24 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 40.44 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.24 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 72.24 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 74.23 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 74.04 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 62.14 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 74.44 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.42 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 70.35 111.103 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.04 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 71.41 112.363 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 73.55 111.033 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.956 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 74.01 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.4 111.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.44 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.21 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 75.02 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.44 111.152 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.41 111.191 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 75.23 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.863 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.12 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.1 111.134 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.41 110.866 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 71.34 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 74.01 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 72.21 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.23 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.05 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.4 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.35 110.916 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 72.02 111.098 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 74.22 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 64.32 111.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.23 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 74.41 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 74.22 112.343 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.23 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.121 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.3 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 71.21 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 75.44 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.21 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.951 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 73.43 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.4 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 63.54 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.23 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.811 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 73.11 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.54 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.05 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 65.13 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' TRP . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 75.44 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.42 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.31 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.42 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 71.33 110.928 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 133' ' ' TRP . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.55 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 70.23 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.31 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 72.24 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.51 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.949 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.04 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.33 110.929 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.793 0.33 . . . . 74.13 110.974 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 71.15 110.872 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.55 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.967 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.35 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.885 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 75.12 110.882 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 72.31 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.53 110.925 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.52 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 64.21 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.02 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.12 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.41 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 51.44 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.41 111.111 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 72.14 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.31 110.882 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.44 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.51 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.31 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.41 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 73.52 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 71.23 110.826 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.2 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 63.11 110.878 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.23 111.11 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.22 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.51 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.33 111.17 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.41 111.138 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.44 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.94 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.35 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 63.42 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.01 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 72.12 111.095 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 75.1 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.34 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.34 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.945 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.2 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.13 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.15 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.162 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.31 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 72.35 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.53 112.497 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.53 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 72.14 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.785 0.326 . . . . 74.53 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.55 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 75.34 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 75.21 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 74.31 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 11' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 71.34 111.13 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 64.54 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.43 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.145 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 75.42 111.096 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.33 112.378 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.819 0.342 . . . . 73.34 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.916 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 73.03 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.44 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.01 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.01 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.33 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 73.4 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 73.31 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.41 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 75.24 110.905 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 43.43 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.1 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 71.24 110.917 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.54 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 75.1 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 70.43 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.13 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.53 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 73.14 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.762 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.876 0.37 . . . . 70.31 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 63.32 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.54 111.164 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.438 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.53 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.813 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.22 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 70.25 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.24 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.05 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 74.13 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.34 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.1 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.821 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.52 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.11 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 73.44 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 75.41 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.55 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.15 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.15 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.21 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' TRP . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 70.53 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 74.53 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.22 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 73.15 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 73.44 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 74.24 110.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.104 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 65.43 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 72.2 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 74.04 110.899 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.779 0.324 . . . . 73.14 111.012 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 72.05 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 71.02 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.43 110.814 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.32 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.35 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.1 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.22 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.14 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 73.2 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 75.44 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 73.33 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 75.13 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.913 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.011 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.35 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.43 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.922 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.911 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.12 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 75.53 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 65.34 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.236 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.33 110.888 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.53 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.02 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.175 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.13 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.4 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 75.23 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.912 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.34 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.05 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 71.21 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.53 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.837 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 72.4 110.946 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.04 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.22 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 73.41 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 75.51 111.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.854 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.33 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.3 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.41 111.108 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.21 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 63.03 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 64.13 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.79 0.328 . . . . 73.41 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.35 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.34 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.43 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.51 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.725 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.51 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.03 110.794 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.155 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.42 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 74.14 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 70.3 111.052 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.43 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 74.33 112.385 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.725 0.298 . . . . 71.5 111.14 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.875 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.44 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.3 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.15 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.54 110.776 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.21 111.151 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.892 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.21 110.886 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 72.02 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 71.23 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.15 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.3 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 74.3 111.228 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.32 110.831 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 72.21 110.888 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.01 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 74.01 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 74.13 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 73.04 111.215 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.13 112.36 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 73.03 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 73.42 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 70.34 110.774 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.793 0.33 . . . . 64.22 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.24 111.189 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.824 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.24 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.824 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.03 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 71.2 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.854 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 65.23 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.43 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.14 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.32 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.34 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 75.43 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.44 110.948 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 64.21 112.345 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.42 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.02 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.34 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.11 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 63.34 111.103 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.44 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 75.23 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.2 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.43 110.875 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.34 110.884 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.939 0.399 . . . . 74.43 110.935 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.01 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.31 110.956 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 73.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.13 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.802 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.795 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.34 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 73.53 111.086 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.33 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 61.12 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 74.41 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 74.35 111.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.53 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.13 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 73.43 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.53 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 62.24 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.152 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.52 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.22 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.065 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.34 111.16 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.44 111.044 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.03 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.14 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.921 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.54 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.56 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.15 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.02 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.43 110.955 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 64.31 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.31 110.808 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.51 111.186 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 75.12 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.04 110.908 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.454 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 73.52 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.35 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 75.32 110.908 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.54 111.115 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.05 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.41 110.735 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 72.54 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 74.33 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.33 110.948 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.1 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.713 0.292 . . . . 73.24 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.55 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.21 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.803 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 75.15 110.918 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.919 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.22 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.44 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.33 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.3 111.128 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.22 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 64.33 112.352 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.822 0.344 . . . . 75.15 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 75.03 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.14 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 74.13 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.45 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.32 110.918 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.52 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 74.54 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.791 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.21 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 73.14 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 74.43 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.126 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.45 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.04 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 73.33 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 74.04 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.45 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.43 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.03 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 72.33 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.32 110.784 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.877 0.37 . . . . 75.34 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.03 111.136 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.24 111.235 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 74.43 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.817 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.31 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.817 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.44 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.44 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.0 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.31 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.4 110.928 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 74.13 110.94 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 74.2 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.11 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.41 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.45 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.22 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.51 112.344 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.94 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 71.13 111.153 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.11 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 72.5 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.31 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.44 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.53 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.13 111.203 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.844 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.45 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.52 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 74.32 110.916 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.8 0.333 . . . . 75.21 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.43 110.772 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.52 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 64.23 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 75.3 110.962 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.41 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.13 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 74.33 110.9 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 75.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.2 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.32 111.106 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.53 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.34 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.109 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 50.44 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 71.22 111.146 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.41 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.02 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 75.21 110.976 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.14 111.193 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.44 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.945 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 71.13 110.944 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.1 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.45 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.44 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 72.13 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.945 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 75.15 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.34 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.34 110.809 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 72.14 111.16 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 70.35 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.15 111.125 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 72.22 111.147 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 63.02 111.148 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.42 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.02 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.45 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.2 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.04 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.3 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.42 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.35 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.04 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 75.23 111.134 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 72.22 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.888 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.466 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.03 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.52 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 75.02 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 73.34 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 74.33 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.54 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 51.01 110.889 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.15 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 71.24 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 71.12 110.948 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 74.51 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.75 0.31 . . . . 63.15 110.749 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 72.14 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 74.22 111.157 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.24 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 75.5 110.959 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 11' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 72.02 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 73.53 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 33.23 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.23 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 73.2 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.118 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 74.33 111.101 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.24 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 73.34 112.28 -179.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.428 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 65.1 111.218 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.53 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 73.21 111.212 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.1 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 72.32 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 65.12 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.3 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 75.13 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.31 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.576 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.43 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 55.13 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.184 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 70.43 112.56 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 75.12 111.158 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.05 110.889 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.917 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.44 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 65.24 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.455 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 74.54 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 73.43 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.869 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.808 0.337 . . . . 72.51 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.12 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' CG2' ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.33 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 74.31 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.14 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 73.34 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.44 112.443 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 70.25 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.2 111.06 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 75.2 110.852 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.3 111.125 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.954 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.32 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.34 110.872 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 74.15 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 74.24 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.35 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.43 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.44 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.51 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.32 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.42 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.34 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.122 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.32 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.11 112.522 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 73.33 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.21 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 64.44 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 73.21 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.924 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 2.2 t30 -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.23 110.806 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.23 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.43 110.886 -179.868 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 74.34 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.773 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.854 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.924 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 72.42 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.31 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.01 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 72.12 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 60.31 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.21 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.23 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 55.4 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.122 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.02 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 75.24 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 71.25 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 75.51 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 74.31 111.213 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 72.35 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.959 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 74.14 111.135 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.925 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 55.52 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.53 110.885 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 75.31 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 61.51 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.24 111.12 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 70.13 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.04 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 73.32 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 72.21 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.55 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.43 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 73.53 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.54 112.487 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 64.12 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.55 110.904 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.51 110.9 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 52.01 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.1 111.227 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.33 110.933 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.33 112.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.32 111.113 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.41 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 63.42 111.1 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.03 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.42 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 75.04 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.779 0.323 . . . . 75.41 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 64.12 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.161 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.04 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.52 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.24 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' THR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 70.31 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 72.11 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.21 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 71.31 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.05 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.45 111.081 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.3 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 64.24 112.318 -179.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.785 0.326 . . . . 73.13 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.13 110.871 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.43 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.55 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.137 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.32 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.761 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.4 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 75.1 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.33 111.083 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.194 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 75.25 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' THR . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.53 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.13 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.945 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.01 111.071 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 73.34 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 72.21 111.151 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 73.5 112.319 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.51 110.825 -179.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.865 0.364 . . . . 62.44 111.097 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.119 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 62.43 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.05 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.43 110.905 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.23 112.38 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.11 112.399 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.55 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.459 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 64.24 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.31 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.23 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.45 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.3 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.12 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 74.45 112.304 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.45 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.21 111.023 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.13 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.24 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.44 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.15 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 72.52 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.44 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.44 111.133 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 72.35 110.879 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 75.3 110.859 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.03 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.42 110.911 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.3 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.15 110.85 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.806 0.336 . . . . 71.51 110.95 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.01 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.51 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.1 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 74.01 110.876 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 74.15 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 73.1 110.922 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 74.45 110.894 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.809 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.43 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.15 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.03 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.05 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 71.54 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.51 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 73.12 111.13 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 63.41 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 70.1 111.151 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.52 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 75.01 111.042 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.43 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.03 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.52 110.917 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.13 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 74.12 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.24 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.41 110.957 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.53 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 63.41 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 72.25 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.41 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 72.04 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.33 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.51 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.1 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 74.51 110.891 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.25 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 52.24 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.03 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.11 111.048 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 72.11 110.873 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.24 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.14 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.33 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.51 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.52 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.13 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.41 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 74.43 111.177 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.41 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.34 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 54.21 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 73.22 111.217 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 62.01 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.51 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.34 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.32 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.713 0.292 . . . . 73.24 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 72.34 111.09 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 73.53 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.22 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.14 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 72.15 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.01 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.24 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.11 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 64.15 111.117 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 75.34 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.41 112.315 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.764 0.316 . . . . 74.5 111.142 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.44 111.178 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.2 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.01 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.43 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 71.44 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.857 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.115 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 71.35 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.04 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.0 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.23 111.043 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 74.12 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.52 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.02 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 74.41 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.891 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 71.05 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.22 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 74.53 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.34 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.23 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 71.55 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.03 110.953 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.927 0.394 . . . . 72.14 111.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.13 111.099 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.12 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 60.3 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 70.53 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.02 112.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 72.13 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 72.22 110.911 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.3 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.975 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.2 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 75.34 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 73.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.12 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.43 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 75.22 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 74.11 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 70.5 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 75.12 110.904 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 72.3 112.316 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 73.04 111.091 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.14 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 71.14 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.32 112.474 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.42 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.882 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 73.51 111.05 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.162 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 72.01 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.24 112.591 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.33 110.811 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.747 0.308 . . . . 73.44 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.55 110.906 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.33 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.22 110.921 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.05 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.14 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.11 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.34 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.04 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.33 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.2 111.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.729 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.855 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 71.31 110.862 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 73.44 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.45 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.42 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.22 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 74.52 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 71.12 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.871 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.44 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 73.15 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 71.14 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.13 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.03 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.42 111.062 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.2 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.11 111.088 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.43 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.933 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 75.45 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.55 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 73.4 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.13 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.52 110.883 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 55.41 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 71.31 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.35 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.2 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.32 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 75.53 111.095 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.25 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.067 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.24 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.12 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 71.2 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.304 . . . . 74.25 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 70.14 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 62.01 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.419 ' HA ' ' N ' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.32 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 75.32 111.108 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 71.44 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 75.4 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.21 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 73.44 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.02 111.174 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.42 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.35 112.342 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.831 0.348 . . . . 75.21 111.147 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.21 110.836 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.43 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.21 111.1 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.44 110.92 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 72.43 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.04 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 75.32 110.809 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.35 111.124 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.44 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.14 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.5 111.095 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.43 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.34 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 65.04 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.02 110.928 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 53.3 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.34 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.34 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.3 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.45 110.836 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.54 110.863 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 75.33 111.126 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 74.42 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.096 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.45 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 70.04 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.816 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.33 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.54 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.176 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.42 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.947 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.52 110.889 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.41 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 75.2 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 75.5 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 72.44 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 64.44 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.03 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.22 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 75.44 110.856 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.3 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 73.42 111.102 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.02 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.13 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.31 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 64.23 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.35 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 73.31 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 74.41 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.05 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.42 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.3 110.839 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.788 0.327 . . . . 70.55 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 71.2 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 73.11 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 64.13 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.2 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.34 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.24 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.42 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 73.25 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 75.32 111.122 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.02 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.33 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.138 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.21 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.3 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.994 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.32 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 42.02 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.875 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.33 111.141 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 61.03 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.42 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.3 111.028 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.03 110.9 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 64.13 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 75.4 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.12 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 74.15 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 74.3 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.031 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.4 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 73.13 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 63.15 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.32 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.35 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 70.31 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 64.51 111.212 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.23 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.949 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.24 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.55 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.53 111.217 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 65.02 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.085 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 62.53 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.24 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.11 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 73.35 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 72.41 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.21 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.13 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 73.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.34 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.837 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 74.43 111.089 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.4 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 71.42 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 54.32 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.551 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.43 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.34 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.52 112.247 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.762 0.315 . . . . 75.45 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 71.13 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.93 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 74.5 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.01 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 63.32 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 74.45 110.942 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.15 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.45 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 73.43 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 70.22 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.11 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.098 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 73.23 111.21 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.12 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.12 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.44 112.468 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.24 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.783 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.42 111.124 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.45 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 73.14 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.2 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 54.24 110.834 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.891 0.377 . . . . 73.05 111.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.52 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.31 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.42 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.826 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 65.23 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.43 111.243 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 74.11 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.016 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 44.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 74.13 110.935 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.21 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.45 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 75.44 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.24 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 55.1 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 72.12 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 75.22 110.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.24 112.283 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.93 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 74.44 111.139 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.35 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 72.04 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.01 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 73.15 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 73.3 110.881 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.194 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.078 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 65.41 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.21 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.45 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 74.31 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 72.51 110.967 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 71.03 110.846 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.4 111.019 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.21 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 75.05 110.873 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.821 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.14 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 73.23 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 70.33 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.52 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.31 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 62.35 111.124 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.04 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.24 111.113 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.33 110.927 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.12 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 72.54 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.54 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.53 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 75.53 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.1 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 70.31 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 75.31 111.073 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.35 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.24 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.1 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 75.53 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.33 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.14 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 64.1 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 72.44 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 75.22 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 64.42 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.11 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.41 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 65.43 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.34 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.51 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.45 110.831 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.454 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 72.44 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . 0.63 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.41 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 182' ' ' TRP . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.02 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.533 ' H ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.15 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 65.33 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.35 111.039 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.1 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 74.25 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.55 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.814 0.34 . . . . 74.43 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.44 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.31 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.692 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 73.15 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.167 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.15 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.24 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.12 111.117 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 71.35 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.23 111.105 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.31 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.31 112.364 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.784 0.326 . . . . 64.45 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.13 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.31 111.045 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 75.53 110.878 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.692 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.01 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 74.32 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 65.41 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.32 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 72.02 111.139 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.877 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.35 110.813 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.43 111.256 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 55.42 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 74.03 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.12 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.944 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.185 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.41 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.42 112.41 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.946 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.898 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.022 0 CA-C-O 120.92 0.39 . . . . 74.24 111.006 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.12 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.12 111.142 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.885 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 74.02 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.51 112.313 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.51 112.3 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.52 111.076 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.3 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.781 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 72.42 111.147 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.428 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.2 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.54 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 73.44 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 55.13 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 65.42 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 73.03 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.31 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.954 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 73.41 110.906 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 100' ' ' TYR . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.42 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.475 ' HA ' ' C ' ' A' ' 140' ' ' GLY . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 88' ' ' TRP . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.21 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 74.22 111.113 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.34 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 72.05 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.923 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 72.41 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 71.21 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 70.53 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.03 110.797 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 61.25 112.457 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 75.03 110.835 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.749 0.309 . . . . 73.33 110.997 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.03 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 73.25 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.53 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.23 110.952 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.896 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 63.12 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.41 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.23 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 71.21 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 75.1 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.13 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.04 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.475 ' C ' ' HA ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 74.33 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.2 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.574 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.42 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.922 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.54 110.923 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.07 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 73.33 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.01 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.84 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.918 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.42 111.24 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.653 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 60.54 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.33 111.117 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.85 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.867 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.838 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 73.12 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.53 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 64.52 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.835 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.02 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 63.21 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 74.14 111.106 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.32 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.45 110.818 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.32 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.468 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.31 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.31 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.21 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.41 111.165 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 71.24 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.31 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.54 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 73.11 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.33 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.739 0.304 . . . . 74.44 110.774 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.592 ' C ' ' O ' ' A' ' 3' ' ' GLU . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.461 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.42 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.44 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 70.44 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.847 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 74.44 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.14 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 65.43 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.04 111.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 72.43 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 63.43 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 64.2 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.31 112.344 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.029 0 CA-C-O 120.813 0.34 . . . . 72.24 111.116 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 71.3 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 74.35 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.41 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.4 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.53 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.1 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.21 111.061 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 71.13 111.122 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.2 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.504 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 75.5 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.13 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 71.33 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.43 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.983 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.54 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.21 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 73.1 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 54.53 110.822 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.969 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 75.01 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.12 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.41 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 72.3 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.32 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.945 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.861 0.362 . . . . 70.52 111.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 71.31 111.107 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.2 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 73.31 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.829 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 70.32 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 74.42 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.41 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.9 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.3 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 74.12 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.23 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.21 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 74.53 110.899 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.11 112.346 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 65.03 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.03 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 72.31 112.549 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 72.42 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.01 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 71.42 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 73.23 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.43 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.13 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.41 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.43 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.24 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.6 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.22 110.948 -179.887 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 73.22 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.35 110.882 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.966 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 65.24 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.23 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.14 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.44 111.011 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.11 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.52 111.02 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 72.1 111.127 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.43 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.04 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 75.13 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.15 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 71.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 74.3 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.04 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 63.52 110.982 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 72.41 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.601 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 74.5 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.22 110.822 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.22 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 71.25 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.956 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 62.22 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.852 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 70.44 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.35 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.45 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 70.14 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.41 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 74.32 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.55 110.996 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.12 110.84 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.34 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 75.03 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.53 111.017 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.1 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.4 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.974 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.54 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.35 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.136 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.23 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.042 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 72.11 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 72.51 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.41 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.42 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 73.34 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.31 111.128 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.21 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.24 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 71.43 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.15 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 73.32 110.855 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.55 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.22 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.32 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.31 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.41 111.119 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.41 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.31 112.405 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.858 0.361 . . . . 72.34 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.908 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.23 110.941 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.02 111.226 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.32 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.54 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 75.1 110.943 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 74.3 111.076 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.749 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.572 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 71.04 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.45 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 75.42 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.126 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.31 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.931 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.12 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.059 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.11 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.24 112.455 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.965 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 65.12 110.92 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 m170 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.849 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.85 0.357 . . . . 70.31 111.104 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.23 111.085 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 72.35 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 72.31 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.14 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.438 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 75.14 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.817 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.31 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.817 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 63.15 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 75.13 111.084 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.41 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.4 111.131 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.55 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 64.01 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.44 111.032 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.14 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 71.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.31 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 74.24 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.33 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 73.24 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 65.11 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 72.4 111.111 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 71.33 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.22 111.105 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.21 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.41 111.07 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.15 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 74.53 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.33 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.15 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 72.12 110.799 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 53.33 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 73.31 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.811 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 70.21 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.34 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.12 112.504 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 72.41 111.053 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.12 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.55 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 74.31 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 72.41 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 73.42 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.42 110.933 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 72.51 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.41 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 62.33 110.909 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.44 111.083 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 72.52 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.01 111.145 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.4 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.41 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 62.5 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 75.41 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.11 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.11 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.55 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.22 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 74.21 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 73.34 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 73.34 111.162 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.936 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.45 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 74.23 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 74.52 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 73.11 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 72.42 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.702 0.287 . . . . 73.41 110.865 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.33 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 53.24 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.4 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.924 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.45 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 50.53 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.21 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.41 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.35 111.116 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.112 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 74.33 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.45 112.387 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.781 0.324 . . . . 74.5 111.13 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 71.02 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.43 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 72.25 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 73.3 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.33 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 72.14 111.058 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 72.31 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.44 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 65.51 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.2 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.02 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.826 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.44 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.41 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 73.42 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.41 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.44 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.5 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.44 110.842 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.807 0.336 . . . . 72.51 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 73.14 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 70.14 111.128 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.42 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 72.33 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.824 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.42 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.824 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 72.14 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.31 111.085 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.3 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.01 111.079 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 72.11 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 73.31 110.89 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 55.04 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 64.03 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.05 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.43 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 73.43 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 75.53 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.35 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.21 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.02 111.059 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.51 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 73.41 111.073 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 71.31 112.442 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 75.11 111.12 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 74.32 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.782 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.35 111.093 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.12 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 71.45 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.35 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 74.1 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 74.44 110.786 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.767 0.318 . . . . 74.4 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.83 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.35 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.897 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 73.0 110.884 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 72.34 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.782 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.03 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.45 112.625 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.52 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 73.4 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 73.3 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 74.33 110.943 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.152 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.32 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.1 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.33 110.938 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.11 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.44 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 73.32 111.009 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.43 111.049 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.13 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 64.14 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 71.52 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.02 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.3 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 75.44 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 65.1 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.3 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.43 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.44 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.41 111.236 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.099 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.923 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.966 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.53 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.15 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.01 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.31 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.25 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.11 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.11 110.898 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.04 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.235 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.53 110.859 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.33 110.8 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 74.44 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.231 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.11 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.42 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 62.01 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.51 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.728 0.299 . . . . 74.14 110.849 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 70.51 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.3 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.54 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.865 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.52 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.55 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.44 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 60.12 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.21 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.087 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 73.31 112.306 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.524 -0.047 0 CA-C-O 120.877 0.37 . . . . 74.5 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.31 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 72.52 110.895 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 75.44 111.188 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.793 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 73.35 111.147 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.21 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.2 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 73.53 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 73.13 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 75.01 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.4 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.854 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 65.25 111.03 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.53 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.23 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.85 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.861 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.892 0.377 . . . . 74.32 111.112 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.31 111.063 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.151 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.32 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.828 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.32 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.42 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 75.34 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.31 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.675 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.23 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 70.34 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.55 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.23 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 62.14 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.24 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 63.31 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 74.21 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.22 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 73.23 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.22 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 86' ' ' ALA . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.42 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.23 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 74.01 111.12 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.13 110.799 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 74.02 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 73.13 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.01 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 74.32 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 74.11 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 74.42 110.812 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 74.42 110.853 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.52 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 29.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.31 110.906 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 63.53 110.825 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.31 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 63.3 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.22 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.13 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 73.05 111.019 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.12 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.445 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 74.53 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.1 111.123 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.41 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 73.51 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.15 111.011 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.42 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.642 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.498 ' N ' HD21 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.42 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 74.44 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 75.31 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.33 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.795 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.121 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.41 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.53 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 70.51 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.52 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.41 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 74.34 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 64.13 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.235 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.23 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.2 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 75.21 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.932 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.05 112.529 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 70.42 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 64.33 111.017 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.24 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.11 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.4 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.904 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.903 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 75.11 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.23 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 70.45 111.172 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.4 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.093 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 71.2 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.14 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 75.15 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 74.13 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -116.17 26.63 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 62.11 110.912 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.15 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 71.53 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.52 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 61.11 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.859 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.121 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 64.32 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 64.33 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.22 111.092 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.43 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 73.12 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 119.25 6.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.22 112.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -174.14 31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 73.31 111.137 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.38 -170.04 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 73.54 110.844 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.86 -98.47 1.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.763 -0.732 . . . . 74.44 112.38 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.48 -67.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 74.14 111.033 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.16 -110.75 1.49 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 71.13 112.512 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.95 40.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.524 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.71 -73.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.847 0.356 . . . . 74.3 111.211 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.02 34.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.01 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.39 171.21 23.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 75.21 112.435 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.56 103.66 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 74.02 110.926 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.17 133.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 74.04 110.911 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.12 43.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 64.11 112.436 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 146.23 36.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 75.41 112.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.09 164.42 30.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 71.51 110.849 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -148.06 103.23 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.931 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 142.02 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 72.22 111.175 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 146.89 31.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.14 111.062 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 74.55 110.934 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 74.03 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.1 111.182 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.45 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 75.25 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.04 111.12 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.15 111.161 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.21 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 72.35 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 74.24 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.41 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.52 111.157 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 72.12 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 73.32 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 62.33 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 73.11 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 65.23 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 75.13 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.03 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.52 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 75.51 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 -176.15 5.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.786 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 150.03 43.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.976 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.06 128.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 75.33 111.147 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.73 40.61 2.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 72.23 112.429 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -94.01 151.22 19.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 74.41 111.178 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -71.02 -18.16 62.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.424 . . . . 74.14 110.889 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.25 -51.2 56.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 64.43 111.139 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 t -121.67 -32.53 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 71.11 111.21 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.67 56.32 3.62 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.69 -0.767 . . . . 63.15 112.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.85 126.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.798 0.332 . . . . 74.15 110.898 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.9 tt -176.72 -35.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 73.44 111.132 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.73 163.09 14.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 73.01 111.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.54 111.09 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 72.53 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.11 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.33 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.823 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.31 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.44 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 65.33 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.44 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 64.53 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 73.15 110.941 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.4 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.41 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 71.44 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.42 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.43 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.52 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.13 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.127 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 72.21 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.1 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 70.32 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.33 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 71.01 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.21 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.31 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 74.4 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 75.41 110.911 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 73.34 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.42 112.56 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -48.77 167.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 73.23 110.901 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -153.6 -160.06 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.832 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.867 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -44.73 20.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.905 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.66 13.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 71.02 112.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -45.25 95.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 73.41 110.957 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -16.5 63.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 74.44 110.979 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.21 2.98 18.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 73.43 111.12 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.11 24.56 9.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.808 -0.71 . . . . 74.04 112.424 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 44.0 mt -154.38 -172.47 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 74.1 110.842 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.21 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.21 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.46 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 74.24 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.43 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 71.44 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 75.41 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.03 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 139' ' ' VAL . 1.6 mm100 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.32 110.982 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.502 ' H ' ' NE2' ' A' ' 138' ' ' GLN . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.11 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.21 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.99 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.45 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.22 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 75.35 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.01 110.938 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.32 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.33 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.21 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.21 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.819 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 74.34 111.133 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 75.51 110.818 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.44 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.1 111.176 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.46 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.05 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.405 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 75.42 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.45 110.886 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.924 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.33 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.11 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 73.33 111.076 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.2 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.2 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.04 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.43 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.959 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.928 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.41 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.34 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.41 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 71.03 110.815 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 75.03 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 71.11 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 74.34 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.905 0.383 . . . . 64.54 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -123.63 25.52 8.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.779 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 64.13 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.33 111.052 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 65.21 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.34 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 73.23 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 63.14 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' NE ' ' H ' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.44 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.04 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.12 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.15 111.065 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 72.11 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.3 111.187 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 75.14 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 -173.23 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 74.54 112.371 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.0 p -104.91 -179.39 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.186 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.67 -171.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.846 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.12 -136.02 9.16 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 65.12 112.507 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -75.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 72.2 111.031 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.93 103.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.813 -0.708 . . . . 62.03 112.483 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.16 173.25 19.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 40.22 112.462 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 53.86 34.46 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 70.53 111.202 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -179.12 109.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.38 149.98 21.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 64.31 112.515 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.24 -177.7 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 74.14 110.924 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.63 -178.66 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.873 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.71 43.36 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.14 112.54 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.59 148.43 9.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 54.34 112.496 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.81 165.26 15.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 75.22 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -118.63 152.07 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.86 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.66 -176.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 74.02 111.146 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t -80.19 145.38 32.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 71.02 111.126 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 74.2 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.096 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 73.21 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 73.24 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 73.24 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 74.43 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.211 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.4 111.095 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 73.3 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.12 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.22 111.211 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 61.42 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.51 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.841 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.53 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.929 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 72.42 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.44 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.54 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 73.22 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -99.04 106.25 18.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.862 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -113.06 156.55 22.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.942 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.84 106.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 74.33 111.194 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.95 72.02 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 53.43 112.429 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.23 151.73 19.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 73.42 111.139 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.44 -25.89 33.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 75.21 110.883 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.76 -36.96 49.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.122 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 p -120.32 -32.49 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.43 111.082 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 52.18 71.5 0.66 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 63.32 112.556 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 102.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 71.5 110.853 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.02 -28.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.21 111.146 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.77 44.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.31 111.155 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.44 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 75.14 111.122 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.22 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.819 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.05 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 54.25 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 74.1 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.44 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.14 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.54 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 74.21 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 70.44 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 72.23 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.31 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.33 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.41 111.233 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.45 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 73.44 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 75.02 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.11 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.13 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 73.52 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -51.13 104.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 75.03 110.879 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -165.88 -157.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 73.1 110.959 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.49 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.869 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.08 -47.23 16.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.24 -58.64 12.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -47.65 84.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.755 0.312 . . . . 70.12 110.949 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -67.28 -10.96 55.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 71.25 110.764 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.98 -5.89 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.03 111.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.34 36.98 8.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 53.34 112.59 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.03 133.59 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.748 0.309 . . . . 75.21 111.016 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 73.24 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.854 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.939 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 72.43 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 73.43 110.851 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 74.13 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 75.05 112.591 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 75.44 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.097 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 62.11 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.12 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 63.13 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.42 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.32 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.52 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.844 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.15 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.88 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.03 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.213 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 72.31 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.14 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 168' ' ' LEU . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 71.3 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.2 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 71.15 111.025 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 75.42 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 63.31 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 74.11 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 71.2 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.43 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 75.32 111.167 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.461 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 74.4 112.542 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 75.33 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 75.24 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 72.43 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.815 0.34 . . . . 73.22 110.83 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -156.38 44.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.43 110.832 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.081 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.12 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.34 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.746 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 71.0 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.54 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 71.01 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.35 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.31 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.45 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 72.33 111.161 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.45 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 -171.82 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 75.33 112.36 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.17 -42.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 73.32 111.148 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -178.55 175.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 71.52 110.896 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.15 -135.87 7.47 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.688 -0.768 . . . . 62.54 112.473 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.14 -75.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.791 0.329 . . . . 71.04 111.088 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.684 -0.77 . . . . 74.53 112.396 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.19 -177.19 14.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.733 -0.746 . . . . 73.13 112.49 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -57.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.737 0.303 . . . . 74.11 111.177 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -87.6 -61.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 72.43 110.971 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.66 156.24 27.69 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.686 -0.769 . . . . 70.43 112.472 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.0 -68.61 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.96 0.41 . . . . 64.54 110.912 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 57.14 -169.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 74.34 110.966 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.14 -18.74 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 73.33 112.536 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 124.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.802 -0.713 . . . . 74.11 112.432 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -143.18 113.61 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 73.51 110.979 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -124.14 80.65 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.889 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -149.9 109.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 72.53 111.058 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 137.63 36.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 74.42 111.084 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.02 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.55 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.33 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 75.01 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.34 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 73.11 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.24 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.25 111.222 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.32 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.55 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 75.04 111.071 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 72.2 111.157 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.2 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.23 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 72.03 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 73.14 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.3 111.147 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.11 112.332 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 74.0 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 72.43 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -67.44 144.01 55.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.814 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -82.74 173.48 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.888 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.0 tt -152.73 122.82 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.34 111.073 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.76 -154.54 25.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 55.4 112.526 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 161.93 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 71.15 111.096 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.834 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.64 -50.85 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 71.25 111.036 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.77 -32.41 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 74.42 111.182 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.93 -28.73 12.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 73.42 112.521 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.56 -75.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.774 0.321 . . . . 72.22 110.87 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.5 mm 64.47 105.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 64.1 111.129 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.41 163.51 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 72.14 111.111 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 73.42 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.31 111.13 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.22 110.843 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 75.4 110.739 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 63.04 112.385 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 71.43 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.914 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.89 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.44 110.859 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.34 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.42 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.51 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 71.03 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.54 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.23 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.41 112.361 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.45 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 62.15 111.076 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.41 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.3 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 73.41 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.973 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.12 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.33 111.116 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.11 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.54 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.988 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.983 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 70.3 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.32 169.12 16.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.02 110.821 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -177.51 -152.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 72.14 110.853 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -46.14 -56.6 5.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 54.55 110.799 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -78.22 -50.16 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.846 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.43 -58.75 11.82 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.734 -0.746 . . . . 42.24 112.512 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -58.15 -49.16 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.719 0.295 . . . . 75.11 110.857 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -68.11 -11.7 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.877 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.56 -3.37 58.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.02 111.173 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.76 -9.63 8.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 74.45 112.386 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mt -85.44 166.48 16.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 71.42 110.854 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.24 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.919 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 74.53 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 70.04 110.824 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 71.42 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 71.04 110.792 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 73.41 110.962 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.23 112.36 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 70.44 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.31 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 51.12 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.31 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 73.43 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.2 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 71.31 111.195 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.01 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.15 110.971 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.03 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.44 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 64.23 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 71.43 110.938 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 71.03 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 71.32 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.2 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.52 110.972 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 75.04 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.31 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 72.34 111.067 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.54 111.182 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.05 111.051 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.03 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 75.52 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.52 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 72.31 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.53 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.55 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 72.01 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 75.33 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 71.4 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.911 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 64.54 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.34 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.01 111.091 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 70.41 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.43 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.51 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.53 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.51 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 61.13 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 65.34 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.55 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.739 0.304 . . . . 74.15 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.17 102.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 72.2 110.847 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.3 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.53 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.11 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.722 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 75.11 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.512 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.959 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.8 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.814 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.41 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.54 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 55.2 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 74.41 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.12 111.156 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.02 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.12 112.297 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -67.33 -24.86 65.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 64.23 111.151 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -61.73 -169.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.906 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.05 -38.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 62.2 112.513 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.81 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 74.24 111.044 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.56 -65.81 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 64.35 112.461 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.94 -146.95 7.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 64.2 112.542 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 p -141.91 -73.55 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 73.53 111.119 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.3 mt -121.58 -73.06 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.879 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.84 164.99 16.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.703 -0.761 . . . . 65.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.62 -170.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 74.3 110.868 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.06 169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.59 43.52 0.82 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 70.4 112.551 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.27 -150.37 31.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 75.42 112.467 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -136.5 165.34 26.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.764 0.316 . . . . 71.05 110.926 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.13 164.11 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 55.31 110.856 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.39 152.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 54.33 111.098 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t -79.63 124.73 28.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 63.51 111.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.45 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.43 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.12 111.014 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.51 110.94 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 72.22 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.838 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.51 111.176 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.722 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.436 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.2 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 74.2 111.098 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 72.31 111.085 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 71.21 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 64.43 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.526 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 73.3 111.198 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.1 110.803 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.35 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.12 111.064 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 71.31 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 74.15 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 72.22 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -160.51 139.28 10.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.841 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -79.23 -164.51 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 74.44 110.874 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.8 tt -148.94 153.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 72.35 111.212 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.81 -139.11 9.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 63.11 112.478 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -89.79 166.38 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 72.33 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -64.97 -15.15 61.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.925 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.0 57.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 52.11 111.115 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 t -122.23 -31.61 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.43 111.099 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.97 -93.69 0.49 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.438 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -82.65 175.25 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 74.14 110.826 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 tt -141.63 -41.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.13 111.067 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.67 152.31 40.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 74.4 111.027 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.215 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 75.25 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.42 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 71.24 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' N ' ' HG ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.33 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 71.21 112.319 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 75.21 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.32 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 74.34 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 64.42 111.173 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.55 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.42 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 63.54 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.23 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 74.15 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.35 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 75.4 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.35 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.02 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 74.55 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 70.22 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.55 111.049 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 73.54 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.55 110.826 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 73.43 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.43 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.21 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.978 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 74.3 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 53.42 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.25 166.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.52 110.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.437 ' H ' ' H ' ' A' ' 120' ' ' LYS . 3.6 t-20 -162.44 -168.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.44 110.978 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.08 -62.75 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.879 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.73 -44.58 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 72.5 110.87 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.09 -57.04 21.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.805 -0.712 . . . . 73.52 112.396 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.64 -47.54 85.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 73.44 110.908 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.11 -11.76 58.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.869 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.25 7.17 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 64.15 111.151 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.01 30.52 66.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.777 -0.725 . . . . 72.52 112.428 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 -168.16 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.851 0.358 . . . . 73.53 110.942 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 65.41 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.44 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.917 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.876 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.05 110.926 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 72.54 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.12 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 72.2 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 75.13 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.33 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.04 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 72.12 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 74.04 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.15 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 74.24 110.823 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.23 111.051 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 71.43 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.53 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 74.15 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.916 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.138 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.13 111.069 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 65.22 111.126 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.32 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 74.44 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.04 110.906 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 62.44 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.53 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 50.54 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.44 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.03 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.44 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.04 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.42 111.193 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 73.51 110.872 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 74.43 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.02 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.13 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 75.44 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 74.21 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.33 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.1 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.366 . . . . 74.42 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -106.9 80.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.892 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.33 111.158 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.22 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.34 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.581 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.581 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.35 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 72.35 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 74.35 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.4 111.096 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 72.24 111.179 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.42 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 115.78 4.26 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.3 112.381 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -92.72 163.1 13.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.162 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.29 150.42 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 61.23 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.37 -116.06 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 64.2 112.519 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.97 105.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 72.44 111.106 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.95 -107.35 1.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 53.21 112.437 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.62 -145.38 4.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 73.44 112.475 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 t 179.1 93.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.886 0.374 . . . . 75.03 111.14 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.8 -74.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 74.35 110.949 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.13 163.53 11.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 73.31 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -160.8 -172.09 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.21 110.876 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.91 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 73.14 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.3 18.45 6.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 64.33 112.44 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.92 -52.19 30.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 63.41 112.467 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -143.3 161.94 37.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 72.21 110.868 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -123.8 164.61 18.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.85 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.83 124.97 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 72.21 111.146 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.64 167.59 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 75.12 111.152 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.24 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.34 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 73.21 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.2 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 75.53 111.172 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 75.11 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.23 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 74.04 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.134 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.03 110.893 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 71.12 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.24 111.12 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.31 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 75.32 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.3 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.23 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 65.23 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -63.03 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.868 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -132.22 107.86 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 73.02 110.799 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.19 145.32 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 74.11 111.172 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.51 -145.49 10.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.818 -0.706 . . . . 74.22 112.566 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -95.78 151.62 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 74.4 111.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -17.41 64.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 73.43 110.813 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.55 -50.11 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.074 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.81 -32.49 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 71.42 111.19 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.64 -85.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 74.51 112.499 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -109.58 93.06 4.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 71.14 110.876 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.2 pt -152.17 39.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 65.44 111.029 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.69 162.99 16.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 74.33 111.126 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.092 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.52 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.41 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.828 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 73.52 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.22 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.21 111.216 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.51 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.33 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.995 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.1 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.14 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.42 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.13 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.015 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 61.13 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 65.32 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.42 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 71.05 110.969 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 75.32 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.33 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HA ' ' HA2' ' A' ' 137' ' ' GLY . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.52 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.43 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.24 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.915 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 75.55 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.129 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 63.13 110.83 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.01 110.922 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.871 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.953 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 73.45 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 64.42 109.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.44 110.803 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -165.06 -158.81 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 74.13 110.891 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.28 -59.96 2.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.929 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.88 -46.33 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.804 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.13 -58.86 11.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 61.12 112.42 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -58.18 -48.77 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 74.54 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.1 -12.42 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.12 110.883 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.73 15.34 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 72.2 111.056 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.39 31.35 42.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 62.21 112.434 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.57 104.3 12.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 72.34 110.861 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 70.23 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.804 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.12 110.885 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.833 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 73.21 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 71.15 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 75.13 110.834 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 74.52 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.31 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.02 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 74.02 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.24 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.33 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 62.22 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 74.53 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.898 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.24 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 71.43 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.02 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.53 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.12 111.158 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.41 110.911 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 73.23 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 74.43 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.2 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.55 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 73.53 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 74.03 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.44 111.223 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.51 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 71.22 110.815 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 74.14 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.41 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.31 111.135 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.44 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 74.15 110.901 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.55 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 73.24 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.23 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.51 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.31 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.3 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 72.41 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 70.51 111.158 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.21 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.23 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 74.4 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.54 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 52.22 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -158.31 25.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.764 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 65.02 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.42 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.52 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.45 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.12 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.43 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.835 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 70.25 111.029 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.31 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.34 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 71.53 111.189 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.175 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 74.32 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 148.13 64.1 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.12 112.355 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.9 p -74.97 71.88 2.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 60.89 73.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.93 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.08 113.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.699 . . . . 73.23 112.591 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.09 67.02 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 33.13 111.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.5 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 61.11 112.515 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.48 63.44 0.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 71.03 112.381 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -114.82 -29.78 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 64.43 111.07 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.63 -65.93 0.51 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.36 -0.382 . . . . 74.54 110.957 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.95 172.49 10.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.695 -0.764 . . . . 65.44 112.41 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.07 147.2 45.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 65.41 110.906 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 tt -170.45 157.62 6.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 74.53 110.931 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.03 32.28 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 73.21 112.487 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.97 35.75 17.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 73.0 112.491 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 123.26 13.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 75.11 110.875 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -147.1 119.12 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.4 110.822 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.0 t -138.78 149.36 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.146 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 145.57 32.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 75.12 111.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.02 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.51 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 70.11 110.95 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.4 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.049 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.32 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.131 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.117 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m120 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.21 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.33 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 74.42 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.11 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.904 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 53.23 111.099 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.13 111.101 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.4 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.24 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 73.53 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 171.07 19.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -175.96 73.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.848 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 tp -95.74 111.03 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 74.13 111.109 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.45 104.7 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 62.42 112.447 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -160.74 151.18 18.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 70.54 111.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 154.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 72.43 110.821 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.99 -22.41 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 75.54 111.133 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -33.51 27.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.31 111.126 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.96 1.76 62.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 20.14 112.485 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.56 -78.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 72.24 110.869 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.3 mt 56.58 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 65.14 111.188 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.16 161.03 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 72.32 111.208 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.4 111.14 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.176 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 74.25 110.87 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.2 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.02 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.831 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 62.53 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.24 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.1 111.121 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.12 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 65.05 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 72.42 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.02 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 73.22 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.4 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.23 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.14 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.32 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.4 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.41 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 70.42 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.01 111.123 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 75.13 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 72.23 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 75.12 110.997 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.44 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 73.0 111.052 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.03 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.33 112.508 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.401 ' CD1' ' HG ' ' A' ' 124' ' ' LEU . 2.6 m-85 -113.78 170.19 8.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.12 110.906 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 120' ' ' LYS . 7.9 t-20 -179.65 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.838 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -44.94 -54.63 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 72.45 110.806 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -78.05 -51.29 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 74.34 110.809 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.66 -59.99 9.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 54.23 112.516 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 116' ' ' ASN . 16.5 ttpt -55.99 -49.81 72.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 74.11 110.959 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -67.76 -13.91 62.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.49 -2.62 58.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 71.11 111.067 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.69 -7.45 6.53 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.425 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 115' ' ' PHE . 4.0 mm? -91.23 169.8 10.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 74.45 110.974 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.41 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.14 110.774 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.35 110.863 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.31 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 74.34 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.44 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.12 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 65.1 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.21 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.43 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.14 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.4 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 71.02 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.4 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.42 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.956 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 72.02 111.156 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.777 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.2 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.879 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.45 111.119 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 186' ' ' PHE . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 62.42 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 73.13 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.04 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.44 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 75.21 111.126 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 75.31 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.12 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.44 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.01 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.03 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.34 110.937 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 70.44 110.867 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.44 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 63.12 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.43 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 73.12 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.43 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 70.14 111.166 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 74.35 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.3 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.21 112.336 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.34 111.162 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.32 110.824 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 65.32 111.126 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 74.54 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.22 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 71.25 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.338 . . . . 73.24 110.808 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.42 23.93 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.888 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.24 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 40.44 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.24 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 72.24 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 74.4 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 74.23 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 74.04 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 62.14 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 74.44 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.42 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 70.35 111.103 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.04 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 138.64 38.31 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 71.41 112.363 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.77 150.21 23.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 74.43 111.036 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -172.51 152.24 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 72.43 110.92 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.92 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.669 -0.777 . . . . 74.34 112.505 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 -67.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 62.2 111.039 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.84 57.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.744 . . . . 65.44 112.467 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.28 -126.24 30.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.808 -0.711 . . . . 71.23 112.43 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -48.53 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 72.13 111.017 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.42 -60.82 1.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 74.22 110.933 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.07 63.48 3.61 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.33 112.486 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.2 t -174.44 158.68 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 72.44 110.932 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 tt 63.16 105.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.979 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 42.14 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 62.01 112.535 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.64 105.15 0.99 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.68 -0.771 . . . . 73.31 112.594 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.46 165.3 21.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 62.3 110.897 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 m -151.5 84.78 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.899 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.98 123.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 73.12 111.159 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 139.72 36.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.465 . . . . 73.55 111.033 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.956 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 74.01 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.4 111.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.44 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.21 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 75.02 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.44 111.152 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.41 111.191 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 75.23 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.863 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 73.22 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.12 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.1 111.134 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.41 110.866 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 71.34 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 74.01 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 72.21 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.23 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.05 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.4 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -68.08 163.52 22.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.35 110.916 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 158.96 15.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 73.25 110.931 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 tt -140.26 145.68 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.431 . . . . 75.31 111.123 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.7 39.97 0.73 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.639 -0.791 . . . . 63.14 112.359 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -133.46 171.11 14.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 72.41 111.216 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -62.22 -17.09 57.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 72.34 110.896 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.38 -51.81 42.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 62.44 111.022 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 p -128.91 -32.96 2.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 74.05 111.107 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.47 -98.61 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 71.41 112.437 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p30 175.54 -175.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 73.23 110.884 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.0 mt 65.67 79.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 65.13 111.125 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.48 108.94 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 72.02 111.098 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 74.22 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 64.32 111.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.23 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 74.41 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 74.22 112.343 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.23 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.121 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.3 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 71.21 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 75.44 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 89' ' ' TYR . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.21 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.951 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 73.43 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.4 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 63.54 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.23 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.811 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 73.11 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.54 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.05 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 65.13 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 88' ' ' TRP . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 75.44 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.42 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.31 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.42 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 71.33 110.928 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 133' ' ' TRP . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.55 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 70.23 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.31 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 72.24 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.51 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 64.4 110.949 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.04 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -49.37 105.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.33 110.929 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.01 -161.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 73.5 110.901 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.5 -59.45 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 75.0 110.84 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.27 -46.38 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 72.41 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.41 -58.72 12.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 62.43 112.485 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -45.75 91.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 75.45 110.881 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.5 -11.64 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 71.23 110.883 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.81 10.92 28.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.34 111.018 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.85 34.48 37.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.79 -0.719 . . . . 61.12 112.497 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.75 149.22 42.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 74.13 110.974 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 71.15 110.872 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.55 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.967 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.35 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.885 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 75.12 110.882 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 72.31 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.53 110.925 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.52 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 64.21 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.02 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.12 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.41 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 51.44 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.41 111.111 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 72.14 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.31 110.882 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.44 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 72.51 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.31 110.9 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.41 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 73.52 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 71.23 110.826 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.2 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 63.11 110.878 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.23 111.11 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.22 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.51 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.33 111.17 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.41 111.138 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.44 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.94 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.35 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 73.0 110.818 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 63.42 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.01 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 72.12 111.095 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 75.1 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.34 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.34 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.945 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.2 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.13 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.15 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.31 111.162 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 73.32 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.31 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 72.35 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.53 112.497 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.53 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 72.14 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ttm . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.732 0.301 . . . . 75.1 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -95.33 25.6 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 74.53 110.846 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.55 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 75.34 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 75.21 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 74.31 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 11' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 71.34 111.13 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 64.54 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.43 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.145 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 75.42 111.096 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -14.42 36.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.33 112.378 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 p 51.71 -171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.18 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.98 -174.47 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 70.22 110.91 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.66 -114.06 0.6 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.688 . . . . 64.23 112.563 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.03 68.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.947 0.403 . . . . 73.41 111.091 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.58 88.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.81 -0.709 . . . . 74.42 112.527 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.61 133.05 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.78 -0.724 . . . . 72.35 112.529 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -115.85 24.87 11.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.73 0.3 . . . . 73.12 111.056 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.82 102.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 73.32 110.89 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 126.77 1.11 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 72.31 112.501 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.28 96.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 74.24 110.895 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.11 170.02 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.083 -0.508 . . . . 74.22 110.886 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.12 43.36 1.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 72.54 112.476 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.46 162.81 18.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.838 -0.696 . . . . 64.55 112.496 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.93 124.91 17.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.908 0.385 . . . . 74.42 110.936 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.19 153.03 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 64.2 110.868 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.88 154.36 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 74.04 111.124 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -173.9 61.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.081 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.916 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 73.03 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.44 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.01 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 74.04 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.01 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.33 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 73.4 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 73.31 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.41 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 75.24 110.905 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 43.43 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.1 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 71.24 110.917 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.54 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 75.1 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 70.43 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.13 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.53 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 73.14 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -159.94 129.69 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.762 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.93 93.66 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 73.14 110.961 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.3 tt -74.91 147.08 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 75.44 111.123 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.51 40.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.661 -0.78 . . . . 71.33 112.428 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -104.76 157.09 17.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 71.33 111.144 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -19.17 58.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.827 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.99 -50.93 60.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 75.23 111.122 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -25.2 6.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.103 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.41 -94.01 0.56 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.506 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 179.75 177.71 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 62.52 110.817 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 64.35 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 75.34 111.016 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.92 157.45 44.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.31 111.094 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 63.32 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 71.54 111.164 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.25 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.53 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.813 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.22 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 70.25 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.24 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.05 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 74.13 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.34 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.1 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.821 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.52 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.11 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 73.44 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 75.41 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.55 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.15 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.15 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.21 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' TRP . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 70.53 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 74.53 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.22 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 73.15 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 73.44 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 74.24 110.916 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.104 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 75.1 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 65.43 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 72.2 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -50.89 145.68 6.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 74.04 110.899 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -162.3 -160.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.9 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -46.97 -61.0 2.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 64.41 110.854 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.94 -45.04 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 65.44 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.1 -57.96 16.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 64.33 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -60.65 -46.63 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 71.13 110.934 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.32 -10.98 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 63.23 110.939 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.04 3.32 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.13 111.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.38 41.49 52.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 72.23 112.439 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.23 123.6 50.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 73.14 111.012 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 72.05 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 71.02 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.43 110.814 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.32 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.35 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.1 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.22 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.14 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 73.2 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 75.44 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 73.33 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 75.13 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.913 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.011 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.35 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.43 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.922 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.911 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.12 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 75.53 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 65.34 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.236 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.33 110.888 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.53 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.02 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.175 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.13 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.4 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 75.23 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.912 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.34 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.05 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 71.21 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 74.53 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.837 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 72.4 110.946 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.04 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.22 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 73.41 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 75.51 111.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.854 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.33 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.3 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.41 111.108 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.21 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 63.03 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 64.13 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtm . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.671 0.272 . . . . 75.53 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 55.22 70.73 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 73.41 110.867 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.35 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.34 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.43 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.51 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.725 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.51 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.03 110.794 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.155 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.42 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 74.14 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 70.3 111.052 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.43 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 157.81 59.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 74.33 112.385 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.0 m -119.06 150.44 39.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.136 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 126.86 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 74.1 110.841 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.807 -0.711 . . . . 73.01 112.448 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.6 40.58 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 54.41 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.05 -105.65 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 62.44 112.527 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.37 -93.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.476 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -140.83 74.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 72.11 111.125 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.22 40.14 9.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 74.31 110.946 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.6 138.22 3.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 74.4 112.482 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.38 80.66 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 71.01 110.835 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 mp -144.69 126.84 15.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 74.24 110.912 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.25 43.56 1.16 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.742 -0.742 . . . . 62.54 112.47 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 -161.21 0.82 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.795 -0.716 . . . . 75.5 112.487 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 126.38 16.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.392 . . . . 72.23 110.863 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.26 -174.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 71.32 110.87 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.0 m -137.96 -176.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.122 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p -78.7 120.47 23.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 71.5 111.14 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.875 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.44 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.3 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 74.15 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.54 110.776 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.21 111.151 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.892 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.725 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.21 110.886 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 72.02 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 71.23 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.15 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.3 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 74.3 111.228 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.32 110.831 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 72.21 110.888 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.01 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 74.01 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 74.13 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 73.04 111.215 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.13 112.36 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 73.03 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 73.42 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.01 106.69 1.61 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 70.34 110.774 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 79.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 61.14 110.908 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.79 138.08 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 71.32 111.177 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.14 40.12 1.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 62.33 112.515 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 -178.74 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.706 0.289 . . . . 64.43 111.228 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -77.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 74.13 110.911 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.75 -9.26 59.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 60.14 111.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -21.48 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 74.14 111.173 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 76.65 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 64.53 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.95 -15.57 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 74.34 110.896 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp 64.55 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.027 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.55 163.29 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 64.22 111.101 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.24 111.189 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.824 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.24 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.824 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.03 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 71.2 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.854 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 65.23 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.43 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.14 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.32 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.34 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 75.43 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.44 110.948 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 64.21 112.345 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.42 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.02 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.34 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.11 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 63.34 111.103 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.44 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 75.23 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.2 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.43 110.875 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 65.81 147.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.34 110.884 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.0 OUTLIER -156.74 -173.1 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 63.33 110.864 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -62.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 72.42 110.886 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.42 -46.17 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.827 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -57.32 19.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.763 -0.732 . . . . 64.11 112.435 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 116' ' ' ASN . 2.9 ttpt -61.88 -46.3 89.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 72.31 110.892 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.07 -11.13 56.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 73.12 110.873 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.13 -0.09 18.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.156 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.94 28.21 73.19 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.707 -0.759 . . . . 73.32 112.486 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.01 121.92 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.399 . . . . 74.43 110.935 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.01 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.31 110.956 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 73.32 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.13 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 75.23 110.802 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.795 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.34 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 73.53 111.086 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.33 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 61.12 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 74.41 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 74.35 111.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.53 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.13 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 73.43 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.5 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.53 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 62.24 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.152 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.52 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.22 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.065 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.34 111.16 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.44 111.044 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.03 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.14 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.921 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.54 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.56 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.15 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.02 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.43 110.955 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 64.31 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.31 110.808 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.51 111.186 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 75.12 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.04 110.908 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.454 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 73.52 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.35 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 75.32 110.908 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.54 111.115 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.05 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.41 110.735 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 72.54 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 74.33 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.33 110.948 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 71.1 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.839 0.352 . . . . 53.04 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -160.25 105.98 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.24 110.861 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.55 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.21 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.803 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 75.15 110.918 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.919 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.22 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.44 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 71.44 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.33 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.3 111.128 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.22 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -173.96 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 64.33 112.352 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.4 p -136.47 -175.28 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.05 111.172 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -59.86 112.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 65.32 110.904 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.8 110.71 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 65.22 112.516 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.94 105.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 75.14 111.072 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.55 97.79 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.855 -0.688 . . . . 72.54 112.58 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.3 -171.27 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.85 -0.691 . . . . 73.12 112.418 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.5 m -160.34 -72.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 73.23 111.094 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt 51.87 32.94 10.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.943 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.13 148.43 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.633 -0.794 . . . . 35.33 112.403 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.05 -73.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 75.15 110.82 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 61.92 175.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 74.44 110.962 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.71 43.35 84.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 73.41 112.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.89 75.39 0.33 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 60.23 112.54 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -103.42 101.21 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.373 . . . . 72.03 110.908 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 t -171.95 89.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.912 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.92 115.14 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 72.13 111.185 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -80.37 141.08 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 75.15 111.139 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 75.03 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.14 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 74.13 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.45 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.32 110.918 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.52 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 74.54 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.791 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.21 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 73.14 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 74.43 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.126 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.45 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.04 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 73.33 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 74.04 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.45 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.43 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.03 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 72.33 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -64.31 -169.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.32 110.784 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.81 -169.32 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 72.23 110.78 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.15 140.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 71.11 111.153 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.9 68.9 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.487 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.13 152.79 18.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 65.15 111.114 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -80.66 -0.23 37.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.23 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.16 -51.77 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 75.2 111.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.91 0.05 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 72.52 111.218 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.46 -98.85 2.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 61.32 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 66.4 143.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.787 0.327 . . . . 73.5 110.845 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 pp -163.56 24.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.205 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.42 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 75.34 111.188 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.03 111.136 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.24 111.235 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 74.43 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.817 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.31 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.817 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.44 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.44 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.0 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.31 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.4 110.928 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 74.13 110.94 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 74.2 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.11 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.41 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.45 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.22 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.51 112.344 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.94 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 71.13 111.153 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.11 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 72.5 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.31 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.44 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.53 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.13 111.203 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.844 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.45 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.52 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -51.23 169.06 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 74.32 110.916 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.75 -161.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.905 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -46.34 -59.92 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 60.5 110.85 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -47.68 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.89 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.77 -58.37 13.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.817 -0.706 . . . . 54.12 112.502 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -47.7 84.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 71.44 110.929 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -66.31 -11.66 52.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 73.43 110.946 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.42 13.56 25.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 72.23 110.988 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.92 32.84 66.98 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.711 -0.757 . . . . 72.25 112.491 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.1 179.17 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 75.21 110.868 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.43 110.772 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.52 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 64.23 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 75.3 110.962 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.41 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.13 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 74.33 110.9 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 75.22 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.2 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 71.32 111.106 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.53 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.34 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.109 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 50.44 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 71.22 111.146 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.41 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.02 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 75.21 110.976 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.14 111.193 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.44 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.945 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 71.13 110.944 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.1 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.45 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.44 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 72.13 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 75.41 110.945 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 75.15 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.34 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.34 110.809 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 72.14 111.16 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 70.35 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.15 111.125 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 72.22 111.147 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 63.02 111.148 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.32 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.42 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.02 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.45 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.2 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.04 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.3 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.42 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.35 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.04 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 75.23 111.134 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 72.22 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.888 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.466 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.03 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.52 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 75.02 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 73.34 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 74.33 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.54 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 51.01 110.889 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.15 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 71.24 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 71.12 110.948 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 74.51 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.87 0.367 . . . . 75.44 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -174.29 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 63.15 110.749 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 72.14 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 74.22 111.157 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.576 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.24 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 75.5 110.959 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 11' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 72.02 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 73.53 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 33.23 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.23 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 73.2 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.118 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 74.33 111.101 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.24 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.62 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 73.34 112.28 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.1 t -177.14 -172.07 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 54.22 111.155 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.24 52.64 2.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.892 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.1 133.83 2.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 75.33 112.489 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.26 88.01 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 61.53 111.087 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.82 95.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.649 -0.786 . . . . 71.25 112.486 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.82 127.65 9.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.675 -0.774 . . . . 63.23 112.428 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 t 178.45 78.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 74.35 111.064 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.9 19.65 17.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.853 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.82 157.57 26.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 64.14 112.439 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -115.14 -28.49 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 71.55 110.788 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 tp -151.14 39.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.54 110.834 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.12 40.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.762 -0.732 . . . . 64.25 112.46 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.51 -177.64 18.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 71.34 112.423 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -117.11 121.63 41.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 71.41 110.895 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.2 145.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 61.11 110.799 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.53 168.34 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 75.33 111.071 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.428 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t -137.79 134.91 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 65.1 111.218 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.53 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 73.21 111.212 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.1 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.21 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 72.32 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 65.12 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.3 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 75.13 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.178 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.31 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.576 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.43 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 55.13 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.54 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.184 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 70.43 112.56 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 75.12 111.158 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.05 110.889 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.917 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.44 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' N ' ' HG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 65.24 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.455 ' CB ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 74.54 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 73.43 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -160.05 146.32 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.869 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt -143.37 -175.92 4.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.901 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 mp -140.23 164.42 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.271 -0.422 . . . . 73.32 111.166 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.18 136.36 8.95 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.691 -0.766 . . . . 72.32 112.405 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.1 p -145.87 149.55 34.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 75.42 111.127 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.85 156.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 72.25 110.794 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.47 -17.58 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 72.54 111.014 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.96 -33.38 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 74.15 111.075 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.68 101.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 62.54 112.519 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.97 -58.44 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.51 110.966 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -105.43 -164.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 74.53 111.172 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.9 168.09 20.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 72.51 111.187 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.12 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' CG2' ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.33 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' H ' ' CG2' ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 74.31 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.14 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 73.34 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.44 112.443 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 70.25 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.2 111.06 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 75.2 110.852 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.3 111.125 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.954 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.32 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.34 110.872 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 74.15 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 74.24 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.35 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.43 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.44 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.51 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.32 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.42 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.34 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.122 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.32 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.11 112.522 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 73.33 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.21 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 64.44 111.107 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 73.21 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.924 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 2.2 t30 -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.23 110.806 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.23 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 62.42 156.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.43 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.34 -167.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 75.31 110.923 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -61.29 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 74.03 110.882 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -79.11 -45.18 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.874 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.75 -57.69 18.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 71.42 112.567 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -60.97 -46.72 89.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.698 0.285 . . . . 74.12 110.863 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.11 -14.57 62.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.15 6.73 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 54.33 111.13 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.4 31.2 27.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.646 -0.787 . . . . 71.4 112.505 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 mp -115.5 169.38 9.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 74.34 110.93 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.773 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.854 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.924 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 72.42 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.31 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.01 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 72.12 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 60.31 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.21 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.23 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 55.4 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.122 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.02 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 75.24 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 71.25 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 75.51 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 74.31 111.213 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 72.35 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.959 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 74.14 111.135 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.925 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 55.52 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.53 110.885 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 75.31 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 61.51 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.24 111.12 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 70.13 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.04 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 73.32 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 72.21 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.55 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.43 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 73.53 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.54 112.487 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 64.12 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.55 110.904 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.51 110.9 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 52.01 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.1 111.227 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.33 110.933 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.33 112.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.32 111.113 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.41 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 63.42 111.1 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.03 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.42 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 75.04 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 74.44 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.834 0.35 . . . . 74.34 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -75.76 88.46 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 75.41 110.889 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 64.12 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.161 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.04 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.52 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.24 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 45' ' ' THR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 70.31 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 72.11 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.21 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 71.31 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.05 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.45 111.081 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.3 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -19.31 36.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 64.24 112.318 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 t -101.51 117.16 34.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.142 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -127.05 26.56 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.21 110.846 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.84 93.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 72.4 112.584 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.54 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 73.33 111.181 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.76 -108.56 0.52 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 20.13 112.495 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.13 4.7 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.851 -0.69 . . . . 73.4 112.52 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -152.28 -60.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 53.33 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.03 26.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.952 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.32 -148.65 5.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.486 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.82 -35.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 73.55 110.853 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -51.95 166.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.849 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.09 43.52 2.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 74.32 112.466 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.51 129.69 5.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.785 -0.722 . . . . 64.33 112.509 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -138.39 102.04 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 74.41 110.926 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -167.69 161.91 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.32 110.867 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.52 106.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 75.44 111.149 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.62 130.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.161 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.13 110.871 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.43 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.55 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.137 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.32 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.761 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.4 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 75.1 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.33 111.083 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.194 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 75.25 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' THR . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.53 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.13 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.945 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.01 111.071 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 73.34 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 72.21 111.151 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 73.5 112.319 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 72.21 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -61.0 127.53 32.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.51 110.825 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -169.77 65.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.82 140.94 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.3 111.112 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.22 102.09 0.9 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.793 -0.717 . . . . 43.24 112.475 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.0 t -160.63 151.32 18.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 70.33 111.192 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 155.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 73.14 110.867 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.95 -22.39 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 65.24 111.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.5 p -82.51 -33.48 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 71.34 111.156 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.22 -74.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 60.21 112.471 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 t70 178.64 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 72.32 110.934 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 mp 62.33 53.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 74.24 111.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.64 163.84 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.44 111.097 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.119 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 62.43 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.05 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.43 110.905 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.23 112.38 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.11 112.399 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.55 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.459 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 64.24 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.31 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.23 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.45 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.3 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.12 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 74.45 112.304 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.45 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.21 111.023 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.13 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.24 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.44 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.15 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 72.52 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.44 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.44 111.133 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 72.35 110.879 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 75.3 110.859 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.03 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.42 110.911 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.3 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -51.46 130.19 26.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.15 110.85 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.46 -161.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.934 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 64.1 110.83 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -79.11 -46.95 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.42 110.9 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.62 -58.16 15.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 52.11 112.548 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.56 -48.16 82.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.767 0.318 . . . . 74.42 110.956 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.35 -9.98 46.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.84 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.66 -6.84 45.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.35 111.07 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.34 3.23 31.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.686 -0.768 . . . . 65.21 112.5 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp -80.24 122.4 26.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.806 0.336 . . . . 71.51 110.95 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.01 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.1 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 74.01 110.876 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 74.15 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 73.1 110.922 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 74.45 110.894 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.809 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.43 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.15 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.03 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.05 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 71.54 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.51 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 73.12 111.13 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 63.41 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 70.1 111.151 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.52 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 75.01 111.042 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.43 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.03 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.52 110.917 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.13 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 74.12 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.24 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.41 110.957 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.53 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 63.41 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 72.25 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.41 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 72.04 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.33 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.51 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.1 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 74.51 110.891 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.25 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 52.24 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.03 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.11 111.048 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 72.11 110.873 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.24 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.14 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.33 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.51 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.52 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.13 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.41 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 74.43 111.177 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.41 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.34 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 54.21 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 73.22 111.217 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 62.01 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.51 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.34 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.32 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.764 0.316 . . . . 73.31 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -176.8 61.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.781 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 72.34 111.09 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 73.53 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.22 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.14 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 72.15 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.01 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.24 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.11 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 64.15 111.117 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 75.34 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 169.33 19.08 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.41 112.315 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.35 -54.62 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 -64.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 71.25 110.866 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.5 138.02 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.664 -0.779 . . . . 61.41 112.468 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.47 -75.73 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.313 . . . . 74.4 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.02 -97.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 63.13 112.486 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.2 -159.39 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.466 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.8 p -117.03 27.5 9.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.33 . . . . 70.23 111.16 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.93 24.51 14.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 72.31 110.896 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.19 119.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 62.52 112.408 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -179.41 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 75.3 110.839 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -141.16 -176.36 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 73.01 110.903 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.59 44.18 7.46 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.696 -0.764 . . . . 75.31 112.47 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.28 118.78 7.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.77 . . . . 73.01 112.496 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -88.89 165.18 14.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 72.54 110.905 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.13 97.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.907 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.01 145.92 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.1 111.155 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p -79.77 118.63 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.142 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.44 111.178 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.2 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.01 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.43 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 71.44 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.857 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.51 111.115 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 71.35 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.04 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.0 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.23 111.043 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 74.12 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.52 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.02 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 74.41 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.891 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 71.05 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.22 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 74.53 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.34 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.23 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 71.55 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -107.26 75.48 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.03 110.953 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -151.25 165.01 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 73.4 110.824 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.3 tt -154.65 105.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.4 111.169 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.24 69.47 0.67 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.683 -0.77 . . . . 63.5 112.39 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -160.56 157.55 27.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.77 0.319 . . . . 74.53 111.256 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.83 157.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.862 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -14.75 24.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.083 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.8 p -82.14 -31.22 30.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 75.13 111.126 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.65 -91.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 64.24 112.39 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.86 36.05 2.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.72 0.295 . . . . 73.41 110.85 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.6 -165.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.34 111.142 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -133.81 163.24 29.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.096 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.13 111.099 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.12 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 60.3 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 70.53 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.02 112.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 72.13 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 72.22 110.911 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.3 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.975 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.2 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 75.34 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 73.25 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.12 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.43 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 75.22 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 74.11 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 70.5 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 75.12 110.904 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 72.3 112.316 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 73.04 111.091 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.14 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 71.14 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.32 112.474 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.42 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.882 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 73.51 111.05 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.162 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 72.01 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.24 112.591 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.87 121.92 26.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.33 110.811 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -172.11 -152.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 62.35 110.865 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -46.08 -57.83 4.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 55.24 110.901 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -48.35 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 74.04 110.767 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.26 -59.13 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 54.44 112.462 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -48.96 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 73.33 110.857 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -11.3 57.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 72.3 110.881 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.55 -1.96 57.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 63.25 111.077 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.45 55.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.33 112.522 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.55 102.85 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 73.44 110.949 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.55 110.906 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.33 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.22 110.921 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.05 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.14 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.11 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.34 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.04 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.33 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.2 111.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.729 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.855 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 71.31 110.862 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 73.44 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.45 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.42 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 74.22 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 74.52 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 71.12 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.871 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.44 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 73.15 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 71.14 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.13 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.03 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.42 111.062 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.2 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.11 111.088 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.43 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.933 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 75.45 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.55 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 73.4 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.13 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.52 110.883 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 55.41 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 71.31 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.35 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.2 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.32 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 75.53 111.095 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.25 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.067 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.24 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.12 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 71.2 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 75.43 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.31 25.53 12.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.845 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 70.14 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 62.01 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.419 ' HA ' ' N ' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.32 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 75.32 111.108 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 71.44 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 75.4 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.21 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 73.44 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.02 111.174 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.42 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -25.06 29.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.35 112.342 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m 61.47 74.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.23 111.176 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.83 134.39 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.856 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.86 22.69 52.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.808 -0.711 . . . . 73.05 112.518 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.64 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 71.21 111.061 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.09 27.99 6.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 64.3 112.498 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.03 -97.56 1.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.78 -0.724 . . . . 64.14 112.523 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 t -114.39 25.64 10.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.86 0.362 . . . . 75.45 111.174 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 mt -139.43 71.79 1.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 74.25 110.887 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.53 -37.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 64.53 112.403 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 t -95.93 50.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 72.0 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.6 mt -143.11 -62.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 110.829 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -18.13 49.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.75 . . . . 71.13 112.467 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.45 117.39 4.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 72.13 112.486 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.92 123.96 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 74.43 110.787 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 t -170.84 98.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 74.3 110.859 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.6 p -160.25 143.66 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 72.12 111.129 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 p -80.23 121.31 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.21 111.147 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.21 110.836 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.43 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.21 111.1 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.44 110.92 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 72.43 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.04 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 75.32 110.809 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.35 111.124 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.44 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.14 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.864 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.5 111.095 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.43 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.34 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 65.04 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.02 110.928 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 53.3 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.34 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.34 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.3 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.45 110.836 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.06 145.62 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.54 110.863 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -179.22 126.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.898 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.7 tt -118.3 143.5 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 64.2 111.178 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.52 48.82 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 74.22 112.541 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -148.21 148.74 30.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 74.42 111.143 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 62.15 157.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.929 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.16 24.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 72.33 111.092 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.2 t -86.08 -32.05 21.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 74.02 111.237 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.8 -101.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 72.22 112.432 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.81 -75.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 74.21 110.811 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 pt -153.97 138.35 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.23 111.123 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.37 117.5 31.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.33 111.126 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 74.42 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.096 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.45 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 70.04 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.816 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.33 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.816 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.54 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.176 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.42 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.947 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.52 110.889 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.41 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 75.2 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 75.5 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 72.44 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 64.44 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.03 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.22 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 75.44 110.856 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.3 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 73.42 111.102 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.02 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.13 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.31 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 64.23 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.35 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 73.31 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 74.41 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.05 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.42 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 63.45 149.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.3 110.839 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.8 OUTLIER -161.75 -164.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.55 110.872 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.53 -60.99 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 62.13 110.907 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -45.56 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 72.35 110.859 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.96 16.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.759 . . . . 74.25 112.502 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 116' ' ' ASN . 12.1 tmtt? -60.53 -47.02 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.289 . . . . 74.53 110.846 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.22 -13.61 60.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.421 . . . . 74.43 110.861 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.71 9.95 20.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 75.23 111.089 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.52 31.34 43.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.607 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.54 -172.99 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 70.55 110.918 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 71.2 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 73.11 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 64.13 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.2 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.34 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.24 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.42 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 73.25 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 75.32 111.122 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.02 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.33 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.138 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.21 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.3 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.994 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.32 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 42.02 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.875 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.33 111.141 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 61.03 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.42 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.3 111.028 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.03 110.9 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 64.13 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 75.4 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.12 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 74.15 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 74.3 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.031 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.4 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 73.13 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 63.15 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.32 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.35 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 70.31 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 64.51 111.212 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.23 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.949 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.24 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.55 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 72.2 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.53 111.217 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 65.02 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.085 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 62.53 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.24 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.521 ' CB ' ' O ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.11 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 73.35 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.839 0.352 . . . . 65.4 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -175.48 77.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 72.41 110.803 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.21 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 73.13 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 73.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.34 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.837 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 74.43 111.089 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.4 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 71.42 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 54.32 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.551 ' O ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 72.43 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.34 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 114.4 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.52 112.247 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.9 t -51.71 119.83 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 74.33 111.151 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -117.89 162.83 17.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 75.2 110.859 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.15 84.3 0.12 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.688 -0.768 . . . . 74.43 112.464 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.7 -36.87 48.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 74.41 111.113 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.32 -54.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.485 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.23 -41.43 1.5 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.687 -0.768 . . . . 71.51 112.534 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -115.36 -27.14 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 64.13 111.127 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.45 68.89 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.855 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.01 107.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.688 . . . . 75.3 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.86 -170.16 2.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 74.22 110.841 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.5 177.94 5.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.95 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.33 43.49 0.91 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 62.04 112.459 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.77 -20.42 24.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 63.03 112.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.94 117.68 23.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 74.23 111.0 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.2 t -169.24 83.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.825 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 m -77.16 139.41 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.34 111.219 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 130.93 35.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 75.45 111.102 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 71.13 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.93 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 74.5 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.01 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 63.32 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 74.45 110.942 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.15 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.45 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 73.43 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 70.22 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.11 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.098 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 73.23 111.21 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.12 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 75.12 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.44 112.468 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.24 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.783 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.42 111.124 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.45 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 73.14 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.2 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 158.99 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 54.24 110.834 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -179.14 106.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 75.33 110.862 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 15.4 tt -152.69 145.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 73.43 111.123 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.9 96.83 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 64.25 112.457 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.4 p -61.78 171.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 72.32 111.088 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -16.97 52.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 75.05 110.799 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.04 -50.96 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 72.31 111.154 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 -32.68 13.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 74.32 111.168 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 53.93 42.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 44.0 112.449 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.41 -73.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 72.25 110.856 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm 65.0 56.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.087 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -115.09 147.02 40.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 73.05 111.09 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.52 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.31 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.42 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.826 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 65.23 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.43 111.243 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 74.11 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.016 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 44.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 74.13 110.935 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.21 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.45 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 75.44 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.24 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 55.1 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 72.12 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 75.22 110.984 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.24 112.283 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.93 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 74.44 111.139 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.35 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 72.04 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.01 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 73.15 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 73.3 110.881 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.194 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.078 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 65.41 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.21 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.45 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 74.31 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -50.58 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 120' ' ' LYS . 10.9 t30 -174.12 -168.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.894 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -47.85 -61.54 1.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.905 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.62 -48.07 14.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 72.43 110.83 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.8 -56.73 21.23 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.688 -0.768 . . . . 75.44 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -61.49 -48.34 81.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.627 0.251 . . . . 73.52 110.813 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.77 -8.04 32.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.913 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.27 -4.94 47.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.141 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.75 -0.25 32.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 65.04 112.425 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -86.8 93.35 9.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 72.51 110.967 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 71.03 110.846 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.4 111.019 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.21 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 75.05 110.873 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.821 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.14 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 73.23 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 70.33 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.52 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.31 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 62.35 111.124 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.04 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.24 111.113 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.33 110.927 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.12 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 72.54 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.54 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.53 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 75.53 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.032 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.1 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 70.31 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 75.31 111.073 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.35 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.24 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.1 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 75.53 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.33 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.14 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 64.1 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 72.44 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 75.22 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 64.42 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.11 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.41 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 65.43 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.34 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.51 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.45 110.831 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.454 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 72.44 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . 0.63 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.41 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 182' ' ' TRP . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.02 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.533 ' H ' HG21 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.15 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 65.33 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.35 111.039 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 63.33 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.1 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 74.25 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.55 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.735 0.303 . . . . 65.33 110.924 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.93 52.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.877 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.44 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.31 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 75.35 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.692 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 73.15 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.167 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.15 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.24 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.12 111.117 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 71.35 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.23 111.105 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.31 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -171.16 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.31 112.364 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -54.75 -28.5 49.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 73.25 111.017 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 62.88 164.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.013 0.435 . . . . 74.2 110.836 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 54.14 112.435 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.83 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 71.5 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.71 105.9 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 61.04 112.487 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.62 169.03 30.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.734 -0.746 . . . . 61.24 112.496 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.63 -25.43 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 62.41 111.108 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.37 -73.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 72.43 110.926 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.01 177.52 39.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.698 . . . . 65.24 112.518 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 160.65 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 73.23 110.943 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -144.31 -169.48 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 75.1 110.859 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.11 43.14 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.723 . . . . 75.3 112.562 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.03 -177.84 15.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 74.52 112.409 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -113.01 115.46 28.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 70.01 110.879 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 p -172.16 129.76 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 61.32 110.802 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.0 m -109.98 106.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 73.1 111.074 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.9 99.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 64.45 111.132 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.13 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.31 111.045 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 75.53 110.878 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.692 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.01 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 74.32 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 65.41 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.32 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 72.02 111.139 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.877 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.35 110.813 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.43 111.256 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 55.42 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 74.03 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.12 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.944 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.185 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.41 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.42 112.41 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.946 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -64.53 -170.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.898 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -147.21 124.2 11.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.929 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.28 136.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 75.24 111.141 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.9 63.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.604 -0.808 . . . . 74.1 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -160.32 151.37 19.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.727 0.299 . . . . 75.11 111.184 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -2.95 38.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 74.31 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.92 -51.56 9.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.451 . . . . 71.11 111.141 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.66 17.66 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 71.01 111.2 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.98 100.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.7 -0.762 . . . . 72.4 112.55 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.99 -36.4 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 74.2 110.79 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.8 mt 64.37 97.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.175 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.89 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 74.24 111.006 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.12 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.12 111.142 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.885 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.419 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 74.02 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.51 112.313 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.51 112.3 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.52 111.076 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.3 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.781 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 72.42 111.147 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.428 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.2 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.54 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 73.44 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 55.13 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 65.42 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 73.03 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.31 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.954 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 73.41 110.906 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 100' ' ' TYR . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.42 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.475 ' HA ' ' C ' ' A' ' 140' ' ' GLY . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 88' ' ' TRP . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.21 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 74.22 111.113 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.34 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 72.05 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.923 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 72.41 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 71.21 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 70.53 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.51 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.03 110.797 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 61.25 112.457 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -49.25 152.73 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 75.03 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -166.37 -158.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.859 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -46.47 -59.16 3.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.906 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -78.32 -47.3 18.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.921 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.81 -59.6 10.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 75.22 112.469 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.94 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.67 0.271 . . . . 72.01 110.859 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.46 -11.02 56.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 75.32 110.797 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.35 -6.97 36.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 74.51 111.126 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.67 18.8 43.17 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.403 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.86 130.78 36.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.749 0.309 . . . . 73.33 110.997 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.03 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 73.25 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.53 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.23 110.952 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.896 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 63.12 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.41 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.23 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 71.21 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 75.1 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.13 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.04 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' C ' ' HA ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 74.33 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.653 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.2 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.574 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.42 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.922 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.54 110.923 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.07 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 73.33 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.01 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.84 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.918 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.42 111.24 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.653 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 60.54 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.15 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.33 111.117 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.85 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.867 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.838 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 73.12 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.53 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 64.52 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 74.31 110.835 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.02 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 63.21 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 74.14 111.106 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.32 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.45 110.818 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.32 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 73.21 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.468 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.31 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.31 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.21 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.41 111.165 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 71.24 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.31 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.54 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 73.11 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.33 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.872 0.367 . . . . 73.22 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -159.34 140.31 12.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.774 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.592 ' C ' ' O ' ' A' ' 3' ' ' GLU . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.461 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.42 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.44 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 70.44 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 72.34 110.847 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 74.44 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.14 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 65.43 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.04 111.134 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 72.43 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 63.43 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 64.2 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 152.7 69.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.31 112.344 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -175.51 173.39 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 72.24 111.105 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.93 166.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.23 110.92 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.13 41.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 75.11 112.46 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.09 76.58 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.384 . . . . 73.21 111.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.75 -37.78 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 72.12 112.547 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.36 178.49 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 61.44 112.473 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.8 m -132.39 -43.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 74.24 111.145 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.11 108.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.22 110.876 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.97 176.08 19.49 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.699 -0.762 . . . . 51.13 112.436 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -53.85 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 73.34 110.907 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.8 -171.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 72.24 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 -17.74 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 63.43 112.458 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 146.46 4.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 63.11 112.503 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 165.29 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 75.21 110.888 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -71.49 -171.41 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.95 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.98 154.39 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.13 111.202 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.2 25.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.24 111.116 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 71.3 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 74.35 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.41 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.4 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.53 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.1 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.21 111.061 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 71.13 111.122 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.2 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.504 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 75.5 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.13 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 71.33 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.43 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.983 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.54 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.21 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 73.1 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 54.53 110.822 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.969 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 75.01 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.12 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.41 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 72.3 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.32 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -60.26 128.91 39.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.945 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -169.18 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 74.34 110.851 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.36 163.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.109 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.29 169.78 31.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.699 -0.762 . . . . 71.45 112.442 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 t -72.4 162.75 29.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 52.43 111.167 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -11.63 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.825 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.49 -51.07 71.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 71.14 111.167 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -121.45 -32.74 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 75.0 111.204 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.67 22.4 14.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.876 -0.678 . . . . 72.32 112.496 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -177.2 132.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 75.24 110.859 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -123.24 -35.21 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 73.41 111.081 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.95 130.15 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 70.52 111.141 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 71.31 111.107 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.55 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.2 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 73.31 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.829 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 70.32 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 74.42 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.471 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.41 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.9 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.3 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 74.12 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.23 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.21 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 74.53 110.899 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.11 112.346 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 65.03 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.03 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 72.31 112.549 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 72.42 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.01 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 71.42 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 73.23 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.43 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.13 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.41 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.43 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.24 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 61.6 t80 59.56 98.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.22 110.948 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -163.42 -159.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.878 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.86 -60.33 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 64.44 110.805 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -79.42 -45.87 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.76 -58.26 14.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.731 -0.747 . . . . 71.44 112.437 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -47.36 86.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.3 110.913 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.19 -10.4 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 73.5 110.975 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.6 -6.84 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 64.43 111.188 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.09 18.86 30.22 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.761 -0.733 . . . . 52.14 112.492 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.92 134.68 36.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 73.22 110.94 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.35 110.882 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.966 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 65.24 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.23 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.14 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.44 111.011 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.11 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.52 111.02 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 72.1 111.127 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.615 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.43 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.04 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 75.13 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.15 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 71.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 74.3 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.04 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 63.52 110.982 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 72.41 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.601 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 74.5 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.22 110.822 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.22 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 71.25 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.956 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 62.22 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.852 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 70.44 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.35 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.45 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 70.14 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.41 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 74.32 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.55 110.996 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.12 110.84 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.34 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 75.03 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.53 111.017 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.1 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.4 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.974 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.54 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.35 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.136 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.23 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.042 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 72.11 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 72.51 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.41 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.42 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 74.31 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -85.79 55.28 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.871 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 73.44 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.31 111.128 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.21 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.24 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 71.43 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.15 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 73.32 110.855 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.55 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.22 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.32 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.31 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.41 111.119 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.41 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -170.69 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.31 112.405 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.52 -171.54 2.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 64.51 111.082 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -51.76 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 71.43 110.902 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.27 132.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 63.33 112.531 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.306 . . . . 71.4 111.076 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -94.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.711 -0.757 . . . . 71.15 112.499 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.01 -150.57 13.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.808 -0.71 . . . . 74.44 112.544 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.46 -74.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 70.13 111.163 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.44 -69.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 71.15 110.937 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.29 19.59 48.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 70.3 112.443 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.11 155.5 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 72.22 110.855 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.74 -177.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.91 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.47 41.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.644 -0.788 . . . . 64.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.44 143.1 33.64 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.733 -0.746 . . . . 74.34 112.426 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -50.7 165.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 71.51 110.889 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.27 165.63 23.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.15 110.799 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.57 -178.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.24 111.112 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t 175.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.184 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.908 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.23 110.941 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.02 111.226 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.32 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.54 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 75.1 110.943 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 74.3 111.076 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.749 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.572 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 71.04 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.45 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 75.42 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.126 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.31 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.931 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.12 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.059 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.11 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.24 112.455 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.965 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 65.12 110.92 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -149.92 94.91 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.849 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.64 45.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 64.14 110.811 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.1 mm -135.05 133.72 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.189 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.31 -138.79 5.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 44.24 112.541 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -179.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 74.2 111.205 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -51.32 -97.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 64.24 110.847 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.13 -12.09 57.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.25 111.076 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.431 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -82.69 -36.05 26.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 73.03 111.139 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 33.7 83.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.736 -0.745 . . . . 74.03 112.465 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.81 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 73.14 110.705 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt 171.71 113.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 72.23 111.088 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.88 106.62 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 70.31 111.104 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.23 111.085 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 72.35 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 72.31 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.14 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 75.14 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.817 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.31 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.817 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 63.15 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 75.13 111.084 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.41 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.4 111.131 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.55 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 64.01 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.44 111.032 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.14 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 71.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.31 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 74.24 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.33 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 73.24 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 65.11 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 72.4 111.111 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 71.33 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.22 111.105 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.21 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.41 111.07 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.15 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 74.53 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.33 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.15 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -53.77 168.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 72.12 110.799 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -162.54 -160.56 0.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 74.24 110.905 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -60.22 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 75.51 110.871 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -79.36 -46.48 17.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 70.21 110.897 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.34 -58.32 14.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.754 . . . . 71.33 112.435 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -60.21 -47.36 86.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.6 0.238 . . . . 75.14 110.874 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.75 -11.11 53.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.873 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.09 10.67 28.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 75.21 111.171 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.25 34.08 88.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.691 -0.766 . . . . 65.23 112.502 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -90.94 80.75 5.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 53.33 110.968 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 73.31 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.811 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 70.21 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.34 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.12 112.504 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 72.41 111.053 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.12 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.55 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 74.31 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 72.41 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 73.42 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.42 110.933 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 72.51 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.41 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 62.33 110.909 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.44 111.083 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 64.12 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 72.52 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.01 111.145 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.4 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.41 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 62.5 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 75.41 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.11 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.11 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.55 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.54 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.22 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 74.21 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 73.34 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 73.34 111.162 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.936 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.45 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.54 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 74.23 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 74.52 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 73.11 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 72.42 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.8 0.333 . . . . 53.03 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -82.25 68.33 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.33 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 53.24 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.4 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.924 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.45 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 50.53 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.21 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.41 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.35 111.116 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.112 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 74.33 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -17.23 37.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.45 112.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.4 p -58.19 108.08 0.56 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.104 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.05 -170.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 72.33 110.865 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.9 -73.69 1.26 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.728 -0.748 . . . . 73.31 112.364 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.63 106.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 74.4 111.074 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.97 -28.06 7.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.52 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.68 154.98 11.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 64.44 112.483 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.5 t -55.41 -32.04 62.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 54.52 111.131 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 59.72 98.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.977 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.84 -116.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.79 . . . . 44.24 112.486 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 -39.2 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 71.33 110.82 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.06 152.5 23.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.979 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.91 24.25 5.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 72.15 112.523 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.15 107.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 63.44 112.552 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -108.7 154.25 22.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 75.45 110.898 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 m -154.12 114.08 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.894 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.2 176.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 74.12 111.208 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.82 139.75 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.5 111.13 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 71.02 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.43 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 72.25 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 73.3 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.33 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 72.14 111.058 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 72.31 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.44 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 65.51 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.2 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.02 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.826 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.44 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.41 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 73.42 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.41 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.44 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -160.0 161.94 34.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.44 110.842 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -151.56 112.79 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.902 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.91 106.09 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 71.12 111.192 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.41 42.63 1.35 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.788 -0.72 . . . . 74.1 112.574 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 -178.33 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 73.54 111.23 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.6 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 72.43 110.821 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.71 -8.63 59.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 71.0 111.071 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.94 -5.36 30.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.35 111.111 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.97 71.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.785 -0.722 . . . . 74.43 112.513 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.63 -12.9 18.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 74.03 110.856 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 64.43 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 75.3 111.064 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.62 163.48 18.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 72.51 111.14 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 73.14 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 70.14 111.128 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.42 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 72.33 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.824 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.42 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.824 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 72.14 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.31 111.085 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.3 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.01 111.079 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 72.11 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 73.31 110.89 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 55.04 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 64.03 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.05 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.43 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 73.43 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 75.53 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.35 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.21 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.02 111.059 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.51 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 73.41 111.073 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 71.31 112.442 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 75.11 111.12 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 74.32 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.782 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.35 111.093 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.12 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 71.45 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.35 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 74.1 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.27 124.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 74.44 110.786 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.11 -161.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 65.14 110.826 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.54 -60.1 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.876 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -78.44 -46.48 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 74.05 110.755 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -57.79 16.72 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.743 -0.741 . . . . 72.01 112.437 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -47.52 85.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 74.23 110.852 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -67.42 -11.11 56.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.44 111.0 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.04 13.35 29.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 75.34 111.204 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.26 28.58 19.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 64.34 112.545 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -144.74 -175.98 4.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 74.4 110.882 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.83 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.35 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.897 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 73.0 110.884 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 72.34 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.782 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.488 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.03 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.45 112.625 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.52 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 73.4 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 73.3 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 74.33 110.943 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.152 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.32 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.1 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.33 110.938 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.11 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.44 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 75.23 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 73.32 111.009 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.43 111.049 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.13 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 64.14 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 71.52 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.02 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.3 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 75.44 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 65.1 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.3 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.43 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.44 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.41 111.236 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.099 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.923 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.966 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.53 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.15 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.01 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.31 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.25 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.11 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.11 110.898 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.04 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.235 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.53 110.859 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.33 110.8 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 74.44 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 73.51 111.231 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.11 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.42 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 62.01 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.51 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.767 0.317 . . . . 74.41 110.844 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -174.99 91.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.849 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 70.51 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.3 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.54 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.865 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.52 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.55 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.44 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 60.12 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.21 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.087 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 133.58 25.91 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 73.31 112.306 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.2 p -128.77 -173.0 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 73.35 111.113 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 139.14 26.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 73.05 110.882 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.54 109.69 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.486 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.17 106.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 71.43 111.162 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.41 -110.34 1.3 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.742 -0.742 . . . . 63.54 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.55 171.91 55.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 72.23 112.425 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -105.69 -31.66 8.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 72.34 111.169 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 52.11 88.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.859 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 39.55 2.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 50.11 112.457 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.28 -73.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 72.34 110.793 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 pp -174.34 172.08 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 75.51 110.934 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.67 43.68 35.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.755 -0.736 . . . . 70.24 112.487 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.58 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 44.24 112.572 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.64 160.26 40.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 74.24 110.9 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -111.95 -171.57 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 64.12 110.821 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.11 163.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -80.26 123.38 27.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 74.5 111.086 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.31 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 72.52 110.895 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 75.44 111.188 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.793 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 73.35 111.147 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.21 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.2 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 73.53 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 73.13 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 75.01 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.4 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.854 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 65.25 111.03 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.53 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 73.11 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.23 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.85 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -160.1 156.91 27.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.861 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -179.99 84.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.92 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.4 mm -129.17 151.39 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 74.32 111.178 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.57 96.28 0.38 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.762 -0.733 . . . . 72.04 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.02 151.53 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 73.34 111.132 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.27 159.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.32 6.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.01 111.077 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -33.3 31.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 74.02 111.155 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.87 90.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.529 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.76 173.47 10.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 74.24 110.837 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.55 -171.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 73.52 111.096 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.4 19.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 74.32 111.112 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.31 111.063 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.151 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.32 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' C ' ' CD ' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.828 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.32 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.828 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.42 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 75.34 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.31 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.675 ' CB ' ' HA2' ' A' ' 102' ' ' GLY . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.23 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 70.34 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.55 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.23 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 62.14 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.24 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 63.31 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 74.21 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.22 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 73.23 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.22 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 86' ' ' ALA . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.42 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.23 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 74.01 111.12 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.13 110.799 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 74.02 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 73.13 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.01 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 74.32 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 74.11 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 74.42 110.812 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 74.42 110.853 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.52 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 29.8 p90 -47.46 105.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.31 110.906 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -179.09 -148.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 73.43 110.866 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -45.68 -57.09 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.802 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -79.36 -48.81 13.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.801 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.33 -59.52 10.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 73.45 112.431 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -46.61 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 74.4 110.837 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.45 -15.4 63.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.917 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.82 -5.17 58.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 73.43 111.123 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 124' ' ' LEU . . . 115.56 -25.12 9.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.797 -0.716 . . . . 74.14 112.485 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER 164.99 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 63.53 110.825 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.31 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 63.3 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 126' ' ' ASP . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.22 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.13 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 73.05 111.019 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.12 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.445 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 74.53 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.1 111.123 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.41 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 73.51 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.15 111.011 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.42 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.642 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.498 ' N ' HD21 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.42 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 74.44 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 75.31 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.33 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.795 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.24 111.121 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.41 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 64.53 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 70.51 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.52 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.41 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 74.34 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 64.13 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.235 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.23 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.2 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 75.21 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.932 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.05 112.529 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 70.42 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 64.33 111.017 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.24 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.11 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.4 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.904 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.903 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 75.11 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.23 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 70.45 111.172 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.4 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.093 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 71.2 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.14 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 75.15 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.754 0.312 . . . . 62.11 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.15 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 61.45 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.52 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 32.35 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.24 110.859 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 187' ' ' SER . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.121 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 54.34 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 62.24 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 38' ' ' THR . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.22 111.092 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.79 HG22 ' HD3' ' A' ' 18' ' ' PRO . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.43 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 72.45 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.22 112.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.821 0.343 . . . . 72.14 111.062 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB2' HG13 ' A' ' 16' ' ' VAL . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.934 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 64.3 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' ALA . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 52.13 111.182 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.45 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 55.01 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 72.34 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.544 HG21 ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.04 111.12 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 10' ' ' ARG . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.15 111.161 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.21 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 71.33 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 54.44 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.41 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.6 HD12 ' CE3' ' A' ' 88' ' ' TRP . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.157 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 42.43 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 35.15 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' HG21 ' A' ' 43' ' ' THR . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.15 110.833 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 71.21 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 53.34 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 64.43 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 52.21 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.03 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.52 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.786 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.822 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.907 0.384 . . . . 61.52 111.066 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.553 HG23 ' OD2' ' A' ' 112' ' ' ASP . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 64.53 111.09 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 71.12 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.856 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.33 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.31 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.44 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 52.32 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.14 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 51.41 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 52' ' ' ILE . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 71.24 110.941 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.4 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.21 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 64.2 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 50.53 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.42 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.43 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.52 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.13 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 139' ' ' VAL . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.127 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 34.42 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.1 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 42.23 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.33 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.21 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.31 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 73.11 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 77' ' ' VAL . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 71.52 110.911 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 71.34 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.822 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.42 112.56 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 72.53 110.901 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 167' ' ' LYS . 44.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.9 0.381 . . . . 73.33 110.842 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.21 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.21 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.47 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 62.21 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 63.44 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.43 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 55.32 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.43 111.157 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.03 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.32 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 101' ' ' VAL . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 53.21 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.11 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.21 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.692 ' HA ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.99 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.45 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.22 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 61.45 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 74.2 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.01 110.938 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.32 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.33 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 65.23 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 63.11 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.21 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.21 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.819 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 70.34 111.133 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 160' ' ' ILE . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 42.43 110.818 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.44 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 175' ' ' ASP . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.1 111.176 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.47 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 71.23 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.715 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.886 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.81 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.33 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.11 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.81 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 23.3 111.076 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.25 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.2 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 164' ' ' ALA . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.04 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.43 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 55.22 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.701 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.959 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 178' ' ' ARG . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.24 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.34 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.41 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.815 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 44.51 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 63.15 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.607 0.241 . . . . 75.12 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.33 111.052 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 62.54 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.34 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.41 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 60.42 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.44 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.04 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.12 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 38' ' ' THR . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.15 111.065 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 183' ' ' VAL . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 32.54 111.187 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 73.2 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 64.14 112.371 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.844 0.354 . . . . 71.02 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 54.24 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 14' ' ' ALA . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 62.43 111.096 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.44 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.15 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 63.42 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 71.31 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 57' ' ' LEU . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.211 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 55' ' ' GLU . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.4 111.095 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 72.12 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 71.01 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.12 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.22 111.211 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 63.15 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 53.42 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.11 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 45' ' ' THR . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.841 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.53 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.929 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.54 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 34.31 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.44 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.54 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 71.24 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.862 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.853 0.359 . . . . 60.32 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.44 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' OG ' ' A' ' 128' ' ' SER . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 62.51 111.122 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.43 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.866 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.924 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.22 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.924 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.05 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 41.33 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 107' ' ' TYR . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 40.21 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 61.13 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.44 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.14 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.54 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 72.13 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 64.21 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.24 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 63.21 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.13 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.15 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 134' ' ' GLY . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.41 111.233 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 65.31 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 84' ' ' LEU . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.937 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.45 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 62.44 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 74.12 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.11 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 43.31 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.13 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 32.54 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 74.53 110.879 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.748 0.309 . . . . 73.41 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 61.23 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 77' ' ' VAL . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.854 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 162' ' ' THR . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 64.4 110.939 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 63.44 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 54.3 110.851 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 73.43 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 72.03 112.591 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 51.55 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' A' ' 158' ' ' MET . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.097 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 34.13 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.12 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 62.31 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 51.4 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.42 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.32 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.52 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 64.44 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 62.14 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 189' ' ' GLY . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 62.55 110.844 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 31.54 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 60.33 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.1 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.729 ' HG3' ' HB1' ' A' ' 136' ' ' ALA . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 71.01 110.88 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.03 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 132' ' ' SER . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.32 111.213 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 71.4 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.14 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.548 ' HG2' ' C ' ' A' ' 171' ' ' ALA . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 63.33 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.2 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.548 ' C ' ' HG2' ' A' ' 167' ' ' LYS . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 65.41 111.025 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 62.4 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 62.11 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 62.41 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 73.02 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 65.22 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.43 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 16' ' ' VAL . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 73.1 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 71.53 112.542 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 72.43 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 62.13 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 71.23 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.748 0.309 . . . . 71.43 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 62.42 111.081 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.12 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 54.45 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 45' ' ' THR . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.746 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 64.4 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.54 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 33.12 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.35 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.31 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.45 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.753 HG22 HG12 ' A' ' 183' ' ' VAL . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 71.34 111.161 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.45 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 73.21 112.36 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.78 0.324 . . . . 74.42 111.084 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.02 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 16' ' ' VAL . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.55 110.9 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.33 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 71.51 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.34 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 70.05 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.24 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 8' ' ' PHE . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.22 111.222 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.23 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.55 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' THR . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 73.24 111.071 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.757 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 64.11 111.157 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.44 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.2 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.23 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 64.44 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 72.12 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.3 111.147 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 60' ' ' THR . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.11 112.332 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 70.04 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 71.21 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.814 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.793 0.33 . . . . 63.52 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 70.41 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 112' ' ' ASP . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.01 111.13 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.45 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.22 110.843 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 74.51 110.739 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 45.22 112.385 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 64.05 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 70.43 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 65.23 110.914 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.43 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 71.04 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.493 ' O ' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 72.13 110.89 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 99' ' ' PRO . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' HB2' HG11 ' A' ' 101' ' ' VAL . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.44 110.859 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.34 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.41 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.51 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.54 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.54 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.23 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 144' ' ' LEU . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.41 112.361 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.45 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 60.5 111.076 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.41 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.3 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 133' ' ' TRP . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 70.21 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.973 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.12 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.587 HG22 HD13 ' A' ' 80' ' ' LEU . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.33 111.116 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.21 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 77' ' ' VAL . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.988 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.608 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.983 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 55.53 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.784 ' CE1' HD22 ' A' ' 124' ' ' LEU . 2.5 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.02 110.821 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.784 HD22 ' CE1' ' A' ' 115' ' ' PHE . 4.4 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 61.14 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 70.12 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 54.41 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.608 HD13 ' O ' ' A' ' 113' ' ' ASN . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.919 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 71.04 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.489 ' CD1' HD12 ' A' ' 127' ' ' LEU . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.11 110.824 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 62.24 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.541 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 62.25 110.792 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' HB2' HD11 ' A' ' 105' ' ' ILE . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.32 110.962 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 160' ' ' ILE . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.23 112.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 62.3 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 63.11 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 31.44 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.31 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 54.41 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.2 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 100' ' ' TYR . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 54.2 111.195 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.01 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.529 ' HA ' HD23 ' A' ' 150' ' ' LEU . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.15 110.971 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 62.35 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.03 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.44 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.54 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 62.13 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 144' ' ' LEU . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 62.25 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 51.21 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.2 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.516 ' HB2' HG23 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.24 110.972 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 74.54 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.31 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 134' ' ' GLY . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 132' ' ' SER . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.54 111.182 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.05 111.051 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.03 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 74.3 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.52 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.45 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.53 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.55 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 55.21 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 65.13 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.911 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 178' ' ' ARG . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.948 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 60.53 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.34 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.753 HG12 HG22 ' A' ' 16' ' ' VAL . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 64.01 111.091 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 61.52 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.51 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 54.04 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.51 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 54.25 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 64.42 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.55 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.787 0.327 . . . . 72.2 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.3 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.53 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.11 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 74.34 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.751 ' CE2' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.959 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.504 ' HE1' HD22 ' A' ' 42' ' ' LEU . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 54.11 110.8 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' NH2' HG21 ' A' ' 45' ' ' THR . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.814 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.41 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.54 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 42.43 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 62.11 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.02 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.12 112.297 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.788 0.328 . . . . 63.51 111.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.45 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.43 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.23 111.014 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.51 110.94 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 64.11 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.12 110.838 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 55' ' ' GLU . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.51 111.176 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.72 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.435 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.2 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 64.12 111.098 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 64.42 111.085 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 65.31 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 71.32 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 51.11 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.526 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 48' ' ' ALA . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 61.25 111.198 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' HG22 ' A' ' 45' ' ' THR . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.1 110.803 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.35 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 63.54 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.12 111.064 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 55.02 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 72.12 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 53.34 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 76' ' ' THR . 7.0 p-80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.841 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.947 0.403 . . . . 74.4 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 64' ' ' HIS . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.215 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 64.1 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 73.4 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.42 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 70.4 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.33 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 64.32 112.319 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.32 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 72.23 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 63.45 111.173 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.42 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 52.1 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.23 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 44.43 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.35 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 62.25 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.35 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.02 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 64.43 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.02 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 61.52 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.55 111.049 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 72.33 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 63.43 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.633 ' O ' HD11 ' A' ' 80' ' ' LEU . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.55 110.826 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.43 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.21 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.558 ' OD2' HD21 ' A' ' 129' ' ' LEU . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.978 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.1 t30 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 61.24 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 23.31 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.52 110.919 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.851 0.358 . . . . 73.53 110.942 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 53.12 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.44 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 128' ' ' SER . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.917 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.876 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' OD2' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.05 110.926 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.52 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 160' ' ' ILE . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 71.11 110.923 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.12 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 71.13 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 73.5 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.33 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.04 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 71.13 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 64.01 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 73.45 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.15 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.751 HD22 ' CE2' ' A' ' 8' ' ' PHE . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.5 110.823 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 151' ' ' VAL . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.23 111.051 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 70.41 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 73.21 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 160' ' ' ILE . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.916 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.611 HG13 HD12 ' A' ' 179' ' ' LEU . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 52.03 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 177' ' ' VAL . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.13 111.069 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 163' ' ' THR . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 64.21 111.126 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.32 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 72.12 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.566 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.04 110.906 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 52.24 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.53 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 32.35 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.44 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 63.02 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.44 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.04 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 162' ' ' THR . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.42 111.193 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 160' ' ' ILE . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.872 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 63.13 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.02 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.13 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 64.4 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 54.33 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.1 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.834 0.349 . . . . 74.44 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 49' ' ' THR . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.33 111.158 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 51.51 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.34 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 61.21 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.6 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 61.2 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.6 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 61.13 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 61.43 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 73.12 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 183' ' ' VAL . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.4 111.096 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 18' ' ' PRO . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 64.32 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.42 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.3 112.381 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.818 0.342 . . . . 72.14 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.24 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.34 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 54.34 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.2 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 34.14 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 74.43 111.172 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 72.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.23 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 52.5 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 4' ' ' ALA . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 71.54 111.134 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.03 110.893 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 53.25 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 50' ' ' ASP . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.24 111.12 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.31 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 45' ' ' THR . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.3 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.23 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 55.14 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 62.24 110.868 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.801 0.334 . . . . 72.03 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 111' ' ' PHE . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.092 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.52 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.41 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.94 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 55.05 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.22 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.825 HG23 ' HA ' ' A' ' 106' ' ' ASN . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.216 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.51 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.14 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.995 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.1 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.14 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.42 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.13 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 97' ' ' PHE . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.015 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 63.25 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.42 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 93' ' ' ALA . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 64.11 110.969 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 73.31 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.33 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 63.51 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.1 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.43 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.24 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HG23 ' A' ' 83' ' ' THR . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.44 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.647 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.129 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.527 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 61.35 110.83 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' HA ' HG23 ' A' ' 77' ' ' VAL . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.01 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.492 ' OD1' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.871 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.953 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 71.31 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.44 110.803 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.34 110.861 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 43.1 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' HD23 ' A' ' 168' ' ' LEU . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.804 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.492 HD23 ' OD1' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.12 110.885 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.647 HD11 HG22 ' A' ' 109' ' ' THR . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.833 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 64.35 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 52.4 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 162' ' ' THR . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 70.54 110.834 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.31 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.02 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 73.23 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.22 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.33 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 42.53 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 61.24 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 151' ' ' VAL . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.898 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.22 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 63.03 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.02 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 152' ' ' ASN . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.12 111.158 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.41 110.911 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 53.34 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 72.01 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.2 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.55 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 40.43 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 63.21 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 132' ' ' SER . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.44 111.223 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.51 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 171' ' ' ALA . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.635 HD23 ' OD1' ' A' ' 126' ' ' ASP . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.815 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.41 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.31 111.135 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.44 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.459 ' CA ' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 51.11 110.901 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.55 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.33 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.23 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 70.2 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.01 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.31 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.3 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 64.04 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.554 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 64.45 111.158 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 70.11 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.21 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 64.01 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 70.43 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.54 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.696 0.284 . . . . 73.52 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.2 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.52 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.45 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.12 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.43 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.835 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 63.1 111.029 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.31 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.34 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.02 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.65 ' C ' HG23 ' A' ' 183' ' ' VAL . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 50.13 111.189 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 ' HB ' ' A' ' 183' ' ' VAL . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 60.55 111.175 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 61.24 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.12 112.355 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.814 0.34 . . . . 64.44 111.142 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.02 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.51 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 60' ' ' THR . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 55.14 110.95 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.4 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 57' ' ' LEU . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.049 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.15 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' THR . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.1 111.131 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.117 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.21 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.33 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 71.34 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.904 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 45.2 111.099 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 39' ' ' GLN . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.13 111.101 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.4 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.24 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 71.33 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.332 . . . . 72.32 111.208 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' N ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.33 111.14 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 64' ' ' HIS . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.176 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 72.11 110.87 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.2 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.887 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.02 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.945 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 55.34 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.24 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 106' ' ' ASN . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.1 111.121 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 55.31 111.12 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 62.41 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 63.43 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.02 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 60.35 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.4 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.23 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.14 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 72.1 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.4 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.41 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 63.43 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.01 111.123 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 45.33 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 63.2 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.633 ' OD1' HG23 ' A' ' 108' ' ' THR . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 54.55 110.997 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.44 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' OD1' ' A' ' 106' ' ' ASN . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 52.43 111.052 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.566 ' H ' HG22 ' A' ' 76' ' ' THR . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.03 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.706 ' N ' HG23 ' A' ' 76' ' ' THR . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.33 112.508 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 124' ' ' LEU . 2.6 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.12 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 115' ' ' PHE . 4.0 mm? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.859 0.361 . . . . 74.45 110.974 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.41 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HD22 ' A' ' 127' ' ' LEU . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.14 110.774 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.35 110.863 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.31 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 62.13 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 63.22 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.45 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.44 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.12 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 42.25 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.21 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.43 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.14 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.4 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 70.32 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.4 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.42 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 147' ' ' ARG . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.956 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.667 HD11 ' CG1' ' A' ' 151' ' ' VAL . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 62.13 111.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.567 ' HG2' HD21 ' A' ' 144' ' ' LEU . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.777 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 74.43 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 54.45 110.879 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 145' ' ' ILE . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.41 111.119 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 152' ' ' ASN . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 61.43 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 72.11 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 70.31 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.2 111.126 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.12 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.44 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.01 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.03 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.747 ' HB2' HD23 ' A' ' 127' ' ' LEU . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.34 110.937 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 168' ' ' LEU . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 65.55 110.867 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.44 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 52.34 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.43 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.2 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 177' ' ' VAL . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.166 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 64.32 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.3 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.21 112.336 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 15' ' ' THR . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.34 111.162 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.504 ' H ' ' HB2' ' A' ' 153' ' ' MET . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.32 110.824 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 10' ' ' ARG . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 44.43 111.126 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 65.52 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.22 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 70.44 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.321 . . . . 74.14 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.24 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 34.41 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.24 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 70.34 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.54 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 70.31 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 62.3 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 65.41 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 55.55 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 70.41 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 63.03 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.33 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 183' ' ' VAL . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 61.22 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.04 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD3' HG22 ' A' ' 16' ' ' VAL . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 43.35 112.363 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 73.55 111.033 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.956 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 70.22 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' THR . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.3 111.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.44 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.21 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 72.34 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.44 111.152 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.41 111.191 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 70.14 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 73.05 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 71.24 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.12 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.1 111.134 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.733 ' HB2' HG23 ' A' ' 45' ' ' THR . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.41 110.866 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 61.34 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 64.12 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 33.32 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.23 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.05 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 70.41 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.4 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.35 110.916 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 72.02 111.098 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 71.54 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 113' ' ' ASN . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 44.31 111.087 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.23 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 73.53 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 63.14 112.343 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.23 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 71.3 111.121 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.3 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 62.33 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.421 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 99' ' ' PRO . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.21 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' HG11 ' A' ' 101' ' ' VAL . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.951 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 43.31 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.4 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.23 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.712 ' HG2' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 73.15 110.811 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 71.13 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.54 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.05 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.744 ' HB3' HG13 ' A' ' 141' ' ' VAL . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 90' ' ' PHE . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 65.42 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.04 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.31 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' ILE . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.42 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.741 ' HA ' HG22 ' A' ' 83' ' ' THR . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.35 110.928 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.469 ' HE1' HG23 ' A' ' 105' ' ' ILE . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.55 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 62.02 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.31 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 62.42 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.51 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 60.55 110.949 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.04 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.33 110.929 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 125' ' ' SER . 2.9 pp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.793 0.33 . . . . 73.11 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 65.21 110.872 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.55 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 130' ' ' LYS . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 35.05 110.967 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.35 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.683 HD22 ' HB2' ' A' ' 164' ' ' ALA . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.885 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 127' ' ' LEU . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 63.35 110.882 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 54.14 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.03 110.925 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.52 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 53.23 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.02 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.12 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.41 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 33.1 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.41 111.111 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 71.45 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 96' ' ' LYS . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.03 110.882 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.05 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 70.21 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 64.22 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 144' ' ' LEU . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 65.1 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.41 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 72.51 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 43.13 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.585 ' HH2' HG21 ' A' ' 83' ' ' THR . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.826 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.2 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HD13 ' A' ' 160' ' ' ILE . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.858 HG21 HD22 ' A' ' 179' ' ' LEU . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.23 111.11 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.22 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.51 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.33 111.17 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.41 111.138 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.44 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.464 ' CZ ' HD22 ' A' ' 168' ' ' LEU . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.94 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.35 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 72.0 110.818 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 62.41 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.01 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.467 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 43.11 111.095 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 63.53 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.34 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.34 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 160' ' ' ILE . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.945 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.2 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.13 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.15 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 41.13 111.162 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 60.21 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 62.31 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.31 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 64.21 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.53 112.497 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.53 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 64.41 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.785 0.326 . . . . 74.53 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.55 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.3 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 65.51 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 62.03 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.03 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 61.32 111.13 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 33.41 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.43 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 183' ' ' VAL . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 61.5 111.145 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.631 ' C ' HG23 ' A' ' 183' ' ' VAL . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB ' ' A' ' 183' ' ' VAL . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 71.31 111.096 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.33 112.378 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.819 0.342 . . . . 71.13 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 63.43 110.916 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.33 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 70.43 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 61.4 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.01 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 65.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.33 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 64.21 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 64.54 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.41 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.905 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 24.14 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.1 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.485 HD13 ' HE1' ' A' ' 156' ' ' TRP . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 55.51 110.917 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.54 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.33 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 63.1 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.13 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.53 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.41 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' HG21 ' A' ' 77' ' ' VAL . 9.5 t60 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.762 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.876 0.37 . . . . 63.32 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 60.13 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 64' ' ' HIS . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 54.41 111.164 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 63.24 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.877 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 64.44 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.934 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.22 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.934 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 64.31 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.24 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.05 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 72.21 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.05 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.34 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.1 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.554 ' H ' HG21 ' A' ' 101' ' ' VAL . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.821 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.52 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.11 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 61.22 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 70.12 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.55 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 71.55 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.15 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.15 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.21 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 90' ' ' PHE . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 61.25 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 23.24 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.22 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 72.15 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 62.44 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.584 ' CG ' HD12 ' A' ' 160' ' ' ILE . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 65.21 110.916 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.566 ' H ' HD12 ' A' ' 80' ' ' LEU . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 71.53 111.104 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.12 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 73.14 110.899 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 168' ' ' LEU . 4.3 mm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.779 0.324 . . . . 73.14 111.012 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 65.14 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 71.15 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 63.5 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' CB ' HG23 ' A' ' 109' ' ' THR . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.43 110.814 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.32 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.35 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.1 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.22 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.14 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 65.44 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 64.14 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 23.4 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 51.52 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.764 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.913 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 54.43 111.011 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.35 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.43 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.481 ' C ' HD23 ' A' ' 150' ' ' LEU . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 62.42 110.911 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.12 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 64.31 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 62.54 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 184' ' ' PHE . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.43 111.236 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.485 ' HE1' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.33 110.888 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.53 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.02 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 106' ' ' ASN . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 71.51 111.175 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 43.33 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 71.53 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.11 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 73.23 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.715 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.912 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.34 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.05 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 40.41 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 62.31 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 63.4 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.837 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 53.4 110.946 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.04 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.22 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 72.21 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.631 HG23 ' C ' ' A' ' 15' ' ' THR . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 70.2 111.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.479 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 65.51 110.854 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.33 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.3 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 43.33 111.108 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.21 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 62.12 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.79 0.328 . . . . 73.41 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.35 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.34 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.43 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.51 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.748 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.51 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.03 110.794 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 187' ' ' SER . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.2 111.155 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.42 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 73.14 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 42.52 111.052 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 64.35 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.43 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 72.54 112.385 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.725 0.298 . . . . 71.5 111.14 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' OD1' ' HB1' ' A' ' 14' ' ' ALA . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.875 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 45.52 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.3 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 62.43 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 44' ' ' PHE . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.54 110.776 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 56' ' ' LEU . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.21 111.151 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 73.21 110.892 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.21 110.886 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 71.51 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 52.25 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.15 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.3 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 85' ' ' MET . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 43.44 111.228 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.831 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 43' ' ' THR . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 52.54 110.888 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.01 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 55.01 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 34.21 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 63.42 111.215 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.13 112.36 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 70.11 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.15 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 63.25 110.774 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.793 0.33 . . . . 64.22 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 113' ' ' ASN . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.24 111.189 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 70.2 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.883 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.24 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.03 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.25 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' VAL . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.854 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 70.05 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 60.22 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.43 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.14 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.32 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.34 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.42 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 71.53 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.44 110.948 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 98' ' ' ARG . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 62.14 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.42 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.02 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.21 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.11 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 54.54 111.103 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.44 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 72.21 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.2 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.708 ' HB2' HG12 ' A' ' 77' ' ' VAL . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.43 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.33 110.884 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' H ' ' A' ' 169' ' ' GLY . 6.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.939 0.399 . . . . 74.43 110.935 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.1 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.01 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 172' ' ' GLN . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.31 110.956 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 54.14 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.13 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' THR . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 72.42 110.802 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.429 ' OG ' HD13 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.795 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 54.1 111.086 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.33 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 33.21 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 73.54 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.844 HG23 HG11 ' A' ' 155' ' ' VAL . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 53.03 111.194 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.53 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 71.41 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 72.55 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 54.12 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.418 ' HZ3' ' HH ' ' A' ' 190' ' ' TYR . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.53 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 52.11 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.844 HG11 HG23 ' A' ' 139' ' ' VAL . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.152 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.52 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.22 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 160' ' ' ILE . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.065 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 131' ' ' ASP . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.34 111.16 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 174' ' ' HIS . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.44 111.044 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.03 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.14 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.921 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.62 ' HD3' HD13 ' A' ' 127' ' ' LEU . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.855 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.54 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.748 ' H ' HD22 ' A' ' 124' ' ' LEU . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.56 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.15 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.02 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.765 ' HB3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.43 110.955 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 52.51 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 163' ' ' THR . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.31 110.808 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 177' ' ' VAL . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.51 111.186 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.04 110.908 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 50.44 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.35 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.908 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 183' ' ' VAL . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.54 111.115 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.05 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 74.52 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.41 110.735 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 54.54 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 62.52 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.418 ' HH ' ' HZ3' ' A' ' 149' ' ' TRP . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.33 110.948 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 62.11 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 54.31 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.713 0.292 . . . . 52.21 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.55 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.21 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 47' ' ' MET . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.819 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 64.34 110.918 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 72.3 110.919 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.22 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.44 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 70.33 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 64.1 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 37' ' ' ASN . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.3 111.128 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.22 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 54.04 112.352 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.822 0.344 . . . . 73.22 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 60.53 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.14 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 54.14 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.45 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' MET . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.32 110.918 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.52 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.406 ' HB2' ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.791 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.21 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 51.1 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 71.41 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 88' ' ' TRP . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.126 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.45 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.04 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 65.53 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.45 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.43 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.03 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 71.3 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.524 ' O ' HG21 ' A' ' 76' ' ' THR . 3.4 p-80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.784 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.877 0.37 . . . . 75.34 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.03 111.136 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 112' ' ' ASP . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.24 111.235 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 62.53 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.845 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 73.42 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.919 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.31 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.919 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.44 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.44 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.31 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.498 ' CG ' HD13 ' A' ' 52' ' ' ILE . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.4 110.928 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.774 ' HB2' HG22 ' A' ' 101' ' ' VAL . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 72.5 110.94 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 73.15 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 63.3 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 63.03 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.41 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 61.04 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.45 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.22 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.51 112.344 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.406 ' HA ' ' N ' ' A' ' 89' ' ' TYR . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.94 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 89' ' ' TYR . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 70.23 111.153 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.11 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 65.45 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.31 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.44 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.53 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.13 111.203 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.803 ' HB2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.844 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.45 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.52 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 71.3 110.916 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.8 0.333 . . . . 63.21 110.868 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.43 110.772 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.52 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 60.25 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 60.25 110.962 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.41 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.13 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 72.12 110.9 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.43 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 70.52 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.2 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 156' ' ' TRP . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 41.54 111.106 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 65.44 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.34 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 62.1 111.109 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 21.24 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 99' ' ' PRO . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 55.21 111.146 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.41 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.02 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.756 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 71.45 110.976 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 144' ' ' LEU . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.14 111.193 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.44 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.401 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.945 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.756 HD22 ' CB ' ' A' ' 144' ' ' LEU . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 62.31 110.944 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' SER . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 72.04 111.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 62.53 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.45 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.44 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CZ2' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.945 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.34 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 179' ' ' LEU . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.34 110.809 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.93 HG22 HD11 ' A' ' 179' ' ' LEU . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 70.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 65.21 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.933 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.15 111.125 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 65.24 111.147 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.754 ' HA ' HD22 ' A' ' 129' ' ' LEU . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 44.04 111.148 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.42 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.02 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 65.42 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.2 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.04 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.3 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.42 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.21 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 74.45 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.04 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.24 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.485 HG22 ' HB ' ' A' ' 162' ' ' THR . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 63.43 111.134 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.32 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 160' ' ' ILE . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.474 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.03 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.52 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 60.51 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 60.04 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.43 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 50.21 110.889 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 61.13 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.15 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 70.11 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.566 ' CG ' HD11 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 53.32 110.948 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 72.22 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.75 0.31 . . . . 62.42 110.749 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 71.01 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 47' ' ' MET . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 70.21 111.157 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.722 ' H ' ' HE3' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.24 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 61.54 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 74.2 110.959 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 71.34 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 64.14 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 30.41 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.23 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 64.14 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' THR . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.118 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 HG11 ' A' ' 183' ' ' VAL . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.24 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' PRO . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 71.23 112.28 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 65.1 111.218 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.12 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 41.03 111.212 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.1 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 53.3 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 63.12 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 62.45 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.3 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.482 HG23 ' CG ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.178 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.31 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.722 ' HE3' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.43 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 44.21 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 60.1 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 88' ' ' TRP . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.184 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 65.22 112.56 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 64.01 111.158 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' CG ' HG23 ' A' ' 45' ' ' THR . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.05 110.889 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.721 ' CB ' HG23 ' A' ' 83' ' ' THR . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.917 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 54.54 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 53.1 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 63.15 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 55.54 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 62.25 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.869 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.808 0.337 . . . . 72.51 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.12 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 61.35 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 62.21 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.14 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 70.21 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.698 ' HB3' HG23 ' A' ' 108' ' ' THR . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.44 112.443 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 62.12 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.721 HG23 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.06 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.41 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.852 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.3 111.125 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' HB3' HG22 ' A' ' 52' ' ' ILE . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.954 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.32 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HD1' HG21 ' A' ' 101' ' ' VAL . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.34 110.872 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 71.45 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 72.42 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.35 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 44.13 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.43 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.44 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.51 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.32 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.42 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.24 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.422 HG21 ' HD1' ' A' ' 90' ' ' PHE . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.32 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.11 112.522 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 65.21 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.21 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 71.44 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 81' ' ' PRO . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 61.12 111.107 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 64.42 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.421 ' CE1' HG21 ' A' ' 108' ' ' THR . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.924 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 1.0 OUTLIER -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.23 110.806 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.23 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.43 110.886 -179.868 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.448 HD11 ' HA2' ' A' ' 169' ' ' GLY . 1.6 mp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 74.34 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.23 110.773 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.854 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.924 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 71.5 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.31 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.01 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 71.2 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 52.41 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.21 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.23 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 53.32 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.122 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.02 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 63.33 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 52.14 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 73.0 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 151' ' ' VAL . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 73.21 111.213 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 54.34 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.959 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 145' ' ' ILE . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 62.14 111.135 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.925 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 44.31 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.492 ' CD2' HG22 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.53 110.885 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 54.45 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 180' ' ' ASP . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 55.4 111.12 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 52.33 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.04 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 62.45 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 53.14 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.55 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.43 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 124' ' ' LEU . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.54 112.487 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 52.4 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.55 110.904 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.51 110.9 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 51.22 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 177' ' ' VAL . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.227 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 34.01 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.526 ' CG ' HD11 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.33 110.933 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.33 112.346 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 63.04 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.594 HG11 HG12 ' A' ' 16' ' ' VAL . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.24 111.113 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.41 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 61.53 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 50.51 111.1 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.03 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.42 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 71.34 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 60.24 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.779 0.323 . . . . 75.41 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 63.32 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HB2' ' CA ' ' A' ' 49' ' ' THR . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.161 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.04 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.52 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HB2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.24 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' H ' ' HB2' ' A' ' 46' ' ' TYR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 61.21 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 65.1 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.21 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.05 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 72.44 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 18' ' ' PRO . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.14 111.081 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.3 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 16' ' ' VAL . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 63.11 112.318 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.785 0.326 . . . . 43.55 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.037 HD22 HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.13 110.871 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.43 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.55 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 57' ' ' LEU . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.137 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 40.14 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 54' ' ' VAL . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.33 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.696 ' CA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.194 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.13 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 48' ' ' ALA . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.43 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.13 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.945 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.12 111.071 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 70.03 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 1.037 HG23 HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 65.12 111.151 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 62.54 112.319 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 63.13 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.51 110.825 -179.932 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.865 0.364 . . . . 62.41 111.097 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 111' ' ' PHE . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 72.14 111.119 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 61.23 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.05 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 109' ' ' THR . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.43 110.905 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.23 112.38 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.11 112.399 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.55 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 54.14 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 45.54 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.31 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.23 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.45 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 52.22 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 63.05 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.3 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 55.03 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.12 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 71.01 112.304 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.45 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 139' ' ' VAL . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.21 111.023 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.13 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.24 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.44 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.15 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 64.01 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 64.02 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.42 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.22 111.133 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 109' ' ' THR . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 71.45 110.879 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HB3' HG23 ' A' ' 77' ' ' VAL . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 73.21 110.859 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.03 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' HG11 ' A' ' 77' ' ' VAL . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 65.21 110.911 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.3 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.15 110.85 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.806 0.336 . . . . 63.45 110.95 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.01 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.521 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.1 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.43 110.876 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 130' ' ' LYS . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 64.51 110.922 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 129' ' ' LEU . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.894 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.714 ' HA ' HG23 ' A' ' 109' ' ' THR . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.809 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.43 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.15 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.03 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.05 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 70.0 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.51 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 101' ' ' VAL . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 64.03 111.13 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 24.23 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 63.14 111.151 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 61.41 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.21 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.922 HD12 HD21 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 145' ' ' ILE . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 73.43 111.042 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.22 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.03 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.922 HD21 HD12 ' A' ' 144' ' ' LEU . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.52 110.917 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.13 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.43 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.24 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.402 ' HZ2' HD22 ' A' ' 57' ' ' LEU . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.41 110.957 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.53 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 52.53 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 53.33 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 70.3 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 54.41 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.33 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.521 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.1 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 71.44 110.891 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 72.52 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 32.14 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.03 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 167' ' ' LYS . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.11 111.048 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 63.34 110.873 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.24 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.14 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.33 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.51 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.52 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.13 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.33 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 71.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.34 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 53.13 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 62.24 111.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 61.2 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.51 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.24 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.3 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.713 0.292 . . . . 73.14 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 49' ' ' THR . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 71.53 111.09 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 63.24 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.11 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.14 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 43.33 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.01 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.24 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.11 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 38' ' ' THR . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 61.13 111.117 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 183' ' ' VAL . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 71.14 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.41 112.315 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.764 0.316 . . . . 71.53 111.142 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 15' ' ' THR . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.32 111.178 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.2 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.01 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.43 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 55.41 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 56' ' ' LEU . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.857 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' NE2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 55.22 111.115 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 65.1 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.04 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 45.31 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.23 111.043 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 53.35 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 53.3 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.02 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 63.21 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 84' ' ' LEU . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.891 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 63.01 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.14 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 55.2 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.34 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.23 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.03 110.953 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.927 0.394 . . . . 72.14 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' THR . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.13 111.099 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.12 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 54.44 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.805 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 62.32 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.02 112.347 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 70.34 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 56' ' ' LEU . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 52.15 110.911 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.3 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.975 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.2 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 73.53 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 71.44 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.12 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.43 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.32 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 65.4 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 144' ' ' LEU . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 72.21 110.904 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.572 ' HA ' HG23 ' A' ' 141' ' ' VAL . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 52.2 112.316 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 101' ' ' VAL . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 61.25 111.091 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.14 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 44.31 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 85' ' ' MET . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.32 112.474 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.25 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.64 ' CZ ' HG22 ' A' ' 109' ' ' THR . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.882 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 62.23 111.05 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 107' ' ' TYR . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.162 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.14 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.24 112.591 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.33 110.811 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.747 0.308 . . . . 65.14 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 166' ' ' TYR . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.55 110.906 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.04 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 162' ' ' THR . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.22 110.921 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 43.45 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.05 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.14 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.11 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.34 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.04 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.33 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 99' ' ' PRO . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.2 111.11 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.725 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 151' ' ' VAL . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 63.44 110.855 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' A' ' 98' ' ' ARG . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 62.24 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 71.14 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.45 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 71.52 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 188' ' ' ALA . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 64.23 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 63.2 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.871 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.44 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.21 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 61.14 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.13 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.03 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.511 ' CG2' HD23 ' A' ' 129' ' ' LEU . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.42 111.062 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.11 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.11 111.088 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.43 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 126' ' ' ASP . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.1 110.933 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 72.21 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.55 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 64.53 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.13 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.52 110.883 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 54.33 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 64.34 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.2 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.32 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 16' ' ' VAL . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 44.32 111.095 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.0 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.067 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.24 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.1 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.4 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.304 . . . . 73.33 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.02 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 63.4 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 61.41 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CA ' ' HB2' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.32 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.505 ' N ' ' HB2' ' A' ' 191' ' ' ARG . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 55.13 111.108 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 54.13 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 73.34 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.21 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 53.35 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 183' ' ' VAL . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.02 111.174 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.42 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.35 112.342 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 63' ' ' ARG . 18.0 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.831 0.348 . . . . 72.14 111.147 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.21 110.836 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.43 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' THR . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.21 111.1 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 52.03 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.04 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 61.25 110.809 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 57' ' ' LEU . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.35 111.124 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 70.31 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.864 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.603 HG22 ' CE3' ' A' ' 88' ' ' TRP . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.15 111.095 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.43 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.34 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 64.43 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 43' ' ' THR . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.02 110.928 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 43.23 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 63.21 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.34 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.3 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.836 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.405 ' CB ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.51 110.863 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 71.55 111.126 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 65.23 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 64' ' ' HIS . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.096 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 73.14 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.865 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 51.34 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.936 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.33 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.936 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.54 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.543 ' OG1' HD22 ' A' ' 57' ' ' LEU . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.15 111.176 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.01 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.42 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.947 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.603 ' CE3' HG22 ' A' ' 52' ' ' ILE . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.22 110.889 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.41 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 74.42 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 71.33 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 61.33 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.03 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.03 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 71.1 110.856 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.3 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 139' ' ' VAL . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 71.23 111.102 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.02 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.13 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.31 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 105' ' ' ILE . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 50.41 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 71.22 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.42 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 70.02 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.05 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.12 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.3 110.839 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.788 0.327 . . . . 61.13 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 62.13 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 63.41 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.21 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 62.14 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 64.15 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.2 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.34 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.24 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.42 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 45.3 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 157' ' ' TYR . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 71.31 111.122 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.02 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.33 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HA ' HG23 ' A' ' 101' ' ' VAL . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.138 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.1 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.3 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 62.31 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 72.54 110.994 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.32 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 33.05 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 151' ' ' VAL . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.875 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' N ' HD12 ' A' ' 150' ' ' LEU . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.33 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.938 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 55.11 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.42 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 156' ' ' TRP . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.3 111.028 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 155' ' ' VAL . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.03 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.646 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.52 110.927 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 74.33 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.6 ' CD1' HD12 ' A' ' 179' ' ' LEU . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.12 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 64.35 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 53.22 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.6 ' HB2' ' CG2' ' A' ' 177' ' ' VAL . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 64.53 111.031 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.4 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 53.41 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.32 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.35 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 55.15 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 164' ' ' ALA . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 63.12 111.212 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.23 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 160' ' ' ILE . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.42 110.949 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.24 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.55 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.12 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 16' ' ' VAL . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.53 111.217 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 43.41 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 61.13 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.085 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 12.2 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.24 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.522 ' HB2' ' CA ' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.11 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 65.12 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 72.11 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.21 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.409 ' HB2' ' C ' ' A' ' 48' ' ' ALA . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.32 111.048 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 65.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.34 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 43' ' ' THR . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 70.01 110.837 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 43' ' ' THR . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 53.4 111.089 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.4 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 64.21 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 42.04 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.456 ' C ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.679 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 71.12 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.34 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' CB ' HD13 ' A' ' 179' ' ' LEU . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.52 112.247 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.762 0.315 . . . . 75.45 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 55.23 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.93 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 70.31 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.01 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 44.33 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 73.04 110.942 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 11' ' ' ALA . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.15 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.34 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 70.55 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 65.34 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.11 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' C ' ' HB2' ' A' ' 4' ' ' ALA . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.098 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 61.22 111.21 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 71.24 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.44 112.468 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.21 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.783 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.42 111.124 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.45 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 63.33 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.2 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 35.24 110.834 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB1' ' OD2' ' A' ' 126' ' ' ASP . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.891 0.377 . . . . 55.02 111.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.52 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.31 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 64.55 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.42 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.944 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 63.01 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.944 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 106' ' ' ASN . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.43 111.243 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 64.22 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 30.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.705 ' CD2' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 72.04 110.935 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.21 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.45 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 62.03 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.24 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 54.23 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 63.05 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 72.35 110.984 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.24 112.283 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.93 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.705 HG22 ' CD2' ' A' ' 89' ' ' TYR . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 71.24 111.139 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.35 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 70.35 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.01 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 65.41 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 72.44 110.881 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 80' ' ' LEU . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.194 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 62.31 111.078 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 63.54 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.21 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.45 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 71.1 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 71.21 110.967 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 75' ' ' ALA . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 70.12 110.846 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.428 HD12 ' HE2' ' A' ' 130' ' ' LYS . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.4 111.019 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.21 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 74.52 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.428 ' HE2' HD12 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.873 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' HA ' HG23 ' A' ' 109' ' ' THR . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.821 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 64.11 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.14 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 61.02 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.52 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.31 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.65 HG23 HG22 ' A' ' 155' ' ' VAL . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 55.32 111.124 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.04 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.24 111.113 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.666 ' OD2' HD13 ' A' ' 150' ' ' LEU . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.33 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 45.52 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 51.23 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.54 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.53 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.666 HD13 ' OD2' ' A' ' 142' ' ' ASP . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.12 110.903 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 188' ' ' ALA . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.032 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.1 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 63.41 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 62.14 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 184' ' ' PHE . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.073 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.24 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.1 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 53.31 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 61.11 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.35 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.43 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.35 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 62.24 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 64.41 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 62.35 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.11 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.41 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 62.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.14 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.51 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.45 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.619 ' O ' HD12 ' A' ' 179' ' ' LEU . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.24 110.831 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 65.33 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.634 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.41 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 184' ' ' PHE . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.02 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.773 ' N ' HG13 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 65.55 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 33.15 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 53.53 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.35 111.039 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 51.24 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.1 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 71.21 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.55 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.814 0.34 . . . . 74.43 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 61.43 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.44 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.31 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.167 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.15 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.24 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 38' ' ' THR . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.12 111.117 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 53.33 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 16' ' ' VAL . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.23 111.105 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.31 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.31 112.364 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.784 0.326 . . . . 54.02 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.13 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' ALA . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 72.54 111.045 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 73.31 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 11' ' ' ALA . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 64.4 110.878 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.01 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 9' ' ' MET . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 72.15 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 53.22 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.32 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.827 HG22 ' HB ' ' A' ' 52' ' ' ILE . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 53.11 111.139 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 49' ' ' THR . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.877 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' N ' HG23 ' A' ' 49' ' ' THR . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.35 110.813 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.827 ' HB ' HG22 ' A' ' 49' ' ' THR . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.43 111.256 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 32.42 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 70.51 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.12 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.42 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 44.12 110.944 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 53.11 111.185 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.41 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 79' ' ' HIS . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.42 112.41 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.946 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 71.31 110.898 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . . . . . . 0 N--CA 1.459 0.022 0 CA-C-O 120.92 0.39 . . . . 72.43 111.006 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.12 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 112' ' ' ASP . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 60.13 111.142 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.885 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 63.4 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.51 112.313 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.51 112.3 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' TYR . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.52 111.076 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.3 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.416 ' HE1' HD13 ' A' ' 57' ' ' LEU . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.781 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 35.32 111.147 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.434 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.2 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.54 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 42.53 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 53.32 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 62.34 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 51.22 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.31 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 144' ' ' LEU . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 63.45 110.954 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 71.3 110.906 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' A' ' 101' ' ' VAL . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.42 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.672 ' HB2' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 99' ' ' PRO . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 52.34 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.21 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 62.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.34 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 62.4 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 63.05 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' H ' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.923 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 70.03 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 70.11 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 54.4 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.518 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.03 110.797 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.22 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 60.03 112.457 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 71.34 110.835 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.749 0.309 . . . . 73.33 110.997 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.03 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 64.2 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.53 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.23 110.952 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 129' ' ' LEU . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.896 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 53.34 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.41 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.23 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.44 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 34.04 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.13 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 100' ' ' TYR . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 50.14 111.124 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 70.32 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.783 HG22 ' OD1' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.2 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.1 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.449 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.922 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.54 110.923 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 151' ' ' VAL . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.31 111.07 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 70.22 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.01 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.565 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.84 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.918 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.468 HG12 ' HB ' ' A' ' 145' ' ' ILE . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.42 111.24 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 53.32 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 63.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 183' ' ' VAL . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.33 111.117 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.422 ' N ' HG22 ' A' ' 155' ' ' VAL . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.85 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.623 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.867 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.61 ' HA ' HD13 ' A' ' 179' ' ' LEU . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.838 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 62.24 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.53 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 41.31 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.656 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.1 110.835 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 32.33 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.02 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 52.42 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 60.53 111.106 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.32 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 167' ' ' LYS . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.45 110.818 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.32 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 61.43 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 64.21 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.468 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.31 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.31 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.21 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 155' ' ' VAL . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.41 111.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 65.32 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.31 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.22 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 72.33 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.33 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.739 0.304 . . . . 73.32 110.774 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 47' ' ' MET . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 48' ' ' ALA . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.461 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.42 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.44 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 64.11 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.847 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 52.33 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.14 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 44.05 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 38' ' ' THR . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.04 111.134 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 55.44 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 61.51 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 55.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.31 112.344 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.029 0 CA-C-O 120.813 0.34 . . . . 60.32 111.116 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 42.02 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 64.54 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' ALA . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.43 111.147 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.4 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 65.51 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.1 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.11 111.061 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 62.43 111.122 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.15 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.722 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 70.51 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.13 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 64.33 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.43 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.983 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.54 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.21 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 65.53 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 45' ' ' THR . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 45.1 110.822 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.1 110.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 54.53 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 62.33 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.41 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 63.5 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.32 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.945 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.861 0.362 . . . . 52.23 111.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 43.1 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 HD12 ' A' ' 129' ' ' LEU . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.12 111.107 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 71.04 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.2 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 64.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.925 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 63.05 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.925 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 64.14 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.04 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.488 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.41 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.9 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.34 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.3 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 70.52 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.23 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.21 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.468 ' C ' HG23 ' A' ' 141' ' ' VAL . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 71.22 110.899 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.573 ' N ' HG23 ' A' ' 141' ' ' VAL . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.11 112.346 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 61.22 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.03 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 87' ' ' GLN . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 63.31 112.549 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 44.51 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.01 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 63.4 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 71.55 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.43 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 80' ' ' LEU . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.13 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.13 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.24 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.725 ' H ' HD23 ' A' ' 124' ' ' LEU . 61.6 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.22 110.948 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 115' ' ' PHE . 13.3 tp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 73.22 110.94 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 124' ' ' LEU . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.35 110.882 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.966 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 65.42 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.55 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 64.42 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.23 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.14 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.517 ' HB2' ' NE1' ' A' ' 156' ' ' TRP . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.32 111.011 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 74.22 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.11 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.02 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 99' ' ' PRO . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 65.2 111.127 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.613 ' CB ' ' HA ' ' A' ' 152' ' ' ASN . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.43 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.04 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 72.32 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.15 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 43.35 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 71.04 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.04 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 151' ' ' VAL . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.982 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.612 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 62.11 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 64.41 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.506 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.22 110.822 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.22 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 64.13 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.517 ' NE1' ' HB2' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.956 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 51.32 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' VAL . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.852 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 63.21 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 73.4 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.45 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 53.22 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.41 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 15.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 62.11 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.608 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.55 110.996 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.446 ' HB3' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.12 110.84 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.34 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 64.32 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.53 111.017 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.13 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.1 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.4 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 65.2 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 64.13 110.974 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.54 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.35 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' A' ' 158' ' ' MET . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.136 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.23 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.042 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 54.43 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 55.4 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.41 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.42 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 73.34 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 62.15 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.883 ' HB1' HG23 ' A' ' 49' ' ' THR . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.31 111.128 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.21 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.24 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 61.01 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.15 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.836 ' HB2' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 65.44 110.855 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.55 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.22 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.32 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.31 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG22 ' CG2' ' A' ' 183' ' ' VAL . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.41 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.33 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.31 112.405 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.858 0.361 . . . . 72.34 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.908 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' THR . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.23 110.941 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.02 111.226 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.32 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 64.32 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.54 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 74.42 110.943 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 10' ' ' ARG . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 61.45 111.076 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.3 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 62.22 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 64.51 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 61.33 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.01 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.883 HG23 ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.126 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 71.12 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 63.42 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.31 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 83' ' ' THR . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.12 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.059 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.11 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.24 112.455 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.965 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.515 ' O ' HG21 ' A' ' 76' ' ' THR . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 64.34 110.92 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.849 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.85 0.357 . . . . 70.31 111.104 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 63' ' ' ARG . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.23 111.085 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 62.53 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 71.4 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.14 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 73.25 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.929 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.31 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.929 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 62.22 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.403 ' C ' HD23 ' A' ' 56' ' ' LEU . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 71.31 111.084 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.41 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.4 111.131 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.55 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 63.14 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.44 111.032 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.14 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 63.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.31 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 71.22 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.33 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 53.04 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 54.52 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 90' ' ' PHE . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 34.44 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.22 111.105 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.21 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 134' ' ' GLY . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.41 111.07 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.15 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 64.14 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.33 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.15 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 71.03 110.799 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 53.21 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 70.02 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.659 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.811 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 163' ' ' THR . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 64.52 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 64.5 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.34 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.12 112.504 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 51.24 111.053 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.1 111.129 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.12 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.55 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 64.32 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 73.22 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 61.53 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.573 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 71.04 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.42 110.933 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.41 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 64.25 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 63.42 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 150' ' ' LEU . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 53.22 110.909 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 42.42 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.42 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 184' ' ' PHE . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.44 111.083 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 63.34 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 64.03 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 63.03 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.664 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 34.24 111.145 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.4 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.41 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.34 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 74.41 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 65.42 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 53.44 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 64.2 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.11 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.11 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.55 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.51 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.22 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 53.51 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 65.24 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.621 ' CG2' HG22 ' A' ' 16' ' ' VAL . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 35.12 111.162 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.758 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.936 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.31 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 62.21 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 72.34 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 22.03 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 72.11 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 55.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 63.43 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.702 0.287 . . . . 73.41 110.865 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.33 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 51.24 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.4 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.53 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.793 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.924 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 45.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.21 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.41 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.597 ' C ' HG23 ' A' ' 183' ' ' VAL . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.116 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 180' ' ' ASP . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 70.44 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.45 112.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.781 0.324 . . . . 74.5 111.13 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.13 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 63.42 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.43 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 55.15 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 43.04 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.32 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 55' ' ' GLU . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 70.45 111.058 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 63.24 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.44 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 54.41 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.2 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.02 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HB2' HG22 ' A' ' 45' ' ' THR . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.826 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.41 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.41 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 42.24 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.41 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.44 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.692 ' CB ' HG21 ' A' ' 77' ' ' VAL . 6.5 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.44 110.842 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.807 0.336 . . . . 54.43 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 64.43 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 64' ' ' HIS . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 64.03 111.128 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 108' ' ' THR . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.42 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.874 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 71.05 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.931 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.42 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.931 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 62.43 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 107' ' ' TYR . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.31 111.085 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.3 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.01 111.079 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 103' ' ' ALA . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 60.33 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 54.21 110.89 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 45.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 61.33 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.05 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.43 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 65.33 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 53.11 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.35 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.21 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 139' ' ' VAL . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.02 111.059 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.51 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB3' ' CH2' ' A' ' 88' ' ' TRP . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 51.51 111.073 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 35.12 112.442 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 62.33 111.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 62.42 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 79' ' ' HIS . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.11 111.093 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.12 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 61.34 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.35 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 73.13 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 63.0 110.786 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 125' ' ' SER . 1.1 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.767 0.318 . . . . 63.43 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 124' ' ' LEU . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.83 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.35 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 165' ' ' ASN . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 61.53 110.884 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 64.5 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.03 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 107' ' ' TYR . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.1 112.625 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.52 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 71.13 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 62.53 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 63.05 110.943 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 101' ' ' VAL . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 55.51 111.152 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.32 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 151' ' ' VAL . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.33 110.938 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.11 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.44 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 63.23 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 62.22 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 72.13 111.009 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.43 111.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.13 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 61.42 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.15 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.02 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.3 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 71.03 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 61.34 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.3 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.11 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.44 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.484 ' C ' HG23 ' A' ' 177' ' ' VAL . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 52.21 111.236 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.711 ' HB3' ' CB ' ' A' ' 175' ' ' ASP . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.099 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.726 ' HB3' HD23 ' A' ' 127' ' ' LEU . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.923 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.966 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.23 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 65.02 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.01 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.31 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 43.23 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 71.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.11 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.711 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.11 110.898 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.04 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 163' ' ' THR . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.235 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 60.14 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 107' ' ' TYR . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.53 110.859 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 16' ' ' VAL . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.05 110.8 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 64.31 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.597 HG23 ' C ' ' A' ' 15' ' ' THR . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 62.14 111.231 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.11 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 63.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.42 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 61.53 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 53.51 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.51 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.728 0.299 . . . . 74.14 110.849 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.1 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.3 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.54 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 150' ' ' LEU . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 65.55 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.55 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.44 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 45.32 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.21 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.21 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 183' ' ' VAL . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.087 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 62.11 112.306 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.524 -0.047 0 CA-C-O 120.877 0.37 . . . . 44.24 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.31 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 50.34 110.895 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 57' ' ' LEU . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 65.01 111.188 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.506 ' CE2' HD12 ' A' ' 42' ' ' LEU . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.793 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.65 HG23 ' HG2' ' A' ' 55' ' ' GLU . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 53.25 111.147 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.2 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 71.51 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 61.15 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 62.43 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.11 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' HG23 ' A' ' 45' ' ' THR . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.854 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 61.21 111.03 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 51.24 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 70.11 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.23 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' VAL . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.15 110.85 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.04 110.861 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 113' ' ' ASN . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.892 0.377 . . . . 71.02 111.112 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 76' ' ' THR . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.31 111.063 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 63' ' ' ARG . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.151 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.32 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.921 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.32 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.921 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.42 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.31 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.746 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.23 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.43 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.23 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 60.24 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.01 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 64.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 64.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 62.15 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 73.32 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.22 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 54.02 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.676 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.22 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.42 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.23 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 134' ' ' GLY . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 62.02 111.12 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.13 110.799 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 73.23 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 72.12 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.01 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 64.12 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB2' HD23 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 65.43 110.812 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.486 ' CB ' ' HB1' ' A' ' 75' ' ' ALA . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 73.11 110.853 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.52 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 127' ' ' LEU . 29.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.31 110.906 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 60.04 110.825 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.31 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 53.31 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.526 HD13 ' CE1' ' A' ' 115' ' ' PHE . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.13 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 112' ' ' ASP . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.12 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.445 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 62.44 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 52.12 111.123 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.41 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 64.11 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.15 111.011 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.42 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.533 ' N ' HD22 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.42 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 73.02 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.33 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.548 ' O ' ' HB1' ' A' ' 188' ' ' ALA . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.795 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 151' ' ' VAL . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.12 111.121 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.652 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.41 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.02 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 65.21 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.52 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 62.21 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 72.2 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 74.33 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 60.33 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 176' ' ' SER . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 60.51 111.235 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.23 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 45.42 110.947 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.2 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 71.32 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 171' ' ' ALA . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.932 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 124' ' ' LEU . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.05 112.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 65.24 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 168' ' ' LEU . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 52.42 111.017 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.24 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.11 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.4 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 163' ' ' THR . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.904 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.903 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 71.53 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.23 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 16' ' ' VAL . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 63.24 111.172 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.4 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.093 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 63.1 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.14 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 71.32 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 74.13 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -116.17 26.63 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 62.11 110.912 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.11 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.15 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 61.45 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.52 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 32.35 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.24 110.859 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 187' ' ' SER . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.121 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 54.34 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 62.24 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 38' ' ' THR . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.22 111.092 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.79 HG22 ' HD3' ' A' ' 18' ' ' PRO . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.43 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 72.45 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.6 Cg_endo -69.74 119.25 6.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.22 112.324 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -174.14 31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 73.31 111.137 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.38 -170.04 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 73.54 110.844 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.86 -98.47 1.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.763 -0.732 . . . . 74.44 112.38 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.48 -67.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 74.14 111.033 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.16 -110.75 1.49 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 51.22 112.512 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.95 40.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.524 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.71 -73.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.847 0.356 . . . . 61.12 111.211 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.02 34.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.39 171.21 23.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 75.15 112.435 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.553 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -151.56 103.66 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 74.02 110.926 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -177.17 133.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 74.04 110.911 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.12 43.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 64.11 112.436 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 146.23 36.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 75.41 112.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.09 164.42 30.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 71.51 110.849 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -148.06 103.23 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.931 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 142.02 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 43.41 111.175 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 146.89 31.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.14 111.062 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB2' HG13 ' A' ' 16' ' ' VAL . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.934 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 64.3 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' ALA . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 52.13 111.182 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.45 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 55.01 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 72.34 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.544 HG21 ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.04 111.12 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 10' ' ' ARG . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.15 111.161 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.21 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 71.33 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 54.44 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.41 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.11 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.6 HD12 ' CE3' ' A' ' 88' ' ' TRP . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.157 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 42.43 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 35.15 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' HG21 ' A' ' 43' ' ' THR . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.15 110.833 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 71.21 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 53.34 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 64.43 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 52.21 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.03 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.52 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.32 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 -176.15 5.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.786 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 150.03 43.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.976 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -65.06 128.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 75.33 111.147 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.73 40.61 2.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 63.44 112.429 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.535 HG22 HG12 ' A' ' 66' ' ' ILE . 14.7 t -94.01 151.22 19.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 74.41 111.178 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -71.02 -18.16 62.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.424 . . . . 74.14 110.889 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.25 -51.2 56.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 64.43 111.139 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 HG22 ' A' ' 74' ' ' ILE . 13.3 t -121.67 -32.53 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.42 111.21 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.67 56.32 3.62 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.69 -0.767 . . . . 63.15 112.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.554 ' HA ' HG23 ' A' ' 66' ' ' ILE . 0.5 OUTLIER 66.85 126.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.798 0.332 . . . . 73.22 110.898 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.429 HG22 HG21 ' A' ' 71' ' ' THR . 16.9 tt -176.72 -35.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.44 111.132 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.822 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . -112.73 163.09 14.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 61.52 111.066 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.553 HG23 ' OD2' ' A' ' 112' ' ' ASP . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 64.53 111.09 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 71.12 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.856 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.33 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.31 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.44 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 52.32 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.14 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 51.41 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 52' ' ' ILE . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 71.24 110.941 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.04 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.4 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.21 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 64.2 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 50.53 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.42 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.43 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.52 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.13 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 139' ' ' VAL . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.127 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 34.42 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.1 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 42.23 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.33 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.21 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.31 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 73.11 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 77' ' ' VAL . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 71.52 110.911 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 71.34 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.822 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.42 112.56 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -48.77 167.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 72.53 110.901 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 120' ' ' LYS . 5.1 t-20 -153.6 -160.06 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 65.01 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.867 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -44.73 20.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 65.41 110.905 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.66 13.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 71.02 112.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -61.03 -45.25 95.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 64.21 110.957 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -16.5 63.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 74.44 110.979 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.21 2.98 18.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 73.43 111.12 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.11 24.56 9.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.808 -0.71 . . . . 74.04 112.424 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 167' ' ' LYS . 44.0 mt -154.38 -172.47 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 73.33 110.842 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.21 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.21 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.47 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.33 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.42 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 62.21 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 63.44 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.43 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 55.32 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.43 111.157 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.03 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.32 110.982 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 101' ' ' VAL . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 53.21 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.11 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.21 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.692 ' HA ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.99 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.45 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.22 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 61.45 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 74.2 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.01 110.938 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.32 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.33 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 65.23 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 63.11 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.21 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.21 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.32 110.819 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 70.34 111.133 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 160' ' ' ILE . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 42.43 110.818 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.44 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 175' ' ' ASP . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.1 111.176 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.47 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 71.23 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.715 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.886 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.81 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.33 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.11 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.81 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 23.3 111.076 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.25 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.43 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.2 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 164' ' ' ALA . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.04 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.43 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 55.22 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.701 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.959 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 178' ' ' ARG . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.24 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.34 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.41 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 64.42 110.815 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 44.51 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 63.15 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.905 0.383 . . . . 64.13 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -123.63 25.52 8.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.779 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.33 111.052 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 62.54 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.34 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.41 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 60.42 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.44 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.04 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.12 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 38' ' ' THR . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.15 111.065 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.43 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 183' ' ' VAL . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 32.54 111.187 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 73.2 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 -173.23 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 64.14 112.371 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.0 p -104.91 -179.39 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.186 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.67 -171.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 75.41 110.846 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.12 -136.02 9.16 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 65.12 112.507 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -75.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 72.2 111.031 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.93 103.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.813 -0.708 . . . . 61.14 112.483 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.16 173.25 19.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 33.24 112.462 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 53.86 34.46 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 52.14 111.202 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -179.12 109.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.1 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.38 149.98 21.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 64.31 112.515 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.24 -177.7 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 74.14 110.924 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.63 -178.66 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.873 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.71 43.36 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 71.21 112.54 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.59 148.43 9.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 54.34 112.496 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.81 165.26 15.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 75.22 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -118.63 152.07 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.86 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.595 HG11 ' CE1' ' A' ' 64' ' ' HIS . 27.1 m -78.66 -176.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 43.42 111.146 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t -80.19 145.38 32.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 71.02 111.126 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 54.24 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 14' ' ' ALA . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 62.43 111.096 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.44 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.15 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 63.42 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 71.31 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 57' ' ' LEU . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.211 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 55' ' ' GLU . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.4 111.095 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 72.12 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 71.01 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.12 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.22 111.211 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 63.15 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 53.42 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.11 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 45' ' ' THR . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.841 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.53 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.929 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.54 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 34.31 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.44 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.54 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 71.24 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CE1' HG11 ' A' ' 34' ' ' VAL . 7.0 t60 -99.04 106.25 18.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.862 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -113.06 156.55 22.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.942 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.662 HG13 HG22 ' A' ' 74' ' ' ILE . 45.3 mm -63.84 106.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 73.31 111.194 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.95 72.02 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 53.43 112.429 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.23 151.73 19.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 73.23 111.139 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.44 -25.89 33.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.883 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.76 -36.96 49.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.122 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' HG21 ' A' ' 66' ' ' ILE . 20.7 p -120.32 -32.49 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.43 111.082 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 52.18 71.5 0.66 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 63.32 112.556 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 102.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 71.5 110.853 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.662 HG22 HG13 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -97.02 -28.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.21 111.146 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.77 44.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.155 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.44 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' OG ' ' A' ' 128' ' ' SER . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 62.51 111.122 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.43 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.866 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.924 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.22 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.924 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.05 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 41.33 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 107' ' ' TYR . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 40.21 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 61.11 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 61.13 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.54 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.44 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.14 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.54 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 72.13 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 64.21 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.24 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 63.21 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.13 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.15 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 134' ' ' GLY . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.41 111.233 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 65.31 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 84' ' ' LEU . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.937 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.45 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 62.44 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 74.12 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.11 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 43.31 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.13 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 32.54 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -51.13 104.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 74.53 110.879 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.447 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.2 t-20 -165.88 -157.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 73.1 110.959 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.49 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.869 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.08 -47.23 16.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.24 -58.64 12.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 71.1 112.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.22 -47.65 84.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.755 0.312 . . . . 54.4 110.949 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -67.28 -10.96 55.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 71.25 110.764 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.98 -5.89 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.03 111.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.34 36.98 8.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 53.34 112.59 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.03 133.59 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.748 0.309 . . . . 73.41 111.016 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 61.23 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 77' ' ' VAL . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.854 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 162' ' ' THR . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 64.4 110.939 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 63.44 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 54.3 110.851 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 73.43 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 72.03 112.591 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 51.55 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' A' ' 158' ' ' MET . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.097 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 34.13 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.12 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 62.31 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 51.4 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.42 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.32 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.52 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 64.44 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 62.14 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 189' ' ' GLY . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 62.55 110.844 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 31.54 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 60.33 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.1 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.729 ' HG3' ' HB1' ' A' ' 136' ' ' ALA . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 71.01 110.88 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.03 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.44 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 132' ' ' SER . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.32 111.213 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 71.4 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.14 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.41 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.548 ' HG2' ' C ' ' A' ' 171' ' ' ALA . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.42 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 63.33 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.2 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.548 ' C ' ' HG2' ' A' ' 167' ' ' LYS . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 65.41 111.025 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 62.4 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 62.11 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 61.42 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 62.41 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 73.02 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 65.22 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.43 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 16' ' ' VAL . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 73.1 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 71.53 112.542 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 72.43 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 62.13 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 71.23 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.815 0.34 . . . . 73.01 110.83 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -156.38 44.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.43 110.832 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 62.42 111.081 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.12 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 54.45 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 45' ' ' THR . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.746 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 64.4 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.54 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 33.12 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.35 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.31 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.45 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.753 HG22 HG12 ' A' ' 183' ' ' VAL . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 71.34 111.161 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.45 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 -171.82 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 73.21 112.36 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.17 -42.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 64.03 111.148 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -178.55 175.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.03 110.896 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.15 -135.87 7.47 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.688 -0.768 . . . . 62.54 112.473 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.14 -75.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.791 0.329 . . . . 71.04 111.088 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.684 -0.77 . . . . 74.53 112.396 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.19 -177.19 14.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.733 -0.746 . . . . 65.25 112.49 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -57.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.737 0.303 . . . . 71.54 111.177 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -87.6 -61.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 51.42 110.971 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.66 156.24 27.69 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.686 -0.769 . . . . 63.04 112.472 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.0 -68.61 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.96 0.41 . . . . 64.54 110.912 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 57.14 -169.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.11 110.966 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.14 -18.74 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 72.03 112.536 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 124.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.802 -0.713 . . . . 74.11 112.432 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -143.18 113.61 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 71.15 110.979 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -124.14 80.65 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.889 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -149.9 109.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 53.32 111.058 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 137.63 36.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 74.42 111.084 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.02 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 16' ' ' VAL . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.55 110.9 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.33 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 71.51 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.34 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 70.05 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.24 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 8' ' ' PHE . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.22 111.222 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.23 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.55 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' THR . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 73.24 111.071 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.757 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 64.11 111.157 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.44 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.2 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.23 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.34 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.901 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 64.44 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 72.12 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.3 111.147 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 60' ' ' THR . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.11 112.332 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 70.04 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 71.21 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -67.44 144.01 55.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.814 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -82.74 173.48 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.888 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 66' ' ' ILE . 14.0 tt -152.73 122.82 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 60.43 111.073 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.76 -154.54 25.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 41.21 112.526 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 161.93 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 64.11 111.096 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.834 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.64 -50.85 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 71.21 111.036 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.77 -32.41 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 71.21 111.182 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.93 -28.73 12.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 60.41 112.521 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.56 -75.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.774 0.321 . . . . 54.22 110.87 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.5 mm 64.47 105.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 63.13 111.129 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.41 163.51 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 63.52 111.111 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 70.41 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 112' ' ' ASP . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.01 111.13 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.45 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.22 110.843 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 74.51 110.739 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 45.22 112.385 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 64.05 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 70.43 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 65.23 110.914 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.43 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 71.04 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.493 ' O ' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 72.13 110.89 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 99' ' ' PRO . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.892 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' HB2' HG11 ' A' ' 101' ' ' VAL . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.44 110.859 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.34 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.41 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.51 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.54 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.54 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.23 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 144' ' ' LEU . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.41 112.361 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.45 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 60.5 111.076 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.41 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.3 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 133' ' ' TRP . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 70.21 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.13 110.973 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.12 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.587 HG22 HD13 ' A' ' 80' ' ' LEU . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.33 111.116 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.21 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.12 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.35 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 77' ' ' VAL . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.988 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.608 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.983 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 55.53 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.784 ' CE1' HD22 ' A' ' 124' ' ' LEU . 2.5 m-85 -72.32 169.12 16.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.02 110.821 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -177.51 -152.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 72.14 110.853 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -46.14 -56.6 5.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 54.43 110.799 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 52.7 m80 -78.22 -50.16 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.846 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.699 ' CA ' HD12 ' A' ' 124' ' ' LEU . . . -54.43 -58.75 11.82 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.734 -0.746 . . . . 42.24 112.512 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -58.15 -49.16 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.719 0.295 . . . . 73.43 110.857 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -68.11 -11.7 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.877 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' HIS . . . -87.56 -3.37 58.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.02 111.173 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.76 -9.63 8.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 74.45 112.386 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.784 HD22 ' CE1' ' A' ' 115' ' ' PHE . 4.4 mt -85.44 166.48 16.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 61.14 110.854 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 70.12 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 54.41 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.608 HD13 ' O ' ' A' ' 113' ' ' ASN . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.919 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 71.04 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.489 ' CD1' HD12 ' A' ' 127' ' ' LEU . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.11 110.824 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 62.24 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.541 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 62.25 110.792 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' HB2' HD11 ' A' ' 105' ' ' ILE . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.32 110.962 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 160' ' ' ILE . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.23 112.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 62.3 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 63.11 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 31.44 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.31 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 54.41 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.2 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 100' ' ' TYR . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 54.2 111.195 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.01 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.529 ' HA ' HD23 ' A' ' 150' ' ' LEU . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.15 110.971 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 62.35 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.03 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.44 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.54 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 62.13 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 144' ' ' LEU . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 62.25 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 51.21 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.2 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.516 ' HB2' HG23 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.24 110.972 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 74.54 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.31 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 134' ' ' GLY . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 132' ' ' SER . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.54 111.182 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.53 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.05 111.051 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.03 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 74.3 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.52 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.45 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.53 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.55 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 55.21 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 65.13 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.43 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.54 110.911 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 178' ' ' ARG . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.948 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 60.53 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.34 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.753 HG12 HG22 ' A' ' 16' ' ' VAL . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 64.01 111.091 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 61.52 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.51 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 54.04 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.51 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 54.25 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 64.42 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.55 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.739 0.304 . . . . 51.31 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.17 102.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 72.2 110.847 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.3 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.53 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.11 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 74.34 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.751 ' CE2' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.959 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.504 ' HE1' HD22 ' A' ' 42' ' ' LEU . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 54.11 110.8 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' NH2' HG21 ' A' ' 45' ' ' THR . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.814 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.41 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.54 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 42.43 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 62.11 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.34 111.156 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.02 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.12 112.297 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -67.33 -24.86 65.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 61.23 111.151 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -61.73 -169.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 50.2 110.906 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.05 -38.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 62.2 112.513 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.81 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 65.51 111.044 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.56 -65.81 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 64.35 112.461 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.94 -146.95 7.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 64.2 112.542 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 p -141.91 -73.55 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 73.53 111.119 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.3 mt -121.58 -73.06 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.879 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.84 164.99 16.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.703 -0.761 . . . . 65.03 112.453 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.62 -170.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 73.15 110.868 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.06 169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.59 43.52 0.82 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 54.01 112.551 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.27 -150.37 31.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 75.42 112.467 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 66' ' ' ILE . 13.3 t80 -136.5 165.34 26.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.764 0.316 . . . . 71.05 110.926 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.13 164.11 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 51.51 110.856 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.39 152.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 54.24 111.098 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t -79.63 124.73 28.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 63.51 111.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.45 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.43 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.23 111.014 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.51 110.94 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 64.11 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.12 110.838 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 55' ' ' GLU . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.51 111.176 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.72 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.435 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.2 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 64.12 111.098 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 64.42 111.085 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 65.31 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 71.32 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 51.11 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.22 112.526 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 48' ' ' ALA . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 61.25 111.198 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' HG22 ' A' ' 45' ' ' THR . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.1 110.803 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.35 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 63.54 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.12 111.064 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 55.02 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 72.12 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 53.34 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 76' ' ' THR . 7.0 p-80 -160.51 139.28 10.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.841 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 21.1 ptmt -79.23 -164.51 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 74.44 110.874 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 32' ' ' PHE . 18.8 tt -148.94 153.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 72.35 111.212 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.81 -139.11 9.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 63.11 112.478 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -89.79 166.38 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 72.33 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -64.97 -15.15 61.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.925 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.0 57.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 52.11 111.115 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 t -122.23 -31.61 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.43 111.099 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.97 -93.69 0.49 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 51.11 112.438 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -82.65 175.25 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 61.12 110.826 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG22 ' C ' ' A' ' 66' ' ' ILE . 6.5 tt -141.63 -41.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.13 111.067 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . . . -144.67 152.31 40.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 74.4 111.027 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 64' ' ' HIS . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.215 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 64.1 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 73.4 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.42 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 70.4 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.33 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 64.32 112.319 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.32 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 72.23 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 63.45 111.173 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.42 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 52.1 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.23 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 44.43 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.35 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 62.25 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.35 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.02 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 64.43 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.02 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 61.52 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.55 111.049 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 72.33 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 63.43 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.633 ' O ' HD11 ' A' ' 80' ' ' LEU . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.55 110.826 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.43 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.21 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.558 ' OD2' HD21 ' A' ' 129' ' ' LEU . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.978 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.1 t30 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 61.24 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 23.31 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.25 166.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.52 110.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.55 ' H ' ' H ' ' A' ' 120' ' ' LYS . 3.6 t-20 -162.44 -168.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.44 110.978 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.08 -62.75 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.879 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.73 -44.58 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 72.5 110.87 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.09 -57.04 21.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.805 -0.712 . . . . 73.52 112.396 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.55 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.64 -47.54 85.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 73.44 110.908 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.11 -11.76 58.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.869 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.25 7.17 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 64.15 111.151 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.01 30.52 66.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.777 -0.725 . . . . 43.31 112.428 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -122.7 -168.16 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.851 0.358 . . . . 73.53 110.942 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 53.12 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.44 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 128' ' ' SER . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.917 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.876 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' OD2' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.05 110.926 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.52 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 160' ' ' ILE . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 71.11 110.923 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.12 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 71.13 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 73.5 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.33 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.43 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.04 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 71.13 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 64.01 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.53 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 73.45 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.15 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.751 HD22 ' CE2' ' A' ' 8' ' ' PHE . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.5 110.823 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 151' ' ' VAL . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.23 111.051 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.52 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 70.41 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 73.21 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 160' ' ' ILE . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.916 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.611 HG13 HD12 ' A' ' 179' ' ' LEU . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 52.03 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 177' ' ' VAL . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.13 111.069 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 163' ' ' THR . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 64.21 111.126 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.32 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 72.12 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.566 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.04 110.906 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 52.24 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.53 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 32.35 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.44 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 63.02 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.44 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.04 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.2 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 162' ' ' THR . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.42 111.193 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 160' ' ' ILE . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.872 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 63.13 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.02 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.13 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 64.4 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 54.33 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.1 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.366 . . . . 74.42 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -106.9 80.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.892 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 49' ' ' THR . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.33 111.158 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 51.51 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.34 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 61.21 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.54 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.6 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 61.2 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.6 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 61.13 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 61.43 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 73.12 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 183' ' ' VAL . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.4 111.096 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 18' ' ' PRO . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 64.32 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.42 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.3 Cg_endo -69.84 115.78 4.26 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.3 112.381 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -92.72 163.1 13.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.162 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.29 150.42 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 61.23 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.37 -116.06 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 64.2 112.519 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.97 105.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 62.01 111.106 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.95 -107.35 1.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 25.44 112.437 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.62 -145.38 4.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 73.44 112.475 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 t 179.1 93.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.886 0.374 . . . . 75.03 111.14 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.8 -74.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 74.35 110.949 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.13 163.53 11.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 63.25 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -160.8 -172.09 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.21 110.876 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.91 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 63.41 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.3 18.45 6.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 54.43 112.44 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.92 -52.19 30.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 51.33 112.467 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -143.3 161.94 37.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 72.21 110.868 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -123.8 164.61 18.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.85 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 111' ' ' PHE . 91.4 t -88.83 124.97 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 72.21 111.146 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.64 167.59 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.14 111.152 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.24 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.34 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 54.34 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.2 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 34.14 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 74.43 111.172 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 72.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.23 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 52.5 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 4' ' ' ALA . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 71.54 111.134 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.03 110.893 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 53.25 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 50' ' ' ASP . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.24 111.12 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.31 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 45' ' ' THR . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.3 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.23 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 55.14 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -63.03 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 62.24 110.868 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -132.22 107.86 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.53 110.799 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -153.19 145.32 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 74.11 111.172 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 66' ' ' ILE . . . 164.51 -145.49 10.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.818 -0.706 . . . . 71.4 112.566 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -95.78 151.62 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 61.42 111.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -17.41 64.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 73.43 110.813 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.55 -50.11 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 54.01 111.074 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.81 -32.49 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 55.01 111.19 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.64 -85.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 72.35 112.499 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -109.58 93.06 4.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 71.14 110.876 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.2 pt -152.17 39.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 64.31 111.029 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HB1' ' ND2' ' A' ' 113' ' ' ASN . . . -114.69 162.99 16.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 72.03 111.126 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 111' ' ' PHE . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.092 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.52 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.41 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.94 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 55.05 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.22 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.825 HG23 ' HA ' ' A' ' 106' ' ' ASN . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.216 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.51 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.14 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.35 110.995 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.1 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.14 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.42 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.13 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 97' ' ' PHE . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.015 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 63.25 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.42 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 93' ' ' ALA . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 64.11 110.969 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 73.31 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.33 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 63.51 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.42 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.1 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.43 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.24 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HG23 ' A' ' 83' ' ' THR . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.44 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.647 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.129 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.527 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 61.35 110.83 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 34' ' ' VAL . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.01 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.492 ' OD1' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.871 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' ND2' ' HB1' ' A' ' 75' ' ' ALA . 0.8 OUTLIER 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.953 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 71.31 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 64.42 109.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.44 110.803 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.418 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.7 p-10 -165.06 -158.81 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 74.13 110.891 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.28 -59.96 2.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 62.14 110.929 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.88 -46.33 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.804 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.13 -58.86 11.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 53.35 112.42 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ASN . 19.7 ttpt -58.18 -48.77 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 74.1 110.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.1 -12.42 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 74.2 110.883 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.73 15.34 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 72.2 111.056 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.39 31.35 42.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 62.21 112.434 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.57 104.3 12.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 72.34 110.861 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 43.1 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' HD23 ' A' ' 168' ' ' LEU . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.12 110.804 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.492 HD23 ' OD1' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.12 110.885 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.647 HD11 HG22 ' A' ' 109' ' ' THR . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.24 110.833 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 64.35 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 52.4 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 162' ' ' THR . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 70.54 110.834 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.31 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.02 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 73.23 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.22 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.33 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.33 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 42.53 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 61.24 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 151' ' ' VAL . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.898 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.22 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 63.03 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.02 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 152' ' ' ASN . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.12 111.158 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.41 110.911 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 53.34 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 72.01 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.2 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.55 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 40.43 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 63.21 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 132' ' ' SER . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.44 111.223 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.51 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 171' ' ' ALA . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.635 HD23 ' OD1' ' A' ' 126' ' ' ASP . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 70.11 110.815 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.41 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.31 111.135 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.44 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.459 ' CA ' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 51.11 110.901 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.55 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.33 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.23 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 70.2 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.01 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.31 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.3 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 64.04 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.554 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 64.45 111.158 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.3 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 70.11 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.21 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 64.01 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 70.43 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.54 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 52.22 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -158.31 25.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.764 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.2 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.52 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.45 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.12 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.43 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.835 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 63.1 111.029 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.31 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.34 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.02 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.65 ' C ' HG23 ' A' ' 183' ' ' VAL . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 50.13 111.189 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 ' HB ' ' A' ' 183' ' ' VAL . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 60.55 111.175 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 61.24 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 148.13 64.1 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.12 112.355 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.803 HG22 ' HG3' ' A' ' 181' ' ' PRO . 60.9 p -74.97 71.88 2.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.42 111.202 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 60.89 73.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.93 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.08 113.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.699 . . . . 73.23 112.591 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.09 67.02 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 32.43 111.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.5 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 44.52 112.515 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.48 63.44 0.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 51.12 112.381 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -114.82 -29.78 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 64.43 111.07 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.63 -65.93 0.51 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.36 -0.382 . . . . 74.22 110.957 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.95 172.49 10.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.695 -0.764 . . . . 62.42 112.41 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.07 147.2 45.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 65.41 110.906 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 tt -170.45 157.62 6.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 74.53 110.931 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.03 32.28 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 73.21 112.487 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.97 35.75 17.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 60.41 112.491 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 123.26 13.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 75.11 110.875 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -147.1 119.12 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.23 110.822 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.0 t -138.78 149.36 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.146 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 145.57 32.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.44 111.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.02 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.51 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 60' ' ' THR . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 55.14 110.95 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.23 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.4 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 57' ' ' LEU . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.049 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.43 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.15 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' THR . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.1 111.131 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.117 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.21 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.33 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 71.34 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.904 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 45.2 111.099 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 39' ' ' GLN . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.13 111.101 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.4 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.24 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 71.33 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -161.27 171.07 19.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.908 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -175.96 73.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 72.24 110.848 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 66' ' ' ILE . 4.3 tp -95.74 111.03 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 64.5 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.45 104.7 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 54.54 112.447 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -160.74 151.18 18.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 65.3 111.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 154.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 72.43 110.821 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.99 -22.41 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 75.22 111.133 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -33.51 27.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.31 111.126 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.96 1.76 62.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 20.14 112.485 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.56 -78.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 72.24 110.869 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.73 HG22 ' ND2' ' A' ' 113' ' ' ASN . 23.3 mt 56.58 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 65.01 111.188 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.16 161.03 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 72.32 111.208 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' N ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.33 111.14 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 64' ' ' HIS . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.176 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 72.11 110.87 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.2 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.887 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.02 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.945 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 55.34 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.24 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 106' ' ' ASN . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.1 111.121 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 55.31 111.12 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 62.41 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 63.43 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.02 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 60.35 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.4 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.23 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.14 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 72.1 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.4 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.41 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 63.43 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.01 111.123 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 45.33 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 63.2 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.633 ' OD1' HG23 ' A' ' 108' ' ' THR . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 54.55 110.997 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.44 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' OD1' ' A' ' 106' ' ' ASN . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 52.43 111.052 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 73.44 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.566 ' H ' HG22 ' A' ' 76' ' ' THR . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.73 ' ND2' HG22 ' A' ' 74' ' ' ILE . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.03 110.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.706 ' N ' HG23 ' A' ' 76' ' ' THR . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.33 112.508 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 124' ' ' LEU . 2.6 m-85 -113.78 170.19 8.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.12 110.906 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 120' ' ' LYS . 7.9 t-20 -179.65 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.838 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -44.94 -54.63 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 72.45 110.806 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 52.8 m80 -78.05 -51.29 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 74.34 110.809 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.66 -59.99 9.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 54.23 112.516 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 116' ' ' ASN . 16.5 ttpt -55.99 -49.81 72.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 74.11 110.959 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -67.76 -13.91 62.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' HIS . . . -85.49 -2.62 58.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 65.14 111.067 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.69 -7.45 6.53 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 64.2 112.425 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 115' ' ' PHE . 4.0 mm? -91.23 169.8 10.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 74.45 110.974 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.41 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HD22 ' A' ' 127' ' ' LEU . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.14 110.774 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.35 110.863 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.31 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 62.13 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 63.22 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.45 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.44 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.12 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 42.25 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.21 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.43 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.52 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.14 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.4 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 70.32 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.4 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.42 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 147' ' ' ARG . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.956 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.667 HD11 ' CG1' ' A' ' 151' ' ' VAL . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 62.13 111.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.567 ' HG2' HD21 ' A' ' 144' ' ' LEU . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.777 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.464 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 74.43 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 54.45 110.879 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 145' ' ' ILE . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.41 111.119 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 152' ' ' ASN . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 61.43 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 72.11 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 70.31 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.2 111.126 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.12 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.44 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.01 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.03 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.747 ' HB2' HD23 ' A' ' 127' ' ' LEU . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.34 110.937 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 168' ' ' LEU . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 65.55 110.867 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.44 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 52.34 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.43 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.2 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 177' ' ' VAL . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.166 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 64.32 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.3 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.803 ' HG3' HG22 ' A' ' 19' ' ' THR . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.21 112.336 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 15' ' ' THR . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.34 111.162 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.22 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.04 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.504 ' H ' ' HB2' ' A' ' 153' ' ' MET . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.32 110.824 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 10' ' ' ARG . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 44.43 111.126 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 65.52 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.22 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 70.44 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.338 . . . . 73.05 110.808 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.42 23.93 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.888 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.24 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 34.41 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.24 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 70.34 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.54 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 70.31 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 62.3 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 65.41 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 55.55 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 70.41 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 63.03 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.33 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 183' ' ' VAL . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 61.22 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.04 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD3' HG22 ' A' ' 16' ' ' VAL . 54.2 Cg_endo -69.76 138.64 38.31 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 43.35 112.363 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.77 150.21 23.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 72.32 111.036 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -172.51 152.24 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 72.43 110.92 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.92 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.669 -0.777 . . . . 74.31 112.505 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 -67.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 62.2 111.039 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.84 57.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.744 . . . . 65.44 112.467 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.28 -126.24 30.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.808 -0.711 . . . . 71.23 112.43 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -48.53 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 72.13 111.017 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.42 -60.82 1.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 74.22 110.933 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.07 63.48 3.61 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.33 112.486 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.2 t -174.44 158.68 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 63.14 110.932 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 tt 63.16 105.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.979 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 42.14 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 62.01 112.535 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.64 105.15 0.99 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.68 -0.771 . . . . 55.34 112.594 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.46 165.3 21.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 62.3 110.897 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 m -151.5 84.78 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 42.12 110.899 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.98 123.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 61.11 111.159 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 139.72 36.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.465 . . . . 73.55 111.033 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.956 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 70.22 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' THR . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.3 111.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.44 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.21 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 72.34 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.44 111.152 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.41 111.191 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 70.14 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 73.05 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.32 110.863 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 71.24 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.12 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.1 111.134 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.733 ' HB2' HG23 ' A' ' 45' ' ' THR . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.41 110.866 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 61.34 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 64.12 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 33.32 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.23 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.05 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 70.41 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.4 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -68.08 163.52 22.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.35 110.916 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 158.96 15.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.03 110.931 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.525 HG21 ' OG1' ' A' ' 71' ' ' THR . 1.2 tt -140.26 145.68 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.431 . . . . 71.11 111.123 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.7 39.97 0.73 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.639 -0.791 . . . . 52.44 112.359 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 70' ' ' ALA . 11.6 t -133.46 171.11 14.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 72.41 111.216 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -62.22 -17.09 57.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 72.34 110.896 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 68' ' ' THR . . . -50.38 -51.81 42.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 54.33 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.525 ' OG1' HG21 ' A' ' 66' ' ' ILE . 17.6 p -128.91 -32.96 2.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 63.13 111.107 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.47 -98.61 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 34.21 112.437 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p30 175.54 -175.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 73.23 110.884 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.0 mt 65.67 79.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.42 111.125 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.48 108.94 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 72.02 111.098 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 71.54 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 113' ' ' ASN . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 44.31 111.087 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.23 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 73.53 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 63.14 112.343 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.23 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 71.3 111.121 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.3 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 62.33 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.421 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 99' ' ' PRO . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.21 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' HG11 ' A' ' 101' ' ' VAL . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.11 110.951 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 43.31 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.4 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.21 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.23 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.712 ' HG2' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 73.15 110.811 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 71.13 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.54 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.05 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.744 ' HB3' HG13 ' A' ' 141' ' ' VAL . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 55.14 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 90' ' ' PHE . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 65.42 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.04 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.31 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' ILE . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.42 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.741 ' HA ' HG22 ' A' ' 83' ' ' THR . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.35 110.928 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.469 ' HE1' HG23 ' A' ' 105' ' ' ILE . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.55 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 62.02 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.31 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 62.42 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.51 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 60.55 110.949 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.04 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -49.37 105.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.33 110.929 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.446 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -164.01 -161.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 73.5 110.901 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.5 -59.45 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 75.0 110.84 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.27 -46.38 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 72.41 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.41 -58.72 12.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 62.43 112.485 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -60.12 -45.75 91.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 75.45 110.881 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.5 -11.64 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 71.23 110.883 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.658 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -107.81 10.92 28.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.34 111.018 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.85 34.48 37.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.79 -0.719 . . . . 61.12 112.497 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 125' ' ' SER . 2.9 pp -120.75 149.22 42.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 73.11 110.974 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 65.21 110.872 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.55 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 130' ' ' LYS . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 35.05 110.967 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.35 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.683 HD22 ' HB2' ' A' ' 164' ' ' ALA . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.885 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 127' ' ' LEU . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 63.35 110.882 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 54.14 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.03 110.925 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.52 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 53.23 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.02 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.12 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.41 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.44 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 33.1 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.41 111.111 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 71.45 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 96' ' ' LYS . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.03 110.882 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.05 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 70.21 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 64.22 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 144' ' ' LEU . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 65.1 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.41 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 72.51 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 43.13 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.585 ' HH2' HG21 ' A' ' 83' ' ' THR . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.826 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.2 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HD13 ' A' ' 160' ' ' ILE . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.858 HG21 HD22 ' A' ' 179' ' ' LEU . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.23 111.11 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.22 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.51 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.33 111.17 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.41 111.138 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.44 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.464 ' CZ ' HD22 ' A' ' 168' ' ' LEU . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.94 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.35 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 72.0 110.818 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 62.41 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.01 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.467 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 43.11 111.095 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 63.53 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.34 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.34 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 160' ' ' ILE . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.945 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.2 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.13 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.15 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 41.13 111.162 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 60.21 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 62.31 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.31 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 64.21 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.53 112.497 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.53 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 64.41 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ttm . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.732 0.301 . . . . 75.1 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -95.33 25.6 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 74.53 110.846 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.55 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.3 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 65.51 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 62.03 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.03 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 61.32 111.13 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 33.41 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.43 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 183' ' ' VAL . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 61.5 111.145 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.631 ' C ' HG23 ' A' ' 183' ' ' VAL . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB ' ' A' ' 183' ' ' VAL . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 71.31 111.096 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -14.42 36.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.33 112.378 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 p 51.71 -171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.18 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.98 -174.47 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 70.22 110.91 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.66 -114.06 0.6 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.688 . . . . 60.31 112.563 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.03 68.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.947 0.403 . . . . 31.04 111.091 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.58 88.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.81 -0.709 . . . . 62.24 112.527 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.61 133.05 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.78 -0.724 . . . . 72.35 112.529 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -115.85 24.87 11.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.73 0.3 . . . . 43.4 111.056 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.82 102.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 73.32 110.89 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 126.77 1.11 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 50.23 112.501 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.28 96.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 65.45 110.895 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.11 170.02 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.083 -0.508 . . . . 74.22 110.886 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.12 43.36 1.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 52.23 112.476 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.46 162.81 18.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.838 -0.696 . . . . 60.12 112.496 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.93 124.91 17.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.908 0.385 . . . . 74.42 110.936 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.19 153.03 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 62.1 110.868 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 65' ' ' LYS . 7.9 p -137.88 154.36 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 72.14 111.124 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -173.9 61.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 71.13 111.081 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 63.43 110.916 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.33 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 70.43 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 61.4 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.01 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 65.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.41 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.33 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 64.21 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 64.54 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.41 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.905 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 24.14 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.1 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.485 HD13 ' HE1' ' A' ' 156' ' ' TRP . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 55.51 110.917 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.54 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.33 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 63.1 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.13 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.53 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.41 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' HG21 ' A' ' 77' ' ' VAL . 9.5 t60 -159.94 129.69 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.762 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -107.93 93.66 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 73.14 110.961 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.3 tt -74.91 147.08 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 75.35 111.123 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.51 40.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.661 -0.78 . . . . 71.33 112.428 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -104.76 157.09 17.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 71.33 111.144 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -19.17 58.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.827 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.99 -50.93 60.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 70.41 111.122 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -25.2 6.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 74.4 111.103 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.41 -94.01 0.56 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.506 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 179.75 177.71 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 62.52 110.817 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 64.35 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 71.34 111.016 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.92 157.45 44.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.094 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 60.13 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 64' ' ' HIS . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 54.41 111.164 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 63.24 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.877 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 64.44 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.934 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.22 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.934 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 64.31 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.24 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.05 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 72.21 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.05 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.34 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.1 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.554 ' H ' HG21 ' A' ' 101' ' ' VAL . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.821 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.52 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.11 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 61.22 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 70.12 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.55 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 71.55 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.15 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.15 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.21 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 90' ' ' PHE . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 61.25 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 23.24 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.22 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 72.15 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 62.44 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.584 ' CG ' HD12 ' A' ' 160' ' ' ILE . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 65.21 110.916 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.566 ' H ' HD12 ' A' ' 80' ' ' LEU . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 71.53 111.104 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.15 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.12 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -50.89 145.68 6.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 73.14 110.899 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.484 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.9 OUTLIER -162.3 -160.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.9 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -46.97 -61.0 2.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 64.41 110.854 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.94 -45.04 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 65.44 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.1 -57.96 16.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 64.33 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' H ' ' H ' ' A' ' 116' ' ' ASN . 12.1 tmtt? -60.65 -46.63 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 71.13 110.934 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.32 -10.98 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 60.24 110.939 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -107.04 3.32 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.13 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.38 41.49 52.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 72.23 112.439 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 168' ' ' LEU . 4.3 mm? -113.23 123.6 50.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 73.14 111.012 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 65.14 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 71.15 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 63.5 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' CB ' HG23 ' A' ' 109' ' ' THR . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.43 110.814 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.32 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.35 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.1 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.22 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.14 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 65.44 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 64.14 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 23.4 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 51.52 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.21 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.764 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.913 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 54.43 111.011 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.35 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.43 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.481 ' C ' HD23 ' A' ' 150' ' ' LEU . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 62.42 110.911 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.12 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 64.31 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 62.54 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 184' ' ' PHE . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.43 111.236 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.485 ' HE1' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.33 110.888 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.53 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.02 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 106' ' ' ASN . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 71.51 111.175 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 43.33 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 71.53 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.11 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 73.23 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.715 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.912 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.34 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.05 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 40.41 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.05 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 62.31 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 63.4 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.837 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 53.4 110.946 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.04 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.22 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 72.21 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.631 HG23 ' C ' ' A' ' 15' ' ' THR . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 70.2 111.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.479 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 65.51 110.854 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.33 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.3 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 43.33 111.108 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.21 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 62.12 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtm . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.671 0.272 . . . . 75.53 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 55.22 70.73 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 73.41 110.867 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.35 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.34 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.43 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.51 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.748 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.51 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.03 110.794 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 187' ' ' SER . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.2 111.155 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.42 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 73.14 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 42.52 111.052 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 64.35 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.43 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 157.81 59.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 72.54 112.385 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.78 HG23 ' CZ3' ' A' ' 182' ' ' TRP . 15.0 m -119.06 150.44 39.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.136 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 126.86 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 74.1 110.841 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.807 -0.711 . . . . 73.01 112.448 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.6 40.58 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 54.41 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.05 -105.65 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 61.12 112.527 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.37 -93.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 42.11 112.476 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -140.83 74.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 72.11 111.125 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.22 40.14 9.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.13 110.946 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.6 138.22 3.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 63.1 112.482 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.476 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -94.38 80.66 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 71.01 110.835 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.656 HD23 ' HG3' ' A' ' 69' ' ' ARG . 4.3 mp -144.69 126.84 15.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.51 110.912 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.25 43.56 1.16 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.742 -0.742 . . . . 62.54 112.47 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 -161.21 0.82 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.795 -0.716 . . . . 75.5 112.487 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 126.38 16.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.392 . . . . 72.23 110.863 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.26 -174.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 45.21 110.87 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.73 HG13 ' OD1' ' A' ' 159' ' ' ASP . 33.0 m -137.96 -176.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.122 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p -78.7 120.47 23.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 71.5 111.14 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' OD1' ' HB1' ' A' ' 14' ' ' ALA . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.875 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 45.52 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.3 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.34 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 62.43 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 44' ' ' PHE . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.54 110.776 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 56' ' ' LEU . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.21 111.151 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 73.21 110.892 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.23 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.21 110.886 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 71.51 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 52.25 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.15 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.3 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 85' ' ' MET . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 43.44 111.228 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.831 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 43' ' ' THR . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 52.54 110.888 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.01 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 55.01 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 34.21 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 63.42 111.215 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.13 112.36 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 70.11 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.15 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.01 106.69 1.61 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 63.25 110.774 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' O ' HD11 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -138.87 79.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 51.44 110.908 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.518 HG21 HG22 ' A' ' 71' ' ' THR . 3.6 mp -98.79 138.08 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 52.31 111.177 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.14 40.12 1.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 62.33 112.515 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -98.02 -178.74 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.706 0.289 . . . . 61.44 111.228 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HG3' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.44 -77.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 64.31 110.911 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.75 -9.26 59.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 52.01 111.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.518 HG22 HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -98.57 -21.48 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 74.14 111.173 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 76.65 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 64.53 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.529 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.1 p30 -117.95 -15.57 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 74.34 110.896 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 73' ' ' ASP . 3.2 mp 64.55 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.027 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.55 163.29 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 64.22 111.101 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 113' ' ' ASN . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.24 111.189 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 70.2 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.883 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.24 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.03 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.41 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.25 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' VAL . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.854 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 70.05 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 60.22 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.43 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.14 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.32 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.34 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.42 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 71.53 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.44 110.948 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 98' ' ' ARG . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 62.14 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.42 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.02 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.21 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.11 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 54.54 111.103 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.44 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 72.21 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.2 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.708 ' HB2' HG12 ' A' ' 77' ' ' VAL . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.43 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.14 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 65.81 147.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.33 110.884 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.531 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.0 OUTLIER -156.74 -173.1 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 63.33 110.864 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -62.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 63.11 110.886 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.42 -46.17 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.827 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -57.32 19.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.763 -0.732 . . . . 64.11 112.435 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.531 ' H ' ' H ' ' A' ' 116' ' ' ASN . 2.9 ttpt -61.88 -46.3 89.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 72.15 110.892 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.07 -11.13 56.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 73.12 110.873 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.13 -0.09 18.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.156 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.658 ' O ' HD23 ' A' ' 124' ' ' LEU . . . 64.94 28.21 73.19 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.707 -0.759 . . . . 73.2 112.486 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' H ' ' A' ' 169' ' ' GLY . 6.3 mt -127.01 121.92 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.399 . . . . 74.43 110.935 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.1 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.01 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 172' ' ' GLN . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.31 110.956 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 54.14 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.13 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' THR . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 72.42 110.802 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.429 ' OG ' HD13 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.795 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 54.1 111.086 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.33 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 33.21 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 73.54 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.844 HG23 HG11 ' A' ' 155' ' ' VAL . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 53.03 111.194 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.53 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 71.41 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 72.55 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 54.12 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.418 ' HZ3' ' HH ' ' A' ' 190' ' ' TYR . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.928 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.53 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 52.11 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.844 HG11 HG23 ' A' ' 139' ' ' VAL . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.32 111.152 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.52 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.52 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.22 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.73 ' OD1' HG13 ' A' ' 34' ' ' VAL . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 160' ' ' ILE . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.065 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 131' ' ' ASP . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.34 111.16 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 174' ' ' HIS . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.44 111.044 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.03 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.14 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.921 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.62 ' HD3' HD13 ' A' ' 127' ' ' LEU . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.855 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.54 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.748 ' H ' HD22 ' A' ' 124' ' ' LEU . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.56 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.15 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.02 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.765 ' HB3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.43 110.955 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 52.51 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 163' ' ' THR . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.31 110.808 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 177' ' ' VAL . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.51 111.186 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 73.53 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.495 HD11 ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.04 110.908 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 50.44 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.35 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.78 ' CZ3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.908 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 183' ' ' VAL . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.54 111.115 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.05 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 74.52 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.41 110.735 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 54.54 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 62.52 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.418 ' HH ' ' HZ3' ' A' ' 149' ' ' TRP . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.33 110.948 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 62.11 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 54.31 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.839 0.352 . . . . 53.04 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -160.25 105.98 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 52.21 110.861 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.55 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.32 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.21 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 47' ' ' MET . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.819 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 64.34 110.918 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 72.3 110.919 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.15 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.22 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.44 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 70.33 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 64.1 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 37' ' ' ASN . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.3 111.128 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.22 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -173.96 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 54.04 112.352 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.4 p -136.47 -175.28 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.05 111.172 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -59.86 112.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 65.04 110.904 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.8 110.71 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 42.31 112.516 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.94 105.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 54.44 111.072 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.55 97.79 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.855 -0.688 . . . . 52.45 112.58 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.3 -171.27 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.85 -0.691 . . . . 53.5 112.418 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 27' ' ' GLY . 90.5 m -160.34 -72.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 72.14 111.094 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt 51.87 32.94 10.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.943 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.738 ' H ' HG22 ' A' ' 25' ' ' THR . . . 129.13 148.43 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.633 -0.794 . . . . 35.33 112.403 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.05 -73.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 75.15 110.82 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 61.92 175.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 74.44 110.962 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.71 43.35 84.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 70.25 112.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.89 75.39 0.33 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 22.12 112.54 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -103.42 101.21 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.373 . . . . 72.03 110.908 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 t -171.95 89.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.912 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 ' CG ' ' A' ' 64' ' ' HIS . 61.6 t -116.92 115.14 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 72.13 111.185 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -80.37 141.08 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.139 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 60.53 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.2 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.14 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 54.14 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.45 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' MET . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.32 110.918 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.52 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.406 ' HB2' ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.791 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.21 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 51.1 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 71.41 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 88' ' ' TRP . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.34 111.126 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.45 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.04 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 65.53 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.45 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.13 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.43 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.03 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 71.3 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.664 ' CG ' HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -64.31 -169.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.784 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.81 -169.32 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 72.23 110.78 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 73' ' ' ASP . 12.1 tt -123.15 140.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 65.04 111.153 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.9 68.9 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 61.14 112.487 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.13 152.79 18.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 53.55 111.114 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -80.66 -0.23 37.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.16 -51.77 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.52 111.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.91 0.05 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 63.34 111.218 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.46 -98.85 2.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 40.45 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' ILE . 1.4 m-20 66.4 143.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.787 0.327 . . . . 73.5 110.845 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 73' ' ' ASP . 1.1 pp -163.56 24.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.205 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . . . -139.05 163.42 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 75.34 111.188 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.03 111.136 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 112' ' ' ASP . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.24 111.235 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 62.53 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.845 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 73.42 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.919 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.31 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.919 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.44 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.44 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.31 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.498 ' CG ' HD13 ' A' ' 52' ' ' ILE . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.4 110.928 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.774 ' HB2' HG22 ' A' ' 101' ' ' VAL . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 72.5 110.94 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 73.15 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 63.3 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 63.03 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.41 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 61.04 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.11 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.45 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.22 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.51 112.344 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.406 ' HA ' ' N ' ' A' ' 89' ' ' TYR . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.94 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 89' ' ' TYR . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 70.23 111.153 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.11 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 65.45 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.31 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.44 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.53 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.13 111.203 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.44 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.803 ' HB2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.844 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.45 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.52 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -51.23 169.06 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 71.3 110.916 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.473 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -162.75 -161.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.905 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -46.34 -59.92 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 60.5 110.85 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -47.68 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.89 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.77 -58.37 13.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.817 -0.706 . . . . 43.25 112.502 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -59.77 -47.7 84.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 71.44 110.929 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -66.31 -11.66 52.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 73.43 110.946 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.411 ' CB ' HD23 ' A' ' 124' ' ' LEU . . . -108.42 13.56 25.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 72.23 110.988 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.92 32.84 66.98 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.711 -0.757 . . . . 72.25 112.491 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER -147.1 179.17 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 63.21 110.868 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.43 110.772 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.52 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 60.25 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 60.25 110.962 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.41 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.13 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 72.12 110.9 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.43 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 70.52 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.2 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 156' ' ' TRP . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 41.54 111.106 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 65.44 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.34 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 62.1 111.109 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 21.24 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 99' ' ' PRO . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 55.21 111.146 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.41 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.02 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.756 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 71.45 110.976 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 144' ' ' LEU . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.14 111.193 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.44 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.401 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.21 110.945 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.756 HD22 ' CB ' ' A' ' 144' ' ' LEU . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 62.31 110.944 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' SER . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 72.04 111.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 62.53 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.45 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.44 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CZ2' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.945 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.34 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 179' ' ' LEU . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.34 110.809 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.93 HG22 HD11 ' A' ' 179' ' ' LEU . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 70.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 65.21 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.933 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.15 111.125 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 65.24 111.147 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.754 ' HA ' HD22 ' A' ' 129' ' ' LEU . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 44.04 111.148 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.42 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.02 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 65.42 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.2 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.04 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.3 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.42 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.21 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 74.45 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.04 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.24 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.485 HG22 ' HB ' ' A' ' 162' ' ' THR . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 63.43 111.134 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.32 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 160' ' ' ILE . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.474 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.03 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.52 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 60.51 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 60.04 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.43 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 50.21 110.889 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 61.13 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.15 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 70.11 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.566 ' CG ' HD11 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 53.32 110.948 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 72.22 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.87 0.367 . . . . 75.44 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -174.29 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 62.42 110.749 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 71.01 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 47' ' ' MET . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 70.21 111.157 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.722 ' H ' ' HE3' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.24 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 61.54 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 74.2 110.959 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 71.34 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 64.14 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 30.41 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.23 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 64.14 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' THR . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.2 111.118 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 HG11 ' A' ' 183' ' ' VAL . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.24 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' PRO . 53.5 Cg_endo -69.62 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 71.23 112.28 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 1.011 HG21 HD13 ' A' ' 127' ' ' LEU . 7.1 t -177.14 -172.07 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 54.22 111.155 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.24 52.64 2.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.892 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.1 133.83 2.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 52.23 112.489 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.26 88.01 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 61.1 111.087 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.82 95.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.649 -0.786 . . . . 71.25 112.486 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.82 127.65 9.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.675 -0.774 . . . . 54.25 112.428 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.561 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 1.8 t 178.45 78.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 74.35 111.064 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 172' ' ' GLN . 0.7 OUTLIER -111.9 19.65 17.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.853 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.82 157.57 26.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 53.43 112.439 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -115.14 -28.49 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 71.55 110.788 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 tp -151.14 39.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.54 110.834 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.12 40.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.762 -0.732 . . . . 53.25 112.46 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 66' ' ' ILE . . . -69.51 -177.64 18.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 55.22 112.423 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -117.11 121.63 41.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 71.41 110.895 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -172.2 145.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 55.12 110.799 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 65' ' ' LYS . 3.3 m -143.53 168.34 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 75.33 111.071 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t -137.79 134.91 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 65.1 111.218 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.12 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 41.03 111.212 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.1 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 53.3 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 63.12 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 62.45 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.3 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.482 HG23 ' CG ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.178 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.31 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.722 ' HE3' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.43 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 44.21 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 60.1 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 88' ' ' TRP . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.184 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 65.22 112.56 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 64.01 111.158 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' CG ' HG23 ' A' ' 45' ' ' THR . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.05 110.889 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.721 ' CB ' HG23 ' A' ' 83' ' ' THR . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.917 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 54.54 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 53.1 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 63.15 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 55.54 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 62.25 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -160.05 146.32 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.869 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 74' ' ' ILE . 38.2 mmtt -143.37 -175.92 4.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.901 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 31' ' ' GLY . 1.4 mp -140.23 164.42 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.271 -0.422 . . . . 64.54 111.166 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 66' ' ' ILE . . . -129.18 136.36 8.95 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.691 -0.766 . . . . 72.32 112.405 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.1 p -145.87 149.55 34.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 75.42 111.127 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.85 156.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 60.33 110.794 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.47 -17.58 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 72.54 111.014 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.96 -33.38 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 74.15 111.075 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.68 101.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 62.54 112.519 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.97 -58.44 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.51 110.966 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -105.43 -164.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 64.13 111.172 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -138.9 168.09 20.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 72.51 111.187 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.12 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 61.35 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 62.21 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.14 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 70.21 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.698 ' HB3' HG23 ' A' ' 108' ' ' THR . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.44 112.443 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 62.12 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.721 HG23 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.06 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.41 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.852 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.3 111.125 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' HB3' HG22 ' A' ' 52' ' ' ILE . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.13 110.954 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.32 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HD1' HG21 ' A' ' 101' ' ' VAL . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.34 110.872 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 71.45 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 72.42 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.35 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 44.13 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.43 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.44 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.51 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.32 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.42 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.24 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.422 HG21 ' HD1' ' A' ' 90' ' ' PHE . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.21 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.32 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.11 112.522 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 65.21 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.21 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 71.44 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 81' ' ' PRO . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 61.12 111.107 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 64.42 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.05 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.421 ' CE1' HG21 ' A' ' 108' ' ' THR . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.924 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 2.2 t30 -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.23 110.806 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.23 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 25' ' ' THR . 4.8 m-85 62.42 156.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.43 110.886 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.8 OUTLIER -162.34 -167.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.53 110.923 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -61.29 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 74.03 110.882 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -79.11 -45.18 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.874 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.75 -57.69 18.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 50.34 112.567 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' H ' ' H ' ' A' ' 116' ' ' ASN . 9.9 tmtt? -60.97 -46.72 89.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.698 0.285 . . . . 74.12 110.863 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.11 -14.57 62.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.15 6.73 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 54.33 111.13 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.4 31.2 27.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.646 -0.787 . . . . 42.35 112.505 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.448 HD11 ' HA2' ' A' ' 169' ' ' GLY . 1.6 mp -115.5 169.38 9.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 74.34 110.93 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.23 110.773 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.14 110.854 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.924 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 71.5 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.31 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.01 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 71.2 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 52.41 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.21 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.23 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 53.32 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.14 111.122 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.02 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 63.33 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 52.14 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 73.0 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 151' ' ' VAL . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 73.21 111.213 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 54.34 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.42 110.959 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 145' ' ' ILE . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 62.14 111.135 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.925 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 44.31 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.492 ' CD2' HG22 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.53 110.885 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 54.45 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 180' ' ' ASP . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 55.4 111.12 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 52.33 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.04 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 62.45 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 53.14 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 70.31 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.55 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.43 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 124' ' ' LEU . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.54 112.487 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 52.4 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.407 ' HB2' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.55 110.904 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.51 110.9 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 51.22 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 177' ' ' VAL . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.227 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 34.01 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.526 ' CG ' HD11 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.33 110.933 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.33 112.346 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 63.04 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.594 HG11 HG12 ' A' ' 16' ' ' VAL . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.24 111.113 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.41 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 61.53 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 50.51 111.1 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.03 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.42 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 71.34 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 60.24 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.834 0.35 . . . . 74.34 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -75.76 88.46 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 75.41 110.889 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 63.32 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HB2' ' CA ' ' A' ' 49' ' ' THR . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.161 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.04 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.52 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HB2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.24 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' H ' ' HB2' ' A' ' 46' ' ' TYR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 61.21 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 65.1 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.21 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.05 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 72.44 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 18' ' ' PRO . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.14 111.081 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.3 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 16' ' ' VAL . 54.5 Cg_endo -69.76 -19.31 36.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 63.11 112.318 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 t -101.51 117.16 34.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.01 111.142 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -127.05 26.56 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.21 110.846 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.84 93.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 72.4 112.584 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.54 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 73.33 111.181 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.76 -108.56 0.52 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 20.13 112.495 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.13 4.7 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.851 -0.69 . . . . 73.4 112.52 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -152.28 -60.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 53.33 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.03 26.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.952 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.32 -148.65 5.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.486 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.82 -35.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 54.31 110.853 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -51.95 166.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 62.4 110.849 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.09 43.52 2.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 71.4 112.466 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.51 129.69 5.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.785 -0.722 . . . . 62.41 112.509 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CD2' HG21 ' A' ' 68' ' ' THR . 3.6 t80 -138.39 102.04 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 74.41 110.926 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.547 ' H ' HG23 ' A' ' 66' ' ' ILE . 40.3 t -167.69 161.91 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.867 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.8 p -107.52 106.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 73.54 111.149 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.62 130.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 43.55 111.161 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.037 HD22 HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.13 110.871 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.43 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.55 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 57' ' ' LEU . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.137 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 40.14 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 54' ' ' VAL . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.33 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.696 ' CA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.194 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.13 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 48' ' ' ALA . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.43 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.13 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.32 110.945 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.12 111.071 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 70.03 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 1.037 HG23 HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 65.12 111.151 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 62.54 112.319 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 63.13 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -61.0 127.53 32.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.51 110.825 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -169.77 65.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.547 HG23 ' H ' ' A' ' 33' ' ' SER . 3.5 mp -95.82 140.94 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 55.53 111.112 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.22 102.09 0.9 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.793 -0.717 . . . . 43.24 112.475 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.782 HG21 ' CD2' ' A' ' 32' ' ' PHE . 9.0 t -160.63 151.32 18.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 70.33 111.192 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 155.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 73.14 110.867 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.95 -22.39 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 51.01 111.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.5 p -82.51 -33.48 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 52.24 111.156 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.22 -74.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 50.04 112.471 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.409 ' C ' HD12 ' A' ' 74' ' ' ILE . 3.5 t70 178.64 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 72.32 110.934 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' C ' ' A' ' 73' ' ' ASP . 2.0 mp 62.33 53.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 70.25 111.16 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.64 163.84 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.41 111.097 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 111' ' ' PHE . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 72.14 111.119 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 61.23 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.05 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 109' ' ' THR . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.43 110.905 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.23 112.38 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.11 112.399 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.55 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 54.14 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 45.54 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.31 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.23 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.45 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 52.22 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 63.05 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 53.31 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.3 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 55.03 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.12 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 71.01 112.304 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.45 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 139' ' ' VAL . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.21 111.023 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.13 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.24 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.44 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.15 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 64.01 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 64.02 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.42 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.22 111.133 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 109' ' ' THR . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 71.45 110.879 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HB3' HG23 ' A' ' 77' ' ' VAL . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 73.21 110.859 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.03 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' HG11 ' A' ' 77' ' ' VAL . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 65.21 110.911 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.3 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -51.46 130.19 26.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.15 110.85 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -163.46 -161.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.934 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 64.1 110.83 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -79.11 -46.95 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.42 110.9 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.62 -58.16 15.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 52.11 112.548 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' A' ' 116' ' ' ASN . 2.0 tttp -59.56 -48.16 82.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.767 0.318 . . . . 74.42 110.956 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.35 -9.98 46.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 73.22 110.84 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.66 -6.84 45.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.45 111.07 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.34 3.23 31.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.686 -0.768 . . . . 54.41 112.5 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp -80.24 122.4 26.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.806 0.336 . . . . 63.45 110.95 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.01 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.521 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.1 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.43 110.876 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 130' ' ' LYS . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 64.51 110.922 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 129' ' ' LEU . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.894 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.714 ' HA ' HG23 ' A' ' 109' ' ' THR . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.809 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.43 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.15 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.03 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.05 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 70.0 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.51 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 101' ' ' VAL . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 64.03 111.13 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 24.23 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 63.14 111.151 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 61.41 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.21 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.922 HD12 HD21 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 145' ' ' ILE . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 73.43 111.042 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.22 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.03 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.922 HD21 HD12 ' A' ' 144' ' ' LEU . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.52 110.917 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.13 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.43 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.24 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.402 ' HZ2' HD22 ' A' ' 57' ' ' LEU . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.41 110.957 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.53 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.24 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 52.53 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 53.33 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 70.3 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 54.41 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.33 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.521 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.1 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 71.44 110.891 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 72.52 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 32.14 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.03 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 167' ' ' LYS . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.11 111.048 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.4 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 63.34 110.873 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.24 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.14 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.33 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.51 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.32 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.52 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.13 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.33 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 71.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.34 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 53.13 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 62.24 111.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 61.2 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.51 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.24 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.3 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.764 0.316 . . . . 65.54 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -176.8 61.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.781 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 49' ' ' THR . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 71.53 111.09 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 63.24 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.11 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 73.34 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.14 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 43.33 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.01 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.24 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.11 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 38' ' ' THR . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 61.13 111.117 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 183' ' ' VAL . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 71.14 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 169.33 19.08 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.41 112.315 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.35 -54.62 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 61.44 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 -64.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 71.25 110.866 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.5 138.02 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.664 -0.779 . . . . 61.41 112.468 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.47 -75.73 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.313 . . . . 74.4 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.02 -97.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 42.13 112.486 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.2 -159.39 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.466 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.8 p -117.03 27.5 9.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.33 . . . . 51.03 111.16 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.93 24.51 14.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 71.3 110.896 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.19 119.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 62.52 112.408 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -179.41 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 73.3 110.839 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -141.16 -176.36 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 73.01 110.903 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.59 44.18 7.46 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.696 -0.764 . . . . 61.11 112.47 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 66' ' ' ILE . . . -51.28 118.78 7.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.77 . . . . 73.01 112.496 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -88.89 165.18 14.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 72.54 110.905 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.13 97.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.907 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.01 145.92 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 61.31 111.155 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p -79.77 118.63 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 71.53 111.142 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.52 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 15' ' ' THR . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.32 111.178 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.2 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.01 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.43 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 55.41 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 56' ' ' LEU . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.857 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' NE2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 55.22 111.115 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 65.1 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.04 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 45.31 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.23 111.043 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 53.35 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 53.3 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.04 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.02 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 63.21 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 84' ' ' LEU . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.891 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 63.01 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.14 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 55.2 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.34 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.23 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 65.31 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -107.26 75.48 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.03 110.953 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.67 ' HB3' HD13 ' A' ' 74' ' ' ILE . 3.8 mmtt -151.25 165.01 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 71.23 110.824 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.68 HD11 ' O ' ' A' ' 31' ' ' GLY . 9.3 tt -154.65 105.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.24 111.169 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.24 69.47 0.67 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.683 -0.77 . . . . 63.5 112.39 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.487 HG22 ' CG1' ' A' ' 66' ' ' ILE . 13.8 t -160.56 157.55 27.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.77 0.319 . . . . 71.12 111.256 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.83 157.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.862 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -14.75 24.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 74.32 111.083 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.8 p -82.14 -31.22 30.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 75.13 111.126 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.65 -91.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 64.24 112.39 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.86 36.05 2.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.72 0.295 . . . . 73.41 110.85 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 65' ' ' LYS . 2.5 pp -82.6 -165.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 70.43 111.142 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 74' ' ' ILE . . . -133.81 163.24 29.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.096 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' THR . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.13 111.099 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.12 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 54.44 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.805 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 62.32 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.02 112.347 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 70.34 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 56' ' ' LEU . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 52.15 110.911 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.3 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.975 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.2 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 73.53 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 71.44 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.12 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.43 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.32 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 71.35 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 65.4 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 144' ' ' LEU . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 72.21 110.904 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.572 ' HA ' HG23 ' A' ' 141' ' ' VAL . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 52.2 112.316 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 101' ' ' VAL . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 61.25 111.091 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.14 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 44.31 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 85' ' ' MET . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.32 112.474 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.25 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.64 ' CZ ' HG22 ' A' ' 109' ' ' THR . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.882 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 62.23 111.05 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 107' ' ' TYR . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.162 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.14 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.22 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.24 112.591 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.87 121.92 26.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.33 110.811 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -172.11 -152.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 52.24 110.865 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -46.08 -57.83 4.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 55.24 110.901 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -48.35 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 72.53 110.767 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.26 -59.13 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 54.21 112.462 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -48.96 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 64.24 110.857 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -11.3 57.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 72.3 110.881 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.55 -1.96 57.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 61.12 111.077 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.45 55.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 62.55 112.522 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.55 102.85 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 65.14 110.949 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 166' ' ' TYR . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.55 110.906 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.04 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 162' ' ' THR . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.22 110.921 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 43.45 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.05 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.14 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.11 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.34 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.04 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.33 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 99' ' ' PRO . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.2 111.11 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.725 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 151' ' ' VAL . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 63.44 110.855 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' A' ' 98' ' ' ARG . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 62.24 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 71.14 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.45 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 71.52 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 188' ' ' ALA . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 64.23 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 63.2 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.871 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.44 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.21 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 61.14 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.13 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.03 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.511 ' CG2' HD23 ' A' ' 129' ' ' LEU . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.42 111.062 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.11 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.11 111.088 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.43 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 126' ' ' ASP . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.1 110.933 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 72.21 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.55 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 64.53 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.13 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.52 110.883 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 54.33 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 64.34 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.35 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.2 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.32 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 16' ' ' VAL . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 44.32 111.095 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.24 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.0 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.42 111.067 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.24 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.1 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.4 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 72.5 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 58.31 25.53 12.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 73.33 110.845 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.35 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.02 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 63.4 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 61.41 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CA ' ' HB2' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.32 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.505 ' N ' ' HB2' ' A' ' 191' ' ' ARG . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 55.13 111.108 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 54.13 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 73.34 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.21 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 53.35 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 183' ' ' VAL . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.02 111.174 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.42 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -25.06 29.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.35 112.342 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m 61.47 74.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.23 111.176 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.83 134.39 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.856 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.86 22.69 52.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.808 -0.711 . . . . 73.05 112.518 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.64 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 24.23 111.061 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.09 27.99 6.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 53.22 112.498 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.03 -97.56 1.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.78 -0.724 . . . . 64.14 112.523 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 t -114.39 25.64 10.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.86 0.362 . . . . 64.04 111.174 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 mt -139.43 71.79 1.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.887 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.53 -37.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 54.2 112.403 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 t -95.93 50.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 62.12 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD13 ' OG1' ' A' ' 68' ' ' THR . 7.6 mt -143.11 -62.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 71.22 110.829 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -18.13 49.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.75 . . . . 60.52 112.467 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.45 117.39 4.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 72.13 112.486 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.92 123.96 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 74.43 110.787 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 t -170.84 98.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 73.03 110.859 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 36' ' ' ASN . 6.6 p -160.25 143.66 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 72.12 111.129 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 63' ' ' ARG . 18.0 p -80.23 121.31 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 72.14 111.147 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.687 ' OD1' HG13 ' A' ' 34' ' ' VAL . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.21 110.836 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.43 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' THR . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.21 111.1 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 52.03 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.04 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 61.25 110.809 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 57' ' ' LEU . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.35 111.124 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 70.31 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.52 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.864 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.603 HG22 ' CE3' ' A' ' 88' ' ' TRP . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.15 111.095 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.43 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.34 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 64.43 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 43' ' ' THR . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.02 110.928 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 43.23 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 63.21 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.34 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.3 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.12 110.836 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.405 ' CB ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -157.06 145.62 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.51 110.863 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 5.3 mttt -179.22 126.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.898 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' HB2' ' A' ' 75' ' ' ALA . 14.7 tt -118.3 143.5 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 64.04 111.178 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.52 48.82 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 74.22 112.541 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HD13 ' A' ' 29' ' ' LEU . 8.9 t -148.21 148.74 30.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 74.42 111.143 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 71' ' ' THR . 17.2 ttm180 62.15 157.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.33 110.929 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.16 24.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 65.41 111.092 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 69' ' ' ARG . 15.2 t -86.08 -32.05 21.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 74.02 111.237 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.509 ' HA2' HD13 ' A' ' 66' ' ' ILE . . . -59.8 -101.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 53.04 112.432 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.81 -75.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 74.21 110.811 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 pt -153.97 138.35 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.123 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -114.37 117.5 31.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.55 111.126 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 65.23 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 64' ' ' HIS . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.34 111.096 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 73.14 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.865 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 51.34 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.936 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.33 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.936 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.54 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.543 ' OG1' HD22 ' A' ' 57' ' ' LEU . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.15 111.176 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.01 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.42 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.947 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.603 ' CE3' HG22 ' A' ' 52' ' ' ILE . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.22 110.889 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.41 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 74.42 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 71.33 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 61.33 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.03 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.03 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 71.1 110.856 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.3 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.42 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 139' ' ' VAL . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 71.23 111.102 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.02 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.13 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.31 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 105' ' ' ILE . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 50.41 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.23 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 71.22 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.42 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 70.02 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.05 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.12 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 63.45 149.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.3 110.839 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.8 OUTLIER -161.75 -164.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.55 110.872 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.53 -60.99 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 61.34 110.907 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -45.56 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 72.35 110.859 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.96 16.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.759 . . . . 64.54 112.502 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' H ' ' H ' ' A' ' 116' ' ' ASN . 12.1 tmtt? -60.53 -47.02 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.289 . . . . 74.53 110.846 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.22 -13.61 60.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.421 . . . . 74.43 110.861 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.71 9.95 20.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 75.23 111.089 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 124' ' ' LEU . . . 53.52 31.34 43.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.668 -0.777 . . . . 74.03 112.607 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER -136.54 -172.99 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 61.13 110.918 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 62.13 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 63.41 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.21 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 62.14 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 64.15 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.2 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.34 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.24 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.24 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.42 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 45.3 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 157' ' ' TYR . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 71.31 111.122 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.02 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.33 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HA ' HG23 ' A' ' 101' ' ' VAL . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.138 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.1 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.3 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 62.31 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 72.54 110.994 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.55 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.32 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.03 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 33.05 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 151' ' ' VAL . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.32 110.875 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' N ' HD12 ' A' ' 150' ' ' LEU . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.33 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.938 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 55.11 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.42 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 156' ' ' TRP . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.3 111.028 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 155' ' ' VAL . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.03 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.646 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.52 110.927 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 74.33 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.6 ' CD1' HD12 ' A' ' 179' ' ' LEU . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.12 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 64.35 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 53.22 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.6 ' HB2' ' CG2' ' A' ' 177' ' ' VAL . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 64.53 111.031 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.4 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.33 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 53.41 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.32 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.35 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 55.15 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 164' ' ' ALA . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 63.12 111.212 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.23 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 160' ' ' ILE . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.42 110.949 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.24 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.55 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.12 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 16' ' ' VAL . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.53 111.217 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 43.41 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 61.13 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.085 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 12.2 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.24 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.522 ' HB2' ' CA ' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.11 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 65.12 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.839 0.352 . . . . 65.02 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -175.48 77.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 72.11 110.803 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.21 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.409 ' HB2' ' C ' ' A' ' 48' ' ' ALA . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.32 111.048 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 65.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.34 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 43' ' ' THR . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 70.01 110.837 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 43' ' ' THR . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 53.4 111.089 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.4 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 64.21 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 42.04 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.456 ' C ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.679 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 71.12 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.34 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' CB ' HD13 ' A' ' 179' ' ' LEU . 53.3 Cg_endo -69.8 114.4 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.52 112.247 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 19' ' ' THR . 4.9 t -51.71 119.83 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 74.33 111.151 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -117.89 162.83 17.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.859 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.15 84.3 0.12 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.688 -0.768 . . . . 74.43 112.464 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.7 -36.87 48.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 74.41 111.113 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.32 -54.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.485 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.23 -41.43 1.5 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.687 -0.768 . . . . 71.51 112.534 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -115.36 -27.14 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 64.13 111.127 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.45 68.89 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.855 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.01 107.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.688 . . . . 53.23 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.86 -170.16 2.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 52.33 110.841 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.5 177.94 5.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.95 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.33 43.49 0.91 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 62.04 112.459 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.684 ' C ' HG22 ' A' ' 68' ' ' THR . . . 110.77 -20.42 24.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 63.03 112.591 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.94 117.68 23.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 65.42 111.0 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.2 t -169.24 83.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.825 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' CG1' HD12 ' A' ' 66' ' ' ILE . 35.1 m -77.16 139.41 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.34 111.219 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 130.93 35.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 75.45 111.102 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 55.23 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.93 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 70.31 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.01 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 62.54 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 44.33 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 73.04 110.942 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 11' ' ' ALA . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.15 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.34 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 70.55 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 65.34 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.11 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' C ' ' HB2' ' A' ' 4' ' ' ALA . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.098 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 61.22 111.21 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 71.24 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.44 112.468 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.21 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.783 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.35 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.42 111.124 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.45 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 63.33 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.2 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 158.99 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 35.24 110.834 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -179.14 106.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 75.33 110.862 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD12 ' CG1' ' A' ' 34' ' ' VAL . 15.4 tt -152.69 145.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 73.43 111.123 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.9 96.83 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 64.25 112.457 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 31' ' ' GLY . 35.4 p -61.78 171.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 64.1 111.088 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -16.97 52.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 73.03 110.799 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.04 -50.96 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 70.12 111.154 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 -32.68 13.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 65.15 111.168 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 53.93 42.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 44.0 112.449 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.41 -73.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 72.25 110.856 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm 65.0 56.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.21 111.087 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB1' ' OD2' ' A' ' 126' ' ' ASP . . . -115.09 147.02 40.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 55.02 111.09 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.52 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.31 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 64.55 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.42 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.944 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 63.01 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.944 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 106' ' ' ASN . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.43 111.243 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 64.22 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.016 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 30.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.35 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.705 ' CD2' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 72.04 110.935 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.01 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.21 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.45 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 62.03 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.24 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 54.23 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 63.05 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 72.35 110.984 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.24 112.283 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.93 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.705 HG22 ' CD2' ' A' ' 89' ' ' TYR . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 71.24 111.139 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.35 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 70.35 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.01 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 65.41 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 72.44 110.881 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 80' ' ' LEU . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.31 111.194 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 62.31 111.078 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 63.54 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.21 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.45 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 71.1 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -50.58 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.43 110.858 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' H ' ' H ' ' A' ' 120' ' ' LYS . 10.9 t30 -174.12 -168.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.41 110.894 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -47.85 -61.54 1.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.905 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.62 -48.07 14.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 72.13 110.83 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.614 ' CA ' HD12 ' A' ' 124' ' ' LEU . . . -54.8 -56.73 21.23 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.688 -0.768 . . . . 75.44 112.534 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.535 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -61.49 -48.34 81.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.627 0.251 . . . . 73.52 110.813 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.77 -8.04 32.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.913 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.27 -4.94 47.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.141 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.75 -0.25 32.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 54.12 112.425 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.614 HD12 ' CA ' ' A' ' 119' ' ' GLY . 8.9 mt -86.8 93.35 9.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 71.21 110.967 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 75' ' ' ALA . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 70.12 110.846 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.428 HD12 ' HE2' ' A' ' 130' ' ' LYS . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.4 111.019 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.21 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 74.52 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.428 ' HE2' HD12 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.873 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' HA ' HG23 ' A' ' 109' ' ' THR . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.821 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 64.11 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.14 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 61.02 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.52 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.31 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.65 HG23 HG22 ' A' ' 155' ' ' VAL . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 55.32 111.124 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.04 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.24 111.113 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.666 ' OD2' HD13 ' A' ' 150' ' ' LEU . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.33 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.41 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 45.52 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 51.23 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.54 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.53 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.666 HD13 ' OD2' ' A' ' 142' ' ' ASP . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.12 110.903 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 188' ' ' ALA . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.04 111.032 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.1 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 63.41 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 62.14 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 184' ' ' PHE . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.073 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.23 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.24 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.1 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 53.31 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 61.11 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.35 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.43 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.35 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 62.24 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 64.41 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 62.35 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.11 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.41 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 62.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.14 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.43 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.51 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.45 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.619 ' O ' HD12 ' A' ' 179' ' ' LEU . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.24 110.831 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 65.33 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.634 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.41 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 184' ' ' PHE . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.02 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.773 ' N ' HG13 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 65.55 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 33.15 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 53.53 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.35 111.039 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 51.24 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.1 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 71.21 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.55 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.735 0.303 . . . . 65.33 110.924 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.93 52.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 74.43 110.877 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 61.43 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.44 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.23 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.31 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.53 111.167 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.15 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.24 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 38' ' ' THR . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.12 111.117 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 53.33 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 16' ' ' VAL . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.23 111.105 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.31 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -171.16 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.31 112.364 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -54.75 -28.5 49.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 73.25 111.017 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 62.88 164.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.013 0.435 . . . . 74.2 110.836 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 44.14 112.435 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.83 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 54.34 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.71 105.9 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 61.04 112.487 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.62 169.03 30.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.734 -0.746 . . . . 61.24 112.496 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.63 -25.43 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 60.31 111.108 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.37 -73.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 72.43 110.926 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.01 177.52 39.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.698 . . . . 65.24 112.518 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.522 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -178.31 160.65 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 73.23 110.943 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 28' ' ' SER . 15.5 mt -144.31 -169.48 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 72.41 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.11 43.14 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.723 . . . . 53.31 112.562 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.03 -177.84 15.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 71.41 112.409 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -113.01 115.46 28.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 63.05 110.879 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 p -172.16 129.76 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 54.55 110.802 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' VAL . 6.0 m -109.98 106.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 73.1 111.074 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.9 99.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 54.02 111.132 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.13 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' ALA . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 72.54 111.045 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 73.31 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 11' ' ' ALA . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 64.4 110.878 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.01 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 9' ' ' MET . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 72.15 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 53.22 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.32 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.827 HG22 ' HB ' ' A' ' 52' ' ' ILE . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 53.11 111.139 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 49' ' ' THR . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.02 110.877 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' N ' HG23 ' A' ' 49' ' ' THR . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.35 110.813 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.827 ' HB ' HG22 ' A' ' 49' ' ' THR . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.43 111.256 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 32.42 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 70.51 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.12 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.42 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 44.12 110.944 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 53.11 111.185 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.41 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 79' ' ' HIS . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.42 112.41 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.946 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -64.53 -170.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 71.31 110.898 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -147.21 124.2 11.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 70.23 110.929 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 74' ' ' ILE . 2.0 mp -81.28 136.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 65.33 111.141 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.9 63.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.604 -0.808 . . . . 74.1 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 71' ' ' THR . 14.6 t -160.32 151.37 19.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.727 0.299 . . . . 53.32 111.184 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -2.95 38.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 73.14 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.92 -51.56 9.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.451 . . . . 54.23 111.141 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.568 ' H ' HG23 ' A' ' 68' ' ' THR . 0.8 OUTLIER -129.66 17.66 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 62.44 111.2 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.98 100.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.7 -0.762 . . . . 72.4 112.55 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.99 -36.4 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 72.31 110.79 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 66' ' ' ILE . 28.8 mt 64.37 97.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 71.21 111.175 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . -113.67 161.89 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 72.43 111.006 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.12 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 112' ' ' ASP . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 60.13 111.142 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.885 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 63.4 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.51 112.313 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.51 112.3 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' TYR . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.52 111.076 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.3 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.416 ' HE1' HD13 ' A' ' 57' ' ' LEU . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.781 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 35.32 111.147 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.434 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.2 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.54 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 42.53 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 53.32 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 62.34 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 51.22 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.31 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 144' ' ' LEU . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 63.45 110.954 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 71.3 110.906 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' A' ' 101' ' ' VAL . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.42 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.672 ' HB2' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 99' ' ' PRO . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 52.34 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.21 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 62.41 111.113 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.34 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 62.4 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 63.05 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' H ' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.923 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 70.03 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 70.11 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 54.4 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.518 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.03 110.797 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.22 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 60.03 112.457 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -49.25 152.73 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 71.34 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.455 ' H ' ' H ' ' A' ' 120' ' ' LYS . 9.6 p-10 -166.37 -158.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.859 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -46.47 -59.16 3.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.906 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -78.32 -47.3 18.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 73.5 110.921 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.81 -59.6 10.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 75.22 112.469 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -57.62 -47.94 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.67 0.271 . . . . 63.43 110.859 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.46 -11.02 56.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 75.32 110.797 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.755 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -96.35 -6.97 36.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 55.31 111.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.67 18.8 43.17 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.717 -0.754 . . . . 73.33 112.403 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 122' ' ' ALA . 4.4 mm? -78.86 130.78 36.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.749 0.309 . . . . 73.33 110.997 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.03 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 64.2 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.53 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.23 110.952 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 129' ' ' LEU . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.896 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 53.34 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.41 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.23 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.44 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 34.04 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.13 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 100' ' ' TYR . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 50.14 111.124 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 70.32 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.783 HG22 ' OD1' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.2 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.1 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.449 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.922 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.54 110.923 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 151' ' ' VAL . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.31 111.07 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 70.22 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.01 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.565 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.84 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.918 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.468 HG12 ' HB ' ' A' ' 145' ' ' ILE . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.42 111.24 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 53.32 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 63.45 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 183' ' ' VAL . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.33 111.117 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.422 ' N ' HG22 ' A' ' 155' ' ' VAL . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.85 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.623 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.867 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.61 ' HA ' HD13 ' A' ' 179' ' ' LEU . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.838 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 62.24 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.53 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 41.31 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.656 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.1 110.835 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 32.33 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.02 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 52.42 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 60.53 111.106 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.32 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 167' ' ' LYS . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.45 110.818 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.32 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 61.43 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 64.21 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.468 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.31 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.31 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.21 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 155' ' ' VAL . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.41 111.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 65.32 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.31 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.31 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.22 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 72.33 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.33 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.872 0.367 . . . . 73.22 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -159.34 140.31 12.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.774 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 47' ' ' MET . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 48' ' ' ALA . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.22 112.461 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.42 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.44 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 64.11 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 70.44 110.847 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 52.33 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.14 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 44.05 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 38' ' ' THR . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.04 111.134 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 55.44 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 61.51 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 55.24 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 152.7 69.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.31 112.344 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.507 ' OG1' HD22 ' A' ' 179' ' ' LEU . 14.6 t -175.51 173.39 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 72.24 111.105 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.93 166.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 61.34 110.92 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.13 41.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 75.11 112.46 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.09 76.58 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.384 . . . . 70.35 111.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.75 -37.78 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 72.12 112.547 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.36 178.49 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 61.44 112.473 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.8 m -132.39 -43.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 70.35 111.145 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.11 108.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.22 110.876 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.97 176.08 19.49 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.699 -0.762 . . . . 51.13 112.436 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -53.85 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 73.34 110.907 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.8 -171.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 54.1 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 -17.74 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 63.43 112.458 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 146.46 4.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 63.11 112.503 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 165.29 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 75.14 110.888 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -71.49 -171.41 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.95 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.8 m -76.98 154.39 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.13 111.202 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.2 25.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 60.32 111.116 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 42.02 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 64.54 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' ALA . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.43 111.147 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.4 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 65.51 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.34 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.1 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.11 111.061 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 62.43 111.122 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.15 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.722 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 70.51 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.13 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 64.33 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.43 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.42 110.983 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.54 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.21 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 65.53 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 45' ' ' THR . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 45.1 110.822 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.1 110.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 54.53 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 62.33 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.41 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 63.5 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.32 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -60.26 128.91 39.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.945 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -169.18 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 74.34 110.851 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -97.36 163.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.42 111.109 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.29 169.78 31.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.699 -0.762 . . . . 71.45 112.442 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 70' ' ' ALA . 8.7 t -72.4 162.75 29.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 44.44 111.167 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -11.63 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.825 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 68' ' ' THR . . . -59.49 -51.07 71.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 71.14 111.167 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -121.45 -32.74 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 75.0 111.204 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.67 22.4 14.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.876 -0.678 . . . . 62.33 112.496 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -177.2 132.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 75.24 110.859 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -123.24 -35.21 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 73.41 111.081 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.95 130.15 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 52.23 111.141 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 43.1 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 HD12 ' A' ' 129' ' ' LEU . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.12 111.107 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 71.04 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.2 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 64.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.925 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 63.05 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.925 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 64.14 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.04 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.488 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.41 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.9 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.34 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.3 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 70.52 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.23 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.21 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.468 ' C ' HG23 ' A' ' 141' ' ' VAL . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 71.22 110.899 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.573 ' N ' HG23 ' A' ' 141' ' ' VAL . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.11 112.346 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 61.22 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.03 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 87' ' ' GLN . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 63.31 112.549 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 44.51 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.01 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 63.4 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 71.55 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.43 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 80' ' ' LEU . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.13 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.13 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.24 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.725 ' H ' HD23 ' A' ' 124' ' ' LEU . 61.6 t80 59.56 98.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.22 110.948 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.442 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.3 t30 -163.42 -159.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.878 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.86 -60.33 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 63.12 110.805 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -79.42 -45.87 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.76 -58.26 14.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.731 -0.747 . . . . 61.21 112.437 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -60.26 -47.36 86.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.3 110.913 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.19 -10.4 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.975 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.6 -6.84 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 64.43 111.188 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.09 18.86 30.22 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.761 -0.733 . . . . 52.14 112.492 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 115' ' ' PHE . 13.3 tp -79.92 134.68 36.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 73.22 110.94 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 124' ' ' LEU . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.35 110.882 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.966 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 65.42 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.44 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.55 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 64.42 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.23 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.14 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.517 ' HB2' ' NE1' ' A' ' 156' ' ' TRP . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.32 111.011 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 74.22 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.11 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 139' ' ' VAL . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.43 111.02 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 99' ' ' PRO . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 65.2 111.127 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.613 ' CB ' ' HA ' ' A' ' 152' ' ' ASN . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.43 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.04 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 72.32 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.15 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 43.35 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 71.04 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.04 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 151' ' ' VAL . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.4 110.982 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.612 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 62.11 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 64.41 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.506 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.22 110.822 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.22 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 64.13 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.517 ' NE1' ' HB2' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.52 110.956 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 51.32 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' VAL . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.852 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 63.21 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 73.4 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.45 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 53.22 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.41 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 15.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 62.11 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.608 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.55 110.996 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.446 ' HB3' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.12 110.84 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.34 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 64.32 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.53 111.017 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.13 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.3 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.1 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.4 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 65.2 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.507 HD22 ' OG1' ' A' ' 19' ' ' THR . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 64.13 110.974 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.54 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.35 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' A' ' 158' ' ' MET . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.32 111.136 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.23 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.32 111.042 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 54.43 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 55.4 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.41 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.42 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 60.23 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -85.79 55.28 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.871 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 62.15 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.883 ' HB1' HG23 ' A' ' 49' ' ' THR . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.31 111.128 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.21 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.24 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 61.01 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.15 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.836 ' HB2' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 65.44 110.855 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.55 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.22 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.32 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.31 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG22 ' CG2' ' A' ' 183' ' ' VAL . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.41 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.33 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -170.69 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.31 112.405 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.52 -171.54 2.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 62.25 111.082 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -51.76 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 71.43 110.902 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' HB2' ' A' ' 70' ' ' ALA . . . 68.27 132.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 34.34 112.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.306 . . . . 70.03 111.076 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -94.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.711 -0.757 . . . . 71.15 112.499 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.01 -150.57 13.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.808 -0.71 . . . . 73.12 112.544 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.46 -74.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 64.21 111.163 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.44 -69.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 70.04 110.937 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.29 19.59 48.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 70.3 112.443 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.4 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -145.11 155.5 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 72.22 110.855 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER 62.74 -177.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.91 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA2' HG21 ' A' ' 71' ' ' THR . . . 119.47 41.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.644 -0.788 . . . . 34.1 112.487 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 71' ' ' THR . . . -72.44 143.1 33.64 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.733 -0.746 . . . . 71.53 112.426 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -50.7 165.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 71.51 110.889 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.27 165.63 23.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.15 110.799 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -140.57 -178.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.24 111.112 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t 175.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.184 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.908 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' THR . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.23 110.941 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.02 111.226 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.32 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 64.32 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.54 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 74.42 110.943 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 10' ' ' ARG . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 61.45 111.076 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.3 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 62.22 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 64.51 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 61.33 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.01 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.883 HG23 ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.126 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 71.12 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 63.42 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.31 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 83' ' ' THR . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.12 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.059 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.11 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.24 112.455 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.965 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.515 ' O ' HG21 ' A' ' 76' ' ' THR . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 64.34 110.92 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -149.92 94.91 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.849 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER 178.64 45.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 64.14 110.811 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 65' ' ' LYS . 19.1 mm -135.05 133.72 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.31 111.189 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.31 -138.79 5.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 32.22 112.541 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.16 -179.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 74.2 111.205 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -51.32 -97.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 63.11 110.847 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 21' ' ' GLY . . . -83.13 -12.09 57.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 64.44 111.076 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.611 HG21 ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -82.69 -36.05 26.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 73.03 111.139 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 33.7 83.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.736 -0.745 . . . . 74.03 112.465 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' O ' HG13 ' A' ' 34' ' ' VAL . 9.1 t0 -49.81 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 73.14 110.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG22 ' OD1' ' A' ' 73' ' ' ASP . 4.3 tt 171.71 113.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 72.23 111.088 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.88 106.62 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 70.31 111.104 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 63' ' ' ARG . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.23 111.085 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 62.53 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 71.4 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.14 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 73.25 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.929 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.31 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.929 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 62.22 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.403 ' C ' HD23 ' A' ' 56' ' ' LEU . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 71.31 111.084 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.41 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.4 111.131 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.55 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 63.14 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.44 111.032 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.14 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 63.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.31 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 71.22 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.33 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.35 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 53.04 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 54.52 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 90' ' ' PHE . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 34.44 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.22 111.105 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.21 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 134' ' ' GLY . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.41 111.07 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.15 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.31 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 64.14 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.33 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.15 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -53.77 168.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 71.03 110.799 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.47 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.3 t30 -162.54 -160.56 0.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 74.24 110.905 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -60.22 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 75.51 110.871 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -79.36 -46.48 17.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 70.21 110.897 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.765 ' HA2' HD12 ' A' ' 124' ' ' LEU . . . -55.34 -58.32 14.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.754 . . . . 71.33 112.435 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' H ' ' H ' ' A' ' 116' ' ' ASN . 1.6 ttpm? -60.21 -47.36 86.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.6 0.238 . . . . 71.32 110.874 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.75 -11.11 53.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 75.03 110.873 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.09 10.67 28.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 75.21 111.171 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.25 34.08 88.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.691 -0.766 . . . . 65.23 112.502 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.765 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.5 mt -90.94 80.75 5.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 53.21 110.968 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 70.02 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.659 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.811 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 163' ' ' THR . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 64.52 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 64.5 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.34 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.12 112.504 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 51.24 111.053 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.1 111.129 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.12 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.55 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 64.32 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 73.22 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 61.53 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.573 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 71.04 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.42 110.933 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.41 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 64.25 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 63.42 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 150' ' ' LEU . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 53.22 110.909 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 42.42 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.42 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 184' ' ' PHE . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.44 111.083 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 63.34 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 64.03 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.43 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 63.03 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.664 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 34.24 111.145 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.4 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.41 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.34 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 74.41 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 65.42 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 53.44 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 64.2 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.11 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.11 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.11 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.55 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.51 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.22 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 53.51 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 65.24 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.621 ' CG2' HG22 ' A' ' 16' ' ' VAL . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 35.12 111.162 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.758 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.936 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.31 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 62.21 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 72.34 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 22.03 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 72.11 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 55.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 63.43 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.8 0.333 . . . . 53.03 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -82.25 68.33 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.865 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.33 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 51.24 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.4 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.53 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.793 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.924 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 45.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.21 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.41 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.597 ' C ' HG23 ' A' ' 183' ' ' VAL . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.2 111.116 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 180' ' ' ASP . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.43 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 70.44 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.9 Cg_endo -69.74 -17.23 37.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.45 112.387 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.4 p -58.19 108.08 0.56 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 74.24 111.104 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.05 -170.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 72.33 110.865 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.9 -73.69 1.26 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.728 -0.748 . . . . 43.53 112.364 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.63 106.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 71.53 111.074 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.97 -28.06 7.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 52.32 112.52 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.68 154.98 11.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 64.44 112.483 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.5 t -55.41 -32.04 62.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 42.23 111.131 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 59.72 98.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.977 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.84 -116.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.79 . . . . 44.24 112.486 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 -39.2 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 71.33 110.82 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.06 152.5 23.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 70.45 110.979 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.91 24.25 5.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 72.15 112.523 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' THR . . . -63.15 107.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 63.44 112.552 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -108.7 154.25 22.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 71.5 110.898 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 m -154.12 114.08 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 62.21 110.894 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.2 176.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 65.31 111.208 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.82 139.75 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.5 111.13 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.13 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 63.42 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.43 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 55.15 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 43.04 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.32 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 55' ' ' GLU . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 70.45 111.058 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.54 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 63.24 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.44 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 54.41 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.24 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.2 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.02 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HB2' HG22 ' A' ' 45' ' ' THR . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.14 110.826 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.41 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.41 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 42.24 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.41 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.44 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.692 ' CB ' HG21 ' A' ' 77' ' ' VAL . 6.5 t60 -160.0 161.94 34.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.44 110.842 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -151.56 112.79 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.902 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.91 106.09 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 71.12 111.192 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.41 42.63 1.35 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.788 -0.72 . . . . 32.42 112.574 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.722 HG22 ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -90.54 -178.33 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 73.54 111.23 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.722 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -48.6 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 72.43 110.821 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.71 -8.63 59.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 65.14 111.071 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.94 -5.36 30.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 72.5 111.111 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.97 71.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.785 -0.722 . . . . 74.43 112.513 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.63 -12.9 18.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 74.03 110.856 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 64.43 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 72.22 111.064 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.62 163.48 18.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 54.43 111.14 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 64.43 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 64' ' ' HIS . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 64.03 111.128 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 108' ' ' THR . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.42 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.874 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 71.05 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.931 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.42 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.931 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 62.43 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 107' ' ' TYR . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.31 111.085 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.3 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.01 111.079 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 103' ' ' ALA . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 60.33 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 54.21 110.89 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 45.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 61.33 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.05 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.43 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 65.33 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 53.11 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.35 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.21 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 139' ' ' VAL . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.02 111.059 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.51 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB3' ' CH2' ' A' ' 88' ' ' TRP . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 51.51 111.073 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 35.12 112.442 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 62.33 111.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 62.42 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 79' ' ' HIS . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.11 111.093 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.12 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 61.34 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.35 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 73.13 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.27 124.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 63.0 110.786 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.8 t30 -169.11 -161.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 65.11 110.826 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.54 -60.1 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 72.23 110.876 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -78.44 -46.48 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 71.35 110.755 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -57.79 16.72 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.743 -0.741 . . . . 72.01 112.437 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.6 -47.52 85.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 74.23 110.852 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -67.42 -11.11 56.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.44 111.0 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.04 13.35 29.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 75.34 111.204 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.26 28.58 19.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 64.34 112.545 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 125' ' ' SER . 1.1 pp -144.74 -175.98 4.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 63.43 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 124' ' ' LEU . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.83 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.35 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 165' ' ' ASN . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 61.53 110.884 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.41 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 64.5 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.03 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 107' ' ' TYR . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.1 112.625 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.52 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 71.13 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 62.53 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 63.05 110.943 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 101' ' ' VAL . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 55.51 111.152 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.32 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 151' ' ' VAL . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.33 110.938 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.11 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.44 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.3 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 63.23 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 62.22 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 72.13 111.009 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.43 111.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.13 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 61.42 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.15 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.02 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.3 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 71.03 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 61.34 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.3 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.11 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.44 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.484 ' C ' HG23 ' A' ' 177' ' ' VAL . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 52.21 111.236 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.711 ' HB3' ' CB ' ' A' ' 175' ' ' ASP . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.4 111.099 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.726 ' HB3' HD23 ' A' ' 127' ' ' LEU . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.923 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.966 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.23 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 65.02 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.01 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.32 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.31 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 43.23 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 71.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.11 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.711 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.11 110.898 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.04 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 163' ' ' THR . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.235 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 60.14 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 107' ' ' TYR . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.53 110.859 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 16' ' ' VAL . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.05 110.8 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 64.31 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.597 HG23 ' C ' ' A' ' 15' ' ' THR . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 62.14 111.231 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.41 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.11 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 63.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.42 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 61.53 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 53.51 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.51 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.767 0.317 . . . . 62.12 110.844 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -174.99 91.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.849 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.1 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.54 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.3 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.54 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 150' ' ' LEU . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 65.55 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.55 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.44 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 45.32 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.21 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.21 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 183' ' ' VAL . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.087 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.44 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 133.58 25.91 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 62.11 112.306 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.2 p -128.77 -173.0 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 55.41 111.113 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 139.14 26.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 73.05 110.882 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.54 109.69 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.486 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.17 106.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 71.43 111.162 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.41 -110.34 1.3 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.742 -0.742 . . . . 63.54 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.55 171.91 55.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 72.23 112.425 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -105.69 -31.66 8.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 72.34 111.169 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 29' ' ' LEU . 2.8 mm? 52.11 88.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 71.12 110.859 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 39.55 2.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 22.04 112.457 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.28 -73.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 72.34 110.793 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.9 pp -174.34 172.08 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 70.31 110.934 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.67 43.68 35.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.487 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.58 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 44.24 112.572 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.64 160.26 40.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 74.24 110.9 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -111.95 -171.57 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 43.34 110.821 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.11 163.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -80.26 123.38 27.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 44.24 111.086 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.34 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.31 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 50.34 110.895 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 57' ' ' LEU . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 65.01 111.188 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.506 ' CE2' HD12 ' A' ' 42' ' ' LEU . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.793 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.65 HG23 ' HG2' ' A' ' 55' ' ' GLU . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 53.25 111.147 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.44 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.2 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 71.51 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 61.15 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 62.43 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.12 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.11 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' HG23 ' A' ' 45' ' ' THR . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.854 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 61.21 111.03 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 51.24 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 70.11 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.23 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.34 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' VAL . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.15 110.85 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.819 ' CG ' HD13 ' A' ' 74' ' ' ILE . 7.9 p80 -160.1 156.91 27.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.04 110.861 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' O ' HD13 ' A' ' 66' ' ' ILE . 1.3 mttt -179.99 84.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.92 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.606 ' H ' HG22 ' A' ' 74' ' ' ILE . 24.4 mm -129.17 151.39 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.52 111.178 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.57 96.28 0.38 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.762 -0.733 . . . . 72.04 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.02 151.53 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 71.01 111.132 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.27 159.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.32 6.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.01 111.077 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -33.3 31.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.55 111.155 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.87 90.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.786 -0.721 . . . . 54.43 112.529 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.76 173.47 10.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 74.24 110.837 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.819 HD13 ' CG ' ' A' ' 64' ' ' HIS . 1.1 pp -95.55 -171.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 73.52 111.096 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -122.03 163.4 19.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 71.02 111.112 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 76' ' ' THR . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.31 111.063 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 63' ' ' ARG . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.151 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.32 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.921 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.32 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.921 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.42 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.31 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.746 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.23 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.43 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.23 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 60.24 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.01 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 64.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 64.4 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 62.15 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 73.32 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.22 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 54.02 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.676 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.22 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.42 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.23 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 134' ' ' GLY . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 62.02 111.12 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.13 110.799 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 73.23 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 72.12 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.01 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 64.12 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB2' HD23 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 65.43 110.812 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.486 ' CB ' ' HB1' ' A' ' 75' ' ' ALA . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 73.11 110.853 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.52 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 127' ' ' LEU . 29.8 p90 -47.46 105.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.31 110.906 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -179.09 -148.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 73.43 110.866 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -45.68 -57.09 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.802 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -79.36 -48.81 13.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.801 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.33 -59.52 10.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 73.45 112.431 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -46.61 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 50.44 110.837 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.45 -15.4 63.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 71.04 110.917 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.82 -5.17 58.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 72.52 111.123 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 124' ' ' LEU . . . 115.56 -25.12 9.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.797 -0.716 . . . . 50.12 112.485 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER 164.99 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 60.04 110.825 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.31 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 53.31 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.526 HD13 ' CE1' ' A' ' 115' ' ' PHE . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.13 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 112' ' ' ASP . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.15 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.12 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.445 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 62.44 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 52.12 111.123 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.41 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 64.11 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.15 111.011 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.42 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.533 ' N ' HD22 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.42 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 73.02 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.33 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.548 ' O ' ' HB1' ' A' ' 188' ' ' ALA . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.795 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 151' ' ' VAL . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.12 111.121 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.652 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.41 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.02 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 65.21 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.52 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 62.21 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 72.2 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 74.33 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 60.33 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 176' ' ' SER . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 60.51 111.235 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.23 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 45.42 110.947 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.2 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 71.32 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 171' ' ' ALA . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.15 110.932 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 124' ' ' LEU . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.05 112.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 65.24 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 168' ' ' LEU . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 52.42 111.017 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.24 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.11 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.4 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 163' ' ' THR . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.44 110.904 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.23 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.903 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 71.53 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.23 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 16' ' ' VAL . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 63.24 111.172 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.4 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.093 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 63.1 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.14 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 71.32 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.754 0.312 . . . . 62.109999999999999 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.150000000000006 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 61.450000000000003 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.549999999999997 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.519999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 32.350000000000001 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 110.859 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 187' ' ' SER . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 111.121 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 54.340000000000003 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 62.240000000000002 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 38' ' ' THR . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.219999999999999 111.092 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.79 HG22 ' HD3' ' A' ' 18' ' ' PRO . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.430000000000007 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 72.450000000000003 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.219999999999999 112.324 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.821 0.343 . . . . 72.140000000000001 111.062 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB2' HG13 ' A' ' 16' ' ' VAL . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 110.934 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 64.299999999999997 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' ALA . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 52.130000000000003 111.182 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.450000000000003 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.109999999999999 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 55.009999999999998 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 72.340000000000003 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.544 HG21 ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.039999999999999 111.12 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 10' ' ' ARG . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.150000000000006 111.161 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.209999999999994 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 71.329999999999998 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 54.439999999999998 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.409999999999997 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.109999999999999 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.6 HD12 ' CE3' ' A' ' 88' ' ' TRP . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 52.130000000000003 111.157 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 42.43 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 35.149999999999999 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' HG21 ' A' ' 43' ' ' THR . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.149999999999999 110.833 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 71.209999999999994 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 53.340000000000003 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 64.430000000000007 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 52.210000000000001 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.030000000000001 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.520000000000003 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 110.786 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.822 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.907 0.384 . . . . 61.520000000000003 111.066 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.553 HG23 ' OD2' ' A' ' 112' ' ' ASP . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 64.530000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 71.120000000000005 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.150000000000006 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.856 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.329999999999998 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.439999999999998 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 52.32 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.140000000000001 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 51.409999999999997 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 52' ' ' ILE . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 71.239999999999995 110.941 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.400000000000006 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.209999999999994 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 64.200000000000003 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 50.530000000000001 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.420000000000002 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.430000000000007 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.519999999999996 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.129999999999995 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 139' ' ' VAL . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 111.127 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 34.420000000000002 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.099999999999994 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 42.229999999999997 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.329999999999998 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.209999999999994 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.310000000000002 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 73.109999999999999 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.400000000000006 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.530000000000001 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 77' ' ' VAL . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 71.519999999999996 110.911 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 71.340000000000003 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.822 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.420000000000002 112.56 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 72.530000000000001 110.901 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 167' ' ' LYS . 44.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.842 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.210000000000001 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.209999999999994 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.47 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.329999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.420000000000002 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 63.340000000000003 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 62.210000000000001 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 63.439999999999998 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.430000000000007 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 55.32 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.43 111.157 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.030000000000001 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.511 ' NE2' ' H ' ' A' ' 139' ' ' VAL . 1.6 mm100 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.319999999999993 110.982 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 101' ' ' VAL . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 53.210000000000001 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.109999999999999 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.210000000000001 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.692 ' HA ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.219999999999999 110.99 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.219999999999999 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 61.450000000000003 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 74.200000000000003 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.010000000000005 110.938 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.030000000000001 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.319999999999993 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.329999999999998 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 65.230000000000004 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 63.109999999999999 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.209999999999994 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.209999999999994 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.319999999999993 110.819 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 70.340000000000003 111.133 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 160' ' ' ILE . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 42.43 110.818 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.439999999999998 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.519999999999996 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 175' ' ' ASP . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 111.176 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.47 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 71.230000000000004 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.715 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.450000000000003 110.886 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.81 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.329999999999998 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.109999999999999 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.81 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 23.300000000000001 111.076 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.25 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.200000000000003 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 164' ' ' ALA . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.040000000000006 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.430000000000007 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 55.219999999999999 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.701 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.400000000000006 110.959 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 178' ' ' ARG . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.239999999999995 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.340000000000003 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.409999999999997 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 110.815 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 44.509999999999998 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 63.149999999999999 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.607 0.241 . . . . 75.120000000000005 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.329999999999998 111.052 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.239999999999995 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 62.539999999999999 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.340000000000003 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.409999999999997 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 60.420000000000002 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.439999999999998 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.040000000000006 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 38' ' ' THR . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 111.065 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 183' ' ' VAL . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 32.539999999999999 111.187 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 64.140000000000001 112.371 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.844 0.354 . . . . 71.019999999999996 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 54.240000000000002 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.140000000000001 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 14' ' ' ALA . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 62.43 111.096 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.439999999999998 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.150000000000006 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 63.420000000000002 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 71.310000000000002 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 57' ' ' LEU . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 111.211 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 55' ' ' GLU . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.400000000000006 111.095 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 71.010000000000005 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.120000000000005 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.219999999999999 111.211 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 63.149999999999999 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 53.420000000000002 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.109999999999999 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 45' ' ' THR . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.310000000000002 110.841 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.530000000000001 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 70.409999999999997 110.929 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 34.310000000000002 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.439999999999998 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.540000000000006 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.219999999999999 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 71.239999999999995 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.862 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.853 0.359 . . . . 60.32 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' OG ' ' A' ' 128' ' ' SER . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 62.509999999999998 111.122 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.43 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.520000000000003 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.866 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.924 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.219999999999999 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.924 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.049999999999997 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 41.329999999999998 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 107' ' ' TYR . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 40.210000000000001 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 61.109999999999999 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 61.130000000000003 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.540000000000006 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.420000000000002 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.439999999999998 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.540000000000006 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.109999999999999 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.349999999999994 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 72.129999999999995 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 64.209999999999994 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 63.210000000000001 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.130000000000003 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.150000000000006 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 134' ' ' GLY . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.233 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 65.310000000000002 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 84' ' ' LEU . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.937 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.450000000000003 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 62.439999999999998 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 74.120000000000005 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.109999999999999 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 43.310000000000002 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 32.539999999999999 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 74.530000000000001 110.879 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.748 0.309 . . . . 73.409999999999997 111.016 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 61.229999999999997 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 77' ' ' VAL . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.854 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 162' ' ' THR . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 64.400000000000006 110.939 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 63.439999999999998 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 54.299999999999997 110.851 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 73.430000000000007 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 72.030000000000001 112.591 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 51.549999999999997 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' A' ' 158' ' ' MET . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 111.097 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 34.130000000000003 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.120000000000005 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 62.310000000000002 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 51.399999999999999 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.420000000000002 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.040000000000006 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 73.450000000000003 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.319999999999993 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.519999999999996 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 64.439999999999998 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 62.140000000000001 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 189' ' ' GLY . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 62.549999999999997 110.844 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 31.539999999999999 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.120000000000005 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 60.329999999999998 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.200000000000003 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.729 ' HG3' ' HB1' ' A' ' 136' ' ' ALA . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 71.010000000000005 110.88 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.030000000000001 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 132' ' ' SER . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 111.213 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 71.400000000000006 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.140000000000001 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.548 ' HG2' ' C ' ' A' ' 171' ' ' ALA . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 72.519999999999996 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 63.329999999999998 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.200000000000003 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.548 ' C ' ' HG2' ' A' ' 167' ' ' LYS . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 65.409999999999997 111.025 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 62.399999999999999 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 62.109999999999999 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 62.409999999999997 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 73.019999999999996 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 65.219999999999999 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 16' ' ' VAL . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.542 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 72.430000000000007 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 62.130000000000003 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 71.230000000000004 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.748 0.309 . . . . 71.430000000000007 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 62.420000000000002 111.081 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.219999999999999 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.120000000000005 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 54.450000000000003 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 45' ' ' THR . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.746 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 64.400000000000006 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.540000000000006 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 33.119999999999997 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.310000000000002 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.753 HG22 HG12 ' A' ' 183' ' ' VAL . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 71.340000000000003 111.161 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.450000000000003 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 73.209999999999994 112.36 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.78 0.324 . . . . 74.420000000000002 111.084 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.019999999999996 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 16' ' ' VAL . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 110.9 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 71.510000000000005 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.340000000000003 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 70.049999999999997 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.239999999999995 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 8' ' ' PHE . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.219999999999999 111.222 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.230000000000004 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.549999999999997 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' THR . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 73.239999999999995 111.071 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.757 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 64.109999999999999 111.157 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.200000000000003 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.340000000000003 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.901 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 72.120000000000005 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 111.147 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 60' ' ' THR . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.109999999999999 112.332 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 70.040000000000006 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.030000000000001 110.814 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.793 0.33 . . . . 63.520000000000003 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 70.409999999999997 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 112' ' ' ASP . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 111.13 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.219999999999999 110.843 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 74.510000000000005 110.739 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 45.219999999999999 112.385 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 64.049999999999997 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 70.430000000000007 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 65.230000000000004 110.914 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.43 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.129999999999995 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.493 ' O ' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 72.129999999999995 110.89 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 99' ' ' PRO . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.892 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' HB2' HG11 ' A' ' 101' ' ' VAL . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.439999999999998 110.859 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.340000000000003 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.409999999999997 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.510000000000005 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.540000000000006 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.150000000000006 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.540000000000006 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.230000000000004 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 144' ' ' LEU . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.409999999999997 112.361 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.450000000000003 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 60.5 111.076 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.409999999999997 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.299999999999997 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.329999999999998 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 133' ' ' TRP . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 70.209999999999994 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.973 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.120000000000005 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.587 HG22 HD13 ' A' ' 80' ' ' LEU . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.329999999999998 111.116 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 77' ' ' VAL . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.988 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.608 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 71.120000000000005 110.983 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 55.530000000000001 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.784 ' CE1' HD22 ' A' ' 124' ' ' LEU . 2.5 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.019999999999996 110.821 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.784 HD22 ' CE1' ' A' ' 115' ' ' PHE . 4.4 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 61.140000000000001 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 70.120000000000005 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 54.409999999999997 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.608 HD13 ' O ' ' A' ' 113' ' ' ASN . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.239999999999995 110.919 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 71.040000000000006 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.489 ' CD1' HD12 ' A' ' 127' ' ' LEU . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.109999999999999 110.824 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.140000000000001 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 62.240000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.541 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 62.25 110.792 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.603 ' HB2' HD11 ' A' ' 105' ' ' ILE . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.32 110.962 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 160' ' ' ILE . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.230000000000004 112.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 62.299999999999997 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 31.440000000000001 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 54.409999999999997 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.200000000000003 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 100' ' ' TYR . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 54.200000000000003 111.195 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.009999999999998 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.529 ' HA ' HD23 ' A' ' 150' ' ' LEU . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.150000000000006 110.971 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 62.350000000000001 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.030000000000001 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.439999999999998 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.539999999999999 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 62.130000000000003 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 144' ' ' LEU . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 62.25 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 51.210000000000001 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.230000000000004 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 52.210000000000001 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.516 ' HB2' HG23 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.972 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 74.540000000000006 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.310000000000002 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 134' ' ' GLY . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 132' ' ' SER . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.540000000000006 111.182 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.049999999999997 111.051 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.030000000000001 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 65.109999999999999 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 74.299999999999997 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.519999999999996 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.439999999999998 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.450000000000003 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.530000000000001 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.549999999999997 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 55.210000000000001 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 65.129999999999995 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.430000000000007 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.911 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 178' ' ' ARG . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.948 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 60.530000000000001 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.340000000000003 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.753 HG12 HG22 ' A' ' 16' ' ' VAL . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.091 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 61.520000000000003 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.510000000000005 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 54.039999999999999 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.509999999999998 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 54.25 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 64.420000000000002 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.549999999999997 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.787 0.327 . . . . 72.200000000000003 110.847 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.299999999999997 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.530000000000001 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.109999999999999 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 74.340000000000003 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.751 ' CE2' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.959 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.504 ' HE1' HD22 ' A' ' 42' ' ' LEU . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 54.109999999999999 110.8 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' NH2' HG21 ' A' ' 45' ' ' THR . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.814 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.409999999999997 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.540000000000006 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 42.43 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 62.109999999999999 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.156 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.019999999999996 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.120000000000005 112.297 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.788 0.328 . . . . 63.509999999999998 111.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.450000000000003 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.014 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.030000000000001 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.510000000000005 110.94 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.838 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 55' ' ' GLU . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 111.176 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.72 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.435 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.200000000000003 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 64.120000000000005 111.098 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 64.420000000000002 111.085 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 65.310000000000002 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 71.319999999999993 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 51.109999999999999 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.219999999999999 112.526 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 48' ' ' ALA . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 61.25 111.198 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' HG22 ' A' ' 45' ' ' THR . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.099999999999994 110.803 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.349999999999994 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 63.539999999999999 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.120000000000005 111.064 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 55.020000000000003 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 72.120000000000005 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 53.340000000000003 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 76' ' ' THR . 7.0 p-80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 110.841 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.947 0.403 . . . . 74.400000000000006 111.027 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 64' ' ' HIS . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.329999999999998 111.215 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 64.099999999999994 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 73.400000000000006 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.420000000000002 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 70.400000000000006 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.329999999999998 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 64.319999999999993 112.319 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 62.409999999999997 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.319999999999993 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 63.450000000000003 111.173 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.420000000000002 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 52.100000000000001 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.230000000000004 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 44.43 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.349999999999994 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 62.25 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.349999999999994 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.019999999999996 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 64.430000000000007 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.019999999999996 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 61.520000000000003 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.549999999999997 111.049 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.010000000000005 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 72.329999999999998 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 63.43 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.633 ' O ' HD11 ' A' ' 80' ' ' LEU . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.549999999999997 110.826 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.209999999999994 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.558 ' OD2' HD21 ' A' ' 129' ' ' LEU . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.530000000000001 110.978 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 61.240000000000002 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 23.309999999999999 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.519999999999996 110.919 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.851 0.358 . . . . 73.530000000000001 110.942 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.439999999999998 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 128' ' ' SER . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.239999999999995 110.917 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 110.876 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' OD2' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.049999999999997 110.926 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 160' ' ' ILE . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 71.109999999999999 110.923 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.120000000000005 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 71.129999999999995 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 73.5 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.329999999999998 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.039999999999999 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 71.129999999999995 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.319999999999993 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.129999999999995 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.150000000000006 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.751 HD22 ' CE2' ' A' ' 8' ' ' PHE . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.5 110.823 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 151' ' ' VAL . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.230000000000004 111.051 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.519999999999996 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 70.409999999999997 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 73.209999999999994 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 160' ' ' ILE . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.519999999999996 110.916 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.611 HG13 HD12 ' A' ' 179' ' ' LEU . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.540000000000006 111.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 52.030000000000001 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 177' ' ' VAL . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 111.069 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 163' ' ' THR . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 64.209999999999994 111.126 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 72.120000000000005 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.566 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.040000000000006 110.906 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.530000000000001 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 32.350000000000001 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.439999999999998 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 63.020000000000003 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.040000000000006 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 162' ' ' THR . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 111.193 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.030000000000001 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 160' ' ' ILE . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 71.150000000000006 110.872 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 63.130000000000003 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.019999999999996 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.129999999999995 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.129999999999995 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 64.400000000000006 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 54.329999999999998 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.834 0.349 . . . . 74.439999999999998 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 49' ' ' THR . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.329999999999998 111.158 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 51.509999999999998 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.340000000000003 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 61.210000000000001 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.540000000000006 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.6 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 61.200000000000003 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.6 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 61.130000000000003 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 61.43 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 73.120000000000005 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 183' ' ' VAL . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.399999999999999 111.096 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.450000000000003 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 18' ' ' PRO . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 64.319999999999993 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.420000000000002 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.299999999999997 112.381 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.818 0.342 . . . . 72.140000000000001 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.340000000000003 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.019999999999996 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 54.340000000000003 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.200000000000003 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 34.140000000000001 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 74.430000000000007 111.172 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 72.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.229999999999997 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 52.5 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 4' ' ' ALA . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 71.540000000000006 111.134 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.030000000000001 110.893 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 53.25 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 50' ' ' ASP . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 111.12 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.310000000000002 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 45' ' ' THR . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.299999999999997 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 55.140000000000001 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.129999999999995 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.868 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HB1' ' ND2' ' A' ' 113' ' ' ASN . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.801 0.334 . . . . 72.030000000000001 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 111' ' ' PHE . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.092 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.329999999999998 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.519999999999996 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.409999999999997 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.94 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 55.049999999999997 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.219999999999999 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.825 HG23 ' HA ' ' A' ' 106' ' ' ASN . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.039999999999999 111.216 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.510000000000005 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.140000000000001 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.349999999999994 110.995 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.140000000000001 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.420000000000002 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.129999999999995 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 97' ' ' PHE . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.015 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 53.439999999999998 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 63.25 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.420000000000002 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 93' ' ' ALA . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 64.109999999999999 110.969 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 73.310000000000002 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.329999999999998 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 63.509999999999998 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.409999999999997 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.100000000000001 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.430000000000007 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.239999999999995 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HG23 ' A' ' 83' ' ' THR . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.647 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.129 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.527 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 61.350000000000001 110.83 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' HA ' HG23 ' A' ' 77' ' ' VAL . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.010000000000005 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.492 ' OD1' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.010000000000005 110.871 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.41 ' ND2' ' HB1' ' A' ' 75' ' ' ALA . 0.8 OUTLIER 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.953 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 71.310000000000002 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 110.803 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 72.340000000000003 110.861 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 43.100000000000001 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' HD23 ' A' ' 168' ' ' LEU . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.804 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.492 HD23 ' OD1' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.120000000000005 110.885 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.647 HD11 HG22 ' A' ' 109' ' ' THR . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.239999999999995 110.833 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 52.399999999999999 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 162' ' ' THR . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 70.540000000000006 110.834 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.310000000000002 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.020000000000003 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 73.230000000000004 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.219999999999999 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.329999999999998 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 42.530000000000001 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 61.240000000000002 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 151' ' ' VAL . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.150000000000006 110.898 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.219999999999999 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.019999999999996 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.209999999999994 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 152' ' ' ASN . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.120000000000005 111.158 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.409999999999997 110.911 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 53.340000000000003 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 72.010000000000005 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.200000000000003 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.549999999999997 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 40.43 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 63.210000000000001 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.329999999999998 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 132' ' ' SER . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.439999999999998 111.223 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.510000000000005 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.430000000000007 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 171' ' ' ALA . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.635 HD23 ' OD1' ' A' ' 126' ' ' ASP . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 70.109999999999999 110.815 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 72.219999999999999 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.409999999999997 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.310000000000002 111.135 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.439999999999998 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.459 ' CA ' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 51.109999999999999 110.901 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.549999999999997 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.230000000000004 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 70.200000000000003 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.310000000000002 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.299999999999997 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 64.040000000000006 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.554 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 64.450000000000003 111.158 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 70.109999999999999 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.209999999999994 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 64.010000000000005 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 70.430000000000007 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.540000000000006 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.696 0.284 . . . . 73.519999999999996 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 64.219999999999999 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.200000000000003 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.519999999999996 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.450000000000003 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.120000000000005 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.340000000000003 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.835 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 63.100000000000001 111.029 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.310000000000002 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.340000000000003 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.65 ' C ' HG23 ' A' ' 183' ' ' VAL . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 50.130000000000003 111.189 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 ' HB ' ' A' ' 183' ' ' VAL . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 60.549999999999997 111.175 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 61.240000000000002 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.119999999999997 112.355 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.088 0 CA-C-O 120.814 0.34 . . . . 64.439999999999998 111.142 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.019999999999996 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.230000000000004 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.510000000000005 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 60' ' ' THR . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 55.140000000000001 110.95 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.400000000000006 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 57' ' ' LEU . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.049 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.150000000000006 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' THR . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.099999999999994 111.131 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.329999999999998 111.117 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m120 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.109999999999999 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.209999999999994 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.329999999999998 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.904 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 45.200000000000003 111.099 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 39' ' ' GLN . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.129999999999995 111.101 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.400000000000006 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.239999999999995 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.332 . . . . 72.319999999999993 111.208 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' N ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.329999999999998 111.14 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 64' ' ' HIS . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.176 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 72.109999999999999 110.87 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.200000000000003 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.887 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.019999999999996 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.945 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 55.340000000000003 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.239999999999995 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 106' ' ' ASN . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.099999999999994 111.121 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 55.310000000000002 111.12 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 62.409999999999997 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 63.43 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.019999999999996 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 60.350000000000001 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.400000000000006 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.229999999999997 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.140000000000001 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 72.099999999999994 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.400000000000006 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.409999999999997 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 63.43 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.439999999999998 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.010000000000005 111.123 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 45.329999999999998 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.507 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 63.200000000000003 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.633 ' OD1' HG23 ' A' ' 108' ' ' THR . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 54.549999999999997 110.997 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.439999999999998 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' OD1' ' A' ' 106' ' ' ASN . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 52.43 111.052 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 73.439999999999998 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.566 ' H ' HG22 ' A' ' 76' ' ' THR . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.030000000000001 110.917 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.706 ' N ' HG23 ' A' ' 76' ' ' THR . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.329999999999998 112.508 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 124' ' ' LEU . 2.6 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.120000000000005 110.906 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 115' ' ' PHE . 4.0 mm? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.859 0.361 . . . . 74.450000000000003 110.974 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.409999999999997 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HD22 ' A' ' 127' ' ' LEU . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.140000000000001 110.774 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.349999999999994 110.863 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.310000000000002 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 62.130000000000003 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 63.219999999999999 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.450000000000003 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.439999999999998 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.120000000000005 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 42.25 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.209999999999994 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.140000000000001 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.400000000000006 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 70.319999999999993 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.400000000000006 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.420000000000002 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 147' ' ' ARG . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 110.956 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.667 HD11 ' CG1' ' A' ' 151' ' ' VAL . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 62.130000000000003 111.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.219999999999999 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.567 ' HG2' HD21 ' A' ' 144' ' ' LEU . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.777 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 54.450000000000003 110.879 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 145' ' ' ILE . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.409999999999997 111.119 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 152' ' ' ASN . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.409999999999997 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 61.43 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 72.109999999999999 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.019999999999996 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 70.310000000000002 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.126 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.120000000000005 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.439999999999998 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.010000000000005 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.030000000000001 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.010000000000005 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.747 ' HB2' HD23 ' A' ' 127' ' ' LEU . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.340000000000003 110.937 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 168' ' ' LEU . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 65.549999999999997 110.867 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.439999999999998 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 52.340000000000003 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.430000000000007 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.430000000000007 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 54.130000000000003 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.200000000000003 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 177' ' ' VAL . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 61.140000000000001 111.166 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.329999999999998 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 64.319999999999993 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.299999999999997 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.209999999999994 112.336 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 15' ' ' THR . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.340000000000003 111.162 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.219999999999999 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.504 ' H ' ' HB2' ' A' ' 153' ' ' MET . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.824 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 10' ' ' ARG . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 44.43 111.126 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 65.519999999999996 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 70.439999999999998 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.775 0.321 . . . . 74.140000000000001 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 34.409999999999997 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.239999999999995 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 70.340000000000003 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.540000000000006 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 70.310000000000002 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 62.299999999999997 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 65.409999999999997 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 55.549999999999997 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 70.409999999999997 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 63.030000000000001 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.329999999999998 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 183' ' ' VAL . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.040000000000006 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD3' HG22 ' A' ' 16' ' ' VAL . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 43.350000000000001 112.363 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.88 0.372 . . . . 73.549999999999997 111.033 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.956 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 70.219999999999999 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' THR . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.299999999999997 111.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.439999999999998 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.210000000000001 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 72.340000000000003 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 111.152 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.409999999999997 111.191 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 70.140000000000001 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 73.049999999999997 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.319999999999993 110.863 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 71.239999999999995 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.120000000000005 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 54' ' ' VAL . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.099999999999994 111.134 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.733 ' HB2' HG23 ' A' ' 45' ' ' THR . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.409999999999997 110.866 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 61.340000000000003 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 64.120000000000005 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 33.32 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.230000000000004 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.049999999999997 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 70.409999999999997 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.400000000000006 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.349999999999994 110.916 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 72.019999999999996 111.098 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 71.540000000000006 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 113' ' ' ASN . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 44.310000000000002 111.087 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.230000000000004 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 73.530000000000001 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 63.140000000000001 112.343 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.230000000000004 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 71.299999999999997 111.121 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.299999999999997 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.310000000000002 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 62.329999999999998 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.421 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 99' ' ' PRO . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' HG11 ' A' ' 101' ' ' VAL . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.951 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 43.310000000000002 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.400000000000006 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.210000000000001 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.229999999999997 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.712 ' HG2' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 110.811 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 71.129999999999995 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.540000000000006 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.049999999999997 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.744 ' HB3' HG13 ' A' ' 141' ' ' VAL . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 55.140000000000001 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 90' ' ' PHE . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 65.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.040000000000006 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.310000000000002 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' ILE . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.420000000000002 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.741 ' HA ' HG22 ' A' ' 83' ' ' THR . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.350000000000001 110.928 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.469 ' HE1' HG23 ' A' ' 105' ' ' ILE . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.549999999999997 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 62.020000000000003 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 62.420000000000002 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.019999999999996 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.510000000000005 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 60.549999999999997 110.949 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.040000000000006 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.329999999999998 110.929 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 125' ' ' SER . 2.9 pp . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.793 0.33 . . . . 73.109999999999999 110.974 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 65.209999999999994 110.872 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.549999999999997 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 130' ' ' LYS . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 35.049999999999997 110.967 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.683 HD22 ' HB2' ' A' ' 164' ' ' ALA . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.210000000000001 110.885 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 127' ' ' LEU . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 63.350000000000001 110.882 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 54.140000000000001 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.030000000000001 110.925 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.520000000000003 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 53.229999999999997 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.020000000000003 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.409999999999997 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 33.100000000000001 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 111.111 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 71.450000000000003 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 96' ' ' LYS . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.030000000000001 110.882 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 70.209999999999994 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 64.219999999999999 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.510000000000005 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 144' ' ' LEU . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 65.099999999999994 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.409999999999997 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 72.510000000000005 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 43.130000000000003 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.585 ' HH2' HG21 ' A' ' 83' ' ' THR . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 70.120000000000005 110.826 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.200000000000003 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HD13 ' A' ' 160' ' ' ILE . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.858 HG21 HD22 ' A' ' 179' ' ' LEU . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.230000000000004 111.11 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.510000000000005 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.329999999999998 111.17 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.409999999999997 111.138 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.439999999999998 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.464 ' CZ ' HD22 ' A' ' 168' ' ' LEU . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 110.94 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.349999999999994 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 72.0 110.818 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 62.409999999999997 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.010000000000005 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.467 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 43.109999999999999 111.095 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 63.530000000000001 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.340000000000003 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.420000000000002 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 160' ' ' ILE . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.945 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.200000000000003 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.129999999999995 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.150000000000006 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 41.130000000000003 111.162 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 60.210000000000001 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 62.310000000000002 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.310000000000002 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 64.209999999999994 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.530000000000001 112.497 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.530000000000001 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 64.409999999999997 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.549999999999997 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.299999999999997 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 65.510000000000005 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 62.030000000000001 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.030000000000001 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 61.32 111.13 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 33.409999999999997 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.430000000000007 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 183' ' ' VAL . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 61.5 111.145 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.631 ' C ' HG23 ' A' ' 183' ' ' VAL . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB ' ' A' ' 183' ' ' VAL . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 71.310000000000002 111.096 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.329999999999998 112.378 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.819 0.342 . . . . 71.129999999999995 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 63.43 110.916 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.329999999999998 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 61.399999999999999 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.549999999999997 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.010000000000005 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 65.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.329999999999998 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 64.209999999999994 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 64.540000000000006 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 24.140000000000001 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.099999999999994 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.485 HD13 ' HE1' ' A' ' 156' ' ' TRP . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 55.509999999999998 110.917 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.539999999999999 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.329999999999998 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 63.100000000000001 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.129999999999995 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.409999999999997 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' HG21 ' A' ' 77' ' ' VAL . 9.5 t60 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.762 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.876 0.37 . . . . 63.32 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 60.130000000000003 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 64' ' ' HIS . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 54.409999999999997 111.164 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 72.439999999999998 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 63.240000000000002 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.877 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 64.439999999999998 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.934 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.219999999999999 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.934 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 64.310000000000002 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.239999999999995 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.049999999999997 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 72.209999999999994 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.049999999999997 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.554 ' H ' HG21 ' A' ' 101' ' ' VAL . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 110.821 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.519999999999996 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.109999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 61.219999999999999 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 70.120000000000005 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.549999999999997 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 71.549999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.150000000000006 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.150000000000006 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.209999999999994 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 90' ' ' PHE . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 61.25 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 23.239999999999998 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.219999999999999 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 72.150000000000006 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 62.439999999999998 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.584 ' CG ' HD12 ' A' ' 160' ' ' ILE . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 65.209999999999994 110.916 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.566 ' H ' HD12 ' A' ' 80' ' ' LEU . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 71.530000000000001 111.104 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.150000000000006 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 71.510000000000005 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 110.899 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 168' ' ' LEU . 4.3 mm? . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.779 0.324 . . . . 73.140000000000001 111.012 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.129999999999995 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 65.140000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 71.150000000000006 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 63.5 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' CB ' HG23 ' A' ' 109' ' ' THR . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.430000000000007 110.814 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.319999999999993 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.310000000000002 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.350000000000001 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.099999999999994 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.219999999999999 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.140000000000001 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 65.439999999999998 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 23.399999999999999 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 51.520000000000003 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.209999999999994 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.764 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.913 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 54.43 111.011 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.430000000000007 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.481 ' C ' HD23 ' A' ' 150' ' ' LEU . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 62.420000000000002 110.911 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 62.539999999999999 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 184' ' ' PHE . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.236 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.485 ' HE1' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 110.888 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.530000000000001 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 106' ' ' ASN . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 71.510000000000005 111.175 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.400000000000006 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 43.329999999999998 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 71.530000000000001 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.109999999999999 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 73.230000000000004 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.715 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.912 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.340000000000003 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.049999999999997 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 40.409999999999997 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.319999999999993 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.049999999999997 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 62.310000000000002 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 63.399999999999999 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 110.837 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 53.399999999999999 110.946 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.040000000000006 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.219999999999999 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 72.209999999999994 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.631 HG23 ' C ' ' A' ' 15' ' ' THR . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 70.200000000000003 111.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.479 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 65.510000000000005 110.854 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.299999999999997 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 43.329999999999998 111.108 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.209999999999994 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 62.119999999999997 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.329999999999998 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.79 0.328 . . . . 73.409999999999997 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.349999999999994 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.430000000000007 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.510000000000005 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.748 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.510000000000005 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.399999999999999 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.030000000000001 110.794 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 187' ' ' SER . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.200000000000003 111.155 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.420000000000002 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 42.520000000000003 111.052 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 64.349999999999994 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.430000000000007 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 72.540000000000006 112.385 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.725 0.298 . . . . 71.5 111.14 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' OD1' ' HB1' ' A' ' 14' ' ' ALA . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.875 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 45.520000000000003 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.299999999999997 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 62.43 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 44' ' ' PHE . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.540000000000006 110.776 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 56' ' ' LEU . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.209999999999994 111.151 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 73.209999999999994 110.892 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.230000000000004 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.209999999999994 110.886 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 71.510000000000005 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 52.25 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.299999999999997 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 85' ' ' MET . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 43.439999999999998 111.228 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.310000000000002 110.831 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 43' ' ' THR . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 52.539999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 55.009999999999998 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 34.210000000000001 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 63.420000000000002 111.215 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.129999999999995 112.36 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 70.109999999999999 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.150000000000006 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 63.25 110.774 179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.793 0.33 . . . . 64.219999999999999 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 113' ' ' ASN . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.189 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 70.200000000000003 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.883 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.240000000000002 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.030000000000001 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.25 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' VAL . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.329999999999998 110.854 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 70.049999999999997 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 60.219999999999999 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.140000000000001 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.319999999999993 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.340000000000003 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.219999999999999 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.439999999999998 110.948 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 98' ' ' ARG . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 62.140000000000001 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.420000000000002 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.020000000000003 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.209999999999994 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.109999999999999 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 54.539999999999999 111.103 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.439999999999998 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 72.209999999999994 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.200000000000003 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.708 ' HB2' HG12 ' A' ' 77' ' ' VAL . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.430000000000007 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.140000000000001 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.329999999999998 110.884 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' H ' ' A' ' 169' ' ' GLY . 6.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.939 0.399 . . . . 74.430000000000007 110.935 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.010000000000005 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 172' ' ' GLN . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.310000000000002 110.956 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 54.140000000000001 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.540000000000006 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' THR . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 72.420000000000002 110.802 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.429 ' OG ' HD13 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.540000000000006 110.795 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.349999999999994 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 71.439999999999998 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 54.100000000000001 111.086 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.329999999999998 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 33.210000000000001 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 73.540000000000006 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.844 HG23 HG11 ' A' ' 155' ' ' VAL . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.194 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.530000000000001 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.400000000000006 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 71.450000000000003 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 71.409999999999997 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 72.549999999999997 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 54.119999999999997 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.418 ' HZ3' ' HH ' ' A' ' 190' ' ' TYR . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 110.928 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.030000000000001 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.530000000000001 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 52.109999999999999 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.844 HG11 HG23 ' A' ' 139' ' ' VAL . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.319999999999993 111.152 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.519999999999996 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 160' ' ' ILE . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.310000000000002 111.065 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 60.219999999999999 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 131' ' ' ASP . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.16 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 174' ' ' HIS . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.439999999999998 111.044 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.030000000000001 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.219999999999999 110.921 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.62 ' HD3' HD13 ' A' ' 127' ' ' LEU . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.855 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.748 ' H ' HD22 ' A' ' 124' ' ' LEU . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.099999999999994 112.56 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.149999999999999 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.019999999999996 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.765 ' HB3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.430000000000007 110.955 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 52.509999999999998 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 163' ' ' THR . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.310000000000002 110.808 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.319999999999993 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.319999999999993 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 177' ' ' VAL . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.510000000000005 111.186 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 73.530000000000001 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.040000000000006 110.908 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 50.439999999999998 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.349999999999994 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.908 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 183' ' ' VAL . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.540000000000006 111.115 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.049999999999997 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 74.519999999999996 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.409999999999997 110.735 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 54.539999999999999 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 62.520000000000003 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.418 ' HH ' ' HZ3' ' A' ' 149' ' ' TRP . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.329999999999998 110.948 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 62.109999999999999 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 54.310000000000002 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.713 0.292 . . . . 52.210000000000001 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.549999999999997 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.319999999999993 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.209999999999994 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 47' ' ' MET . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.819 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 64.340000000000003 110.918 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 72.299999999999997 110.919 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.439999999999998 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 70.329999999999998 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 64.099999999999994 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 37' ' ' ASN . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.299999999999997 111.128 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.219999999999999 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 54.039999999999999 112.352 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.822 0.344 . . . . 73.219999999999999 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 60.530000000000001 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.140000000000001 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 54.140000000000001 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.450000000000003 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' MET . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.319999999999993 110.918 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.519999999999996 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 72.430000000000007 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.406 ' HB2' ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.791 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 51.100000000000001 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 71.409999999999997 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 88' ' ' TRP . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.126 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.450000000000003 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.040000000000006 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.150000000000006 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 70.409999999999997 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 65.530000000000001 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.450000000000003 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.030000000000001 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 71.299999999999997 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.524 ' O ' HG21 ' A' ' 76' ' ' THR . 3.4 p-80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.450000000000003 110.784 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.030000000000001 111.136 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 112' ' ' ASP . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 111.235 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.845 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 73.420000000000002 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.919 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.310000000000002 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.919 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.439999999999998 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.439999999999998 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 72.450000000000003 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.498 ' CG ' HD13 ' A' ' 52' ' ' ILE . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.400000000000006 110.928 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.774 ' HB2' HG22 ' A' ' 101' ' ' VAL . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 72.5 110.94 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 73.150000000000006 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 63.299999999999997 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 63.030000000000001 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.409999999999997 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 61.039999999999999 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.450000000000003 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.219999999999999 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.509999999999998 112.344 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.406 ' HA ' ' N ' ' A' ' 89' ' ' TYR . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.94 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 89' ' ' TYR . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 70.230000000000004 111.153 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.109999999999999 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 65.450000000000003 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.310000000000002 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.439999999999998 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.530000000000001 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.129999999999995 111.203 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.430000000000007 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.803 ' HB2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.140000000000001 110.844 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.450000000000003 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.520000000000003 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 71.299999999999997 110.916 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.8 0.333 . . . . 63.210000000000001 110.868 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.430000000000007 110.772 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 60.25 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 60.25 110.962 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.409999999999997 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.129999999999995 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 110.9 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 70.519999999999996 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.200000000000003 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 156' ' ' TRP . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 41.539999999999999 111.106 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 65.439999999999998 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.340000000000003 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 62.100000000000001 111.109 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 21.239999999999998 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 99' ' ' PRO . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 55.210000000000001 111.146 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.409999999999997 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.756 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 71.450000000000003 110.976 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 144' ' ' LEU . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.140000000000001 111.193 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.439999999999998 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.401 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.209999999999994 110.945 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.756 HD22 ' CB ' ' A' ' 144' ' ' LEU . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 62.310000000000002 110.944 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' SER . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 72.040000000000006 111.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 62.530000000000001 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.450000000000003 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.439999999999998 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CZ2' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 110.945 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 179' ' ' LEU . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.340000000000003 110.809 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.93 HG22 HD11 ' A' ' 179' ' ' LEU . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 70.129999999999995 111.16 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 65.209999999999994 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.933 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 111.125 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 65.239999999999995 111.147 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.754 ' HA ' HD22 ' A' ' 129' ' ' LEU . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 44.039999999999999 111.148 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.420000000000002 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.019999999999996 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 65.420000000000002 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.200000000000003 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.039999999999999 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.299999999999997 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.420000000000002 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.209999999999994 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.039999999999999 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.485 HG22 ' HB ' ' A' ' 162' ' ' THR . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 63.43 111.134 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.32 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 160' ' ' ILE . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.474 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.030000000000001 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.519999999999996 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 60.509999999999998 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 60.039999999999999 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.430000000000007 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 50.210000000000001 110.889 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 61.130000000000003 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.150000000000006 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 70.109999999999999 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.566 ' CG ' HD11 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 53.32 110.948 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.75 0.31 . . . . 62.420000000000002 110.749 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 71.010000000000005 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 47' ' ' MET . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.722 ' H ' ' HE3' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.239999999999995 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 61.539999999999999 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 74.200000000000003 110.959 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 62.200000000000003 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 71.340000000000003 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 64.140000000000001 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 30.41 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.230000000000004 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 64.140000000000001 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' THR . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.200000000000003 111.118 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 HG11 ' A' ' 183' ' ' VAL . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 111.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.239999999999995 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' PRO . 53.5 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 71.230000000000004 112.28 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 65.099999999999994 111.218 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 41.030000000000001 111.212 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.099999999999994 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 53.299999999999997 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 63.119999999999997 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 62.450000000000003 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.299999999999997 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.140000000000001 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.482 HG23 ' CG ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.209999999999994 111.178 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.722 ' HE3' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.430000000000007 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 44.210000000000001 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.349999999999994 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 60.100000000000001 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 88' ' ' TRP . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.184 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 65.219999999999999 112.56 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 64.010000000000005 111.158 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' CG ' HG23 ' A' ' 45' ' ' THR . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.049999999999997 110.889 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.721 ' CB ' HG23 ' A' ' 83' ' ' THR . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.917 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 54.539999999999999 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 53.100000000000001 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 63.149999999999999 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 55.539999999999999 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 62.25 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.420000000000002 110.869 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.808 0.337 . . . . 72.510000000000005 111.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.120000000000005 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 61.350000000000001 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 62.210000000000001 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.140000000000001 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 70.209999999999994 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.698 ' HB3' HG23 ' A' ' 108' ' ' THR . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.439999999999998 112.443 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 62.119999999999997 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.721 HG23 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 111.06 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.019999999999996 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.41 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.852 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.299999999999997 111.125 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.340000000000003 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' HB3' HG22 ' A' ' 52' ' ' ILE . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.129999999999995 110.954 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.319999999999993 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HD1' HG21 ' A' ' 101' ' ' VAL . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.340000000000003 110.872 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 71.450000000000003 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 72.420000000000002 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.349999999999994 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 44.130000000000003 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.430000000000007 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.510000000000005 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.319999999999993 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.239999999999995 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.422 HG21 ' HD1' ' A' ' 90' ' ' PHE . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.230000000000004 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.319999999999993 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.109999999999999 112.522 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.209999999999994 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 81' ' ' PRO . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 61.119999999999997 111.107 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 64.420000000000002 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.049999999999997 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.421 ' CE1' HG21 ' A' ' 108' ' ' THR . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.924 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 2.2 t30 -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 110.806 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.230000000000004 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.430000000000007 110.886 -179.868 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.448 HD11 ' HA2' ' A' ' 169' ' ' GLY . 1.6 mp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 74.340000000000003 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.229999999999997 110.773 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 110.854 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.329999999999998 110.924 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.409999999999997 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 71.5 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.310000000000002 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.219999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.010000000000005 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 71.200000000000003 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 52.409999999999997 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.209999999999994 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.230000000000004 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 53.32 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.122 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.020000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 63.329999999999998 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 52.140000000000001 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 73.0 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 151' ' ' VAL . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 73.209999999999994 111.213 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 54.340000000000003 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 110.959 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 145' ' ' ILE . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 62.140000000000001 111.135 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 70.329999999999998 110.925 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 44.310000000000002 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.492 ' CD2' HG22 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.885 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.239999999999995 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 54.450000000000003 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 180' ' ' ASP . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 55.399999999999999 111.12 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 52.329999999999998 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.040000000000006 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 62.450000000000003 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 53.140000000000001 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 70.310000000000002 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.549999999999997 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.430000000000007 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 71.430000000000007 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 124' ' ' LEU . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.540000000000006 112.487 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 52.399999999999999 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.549999999999997 110.904 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 110.9 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.120000000000005 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.400000000000006 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 51.219999999999999 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 177' ' ' VAL . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.209999999999994 111.227 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 34.009999999999998 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.526 ' CG ' HD11 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.329999999999998 110.933 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.329999999999998 112.346 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 63.039999999999999 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.594 HG11 HG12 ' A' ' 16' ' ' VAL . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.239999999999995 111.113 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.409999999999997 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 61.530000000000001 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 50.509999999999998 111.1 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.030000000000001 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 71.340000000000003 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 60.240000000000002 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.779 0.323 . . . . 75.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 63.32 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HB2' ' CA ' ' A' ' 49' ' ' THR . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 111.161 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.040000000000006 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.520000000000003 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HB2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.239999999999995 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' H ' ' HB2' ' A' ' 46' ' ' TYR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 61.210000000000001 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 65.099999999999994 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.109999999999999 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.209999999999994 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.049999999999997 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 18' ' ' PRO . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 111.081 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.299999999999997 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 16' ' ' VAL . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 63.109999999999999 112.318 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.785 0.326 . . . . 43.549999999999997 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.430000000000007 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.037 HD22 HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.130000000000003 110.871 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.430000000000007 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.549999999999997 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 57' ' ' LEU . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.137 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.430000000000007 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 40.140000000000001 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 54' ' ' VAL . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.329999999999998 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.696 ' CA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 61.329999999999998 111.194 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.230000000000004 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 48' ' ' ALA . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.430000000000007 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.430000000000007 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.129999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.945 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.119999999999997 111.071 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 70.030000000000001 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 1.037 HG23 HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 65.120000000000005 111.151 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 62.539999999999999 112.319 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 63.130000000000003 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.510000000000005 110.825 -179.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.865 0.364 . . . . 62.409999999999997 111.097 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 111' ' ' PHE . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 72.140000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 61.229999999999997 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.049999999999997 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 109' ' ' THR . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.430000000000007 110.905 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.230000000000004 112.38 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.109999999999999 112.399 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.549999999999997 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 45.539999999999999 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.310000000000002 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.229999999999997 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.450000000000003 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 52.219999999999999 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 63.049999999999997 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 53.310000000000002 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.299999999999997 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 55.030000000000001 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.120000000000005 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 71.010000000000005 112.304 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.450000000000003 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 139' ' ' VAL . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.209999999999994 111.023 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.129999999999995 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.439999999999998 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.150000000000006 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 64.010000000000005 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 64.019999999999996 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.133 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 109' ' ' THR . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 71.450000000000003 110.879 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HB3' HG23 ' A' ' 77' ' ' VAL . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 110.859 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.030000000000001 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' HG11 ' A' ' 77' ' ' VAL . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 65.209999999999994 110.911 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.299999999999997 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.150000000000006 110.85 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.806 0.336 . . . . 63.450000000000003 110.95 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.010000000000005 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.521 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.876 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 64.099999999999994 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 130' ' ' LYS . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 64.510000000000005 110.922 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 129' ' ' LEU . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.894 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.714 ' HA ' HG23 ' A' ' 109' ' ' THR . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.510000000000005 110.809 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.150000000000006 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.030000000000001 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.049999999999997 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 70.0 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.510000000000005 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 101' ' ' VAL . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 64.030000000000001 111.13 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 24.23 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 63.140000000000001 111.151 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 61.409999999999997 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.209999999999994 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.922 HD12 HD21 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 145' ' ' ILE . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 111.042 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.219999999999999 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.922 HD21 HD12 ' A' ' 144' ' ' LEU . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.519999999999996 110.917 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.239999999999995 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.402 ' HZ2' HD22 ' A' ' 57' ' ' LEU . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.409999999999997 110.957 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.310000000000002 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 52.530000000000001 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 53.329999999999998 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 70.299999999999997 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 54.409999999999997 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.521 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.099999999999994 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 71.439999999999998 110.891 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 72.519999999999996 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 32.140000000000001 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.030000000000001 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 167' ' ' LYS . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.109999999999999 111.048 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 63.340000000000003 110.873 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.239999999999995 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.140000000000001 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.319999999999993 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.519999999999996 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.129999999999995 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.329999999999998 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 71.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.340000000000003 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 53.130000000000003 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 62.240000000000002 111.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 61.200000000000003 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.510000000000005 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.239999999999995 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.299999999999997 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.713 0.292 . . . . 73.140000000000001 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 49' ' ' THR . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 71.530000000000001 111.09 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 63.240000000000002 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.109999999999999 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 43.329999999999998 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.010000000000005 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.239999999999995 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 38' ' ' THR . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 61.130000000000003 111.117 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 183' ' ' VAL . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 71.140000000000001 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.315 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.764 0.316 . . . . 71.530000000000001 111.142 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.519999999999996 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 15' ' ' THR . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.319999999999993 111.178 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.010000000000005 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.430000000000007 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 55.409999999999997 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 56' ' ' LEU . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.209999999999994 110.857 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' NE2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 55.219999999999999 111.115 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 65.099999999999994 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.040000000000006 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 45.310000000000002 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.230000000000004 111.043 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 53.350000000000001 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 53.299999999999997 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.040000000000006 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.020000000000003 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 63.210000000000001 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 63.340000000000003 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 84' ' ' LEU . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.340000000000003 110.891 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 63.009999999999998 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.140000000000001 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 55.200000000000003 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.340000000000003 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.229999999999997 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 65.310000000000002 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.030000000000001 110.953 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.927 0.394 . . . . 72.140000000000001 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' THR . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.099 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.120000000000005 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 54.439999999999998 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.349999999999994 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 62.32 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.019999999999996 112.347 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 70.340000000000003 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 56' ' ' LEU . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 52.149999999999999 110.911 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.299999999999997 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 110.975 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.200000000000003 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.119999999999997 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.430000000000007 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.319999999999993 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 65.400000000000006 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 144' ' ' LEU . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 72.209999999999994 110.904 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.572 ' HA ' HG23 ' A' ' 141' ' ' VAL . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 52.200000000000003 112.316 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 101' ' ' VAL . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 61.25 111.091 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.140000000000001 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 44.310000000000002 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 85' ' ' MET . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.319999999999993 112.474 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.25 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.64 ' CZ ' HG22 ' A' ' 109' ' ' THR . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.340000000000003 110.882 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 62.229999999999997 111.05 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 107' ' ' TYR . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 111.162 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.239999999999995 112.591 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.329999999999998 110.811 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 166' ' ' TYR . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 110.906 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.040000000000006 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.239999999999995 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 162' ' ' THR . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.219999999999999 110.921 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 43.450000000000003 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.049999999999997 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.140000000000001 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.109999999999999 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.340000000000003 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.040000000000006 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.329999999999998 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 99' ' ' PRO . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.200000000000003 111.11 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.725 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.310000000000002 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 151' ' ' VAL . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 110.855 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' A' ' 98' ' ' ARG . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 62.240000000000002 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.450000000000003 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.140000000000001 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.649 ' C ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 71.519999999999996 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 188' ' ' ALA . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 63.200000000000003 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.871 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.439999999999998 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.210000000000001 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 61.140000000000001 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.129999999999995 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.310000000000002 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.030000000000001 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.511 ' CG2' HD23 ' A' ' 129' ' ' LEU . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.420000000000002 111.062 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.109999999999999 111.088 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 126' ' ' ASP . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.099999999999994 110.933 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 72.209999999999994 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.549999999999997 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 64.530000000000001 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.883 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 54.329999999999998 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 64.340000000000003 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.349999999999994 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.200000000000003 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.319999999999993 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 16' ' ' VAL . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 44.32 111.095 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.239999999999995 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.0 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.420000000000002 111.067 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.239999999999995 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.099999999999994 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.400000000000006 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.010000000000005 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.8 m80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.737 0.304 . . . . 73.329999999999998 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.019999999999996 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 63.399999999999999 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 61.409999999999997 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.409999999999997 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CA ' ' HB2' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.319999999999993 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.505 ' N ' ' HB2' ' A' ' 191' ' ' ARG . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 55.130000000000003 111.108 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 73.340000000000003 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.209999999999994 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 53.350000000000001 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 183' ' ' VAL . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.019999999999996 111.174 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.420000000000002 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.350000000000001 112.342 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 63' ' ' ARG . 18.0 p . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.831 0.348 . . . . 72.140000000000001 111.147 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.210000000000001 110.836 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.430000000000007 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' THR . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.210000000000001 111.1 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 52.030000000000001 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.040000000000006 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 61.25 110.809 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 57' ' ' LEU . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.349999999999994 111.124 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 70.310000000000002 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.430000000000007 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.520000000000003 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 110.864 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.603 HG22 ' CE3' ' A' ' 88' ' ' TRP . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.095 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.430000000000007 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.340000000000003 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 64.430000000000007 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.040000000000006 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 43' ' ' THR . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.019999999999996 110.928 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 43.229999999999997 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 63.210000000000001 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.340000000000003 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.299999999999997 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.836 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.405 ' CB ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.510000000000005 110.863 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 71.549999999999997 111.126 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 65.230000000000004 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 64' ' ' HIS . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 111.096 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.865 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 51.340000000000003 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.936 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.329999999999998 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.936 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.540000000000006 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.543 ' OG1' HD22 ' A' ' 57' ' ' LEU . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.150000000000006 111.176 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.010000000000005 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.420000000000002 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.947 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.603 ' CE3' HG22 ' A' ' 52' ' ' ILE . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 110.889 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 74.420000000000002 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 71.329999999999998 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 61.329999999999998 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.030000000000001 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.030000000000001 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.329999999999998 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 71.099999999999994 110.856 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.299999999999997 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.420000000000002 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 139' ' ' VAL . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 71.230000000000004 111.102 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.019999999999996 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.129999999999995 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.310000000000002 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 105' ' ' ILE . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 50.409999999999997 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.230000000000004 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 71.219999999999999 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 70.019999999999996 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.049999999999997 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.119999999999997 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.299999999999997 110.839 -179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.788 0.327 . . . . 61.130000000000003 110.918 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 62.130000000000003 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 63.409999999999997 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 62.140000000000001 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 64.150000000000006 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.200000000000003 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.340000000000003 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.239999999999995 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.420000000000002 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 45.299999999999997 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 157' ' ' TYR . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 71.310000000000002 111.122 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.019999999999996 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.329999999999998 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HA ' HG23 ' A' ' 101' ' ' VAL . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 111.138 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.099999999999994 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.299999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 62.310000000000002 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 72.540000000000006 110.994 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.319999999999993 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.030000000000001 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 33.049999999999997 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 151' ' ' VAL . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.319999999999993 110.875 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' N ' HD12 ' A' ' 150' ' ' LEU . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 55.109999999999999 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.420000000000002 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 156' ' ' TRP . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 111.028 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 155' ' ' VAL . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.030000000000001 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.646 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.520000000000003 110.927 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.109999999999999 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.6 ' CD1' HD12 ' A' ' 179' ' ' LEU . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.120000000000005 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 64.349999999999994 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 53.219999999999999 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.6 ' HB2' ' CG2' ' A' ' 177' ' ' VAL . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 64.530000000000001 111.031 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.150000000000006 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.400000000000006 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.219999999999999 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.329999999999998 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 53.409999999999997 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.350000000000001 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.540000000000006 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 55.149999999999999 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 164' ' ' ALA . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 63.119999999999997 111.212 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.230000000000004 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 160' ' ' ILE . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.420000000000002 110.949 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.240000000000002 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.549999999999997 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.120000000000005 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 16' ' ' VAL . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.530000000000001 111.217 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.519999999999996 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 43.409999999999997 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 61.130000000000003 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.109999999999999 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 111.085 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 12.199999999999999 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.239999999999995 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.522 ' HB2' ' CA ' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.109999999999999 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 65.120000000000005 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.805 0.336 . . . . 72.109999999999999 110.803 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.210000000000001 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.409 ' HB2' ' C ' ' A' ' 48' ' ' ALA . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.319999999999993 111.048 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 65.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.150000000000006 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 43' ' ' THR . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 70.010000000000005 110.837 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 43' ' ' THR . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 53.399999999999999 111.089 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.400000000000006 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 42.039999999999999 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.456 ' C ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.450000000000003 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.679 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 71.120000000000005 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.340000000000003 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' CB ' HD13 ' A' ' 179' ' ' LEU . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.519999999999996 112.247 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.762 0.315 . . . . 75.450000000000003 111.102 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 55.229999999999997 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.349999999999994 110.93 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.010000000000005 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 62.539999999999999 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 44.329999999999998 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 73.040000000000006 110.942 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 11' ' ' ALA . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 111.15 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.340000000000003 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 70.549999999999997 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 65.340000000000003 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.109999999999999 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' C ' ' HB2' ' A' ' 4' ' ' ALA . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.098 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 61.219999999999999 111.21 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.329999999999998 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 71.239999999999995 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.439999999999998 112.468 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.209999999999994 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.783 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.349999999999994 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.124 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.450000000000003 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 63.329999999999998 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.200000000000003 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 35.240000000000002 110.834 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB1' ' OD2' ' A' ' 126' ' ' ASP . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.891 0.377 . . . . 55.020000000000003 111.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.519999999999996 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 64.549999999999997 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.420000000000002 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.944 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 63.009999999999998 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.944 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 106' ' ' ASN . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.430000000000007 111.243 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 64.219999999999999 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.210000000000001 111.016 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 44.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.705 ' CD2' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 72.040000000000006 110.935 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.010000000000005 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.209999999999994 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.450000000000003 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 62.030000000000001 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.240000000000002 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 54.229999999999997 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 63.049999999999997 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 72.349999999999994 110.984 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.239999999999995 112.283 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 110.93 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.705 HG22 ' CD2' ' A' ' 89' ' ' TYR . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 71.239999999999995 111.139 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.349999999999994 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 70.349999999999994 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.010000000000005 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 72.439999999999998 110.881 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 80' ' ' LEU . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.194 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.078 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 63.539999999999999 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.209999999999994 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.450000000000003 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.439999999999998 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 71.099999999999994 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.430000000000007 110.858 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.759 0.314 . . . . 71.209999999999994 110.967 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 75' ' ' ALA . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 70.120000000000005 110.846 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.428 HD12 ' HE2' ' A' ' 130' ' ' LYS . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.400000000000006 111.019 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.209999999999994 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 74.519999999999996 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.428 ' HE2' HD12 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.873 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' HA ' HG23 ' A' ' 109' ' ' THR . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.821 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 61.020000000000003 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.519999999999996 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.310000000000002 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.65 HG23 HG22 ' A' ' 155' ' ' VAL . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 55.32 111.124 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.039999999999999 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.239999999999995 111.113 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.666 ' OD2' HD13 ' A' ' 150' ' ' LEU . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.329999999999998 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 45.520000000000003 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 51.229999999999997 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.540000000000006 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.530000000000001 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.666 HD13 ' OD2' ' A' ' 142' ' ' ASP . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 110.903 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 188' ' ' ALA . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.032 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.099999999999994 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 62.140000000000001 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 184' ' ' PHE . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.073 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.239999999999995 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.099999999999994 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 53.310000000000002 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 61.109999999999999 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.430000000000007 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.350000000000001 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 62.240000000000002 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.209999999999994 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 64.409999999999997 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 62.350000000000001 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.109999999999999 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.409999999999997 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 62.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.140000000000001 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.619 ' O ' HD12 ' A' ' 179' ' ' LEU . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.239999999999995 110.831 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 65.329999999999998 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.634 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.409999999999997 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 184' ' ' PHE . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.020000000000003 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.773 ' N ' HG13 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 65.549999999999997 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 33.149999999999999 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.109999999999999 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 53.530000000000001 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.349999999999994 111.039 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 51.240000000000002 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.099999999999994 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 71.209999999999994 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.549999999999997 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 110.877 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 61.43 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.439999999999998 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.230000000000004 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.310000000000002 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.129999999999995 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.340000000000003 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.167 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.149999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.239999999999995 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 38' ' ' THR . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.120000000000005 111.117 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 53.329999999999998 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' VAL . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.230000000000004 111.105 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.310000000000002 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.310000000000002 112.364 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.784 0.326 . . . . 54.020000000000003 111.132 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.129999999999995 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' ALA . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 72.540000000000006 111.045 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.099999999999994 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 11' ' ' ALA . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 64.400000000000006 110.878 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.239999999999995 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.010000000000005 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 9' ' ' MET . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 72.150000000000006 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 53.219999999999999 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.319999999999993 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.827 HG22 ' HB ' ' A' ' 52' ' ' ILE . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 53.109999999999999 111.139 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 49' ' ' THR . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.019999999999996 110.877 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' N ' HG23 ' A' ' 49' ' ' THR . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.349999999999994 110.813 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.827 ' HB ' HG22 ' A' ' 49' ' ' THR . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.430000000000007 111.256 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 32.420000000000002 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 70.510000000000005 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.120000000000005 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.420000000000002 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 44.119999999999997 110.944 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 53.109999999999999 111.185 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.409999999999997 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 79' ' ' HIS . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.420000000000002 112.41 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.946 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.898 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . . . . . . 0 N--CA 1.459 0.022 0 CA-C-O 120.92 0.39 . . . . 72.430000000000007 111.006 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.120000000000005 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 112' ' ' ASP . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 60.130000000000003 111.142 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.885 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 63.399999999999999 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.509999999999998 112.313 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.510000000000005 112.3 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' TYR . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.519999999999996 111.076 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.299999999999997 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.416 ' HE1' HD13 ' A' ' 57' ' ' LEU . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.129999999999995 110.781 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 35.32 111.147 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.434 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.200000000000003 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.540000000000006 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 42.530000000000001 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 53.32 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 62.340000000000003 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 51.219999999999999 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.310000000000002 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 144' ' ' LEU . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 63.450000000000003 110.954 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 71.299999999999997 110.906 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' A' ' 101' ' ' VAL . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.420000000000002 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.672 ' HB2' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.409999999999997 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 99' ' ' PRO . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 52.340000000000003 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.209999999999994 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 62.409999999999997 111.113 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.340000000000003 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 62.399999999999999 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 63.049999999999997 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' H ' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.923 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 70.030000000000001 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 70.109999999999999 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 54.399999999999999 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.519999999999996 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.518 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.030000000000001 110.797 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.219999999999999 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.457 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 71.340000000000003 110.835 -179.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.749 0.309 . . . . 73.329999999999998 110.997 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.409999999999997 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.030000000000001 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.530000000000001 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.230000000000004 110.952 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 129' ' ' LEU . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.896 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 53.340000000000003 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.049999999999997 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.409999999999997 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.439999999999998 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 34.039999999999999 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.129999999999995 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 100' ' ' TYR . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 50.140000000000001 111.124 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 70.319999999999993 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.783 HG22 ' OD1' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.200000000000003 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.100000000000001 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.449 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.922 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.539999999999999 110.923 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 151' ' ' VAL . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 111.07 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 70.219999999999999 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.565 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.84 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.918 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.468 HG12 ' HB ' ' A' ' 145' ' ' ILE . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.420000000000002 111.24 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 53.32 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.019999999999996 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 63.450000000000003 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 183' ' ' VAL . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.329999999999998 111.117 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.422 ' N ' HG22 ' A' ' 155' ' ' VAL . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.85 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.623 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.299999999999997 110.867 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.61 ' HA ' HD13 ' A' ' 179' ' ' LEU . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.838 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 62.240000000000002 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.530000000000001 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.430000000000007 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 41.310000000000002 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.656 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.099999999999994 110.835 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 32.329999999999998 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.019999999999996 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 52.420000000000002 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 60.530000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.319999999999993 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 167' ' ' LYS . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.450000000000003 110.818 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.150000000000006 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 61.43 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 64.209999999999994 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.468 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.310000000000002 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.310000000000002 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 155' ' ' VAL . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 111.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 65.319999999999993 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.310000000000002 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.310000000000002 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.319999999999993 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 72.329999999999998 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.329999999999998 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.739 0.304 . . . . 73.319999999999993 110.774 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 47' ' ' MET . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 48' ' ' ALA . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.219999999999999 112.461 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.420000000000002 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.439999999999998 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 64.109999999999999 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 70.439999999999998 110.847 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 52.329999999999998 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.140000000000001 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 44.049999999999997 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 38' ' ' THR . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.040000000000006 111.134 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 55.439999999999998 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 61.509999999999998 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 55.240000000000002 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.310000000000002 112.344 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.524 -0.029 0 CA-C-O 120.813 0.34 . . . . 60.32 111.116 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 42.020000000000003 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 64.540000000000006 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' ALA . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 111.147 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.400000000000006 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 65.510000000000005 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.099999999999994 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 111.061 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 62.43 111.122 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.149999999999999 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.722 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 70.510000000000005 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.430000000000007 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.420000000000002 110.983 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.210000000000001 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 65.530000000000001 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 45' ' ' THR . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 45.100000000000001 110.822 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.100000000000001 110.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 54.530000000000001 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 62.329999999999998 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.409999999999997 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 63.5 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.319999999999993 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 71.349999999999994 110.945 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.861 0.362 . . . . 52.229999999999997 111.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 43.100000000000001 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 HD12 ' A' ' 129' ' ' LEU . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 111.107 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 71.040000000000006 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.200000000000003 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 64.140000000000001 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.925 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 63.049999999999997 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.925 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 64.140000000000001 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.039999999999999 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.488 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.409999999999997 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.340000000000003 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.9 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.340000000000003 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 70.519999999999996 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.229999999999997 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.468 ' C ' HG23 ' A' ' 141' ' ' VAL . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 71.219999999999999 110.899 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.573 ' N ' HG23 ' A' ' 141' ' ' VAL . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.109999999999999 112.346 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 61.219999999999999 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.030000000000001 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 87' ' ' GLN . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 63.310000000000002 112.549 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 44.509999999999998 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.010000000000005 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 63.399999999999999 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 71.549999999999997 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 80' ' ' LEU . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.13 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.219999999999999 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.129999999999995 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.239999999999995 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.725 ' H ' HD23 ' A' ' 124' ' ' LEU . 61.6 t80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.219999999999999 110.948 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 115' ' ' PHE . 13.3 tp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.833 0.349 . . . . 73.219999999999999 110.94 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 124' ' ' LEU . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.349999999999994 110.882 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.150000000000006 110.966 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 65.420000000000002 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.549999999999997 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.230000000000004 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.517 ' HB2' ' NE1' ' A' ' 156' ' ' TRP . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 111.011 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 74.219999999999999 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 139' ' ' VAL . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.02 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.120000000000005 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 99' ' ' PRO . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 65.200000000000003 111.127 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.613 ' CB ' ' HA ' ' A' ' 152' ' ' ASN . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.140000000000001 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.430000000000007 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.040000000000006 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 72.319999999999993 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.150000000000006 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 43.350000000000001 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 71.040000000000006 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 151' ' ' VAL . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.982 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.612 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 62.109999999999999 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 64.409999999999997 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.506 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.219999999999999 110.822 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.219999999999999 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 64.129999999999995 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.517 ' NE1' ' HB2' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.519999999999996 110.956 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 51.32 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' VAL . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.420000000000002 110.852 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 63.210000000000001 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 73.400000000000006 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.450000000000003 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 53.219999999999999 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 15.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 62.109999999999999 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.608 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.549999999999997 110.996 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.446 ' HB3' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.120000000000005 110.84 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.340000000000003 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 64.319999999999993 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.530000000000001 111.017 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.100000000000001 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.400000000000006 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 65.200000000000003 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 64.129999999999995 110.974 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.540000000000006 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.349999999999994 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 73.540000000000006 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' A' ' 158' ' ' MET . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 111.136 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.230000000000004 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.319999999999993 111.042 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 54.43 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 55.399999999999999 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.420000000000002 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 73.340000000000003 110.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 62.149999999999999 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.883 ' HB1' HG23 ' A' ' 49' ' ' THR . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.128 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.209999999999994 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.239999999999995 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 61.009999999999998 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.150000000000006 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.836 ' HB2' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 65.439999999999998 110.855 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.549999999999997 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.310000000000002 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG22 ' CG2' ' A' ' 183' ' ' VAL . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.409999999999997 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.310000000000002 112.405 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.858 0.361 . . . . 72.340000000000003 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.908 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' THR . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.230000000000004 110.941 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 111.226 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.319999999999993 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 64.319999999999993 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.539999999999999 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 74.420000000000002 110.943 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 10' ' ' ARG . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 61.450000000000003 111.076 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.299999999999997 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 62.219999999999999 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 64.510000000000005 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 61.329999999999998 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.010000000000005 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.883 HG23 ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.126 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 71.120000000000005 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 83' ' ' THR . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.120000000000005 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.340000000000003 111.059 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.109999999999999 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.239999999999995 112.455 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.965 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.515 ' O ' HG21 ' A' ' 76' ' ' THR . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.92 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 m170 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.319999999999993 110.849 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.85 0.357 . . . . 70.310000000000002 111.104 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 63' ' ' ARG . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 111.085 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 62.530000000000001 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 71.400000000000006 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.140000000000001 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 73.25 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.929 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.929 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 62.219999999999999 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.403 ' C ' HD23 ' A' ' 56' ' ' LEU . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 111.084 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.329999999999998 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.409999999999997 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.400000000000006 111.131 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 63.439999999999998 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.549999999999997 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 63.140000000000001 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.785 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.439999999999998 111.032 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.319999999999993 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.140000000000001 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 63.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.329999999999998 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 53.039999999999999 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 54.520000000000003 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 90' ' ' PHE . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 71.319999999999993 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 34.439999999999998 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.219999999999999 111.105 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.209999999999994 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 134' ' ' GLY . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.409999999999997 111.07 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.109999999999999 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 64.140000000000001 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.150000000000006 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 71.030000000000001 110.799 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 70.019999999999996 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.659 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 110.811 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 163' ' ' THR . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 64.519999999999996 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 64.5 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.340000000000003 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.120000000000005 112.504 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 51.240000000000002 111.053 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.100000000000001 111.129 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.120000000000005 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.549999999999997 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 64.319999999999993 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 73.219999999999999 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 61.530000000000001 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.573 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.420000000000002 110.933 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.409999999999997 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 64.25 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 63.420000000000002 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 150' ' ' LEU . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 53.219999999999999 110.909 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 42.420000000000002 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.420000000000002 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 184' ' ' PHE . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.439999999999998 111.083 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 64.030000000000001 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.120000000000005 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 63.030000000000001 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.664 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 34.240000000000002 111.145 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.400000000000006 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.409999999999997 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.340000000000003 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 65.420000000000002 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 53.439999999999998 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 64.200000000000003 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.109999999999999 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.109999999999999 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.549999999999997 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.510000000000005 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.219999999999999 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 53.509999999999998 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 65.239999999999995 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.621 ' CG2' HG22 ' A' ' 16' ' ' VAL . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 35.119999999999997 111.162 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.758 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.936 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.140000000000001 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.310000000000002 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 62.210000000000001 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 72.340000000000003 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 22.030000000000001 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 55.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 63.43 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 120.702 0.287 . . . . 73.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.329999999999998 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 51.240000000000002 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.400000000000006 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.450000000000003 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.340000000000003 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.793 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.924 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 45.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.209999999999994 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.409999999999997 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.597 ' C ' HG23 ' A' ' 183' ' ' VAL . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.116 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 180' ' ' ASP . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 70.439999999999998 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.450000000000003 112.387 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.781 0.324 . . . . 74.5 111.13 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.430000000000007 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 55.149999999999999 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 43.039999999999999 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.32 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 55' ' ' GLU . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 70.450000000000003 111.058 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.540000000000006 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 63.240000000000002 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.439999999999998 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 54.409999999999997 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.200000000000003 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.019999999999996 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HB2' HG22 ' A' ' 45' ' ' THR . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 110.826 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.409999999999997 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.019999999999996 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 42.240000000000002 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.409999999999997 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.439999999999998 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.692 ' CB ' HG21 ' A' ' 77' ' ' VAL . 6.5 t60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.842 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.807 0.336 . . . . 54.43 111.14 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 64.430000000000007 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 64' ' ' HIS . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 64.030000000000001 111.128 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 108' ' ' THR . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.874 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 71.049999999999997 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.931 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.420000000000002 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.931 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 62.43 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 107' ' ' TYR . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.310000000000002 111.085 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.299999999999997 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 111.079 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.349999999999994 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 103' ' ' ALA . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 60.329999999999998 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 54.210000000000001 110.89 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 45.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 61.329999999999998 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.049999999999997 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.430000000000007 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 65.329999999999998 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 53.109999999999999 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.349999999999994 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.209999999999994 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 139' ' ' VAL . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.019999999999996 111.059 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.509999999999998 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB3' ' CH2' ' A' ' 88' ' ' TRP . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 51.509999999999998 111.073 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 35.119999999999997 112.442 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 62.329999999999998 111.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 62.420000000000002 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 79' ' ' HIS . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.109999999999999 111.093 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.120000000000005 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 61.340000000000003 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.349999999999994 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 71.340000000000003 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 73.129999999999995 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 63.0 110.786 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 125' ' ' SER . 1.1 pp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.767 0.318 . . . . 63.43 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 124' ' ' LEU . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.019999999999996 110.83 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.349999999999994 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 165' ' ' ASN . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 61.530000000000001 110.884 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.409999999999997 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 64.5 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.030000000000001 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 107' ' ' TYR . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.099999999999994 112.625 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.519999999999996 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 71.129999999999995 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 62.530000000000001 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 63.049999999999997 110.943 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 101' ' ' VAL . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 55.509999999999998 111.152 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 151' ' ' VAL . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.329999999999998 110.938 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 63.229999999999997 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 72.129999999999995 111.009 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.129999999999995 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.149999999999999 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.019999999999996 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.299999999999997 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 61.340000000000003 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.299999999999997 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.109999999999999 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.439999999999998 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.484 ' C ' HG23 ' A' ' 177' ' ' VAL . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 52.210000000000001 111.236 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.711 ' HB3' ' CB ' ' A' ' 175' ' ' ASP . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.099 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.726 ' HB3' HD23 ' A' ' 127' ' ' LEU . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.923 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.966 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.230000000000004 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 65.019999999999996 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.009999999999998 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.319999999999993 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.310000000000002 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 43.229999999999997 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 71.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.109999999999999 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.711 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.109999999999999 110.898 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.040000000000006 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 163' ' ' THR . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.235 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 60.140000000000001 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 107' ' ' TYR . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.530000000000001 110.859 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 16' ' ' VAL . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.049999999999997 110.8 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 64.310000000000002 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.597 HG23 ' C ' ' A' ' 15' ' ' THR . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 62.140000000000001 111.231 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.400000000000006 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.109999999999999 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 63.310000000000002 111.11 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.420000000000002 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 61.530000000000001 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 53.509999999999998 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.510000000000005 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 . . . . . 0 N--CA 1.46 0.072 0 CA-C-O 120.728 0.299 . . . . 74.140000000000001 110.849 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.099999999999994 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.540000000000006 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.299999999999997 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.540000000000006 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 150' ' ' LEU . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.340000000000003 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 65.549999999999997 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.549999999999997 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.439999999999998 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 45.32 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.209999999999994 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.210000000000001 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 183' ' ' VAL . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.087 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.439999999999998 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 62.109999999999999 112.306 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.524 -0.047 0 CA-C-O 120.877 0.37 . . . . 44.240000000000002 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.209999999999994 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.310000000000002 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 50.340000000000003 110.895 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 57' ' ' LEU . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 65.010000000000005 111.188 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.506 ' CE2' HD12 ' A' ' 42' ' ' LEU . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 73.430000000000007 110.793 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.65 HG23 ' HG2' ' A' ' 55' ' ' GLU . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 53.25 111.147 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.439999999999998 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 71.510000000000005 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 61.149999999999999 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.140000000000001 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 62.43 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.119999999999997 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.109999999999999 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' HG23 ' A' ' 45' ' ' THR . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.854 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 61.210000000000001 111.03 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 51.240000000000002 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 70.109999999999999 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.230000000000004 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' VAL . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.150000000000006 110.85 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 110.861 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' CB ' ' A' ' 113' ' ' ASN . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.892 0.377 . . . . 71.019999999999996 111.112 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 76' ' ' THR . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 111.063 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 63' ' ' ARG . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 62.329999999999998 111.151 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.319999999999993 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.230000000000004 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.921 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.319999999999993 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.921 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.420000000000002 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.310000000000002 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.746 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 64.329999999999998 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.430000000000007 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.230000000000004 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 60.240000000000002 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.010000000000005 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.349999999999994 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 64.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 64.400000000000006 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 62.149999999999999 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 73.319999999999993 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.219999999999999 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 54.020000000000003 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.676 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.219999999999999 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.420000000000002 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.229999999999997 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 134' ' ' GLY . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 62.020000000000003 111.12 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.129999999999995 110.799 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 73.230000000000004 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 72.120000000000005 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 64.120000000000005 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB2' HD23 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 65.430000000000007 110.812 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.486 ' CB ' ' HB1' ' A' ' 75' ' ' ALA . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 73.109999999999999 110.853 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.519999999999996 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 127' ' ' LEU . 29.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.906 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.825 0.345 . . . . 60.039999999999999 110.825 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.310000000000002 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 53.310000000000002 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.526 HD13 ' CE1' ' A' ' 115' ' ' PHE . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.129999999999995 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 112' ' ' ASP . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.150000000000006 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.120000000000005 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.445 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 62.439999999999998 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 52.119999999999997 111.123 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.409999999999997 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 64.109999999999999 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.150000000000006 111.011 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.420000000000002 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.549999999999997 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.533 ' N ' HD22 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.140000000000001 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.420000000000002 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.519999999999996 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 73.019999999999996 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.329999999999998 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.548 ' O ' ' HB1' ' A' ' 188' ' ' ALA . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.795 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 151' ' ' VAL . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.120000000000005 111.121 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.652 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.409999999999997 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.020000000000003 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 65.209999999999994 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.519999999999996 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 62.210000000000001 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 72.200000000000003 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.109999999999999 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 60.329999999999998 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 176' ' ' SER . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 60.509999999999998 111.235 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.230000000000004 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 45.420000000000002 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.200000000000003 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 71.319999999999993 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 171' ' ' ALA . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.150000000000006 110.932 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 124' ' ' LEU . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.049999999999997 112.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 65.239999999999995 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 168' ' ' LEU . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 52.420000000000002 111.017 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.109999999999999 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.329999999999998 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.400000000000006 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 163' ' ' THR . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.439999999999998 110.904 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.903 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 71.530000000000001 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.229999999999997 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.420000000000002 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 16' ' ' VAL . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 63.240000000000002 111.172 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.400000000000006 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.340000000000003 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 111.093 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 63.100000000000001 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.140000000000001 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 71.319999999999993 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 74.129999999999995 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -116.17 26.63 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 62.109999999999999 110.912 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -176.97 154.85 1.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.23 103.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.058 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.53 76.69 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.747 -0.739 . . . . 64.150000000000006 112.554 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 127.91 33.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 61.450000000000003 110.89 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -115.26 114.57 25.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 73.549999999999997 110.908 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 119.74 21.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 72.519999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 138.22 36.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.092 -0.504 . . . . 32.350000000000001 110.925 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' NH2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -127.7 -177.79 4.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 110.859 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 187' ' ' SER . . . -92.44 151.63 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 111.121 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.93 65.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 54.340000000000003 112.53 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -95.31 80.67 3.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.929 0.395 . . . . 62.240000000000002 110.88 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 38' ' ' THR . . . -95.28 107.72 19.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 74.219999999999999 111.092 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 98.97 11.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.79 HG22 ' HD3' ' A' ' 18' ' ' PRO . 11.3 p -92.23 134.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 72.430000000000007 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -136.9 74.68 50.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.726 0.774 . . . . 72.450000000000003 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.6 Cg_endo -69.74 119.25 6.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.281 . . . . 74.219999999999999 112.324 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.8 t -174.14 31.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 73.310000000000002 111.137 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -92.38 -170.04 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 73.540000000000006 110.844 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.86 -98.47 1.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.763 -0.732 . . . . 74.439999999999998 112.38 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.48 -67.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 74.140000000000001 111.033 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.16 -110.75 1.49 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 51.219999999999999 112.512 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.95 40.46 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 62.229999999999997 112.524 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.71 -73.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.847 0.356 . . . . 61.119999999999997 111.211 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -176.02 34.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 62.32 110.912 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.39 171.21 23.82 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 75.150000000000006 112.435 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.553 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -151.56 103.66 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 74.019999999999996 110.926 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -177.17 133.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 74.040000000000006 110.911 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.12 43.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.798 -0.715 . . . . 64.109999999999999 112.436 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 146.23 36.0 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 75.409999999999997 112.492 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.09 164.42 30.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 71.510000000000005 110.849 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -148.06 103.23 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 110.931 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 142.02 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 43.409999999999997 111.175 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.48 146.89 31.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.062 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB2' HG13 ' A' ' 16' ' ' VAL . 26.4 p-10 -90.19 123.28 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 110.934 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -179.47 104.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 64.299999999999997 110.844 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' ALA . 9.4 t -176.73 44.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 52.130000000000003 111.182 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -115.86 60.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 75.450000000000003 110.953 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tp -174.77 65.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.116 -0.493 . . . . 73.109999999999999 110.948 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.41 -147.18 5.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.772 . . . . 55.009999999999998 112.44 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.72 141.04 16.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.399 . . . . 72.340000000000003 110.91 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.544 HG21 ' OE2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -111.73 151.62 28.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 63.039999999999999 111.12 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -138.44 111.48 7.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 10' ' ' ARG . 24.1 p -106.02 131.74 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 70.150000000000006 111.161 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -134.64 125.39 27.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 73.209999999999994 110.91 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.5 mtp -97.28 145.33 26.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.329999999999998 110.859 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.06 -77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 71.329999999999998 111.102 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -179.43 57.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 54.439999999999998 111.145 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.48 40.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 65.409999999999997 110.824 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 58.22 22.37 9.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.109999999999999 110.962 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.6 HD12 ' CE3' ' A' ' 88' ' ' TRP . 9.2 tt -125.85 135.15 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 52.130000000000003 111.157 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -151.93 160.3 28.76 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.758 . . . . 42.43 112.548 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -106.1 136.12 41.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 35.149999999999999 111.216 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' HG21 ' A' ' 43' ' ' THR . 70.5 tt0 -111.66 119.01 37.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 61.149999999999999 110.833 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.73 117.34 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 71.209999999999994 110.916 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -105.74 120.04 40.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 53.340000000000003 110.908 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.36 136.35 52.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 64.430000000000007 111.248 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.56 -169.78 3.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.967 0.413 . . . . 52.210000000000001 111.076 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.43 159.56 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.603 0.716 . . . . 74.030000000000001 111.07 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 128.35 15.83 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.514 2.142 . . . . 63.520000000000003 112.392 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 129.95 37.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.85 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 ptt85 -144.23 133.07 22.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 72.319999999999993 110.823 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 -176.15 5.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 110.786 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 150.03 43.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 110.976 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -65.06 128.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 75.329999999999998 111.147 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.73 40.61 2.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 63.439999999999998 112.429 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.535 HG22 HG12 ' A' ' 66' ' ' ILE . 14.7 t -94.01 151.22 19.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.313 . . . . 74.409999999999997 111.178 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -71.02 -18.16 62.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.424 . . . . 74.140000000000001 110.889 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.25 -51.2 56.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 64.430000000000007 111.139 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 HG22 ' A' ' 74' ' ' ILE . 13.3 t -121.67 -32.53 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.420000000000002 111.21 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.67 56.32 3.62 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.69 -0.767 . . . . 63.149999999999999 112.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.554 ' HA ' HG23 ' A' ' 66' ' ' ILE . 0.5 OUTLIER 66.85 126.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.798 0.332 . . . . 73.219999999999999 110.898 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.429 HG22 HG21 ' A' ' 71' ' ' THR . 16.9 tt -176.72 -35.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 65.439999999999998 111.132 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.822 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . -112.73 163.09 14.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 61.520000000000003 111.066 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.02 155.62 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.553 HG23 ' OD2' ' A' ' 112' ' ' ASP . 7.7 p -156.01 137.08 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 64.530000000000001 111.09 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -137.02 138.41 40.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 71.120000000000005 110.81 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -108.99 176.28 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.150000000000006 110.853 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.856 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 25.2 mt -97.59 121.49 58.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.563 0.697 . . . . 74.329999999999998 110.945 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 Cg_endo -69.92 -25.86 27.41 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.651 2.234 . . . . 74.310000000000002 112.359 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 106.13 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.659 2.24 . . . . 74.439999999999998 112.323 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -118.46 156.49 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 52.32 111.205 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 mp -116.97 118.13 31.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 62.140000000000001 110.987 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 mtt -114.7 115.6 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.02 148.67 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 51.409999999999997 111.078 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -134.59 136.98 43.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 73.409999999999997 110.988 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 52' ' ' ILE . 12.1 t-105 -138.29 130.72 29.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 71.239999999999995 110.941 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -85.47 118.84 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 70.25 111.03 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.42 107.87 17.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 75.040000000000006 110.936 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.46 105.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.61 -0.805 . . . . 71.400000000000006 112.507 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.36 147.95 22.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 74.209999999999994 110.931 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.33 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 64.200000000000003 111.074 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.95 105.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 65.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.14 170.2 18.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 50.530000000000001 110.805 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -25.0 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 74.420000000000002 110.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -132.12 167.72 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.872 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -109.25 87.9 5.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.624 0.726 . . . . 74.430000000000007 110.767 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 169.23 19.34 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.703 2.269 . . . . 72.519999999999996 112.4 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -176.27 117.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 72.129999999999995 110.883 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG13 HG12 ' A' ' 139' ' ' VAL . 86.1 t -99.79 130.63 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 111.127 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -152.09 -150.71 5.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.794 -0.717 . . . . 34.420000000000002 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.19 127.45 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.835 0.35 . . . . 73.099999999999994 111.159 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.14 122.45 5.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 42.229999999999997 112.482 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 2.3 mp -114.47 124.09 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.4 . . . . 65.329999999999998 111.068 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.41 109.29 20.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 54.32 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.95 107.3 13.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 74.209999999999994 110.804 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -110.21 120.95 44.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.067 -0.515 . . . . 73.310000000000002 111.178 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 -174.06 4.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 73.109999999999999 111.099 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.55 143.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 74.400000000000006 110.849 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -74.54 -171.5 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 74.530000000000001 110.888 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.553 ' OD2' HG23 ' A' ' 77' ' ' VAL . 25.6 p-10 -161.46 -168.05 1.9 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 71.519999999999996 110.911 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -169.87 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 71.340000000000003 110.86 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.822 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 122.65 -33.62 4.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.821 -0.705 . . . . 42.420000000000002 112.56 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -48.77 167.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 72.530000000000001 110.901 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 120' ' ' LYS . 5.1 t-20 -153.6 -160.06 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 65.010000000000005 110.832 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 110.867 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.48 -44.73 20.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 65.409999999999997 110.905 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.66 13.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 71.019999999999996 112.489 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -61.03 -45.25 95.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 64.209999999999994 110.957 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -16.5 63.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.285 -0.416 . . . . 74.439999999999998 110.979 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.21 2.98 18.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 73.430000000000007 111.12 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.11 24.56 9.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.808 -0.71 . . . . 74.040000000000006 112.424 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 167' ' ' LYS . 44.0 mt -154.38 -172.47 4.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.842 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 t 57.88 162.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 63.210000000000001 110.862 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 127' ' ' LEU . 0.4 OUTLIER 75.14 -51.67 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.892 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' A' ' 126' ' ' ASP . 1.7 mm? -30.99 -79.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 75.209999999999994 110.94 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.47 ' HA ' ' N ' ' A' ' 165' ' ' ASN . 0.2 OUTLIER 73.17 -75.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 75.329999999999998 110.878 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.99 114.99 1.47 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 75.420000000000002 110.936 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.78 -175.63 3.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.340000000000003 110.896 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.12 155.12 40.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 63.340000000000003 110.912 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 174.26 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 62.210000000000001 110.854 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -130.83 118.92 21.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 63.439999999999998 111.018 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -100.03 72.01 0.47 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.694 -0.765 . . . . 64.430000000000007 112.56 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -81.19 132.89 35.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 55.32 111.159 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . . . -145.24 134.94 23.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.43 111.157 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.18 134.51 12.91 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.762 -0.732 . . . . 52.030000000000001 112.376 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.511 ' NE2' ' H ' ' A' ' 139' ' ' VAL . 1.6 mm100 -164.53 163.68 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.351 . . . . 75.319999999999993 110.982 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.713 HG12 HG13 ' A' ' 101' ' ' VAL . 19.5 m -114.45 163.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 111.131 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -147.03 159.72 28.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 53.210000000000001 112.558 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.0 m -141.91 134.82 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.961 0.41 . . . . 72.109999999999999 111.067 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.05 124.16 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 52.210000000000001 110.78 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -88.8 129.16 35.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.93 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.692 ' HA ' HD23 ' A' ' 150' ' ' LEU . 0.7 OUTLIER -78.7 81.11 5.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 64.219999999999999 110.99 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.89 -53.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 111.205 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -124.49 -173.2 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 65.219999999999999 110.795 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -97.2 -15.22 20.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.105 -0.498 . . . . 61.450000000000003 110.821 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.65 -1.72 14.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 74.200000000000003 110.86 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -166.45 146.68 6.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 110.984 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -132.35 -170.72 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.243 -0.435 . . . . 64.010000000000005 110.938 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.3 130.72 60.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 75.030000000000001 111.145 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -102.53 132.26 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 64.319999999999993 110.899 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.38 130.64 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.209999999999994 110.942 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.43 167.68 29.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 64.329999999999998 110.903 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.6 m -152.47 173.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 65.230000000000004 111.155 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.86 -178.62 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 63.109999999999999 110.904 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -135.48 -75.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 65.209999999999994 110.91 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.13 110.02 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 71.209999999999994 110.901 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -179.8 102.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.319999999999993 110.819 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -164.52 143.51 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 70.340000000000003 111.133 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.415 ' N ' HD13 ' A' ' 160' ' ' ILE . 4.7 m-20 -124.75 136.42 53.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 42.43 110.818 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.21 131.6 23.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.439999999999998 111.115 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 19.5 p -89.45 137.05 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 74.519999999999996 111.111 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 175' ' ' ASP . . . -131.46 98.59 4.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 111.176 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.47 ' N ' ' HA ' ' A' ' 128' ' ' SER . 4.3 p-10 -177.5 -175.25 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.898 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER 173.94 -163.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 71.230000000000004 110.882 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.715 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -94.52 105.2 17.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 72.450000000000003 110.886 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.81 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.6 OUTLIER -97.96 85.77 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.924 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.7 13.75 69.14 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.665 -0.779 . . . . 74.329999999999998 112.513 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.46 45.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 73.109999999999999 112.456 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.81 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -136.79 163.67 30.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.737 0.303 . . . . 23.300000000000001 111.076 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.84 99.84 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.25 110.89 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.3 177.1 6.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 110.921 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -175.38 112.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 72.200000000000003 110.91 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 164' ' ' ALA . 1.2 t70 -127.18 131.38 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 71.040000000000006 110.893 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 117.13 23.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 72.430000000000007 110.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.6 t -125.82 130.6 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 55.219999999999999 111.135 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.701 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.43 135.51 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.400000000000006 110.959 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 178' ' ' ARG . 3.6 mp -139.72 86.03 2.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.26 73.95 5.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 71.239999999999995 110.904 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 -179.65 2.98 Favored 'Trans proline' 0 C--N 1.34 0.121 0 C-N-CA 122.773 2.315 . . . . 65.340000000000003 112.291 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -80.1 84.77 5.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.409999999999997 110.963 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.09 124.05 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 111.13 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -103.71 129.71 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.876 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.71 104.26 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.888 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -152.16 135.93 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 110.959 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -176.22 174.36 2.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.182 -0.463 . . . . 64.420000000000002 110.815 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.82 155.57 27.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 44.509999999999998 111.107 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.87 139.85 11.31 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.482 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -144.37 157.15 44.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 63.149999999999999 110.922 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.81 113.72 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.892 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 75.0 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.896 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.905 0.383 . . . . 64.129999999999995 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -123.63 25.52 8.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 110.779 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -174.71 174.5 2.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . 59.11 97.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 62.329999999999998 111.052 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.48 -13.99 62.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 74.239999999999995 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 154.8 34.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 62.539999999999999 110.861 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.34 112.53 13.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 71.340000000000003 110.8 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -112.42 158.08 20.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.409999999999997 110.793 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.87 145.69 26.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 60.420000000000002 110.809 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 25.1 tpt180 -155.23 162.08 41.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.62 -170.36 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 42.439999999999998 111.156 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.02 117.62 4.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.744 . . . . 71.040000000000006 112.481 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.1 80.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 110.84 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 38' ' ' THR . . . -123.16 137.51 54.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 61.149999999999999 111.065 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -112.06 109.04 18.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 111.215 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 183' ' ' VAL . 22.0 t -91.86 128.93 43.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 32.539999999999999 111.187 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -79.96 160.48 68.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 110.928 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 -173.23 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.64 2.227 . . . . 64.140000000000001 112.371 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.0 p -104.91 -179.39 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.186 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.67 -171.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 75.409999999999997 110.846 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.12 -136.02 9.16 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 65.120000000000005 112.507 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -75.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 72.200000000000003 111.031 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.93 103.45 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.813 -0.708 . . . . 61.140000000000001 112.483 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.16 173.25 19.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.76 . . . . 33.240000000000002 112.462 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m 53.86 34.46 19.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 52.140000000000001 111.202 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -179.12 109.69 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 73.099999999999994 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.38 149.98 21.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 64.310000000000002 112.515 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.24 -177.7 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 110.924 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -124.63 -178.66 4.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.873 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.71 43.36 0.96 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 71.209999999999994 112.54 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.59 148.43 9.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 54.340000000000003 112.496 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.81 165.26 15.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 75.219999999999999 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -118.63 152.07 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.86 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.595 HG11 ' CE1' ' A' ' 64' ' ' HIS . 27.1 m -78.66 -176.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 43.420000000000002 111.146 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.1 t -80.19 145.38 32.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 71.019999999999996 111.126 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -174.83 67.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 54.240000000000002 110.875 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -179.45 154.46 0.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.140000000000001 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 14' ' ' ALA . 2.5 t 179.81 68.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 62.43 111.096 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -107.34 41.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.439999999999998 110.849 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -170.0 77.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.150000000000006 110.941 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.01 -144.44 4.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 63.420000000000002 112.518 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.2 157.51 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.372 . . . . 71.310000000000002 110.967 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 57' ' ' LEU . 3.1 m -156.8 142.35 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 111.211 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -124.46 148.59 47.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.836 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 55' ' ' GLU . 3.6 m -138.21 131.89 30.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 71.400000000000006 111.095 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -142.59 137.11 29.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.1 mmt -108.13 136.58 47.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.515 . . . . 71.010000000000005 110.855 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.79 -81.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 74.120000000000005 111.037 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 5.0 t 179.01 57.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 73.219999999999999 111.211 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -179.79 44.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 m120 56.66 23.92 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 63.149999999999999 110.957 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.7 mt -135.22 135.37 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 72.409999999999997 111.241 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.01 170.95 31.39 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.772 -0.728 . . . . 53.420000000000002 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.24 147.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.341 . . . . 72.109999999999999 111.098 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 45' ' ' THR . 1.9 tt0 -127.5 119.11 25.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 73.310000000000002 110.841 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.93 120.54 34.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 62.530000000000001 110.875 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER -97.39 132.85 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 70.409999999999997 110.929 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.22 152.26 41.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.032 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.88 -170.06 0.23 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.17 -0.468 . . . . 34.310000000000002 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 159.58 1.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.655 0.74 . . . . 71.439999999999998 111.149 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 141.96 46.92 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.540000000000006 112.296 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -115.35 130.26 56.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.219999999999999 110.811 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 132.62 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 71.239999999999995 110.836 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' CE1' HG11 ' A' ' 34' ' ' VAL . 7.0 t60 -99.04 106.25 18.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.862 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -113.06 156.55 22.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.942 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.662 HG13 HG22 ' A' ' 74' ' ' ILE . 45.3 mm -63.84 106.25 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 73.310000000000002 111.194 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.95 72.02 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.765 -0.731 . . . . 53.43 112.429 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.23 151.73 19.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 73.230000000000004 111.139 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.44 -25.89 33.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 63.340000000000003 110.883 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.76 -36.96 49.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 111.122 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' HG21 ' A' ' 66' ' ' ILE . 20.7 p -120.32 -32.49 4.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.082 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 52.18 71.5 0.66 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.695 -0.764 . . . . 63.32 112.556 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 62.31 102.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 71.5 110.853 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.662 HG22 HG13 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -97.02 -28.56 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 111.146 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.48 158.77 44.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.155 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 t -99.77 117.72 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 111.176 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG22 ' OG ' ' A' ' 128' ' ' SER . 21.7 t -124.0 132.92 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 62.509999999999998 111.122 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.2 124.77 26.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.43 110.892 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -101.06 176.51 5.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 61.520000000000003 110.852 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.866 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 3.9 mm? -98.28 119.63 61.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 73.5 110.94 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.924 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 Cg_endo -69.83 -25.82 27.88 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.652 2.235 . . . . 74.219999999999999 112.324 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.924 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.74 119.22 6.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.712 2.275 . . . . 63.049999999999997 112.342 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 156.2 37.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 41.329999999999998 111.132 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 107' ' ' TYR . 2.1 mt -108.56 141.04 41.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.98 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 106.21 5.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.939 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.45 146.62 48.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 40.210000000000001 111.091 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -126.48 133.93 51.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -146.27 112.52 5.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 61.109999999999999 110.987 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -79.96 143.08 34.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 61.130000000000003 110.91 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -158.93 128.75 5.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.540000000000006 110.809 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.89 -66.34 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.420000000000002 112.44 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.4 t0 63.4 104.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.773 0.32 . . . . 75.439999999999998 110.852 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.65 127.18 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 111.203 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -74.08 76.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 74.540000000000006 110.756 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.84 -170.05 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.099 -0.5 . . . . 73.109999999999999 110.897 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 34.28 1.6 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -157.88 144.45 17.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.349999999999994 110.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.78 88.23 53.87 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.644 0.735 . . . . 72.129999999999995 110.828 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.23 22.15 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.766 2.311 . . . . 64.209999999999994 112.356 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -175.12 121.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.240000000000002 110.927 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.74 131.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 63.210000000000001 111.075 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.81 -173.7 13.7 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.455 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.78 127.57 25.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 61.130000000000003 111.112 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.83 108.19 2.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.703 -0.761 . . . . 73.150000000000006 112.501 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 134' ' ' GLY . 2.2 mp -106.06 121.48 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 111.233 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -90.89 108.1 19.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 65.310000000000002 110.928 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 84' ' ' LEU . 38.6 t80 -102.87 107.08 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.937 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.86 134.22 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.450000000000003 111.155 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.38 -176.2 3.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 62.439999999999998 111.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -94.59 168.85 10.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 74.120000000000005 110.857 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -168.77 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 75.109999999999999 110.889 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.92 133.9 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 43.310000000000002 110.922 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.4 114.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.785 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 52.95 -102.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 32.539999999999999 112.535 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -51.13 104.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 74.530000000000001 110.879 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.447 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.2 t-20 -165.88 -157.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.959 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.49 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.329999999999998 110.869 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.08 -47.23 16.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.24 -58.64 12.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 71.099999999999994 112.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.447 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.22 -47.65 84.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.755 0.312 . . . . 54.399999999999999 110.949 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -67.28 -10.96 55.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 71.25 110.764 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.98 -5.89 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.030000000000001 111.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.34 36.98 8.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 53.340000000000003 112.59 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.03 133.59 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.748 0.309 . . . . 73.409999999999997 111.016 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 m -112.81 24.45 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 63.25 110.744 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -80.07 58.51 2.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.141 -0.481 . . . . 61.229999999999997 110.929 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.23 -21.8 49.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.914 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 77' ' ' VAL . 4.2 m 63.3 -165.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.854 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 162' ' ' THR . 0.7 OUTLIER -53.66 118.11 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 64.400000000000006 110.939 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -98.44 168.26 10.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.89 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.24 153.31 7.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 63.439999999999998 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.1 OUTLIER -171.19 161.32 6.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 54.299999999999997 110.851 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -133.12 118.34 18.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 73.430000000000007 110.991 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -125.77 168.58 17.86 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.809 -0.71 . . . . 72.030000000000001 112.591 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.36 147.08 26.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 51.549999999999997 111.137 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' A' ' 158' ' ' MET . . . -148.6 167.53 25.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 111.097 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.41 143.98 16.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 34.130000000000003 112.441 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -155.18 159.82 40.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 74.120000000000005 110.938 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.51 136.43 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 62.310000000000002 111.157 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -136.19 157.43 23.47 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.798 -0.715 . . . . 51.399999999999999 112.486 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.82 134.67 61.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 74.420000000000002 111.18 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -130.7 135.62 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.040000000000006 110.887 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -136.93 135.1 37.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.9 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.0 152.56 45.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.167 -0.47 . . . . 73.450000000000003 110.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.1 tp -138.07 -40.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 75.319999999999993 111.207 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -118.3 26.47 9.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 72.519999999999996 110.77 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 71.4 -69.13 0.19 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 64.439999999999998 110.963 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.62 6.67 26.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 62.140000000000001 110.874 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -143.14 129.39 19.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.973 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 189' ' ' GLY . 1.5 mp -123.43 168.85 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 62.549999999999997 110.844 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.03 116.21 49.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 31.539999999999999 111.136 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -107.67 132.73 53.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 74.120000000000005 110.863 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.23 144.37 51.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.807 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -159.9 -169.88 2.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.825 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.1 151.81 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.48 . . . . 60.329999999999998 111.067 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.53 177.07 4.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 75.200000000000003 110.859 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -177.99 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.099999999999994 110.899 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.729 ' HG3' ' HB1' ' A' ' 136' ' ' ALA . 8.2 mmt -58.56 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 71.010000000000005 110.88 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.67 -170.1 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.030000000000001 110.808 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.9 pt -137.01 151.08 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 111.068 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.88 105.55 16.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 75.439999999999998 110.944 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 132' ' ' SER . 34.2 p -141.77 132.55 25.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 111.213 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.1 t -79.95 149.55 30.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 71.400000000000006 111.133 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.34 123.9 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 62.140000000000001 111.133 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -100.75 141.06 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.909 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.12 89.26 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.409999999999997 110.925 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.548 ' HG2' ' C ' ' A' ' 171' ' ' ALA . 1.5 tptt -152.8 162.64 41.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 72.519999999999996 110.947 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.492 ' N ' ' HG3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -132.89 78.5 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.420000000000002 110.921 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 51.47 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.71 -0.757 . . . . 63.329999999999998 112.481 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 168.45 -59.4 0.21 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.808 -0.71 . . . . 54.200000000000003 112.558 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.548 ' C ' ' HG2' ' A' ' 167' ' ' LYS . . . -142.88 90.0 2.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.762 0.315 . . . . 65.409999999999997 111.025 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.02 97.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 62.399999999999999 110.935 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -80.98 159.9 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 62.109999999999999 110.914 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.55 113.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.85 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -137.14 142.01 42.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.923 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.1 t -76.06 105.0 6.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.922 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.34 102.26 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 111.184 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -124.75 93.76 3.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 62.409999999999997 110.873 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.41 126.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.92 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -163.46 160.47 17.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 73.019999999999996 110.84 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.73 0.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.658 2.239 . . . . 65.219999999999999 112.438 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -89.64 162.29 15.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 74.430000000000007 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 16' ' ' VAL . 42.9 t -144.64 115.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.82 123.58 28.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 110.887 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 34.4 mtp -104.79 125.26 50.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.923 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -152.2 122.56 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.864 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.07 175.06 13.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 110.927 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.09 -164.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.102 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -155.1 111.26 0.48 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.754 -0.736 . . . . 71.530000000000001 112.542 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -122.15 154.72 37.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 72.430000000000007 110.876 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -64.35 131.69 47.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 62.130000000000003 110.819 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 71.230000000000004 110.921 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.815 0.34 . . . . 73.010000000000005 110.83 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -156.38 44.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 110.832 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -145.16 -168.88 3.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.917 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' A' ' 49' ' ' THR . . . -46.96 123.07 4.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 62.420000000000002 111.081 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.08 27.58 10.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.688 -0.768 . . . . 74.219999999999999 112.566 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -110.5 142.6 42.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 73.120000000000005 110.85 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -118.32 130.9 56.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 54.450000000000003 110.928 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 45' ' ' THR . 25.1 m-85 -139.31 139.53 37.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.746 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -105.6 142.37 35.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 64.400000000000006 110.966 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -147.54 161.93 40.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 110.869 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.74 152.96 20.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 74.540000000000006 111.067 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.54 118.35 2.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 33.119999999999997 112.437 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.7 t -150.54 101.95 2.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.844 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.43 122.2 20.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.310000000000002 111.103 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 99.23 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.197 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.753 HG22 HG12 ' A' ' 183' ' ' VAL . 96.1 t -73.17 134.67 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 71.340000000000003 111.161 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.35 160.63 67.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.722 . . . . 73.450000000000003 110.863 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 -171.82 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 73.209999999999994 112.36 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.17 -42.19 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.435 . . . . 64.030000000000001 111.148 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -178.55 175.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.030000000000001 110.896 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.15 -135.87 7.47 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.688 -0.768 . . . . 62.539999999999999 112.473 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.14 -75.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.791 0.329 . . . . 71.040000000000006 111.088 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.35 96.39 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.684 -0.77 . . . . 74.530000000000001 112.396 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.19 -177.19 14.81 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.733 -0.746 . . . . 65.25 112.49 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -57.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.737 0.303 . . . . 71.540000000000006 111.177 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -87.6 -61.92 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 51.420000000000002 110.971 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.66 156.24 27.69 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.686 -0.769 . . . . 63.039999999999999 112.472 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.0 -68.61 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.96 0.41 . . . . 64.540000000000006 110.912 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 57.14 -169.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.109999999999999 110.966 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.14 -18.74 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 72.030000000000001 112.536 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.95 124.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.802 -0.713 . . . . 74.109999999999999 112.432 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -143.18 113.61 7.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 71.150000000000006 110.979 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -124.14 80.65 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 71.209999999999994 110.889 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -149.9 109.26 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 53.32 111.058 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 137.63 36.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 74.420000000000002 111.084 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.15 -169.5 2.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 72.019999999999996 110.975 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 16' ' ' VAL . 6.5 m-20 -101.65 103.45 14.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 65.549999999999997 110.9 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.0 t -144.3 40.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.237 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.61 -169.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 70.329999999999998 110.949 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 124.28 40.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 71.5 110.827 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.43 146.43 18.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.691 -0.766 . . . . 71.510000000000005 112.482 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.01 132.33 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.92 0.39 . . . . 74.340000000000003 110.989 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.2 m -114.82 132.3 56.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 70.049999999999997 111.113 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -127.06 108.2 10.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 74.239999999999995 110.912 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.767 HG23 ' HB2' ' A' ' 8' ' ' PHE . 5.3 t -106.97 121.58 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 74.219999999999999 111.222 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.59 152.25 42.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 74.230000000000004 110.858 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 31.4 mmt -82.95 118.04 23.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 74.549999999999997 110.874 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 49' ' ' THR . . . -50.5 -82.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 73.239999999999995 111.071 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.757 ' HA ' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -179.91 48.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 64.109999999999999 111.157 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.88 43.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.854 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.85 15.65 9.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.805 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.1 mt -103.53 133.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 111.179 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.34 151.04 19.88 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.835 -0.698 . . . . 53.200000000000003 112.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.82 104.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.088 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -107.62 118.76 37.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.340000000000003 110.917 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -107.16 137.51 45.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.901 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.912 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.92 163.83 23.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.062 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.57 -168.89 3.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.163 -0.472 . . . . 72.120000000000005 111.046 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -91.95 153.84 43.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.595 0.712 . . . . 74.299999999999997 111.147 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 60' ' ' THR . 53.4 Cg_endo -69.75 78.05 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.687 2.258 . . . . 75.109999999999999 112.332 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -121.91 109.38 14.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 70.040000000000006 110.83 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 132.2 48.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 110.889 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -67.44 144.01 55.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 74.030000000000001 110.814 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -82.74 173.48 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.888 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 66' ' ' ILE . 14.0 tt -152.73 122.82 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 60.43 111.073 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.76 -154.54 25.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 41.210000000000001 112.526 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 161.93 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 64.109999999999999 111.096 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.32 60.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.834 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.64 -50.85 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 71.209999999999994 111.036 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.77 -32.41 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 71.209999999999994 111.182 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.93 -28.73 12.9 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 60.409999999999997 112.521 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.56 -75.48 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.774 0.321 . . . . 54.219999999999999 110.87 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.5 mm 64.47 105.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 63.130000000000003 111.129 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.41 163.51 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 63.520000000000003 111.111 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 t -130.66 105.4 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 70.409999999999997 111.128 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.682 HG21 ' HA ' ' A' ' 112' ' ' ASP . 4.0 m -154.0 -177.65 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 111.13 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -120.6 170.98 8.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 62.450000000000003 110.894 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.87 178.16 6.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 74.219999999999999 110.843 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -95.84 163.02 22.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.742 0.782 . . . . 74.510000000000005 110.739 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.72 171.94 13.51 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.743 2.295 . . . . 45.219999999999999 112.385 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 175.0 8.68 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.684 2.256 . . . . 64.049999999999997 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 p -116.86 153.43 32.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 70.430000000000007 111.086 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -112.05 119.37 38.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 65.230000000000004 110.914 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.43 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 12.0 ttm -118.31 103.06 9.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 71.040000000000006 110.832 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.11 122.2 32.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 72.129999999999995 111.072 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.14 134.37 42.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.968 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.493 ' O ' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -134.42 152.95 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.458 . . . . 72.129999999999995 110.89 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 99' ' ' PRO . 10.7 t80 -105.91 115.25 29.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.892 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' HB2' HG11 ' A' ' 101' ' ' VAL . 2.4 t80 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 75.439999999999998 110.859 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.47 -124.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 73.340000000000003 112.564 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.05 -74.9 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 73.409999999999997 110.798 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.15 41.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 72.510000000000005 111.103 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.0 m -52.06 -42.05 62.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.540000000000006 110.898 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.25 -169.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 71.150000000000006 110.92 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.45 10.3 7.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.540000000000006 110.79 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -173.51 138.47 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 74.230000000000004 110.865 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 144' ' ' LEU . 5.9 mmp_? -71.76 124.33 90.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.571 0.7 . . . . 74.25 110.861 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 53.9 Cg_endo -69.62 149.77 68.2 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.673 2.249 . . . . 75.409999999999997 112.361 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.2 p90 -96.52 33.7 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.282 -0.417 . . . . 75.450000000000003 110.914 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -125.12 80.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 60.5 111.076 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.11 -159.75 8.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.751 -0.738 . . . . 53.409999999999997 112.479 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.9 146.59 29.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 71.299999999999997 111.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -119.55 137.76 12.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 71.329999999999998 112.472 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 133' ' ' TRP . 13.5 tt -116.09 119.67 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.789 0.328 . . . . 70.209999999999994 111.172 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HG21 ' A' ' 160' ' ' ILE . 1.4 m-80 -91.72 109.26 20.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.973 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -91.97 124.7 36.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 75.120000000000005 110.916 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.587 HG22 HD13 ' A' ' 80' ' ' LEU . 17.9 p -121.64 137.82 54.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 74.329999999999998 111.116 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.7 m -100.94 134.18 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -50.15 120.57 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 61.119999999999997 110.855 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 110.941 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.682 ' HA ' HG21 ' A' ' 77' ' ' VAL . 1.3 m-20 73.96 131.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.988 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.608 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.0 m-80 65.94 86.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 71.120000000000005 110.983 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 125.03 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 55.530000000000001 112.499 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.784 ' CE1' HD22 ' A' ' 124' ' ' LEU . 2.5 m-85 -72.32 169.12 16.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 65.019999999999996 110.821 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -177.51 -152.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 72.140000000000001 110.853 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -46.14 -56.6 5.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 54.43 110.799 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 52.7 m80 -78.22 -50.16 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.846 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.699 ' CA ' HD12 ' A' ' 124' ' ' LEU . . . -54.43 -58.75 11.82 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.734 -0.746 . . . . 42.240000000000002 112.512 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -58.15 -49.16 77.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.719 0.295 . . . . 73.430000000000007 110.857 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -68.11 -11.7 59.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.877 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' HIS . . . -87.56 -3.37 58.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.019999999999996 111.173 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.76 -9.63 8.06 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 74.450000000000003 112.386 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.784 HD22 ' CE1' ' A' ' 115' ' ' PHE . 4.4 mt -85.44 166.48 16.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.359 . . . . 61.140000000000001 110.854 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 -76.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 70.120000000000005 110.83 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.55 121.73 4.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 54.409999999999997 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.608 HD13 ' O ' ' A' ' 113' ' ' ASN . 1.9 pt? -73.25 147.65 44.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.169 -0.469 . . . . 73.239999999999995 110.919 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.19 81.15 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 71.040000000000006 110.865 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.489 ' CD1' HD12 ' A' ' 127' ' ' LEU . 4.8 mp -100.6 163.74 12.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.109999999999999 110.824 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.35 157.19 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 73.140000000000001 110.883 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -58.11 162.89 3.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.409 . . . . 62.240000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.541 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.6 OUTLIER -147.86 145.72 28.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 62.25 110.792 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.603 ' HB2' HD11 ' A' ' 105' ' ' ILE . 8.1 p-90 -132.53 118.65 19.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 62.32 110.962 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 160' ' ' ILE . . . -109.17 85.98 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 75.230000000000004 112.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -92.26 134.7 34.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.338 . . . . 62.299999999999997 111.094 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.8 156.92 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 111.143 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 128.1 8.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 31.440000000000001 112.51 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -129.56 165.83 20.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 73.310000000000002 110.861 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 21.2 m -108.12 134.73 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 54.409999999999997 111.233 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -147.72 126.67 2.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 73.200000000000003 112.48 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 100' ' ' TYR . 22.0 t -118.1 125.98 74.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 54.200000000000003 111.195 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.87 132.66 27.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 63.009999999999998 110.909 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.43 113.91 26.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.875 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.529 ' HA ' HD23 ' A' ' 150' ' ' LEU . 1.6 tp -76.58 101.8 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.044 -0.525 . . . . 64.150000000000006 110.971 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.97 74.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 62.350000000000001 111.097 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.36 -58.86 3.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.030000000000001 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -64.92 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 72.439999999999998 110.878 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -130.32 3.12 4.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 53.539999999999999 110.884 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -166.82 -176.02 3.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 62.130000000000003 110.925 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 144' ' ' LEU . 3.3 mp -96.04 158.13 15.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.279 -0.418 . . . . 62.25 110.938 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.73 130.0 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 51.210000000000001 111.12 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -114.87 131.96 56.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.230000000000004 110.852 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -147.89 123.0 10.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 110.863 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -160.24 -170.48 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 52.210000000000001 110.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.52 150.52 30.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 71.200000000000003 111.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.516 ' HB2' HG23 ' A' ' 183' ' ' VAL . 0.5 OUTLIER -102.76 150.63 23.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.972 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.34 -47.49 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 74.540000000000006 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.35 105.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.915 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -174.53 97.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 72.310000000000002 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 134' ' ' GLY . 2.1 pp -137.69 150.93 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.067 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -118.34 108.16 14.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.892 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 132' ' ' SER . 15.4 m -109.27 130.92 55.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 75.540000000000006 111.182 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.23 131.0 35.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 75.530000000000001 111.116 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -135.72 115.92 13.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 75.049999999999997 111.051 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -105.05 101.67 11.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.030000000000001 110.964 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.42 143.73 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 65.109999999999999 110.954 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -114.87 119.84 37.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 74.299999999999997 110.861 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.58 87.09 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 73.519999999999996 110.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.43 64.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 72.439999999999998 112.545 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.68 49.44 1.81 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.450000000000003 112.494 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -134.73 102.1 5.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.667 0.27 . . . . 71.530000000000001 111.064 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.6 98.86 2.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 73.549999999999997 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -175.69 3.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 55.210000000000001 110.891 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -171.92 113.87 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.83 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.7 162.08 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.5 110.82 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.14 101.02 9.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 65.129999999999995 110.891 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.25 111.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 75.430000000000007 111.182 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.481 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -128.27 129.54 46.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.911 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 178' ' ' ARG . 0.2 OUTLIER -151.01 119.67 6.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.948 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -123.97 68.34 45.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.548 0.689 . . . . 60.530000000000001 110.889 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.85 -171.09 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 74.340000000000003 112.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -113.51 117.28 31.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.98 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.753 HG12 HG22 ' A' ' 16' ' ' VAL . 28.4 m -141.98 156.05 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 64.010000000000005 111.091 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -113.07 145.31 41.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 61.520000000000003 110.887 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.82 105.38 9.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 110.867 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -152.17 142.53 22.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 72.510000000000005 110.878 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.15 174.36 2.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.901 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.93 179.57 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 54.039999999999999 111.162 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -144.36 140.09 9.07 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.793 -0.717 . . . . 53.509999999999998 112.458 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -138.16 154.8 49.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 54.25 110.918 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -65.2 142.2 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 64.420000000000002 110.761 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 71.7 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 74.549999999999997 110.85 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.739 0.304 . . . . 51.310000000000002 110.848 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.17 102.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 72.200000000000003 110.847 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -178.57 168.26 1.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.463 . . . . 75.299999999999997 110.764 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 47' ' ' MET . . . -51.54 144.51 10.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 73.530000000000001 111.13 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 -17.12 4.35 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.707 -0.759 . . . . 72.109999999999999 112.512 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.1 mm-40 -93.77 143.89 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 74.340000000000003 110.959 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 46' ' ' TYR . 12.5 m-85 -118.37 143.75 46.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.904 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.751 ' CE2' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -110.36 118.83 37.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.959 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.504 ' HE1' HD22 ' A' ' 42' ' ' LEU . 1.4 tpt -92.17 126.78 37.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 54.109999999999999 110.8 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' NH2' HG21 ' A' ' 45' ' ' THR . 1.1 ptt180 -135.1 163.75 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.814 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.03 123.58 27.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.057 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.92 96.52 1.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.631 -0.795 . . . . 64.409999999999997 112.517 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.8 t -111.86 80.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 75.540000000000006 110.876 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.95 92.54 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 42.43 111.08 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 p -81.01 118.94 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 62.109999999999999 111.142 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -122.61 122.59 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 111.156 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.87 160.47 58.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 75.019999999999996 110.808 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.641 2.228 . . . . 72.120000000000005 112.297 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -67.33 -24.86 65.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 61.229999999999997 111.151 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -61.73 -169.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 50.200000000000003 110.906 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.05 -38.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 62.200000000000003 112.513 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.81 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 65.510000000000005 111.044 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.56 -65.81 0.25 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.713 -0.756 . . . . 64.349999999999994 112.461 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.94 -146.95 7.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 64.200000000000003 112.542 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 p -141.91 -73.55 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.863 0.363 . . . . 73.530000000000001 111.119 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.3 mt -121.58 -73.06 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.879 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.84 164.99 16.42 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.703 -0.761 . . . . 65.030000000000001 112.453 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.62 -170.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.343 . . . . 73.150000000000006 110.868 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.06 169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 73.510000000000005 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.59 43.52 0.82 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 54.009999999999998 112.551 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.27 -150.37 31.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 75.420000000000002 112.467 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CB ' HG22 ' A' ' 66' ' ' ILE . 13.3 t80 -136.5 165.34 26.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.764 0.316 . . . . 71.049999999999997 110.926 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.13 164.11 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 51.509999999999998 110.856 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -78.39 152.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 54.240000000000002 111.098 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.1 t -79.63 124.73 28.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 63.509999999999998 111.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -144.76 61.47 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.450000000000003 110.847 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.25 103.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.926 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.4 p -99.78 74.3 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 111.207 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.87 62.51 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.014 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -159.7 55.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.918 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.07 -156.38 7.48 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 74.030000000000001 112.461 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -139.83 147.85 41.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.956 0.408 . . . . 74.510000000000005 110.94 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 p -143.86 139.6 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 111.084 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 18.1 m-85 -109.79 122.04 46.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.838 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 55' ' ' GLU . 13.0 p -135.39 118.3 16.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 111.176 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.72 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -175.38 -170.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.918 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.435 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . 11.6 mtt -74.44 127.06 32.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 72.200000000000003 110.85 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 54' ' ' VAL . . . -68.97 -77.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.264 -0.425 . . . . 64.120000000000005 111.098 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 4' ' ' ALA . 9.5 t -177.33 44.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 64.420000000000002 111.085 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 34.5 t70 -179.71 46.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.318 -0.401 . . . . 65.310000000000002 110.844 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 6.9 t-20 76.36 -48.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 71.319999999999993 110.917 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.16 144.69 13.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 51.109999999999999 111.126 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -112.02 153.87 17.12 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.782 -0.723 . . . . 74.219999999999999 112.526 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 48' ' ' ALA . 16.4 t -117.62 154.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 61.25 111.198 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' HG22 ' A' ' 45' ' ' THR . 28.3 tt0 -133.44 118.43 18.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.099999999999994 110.803 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.88 122.55 48.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 75.349999999999994 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.58 121.49 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 63.539999999999999 110.914 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -135.57 153.64 51.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.325 -0.398 . . . . 65.120000000000005 111.064 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.41 179.64 3.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 55.020000000000003 111.08 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.7 t -128.62 68.59 78.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.538 0.685 . . . . 72.120000000000005 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -1.54 8.73 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.735 2.29 . . . . 53.340000000000003 112.353 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -56.12 108.92 0.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.851 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.0 173.86 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 110.948 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 76' ' ' THR . 7.0 p-80 -160.51 139.28 10.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 110.841 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 21.1 ptmt -79.23 -164.51 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 74.439999999999998 110.874 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 32' ' ' PHE . 18.8 tt -148.94 153.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 72.349999999999994 111.212 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.81 -139.11 9.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.689 -0.767 . . . . 63.109999999999999 112.478 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.5 p -89.79 166.38 13.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.857 0.361 . . . . 72.329999999999998 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -64.97 -15.15 61.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.925 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.0 57.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 52.109999999999999 111.115 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 t -122.23 -31.61 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.43 111.099 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.97 -93.69 0.49 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 51.109999999999999 112.438 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -82.65 175.25 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 61.119999999999997 110.826 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG22 ' C ' ' A' ' 66' ' ' ILE . 6.5 tt -141.63 -41.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 111.067 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.639 ' HB3' ' HD3' ' A' ' 65' ' ' LYS . . . -144.67 152.31 40.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 74.400000000000006 111.027 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 64' ' ' HIS . 19.8 p -146.02 165.99 27.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 73.329999999999998 111.215 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.52 157.65 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 64.099999999999994 111.056 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -112.75 156.74 22.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 73.400000000000006 110.877 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.85 138.28 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 63.420000000000002 110.902 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -97.58 170.08 7.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.613 0.72 . . . . 70.400000000000006 110.934 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 80' ' ' LEU . 53.0 Cg_endo -69.88 172.18 13.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.807 2.338 . . . . 72.329999999999998 112.294 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 52.4 Cg_endo -69.88 173.29 11.29 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.606 2.204 . . . . 64.319999999999993 112.319 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 106' ' ' ASN . 1.2 p -115.29 158.14 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 62.409999999999997 111.211 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.05 132.55 55.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 71.319999999999993 110.966 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtp -140.39 155.42 46.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 110.867 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -117.89 119.57 35.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 63.450000000000003 111.173 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.11 133.9 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.884 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -141.31 147.35 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.874 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -84.15 108.03 16.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.881 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.26 -69.16 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 75.420000000000002 110.742 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.34 -69.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.776 -0.725 . . . . 52.100000000000001 112.521 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.64 -178.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.385 . . . . 65.230000000000004 110.858 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.19 62.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 44.43 111.047 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m 58.35 74.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 74.0 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.5 p -126.52 152.6 46.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.349999999999994 110.797 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -58.13 -24.42 58.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 62.25 110.966 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -89.56 136.24 33.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.48 89.29 12.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.56 0.695 . . . . 74.349999999999994 110.912 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 177.52 5.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.65 2.233 . . . . 71.019999999999996 112.368 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.22 115.33 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 64.430000000000007 110.878 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.23 116.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 74.019999999999996 111.064 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -104.66 138.83 14.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 61.520000000000003 112.528 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -156.64 123.19 5.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 71.549999999999997 111.049 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.21 -139.33 4.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 70.010000000000005 112.504 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.99 119.39 54.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 72.329999999999998 111.256 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.417 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.5 t30 -102.77 108.37 19.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 63.43 110.957 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.633 ' O ' HD11 ' A' ' 80' ' ' LEU . 19.7 m-85 -107.64 108.64 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.057 0.456 . . . . 72.549999999999997 110.826 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.2 143.43 51.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.09 159.76 15.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.196 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.31 -169.75 2.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 110.843 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -57.7 136.55 56.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 75.209999999999994 110.874 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.558 ' OD2' HD21 ' A' ' 129' ' ' LEU . 2.8 t70 -113.79 -58.56 2.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 71.530000000000001 110.978 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 58.68 90.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 61.240000000000002 110.868 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.97 142.97 17.34 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.645 -0.788 . . . . 23.309999999999999 112.363 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.25 166.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.519999999999996 110.919 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.55 ' H ' ' H ' ' A' ' 120' ' ' LYS . 3.6 t-20 -162.44 -168.99 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 110.978 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.08 -62.75 1.31 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.221 -0.445 . . . . 64.129999999999995 110.879 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.73 -44.58 20.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 72.5 110.87 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.09 -57.04 21.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.805 -0.712 . . . . 73.519999999999996 112.396 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.55 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.64 -47.54 85.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 73.439999999999998 110.908 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.11 -11.76 58.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.869 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.25 7.17 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 64.150000000000006 111.151 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.01 30.52 66.86 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.777 -0.725 . . . . 43.310000000000002 112.428 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -122.7 -168.16 1.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.851 0.358 . . . . 73.530000000000001 110.942 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.89 -179.24 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 110.875 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.8 t70 62.41 36.8 14.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 52.439999999999998 110.875 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 128' ' ' SER . 3.3 tm? -50.31 -71.75 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.239999999999995 110.917 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.596 ' HB3' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 178.12 164.0 0.69 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 110.876 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD21 ' OD2' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -169.83 116.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 65.049999999999997 110.926 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.01 131.49 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 110.861 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.9 -175.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.937 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.09 104.51 14.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.862 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 160' ' ' ILE . 61.3 p-90 -98.51 120.36 38.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 71.109999999999999 110.923 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.22 176.66 21.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 74.120000000000005 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.42 153.93 51.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.815 0.34 . . . . 71.129999999999995 111.117 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.94 23.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 73.5 111.208 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.85 57.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.829 -0.701 . . . . 62.329999999999998 112.499 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -174.86 4.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 65.25 110.99 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.4 p -107.87 127.81 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -106.98 167.86 14.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.694 -0.765 . . . . 63.039999999999999 112.414 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.69 134.39 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 71.129999999999995 111.152 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 128.85 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.819 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.67 133.04 34.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.461 . . . . 64.010000000000005 110.933 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -84.86 130.79 34.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.121 -0.49 . . . . 74.530000000000001 110.896 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 144' ' ' LEU . 11.9 pt 35.48 70.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 111.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -71.98 -9.6 58.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 74.319999999999993 110.913 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -65.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 73.129999999999995 110.883 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.19 -3.26 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 70.150000000000006 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.15 -175.75 2.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 110.934 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.751 HD22 ' CE2' ' A' ' 8' ' ' PHE . 9.0 mp -90.06 165.9 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.5 110.823 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 151' ' ' VAL . 5.7 p -144.24 120.81 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 71.230000000000004 111.051 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.85 141.18 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 71.519999999999996 110.869 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.5 ttm -146.37 130.36 17.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 70.409999999999997 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -133.21 -177.55 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 110.904 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.22 148.26 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 73.209999999999994 111.08 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -132.0 142.29 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 110.865 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -176.9 116.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.259 -0.428 . . . . 71.409999999999997 110.936 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.1 ttm -175.18 173.51 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.875 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 160' ' ' ILE . 4.9 p-10 -102.67 141.67 35.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 74.519999999999996 110.916 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.611 HG13 HD12 ' A' ' 179' ' ' LEU . 26.7 mm -134.37 148.21 29.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 73.540000000000006 111.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 105.74 9.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 52.030000000000001 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 177' ' ' VAL . 1.6 t -130.97 144.48 51.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 70.129999999999995 111.069 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 163' ' ' THR . 4.7 t -90.25 117.44 29.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 64.209999999999994 111.126 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.26 26.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.048 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.58 171.0 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.774 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.34 -177.35 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 72.120000000000005 111.064 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.566 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.7 mttt -118.42 113.61 21.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.504 . . . . 74.040000000000006 110.906 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.86 86.94 3.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 52.240000000000002 110.879 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.05 57.33 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 73.530000000000001 112.559 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 136.16 40.25 0.14 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 32.350000000000001 112.524 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.57 91.34 2.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.745 0.307 . . . . 60.439999999999998 111.113 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 98.39 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 63.020000000000003 110.975 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -82.63 -176.8 6.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 65.439999999999998 110.842 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -156.02 113.45 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 75.040000000000006 110.829 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.96 130.65 55.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.849 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.1 t -81.44 100.86 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.862 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 162' ' ' THR . 91.8 t -96.45 134.65 33.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 111.193 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -119.3 136.35 54.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 75.030000000000001 110.94 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 160' ' ' ILE . 6.0 mt -51.65 128.8 24.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 71.150000000000006 110.872 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.95 155.88 77.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.62 0.724 . . . . 63.130000000000003 110.776 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -8.31 23.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.657 2.238 . . . . 65.25 112.35 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -79.88 59.5 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 65.019999999999996 110.85 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.1 114.12 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.064 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 138.07 54.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.129999999999995 110.805 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.4 ttp -135.83 103.48 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.340000000000003 110.891 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -153.37 140.22 19.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.888 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.19 174.98 1.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.047 -0.524 . . . . 71.129999999999995 110.879 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.96 174.17 11.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.74 154.86 25.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 64.400000000000006 112.471 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -154.01 156.45 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 54.329999999999998 110.889 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.42 137.26 57.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.05 -0.523 . . . . 74.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 110.881 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.366 . . . . 74.420000000000002 110.913 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -106.9 80.18 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.892 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -179.3 -170.81 0.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.914 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 49' ' ' THR . . . -54.8 175.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 75.329999999999998 111.158 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.84 -16.2 60.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 51.509999999999998 112.426 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.17 154.79 35.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 73.340000000000003 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.19 112.48 11.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.97 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -126.03 157.67 37.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 61.210000000000001 110.9 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -164.53 146.6 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 71.540000000000006 110.821 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.6 ' NE ' ' H ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -157.54 -173.14 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 61.200000000000003 110.874 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.6 ' H ' ' NE ' ' A' ' 10' ' ' ARG . . . -97.35 116.62 29.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 61.130000000000003 111.109 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.32 149.17 18.79 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.795 -0.717 . . . . 61.43 112.464 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.22 175.76 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.963 0.411 . . . . 73.120000000000005 110.842 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 183' ' ' VAL . . . -125.82 89.86 3.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 62.399999999999999 111.096 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 112.22 21.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 74.450000000000003 111.194 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 18' ' ' PRO . 14.7 p -72.36 133.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 64.319999999999993 111.179 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -116.04 73.55 4.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.669 0.747 . . . . 73.420000000000002 110.833 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.3 Cg_endo -69.84 115.78 4.26 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.671 2.247 . . . . 74.299999999999997 112.381 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -92.72 163.1 13.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.162 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.29 150.42 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 61.229999999999997 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.37 -116.06 0.35 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.743 -0.741 . . . . 64.200000000000003 112.519 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.97 105.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.917 0.389 . . . . 62.009999999999998 111.106 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.95 -107.35 1.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.803 -0.713 . . . . 25.440000000000001 112.437 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.62 -145.38 4.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 73.439999999999998 112.475 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 t 179.1 93.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.886 0.374 . . . . 75.030000000000001 111.14 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.8 -74.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 74.349999999999994 110.949 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.13 163.53 11.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 63.25 112.473 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -160.8 -172.09 3.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.876 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.91 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 63.409999999999997 110.833 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.3 18.45 6.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.757 . . . . 54.43 112.44 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.92 -52.19 30.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 51.329999999999998 112.467 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -143.3 161.94 37.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.868 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -123.8 164.61 18.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 72.340000000000003 110.85 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 111' ' ' PHE . 91.4 t -88.83 124.97 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 72.209999999999994 111.146 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.64 167.59 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 111.152 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -79.98 -169.27 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 110.872 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -101.65 103.37 14.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.340000000000003 110.876 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.3 t -131.93 39.95 3.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 75.019999999999996 111.137 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -172.96 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.924 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -152.13 134.91 15.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.47 170.38 21.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.792 -0.718 . . . . 54.340000000000003 112.469 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.68 132.28 54.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 75.200000000000003 110.969 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 t -114.02 132.21 56.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 34.140000000000001 111.13 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -123.04 106.58 10.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.905 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -104.24 134.48 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 74.430000000000007 111.172 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -142.37 133.24 25.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 72.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 17.9 mtt -97.83 132.87 43.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 53.229999999999997 110.918 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.66 -79.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 52.5 111.127 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 4' ' ' ALA . 4.9 t 179.98 58.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 71.540000000000006 111.134 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -179.89 40.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 74.030000000000001 110.893 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 60.22 21.41 10.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 53.25 110.902 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 50' ' ' ASP . 5.7 mt -131.25 136.83 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 111.12 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.99 169.13 29.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 51.43 112.541 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.74 144.63 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 71.310000000000002 111.165 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 45' ' ' THR . 9.4 tt0 -122.87 118.8 28.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tp -102.09 118.25 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.906 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.61 125.38 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.72 175.11 8.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 111.12 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.31 -168.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.299999999999997 111.14 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -104.15 145.13 30.07 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 111.14 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.8 79.48 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.73 2.286 . . . . 55.140000000000001 112.34 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 109.88 22.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 110.935 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -101.08 144.67 29.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 72.129999999999995 110.801 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -63.03 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.868 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -132.22 107.86 8.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.530000000000001 110.799 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER -153.19 145.32 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.172 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 66' ' ' ILE . . . 164.51 -145.49 10.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.818 -0.706 . . . . 71.400000000000006 112.566 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -95.78 151.62 19.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 61.420000000000002 111.187 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -17.41 64.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 110.813 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.55 -50.11 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 54.009999999999998 111.074 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.81 -32.49 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 55.009999999999998 111.19 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.64 -85.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 72.349999999999994 112.499 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -109.58 93.06 4.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.691 0.281 . . . . 71.140000000000001 110.876 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.2 pt -152.17 39.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 64.310000000000002 111.029 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HB1' ' ND2' ' A' ' 113' ' ' ASN . . . -114.69 162.99 16.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 72.030000000000001 111.126 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 105.36 5.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 111.169 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 111' ' ' PHE . 7.1 p -155.91 132.8 2.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.092 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 179.7 129.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 71.329999999999998 110.872 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -96.95 156.13 16.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 70.519999999999996 110.858 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.18 117.83 64.4 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 74.409999999999997 110.966 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.94 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.2 Cg_endo -69.81 -25.56 28.25 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 55.049999999999997 112.346 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.4 Cg_endo -69.68 118.26 5.58 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.713 2.276 . . . . 70.219999999999999 112.367 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.825 HG23 ' HA ' ' A' ' 106' ' ' ASN . 60.6 m -140.05 131.22 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 61.039999999999999 111.216 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.47 117.5 34.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 74.510000000000005 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 31.0 ttp -140.72 110.02 6.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.125 -0.488 . . . . 71.140000000000001 110.832 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -78.14 136.25 37.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.459 . . . . 75.349999999999994 110.995 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.33 134.24 45.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.230000000000004 110.902 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -135.13 106.08 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.887 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -101.79 137.31 40.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 73.140000000000001 110.866 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -135.57 30.04 3.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 64.420000000000002 110.851 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -104.82 163.48 14.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.761 . . . . 71.129999999999995 112.47 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.45 119.0 3.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 74.25 110.867 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 97' ' ' PHE . . . -148.66 -166.64 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.015 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -92.45 56.81 2.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 53.439999999999998 110.897 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.18 46.83 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 63.25 110.93 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -121.5 -74.91 0.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.072 -0.513 . . . . 73.420000000000002 110.825 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' CE1' ' HB2' ' A' ' 93' ' ' ALA . 27.5 p90 -112.01 134.18 53.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 64.109999999999999 110.969 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.24 88.67 8.94 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 73.310000000000002 110.929 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 172.98 11.53 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.673 2.249 . . . . 73.329999999999998 112.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.46 122.73 0.64 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 63.509999999999998 110.935 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.05 135.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 73.409999999999997 111.141 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.11 168.24 38.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.74 -0.743 . . . . 74.420000000000002 112.464 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.49 120.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 54.100000000000001 111.132 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' ALA . . . 165.33 -139.93 6.1 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 73.430000000000007 112.423 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 4.1 mp -141.39 126.95 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.832 0.349 . . . . 75.239999999999995 111.161 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HG23 ' A' ' 83' ' ' THR . 9.0 t30 -101.37 111.04 23.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 72.439999999999998 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.13 106.23 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.924 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.39 152.36 46.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.094 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.647 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -145.54 105.77 4.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.129 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.527 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.3 p90 -88.39 160.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 61.350000000000001 110.83 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 34' ' ' VAL . 29.8 p90 -52.99 172.67 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 73.010000000000005 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.492 ' OD1' HD23 ' A' ' 127' ' ' LEU . 0.4 OUTLIER 179.41 -33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.010000000000005 110.871 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' ND2' ' HB1' ' A' ' 75' ' ' ALA . 0.8 OUTLIER 64.74 -169.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.953 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.17 168.97 0.4 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.678 -0.772 . . . . 71.310000000000002 112.538 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 64.42 109.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 110.803 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.418 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.7 p-10 -165.06 -158.81 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 110.891 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.28 -59.96 2.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 62.140000000000001 110.929 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.88 -46.33 18.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.804 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.13 -58.86 11.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.816 -0.706 . . . . 53.350000000000001 112.42 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' H ' ' H ' ' A' ' 116' ' ' ASN . 19.7 ttpt -58.18 -48.77 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 74.099999999999994 110.863 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.1 -12.42 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.883 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.73 15.34 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 72.200000000000003 111.056 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.39 31.35 42.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 62.210000000000001 112.434 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.57 104.3 12.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 72.340000000000003 110.861 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.0 -60.41 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 43.100000000000001 110.848 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' HD23 ' A' ' 168' ' ' LEU . 3.0 m-20 73.16 -64.46 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 75.120000000000005 110.804 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.492 HD23 ' OD1' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -161.67 90.2 0.77 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.284 -0.416 . . . . 74.120000000000005 110.885 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.05 105.46 5.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.89 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.647 HD11 HG22 ' A' ' 109' ' ' THR . 2.6 pt? -53.04 156.87 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 73.239999999999995 110.833 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -120.34 55.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.917 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.87 100.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 52.399999999999999 110.776 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.433 ' HB2' HG21 ' A' ' 162' ' ' THR . 0.1 OUTLIER -74.74 110.4 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 70.540000000000006 110.834 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -98.65 118.31 35.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.939 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.06 72.21 0.34 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.839 -0.696 . . . . 75.310000000000002 112.545 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' GLY . . . -78.01 94.54 4.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.81 0.338 . . . . 62.020000000000003 111.092 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.2 -179.78 4.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.421 . . . . 73.230000000000004 111.089 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 103' ' ' ALA . . . -112.58 -163.05 16.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 74.219999999999999 112.477 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -165.16 -173.46 2.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.365 . . . . 74.329999999999998 110.892 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.99 92.46 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 111.061 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.47 167.97 22.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 42.530000000000001 112.514 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.56 134.51 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 61.240000000000002 111.153 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -116.22 141.67 47.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 110.884 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' O ' HG23 ' A' ' 151' ' ' VAL . 4.2 m-85 -140.13 104.26 4.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 74.150000000000006 110.898 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.35 143.69 27.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 72.219999999999999 110.815 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.8 mt -102.75 -66.84 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 63.030000000000001 111.168 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 178.28 153.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.019999999999996 110.847 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 61.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.805 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.56 8.85 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 110.915 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -99.45 140.99 32.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 64.209999999999994 110.932 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -176.38 4.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 73.439999999999998 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 152' ' ' ASN . 11.5 t -126.19 157.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 75.120000000000005 111.158 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.2 m-20 -151.37 131.75 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 74.409999999999997 110.911 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.1 ttp -119.95 122.36 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 53.340000000000003 110.825 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.04 148.84 25.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.825 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.68 106.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.529 . . . . 72.010000000000005 111.119 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -107.15 169.83 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 73.200000000000003 110.955 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -133.71 -177.71 4.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 65.549999999999997 110.909 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 ttp -93.3 99.49 12.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.049 -0.523 . . . . 40.43 110.842 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -179.71 104.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.5 tt -164.48 145.0 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 63.210000000000001 111.099 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -112.79 123.1 49.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 73.329999999999998 110.907 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 132' ' ' SER . 28.7 p -142.22 147.68 36.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 73.439999999999998 111.223 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -113.71 139.38 49.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 111.196 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.28 128.56 30.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.510000000000005 111.117 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -58.5 138.1 56.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 74.430000000000007 110.892 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.7 58.6 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 63.140000000000001 110.972 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 171' ' ' ALA . 13.6 mmtt -156.15 161.43 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 75.25 110.904 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.635 HD23 ' OD1' ' A' ' 126' ' ' ASP . 0.7 OUTLIER -152.84 159.12 43.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 70.109999999999999 110.815 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.48 -12.02 56.97 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.788 -0.72 . . . . 72.219999999999999 112.503 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 3.54 5.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.759 -0.734 . . . . 72.409999999999997 112.45 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . . . -69.0 174.24 4.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.674 0.273 . . . . 55.310000000000002 111.135 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -90.36 90.2 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.345 -0.389 . . . . 72.439999999999998 110.885 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.459 ' CA ' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -67.67 115.46 7.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 51.109999999999999 110.901 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -173.33 113.6 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.84 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -140.22 130.46 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.11 -0.495 . . . . 73.549999999999997 110.805 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.97 123.28 27.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.811 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.76 88.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 72.230000000000004 111.143 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.56 107.54 6.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 70.200000000000003 110.924 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.52 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 110.947 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -49.0 154.72 1.22 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 63.310000000000002 110.879 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.11 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.68 2.253 . . . . 52.299999999999997 112.416 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -119.75 153.57 35.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.283 -0.417 . . . . 64.040000000000006 110.975 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.554 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 3.9 m -114.62 158.68 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 64.450000000000003 111.158 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -174.67 141.5 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 110.872 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -141.28 155.69 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 70.109999999999999 110.825 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.98 113.51 26.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 64.209999999999994 110.824 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.7 t -115.36 173.73 6.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 64.0 110.787 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.86 -165.67 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 64.010000000000005 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.1 113.33 0.8 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.803 -0.713 . . . . 60.25 112.571 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -113.27 124.8 53.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.932 0.396 . . . . 70.430000000000007 111.008 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.35 136.45 57.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.540000000000006 110.89 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.904 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.82 0.343 . . . . 52.219999999999999 110.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -158.31 25.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 73.519999999999996 110.764 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.0 162.99 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 64.219999999999999 110.942 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.45 93.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 73.200000000000003 111.082 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.65 14.67 81.85 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.724 -0.75 . . . . 73.519999999999996 112.497 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -76.4 135.03 39.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.931 0.396 . . . . 74.450000000000003 110.917 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.38 114.89 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.120000000000005 110.861 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -130.57 137.85 49.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 72.340000000000003 110.837 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.3 ptm -93.72 145.0 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -154.14 -174.26 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.835 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -157.04 -169.48 2.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 63.100000000000001 111.029 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.39 125.6 3.55 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.836 -0.697 . . . . 52.310000000000002 112.475 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.22 84.87 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 71.340000000000003 110.944 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.98 137.83 32.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.019999999999996 111.111 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.65 ' C ' HG23 ' A' ' 183' ' ' VAL . 25.3 m -114.29 106.85 14.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 50.130000000000003 111.189 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 ' HB ' ' A' ' 183' ' ' VAL . 17.3 m -72.74 135.47 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 60.549999999999997 111.175 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.32 160.35 37.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.556 0.693 . . . . 61.240000000000002 110.866 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 148.13 64.1 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.686 2.257 . . . . 55.119999999999997 112.355 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.803 HG22 ' HG3' ' A' ' 181' ' ' PRO . 60.9 p -74.97 71.88 2.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.420000000000002 111.202 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 60.89 73.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 110.93 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.08 113.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.831 -0.699 . . . . 73.230000000000004 112.591 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.09 67.02 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 32.43 111.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.5 -55.79 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.69 -0.767 . . . . 44.520000000000003 112.515 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.48 63.44 0.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 51.119999999999997 112.381 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -114.82 -29.78 6.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.664 0.269 . . . . 64.430000000000007 111.07 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.63 -65.93 0.51 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.36 -0.382 . . . . 74.219999999999999 110.957 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.95 172.49 10.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.695 -0.764 . . . . 62.420000000000002 112.41 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.07 147.2 45.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 65.409999999999997 110.906 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 tt -170.45 157.62 6.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.087 -0.506 . . . . 74.530000000000001 110.931 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.03 32.28 2.45 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 73.209999999999994 112.487 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.97 35.75 17.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.792 -0.718 . . . . 60.409999999999997 112.491 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.1 123.26 13.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 75.109999999999999 110.875 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -147.1 119.12 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.230000000000004 110.822 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.0 t -138.78 149.36 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 111.146 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 145.57 32.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.439999999999998 111.142 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -80.13 -169.78 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.407 . . . . 71.019999999999996 110.898 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -101.61 103.24 14.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 72.230000000000004 110.918 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.6 t -147.29 40.12 1.02 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 65.510000000000005 111.135 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 60' ' ' THR . 1.8 tp60 -101.46 -169.13 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 55.140000000000001 110.95 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 tp -163.68 134.34 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 110.919 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -133.98 172.38 21.73 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.767 -0.73 . . . . 73.25 112.51 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.78 145.29 46.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 71.400000000000006 110.894 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 57' ' ' LEU . 3.8 p -135.34 154.02 51.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.049 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.29 115.09 19.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 73.430000000000007 110.84 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 78.7 m -91.11 133.48 35.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 111.26 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -142.96 119.41 10.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 71.150000000000006 110.923 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.5 143.95 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.5 110.761 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 49' ' ' THR . . . -80.9 -87.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.099999999999994 111.131 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER 177.17 39.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 72.329999999999998 111.117 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -165.33 49.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.847 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.5 m120 57.29 21.39 6.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 75.109999999999999 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.37 120.45 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.209999999999994 111.186 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.77 135.88 13.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.767 -0.73 . . . . 53.329999999999998 112.539 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.6 t -125.58 112.49 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.133 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -114.54 138.33 50.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.908 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.8 mt -99.75 127.89 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.3 OUTLIER -93.16 125.8 37.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.904 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.08 151.39 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.035 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.665 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . . . 179.55 -168.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 45.200000000000003 111.099 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 39' ' ' GLN . 1.1 t -50.79 145.84 10.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.737 . . . . 71.129999999999995 111.101 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.93 -87.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 74.400000000000006 112.263 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -111.66 153.11 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 75.239999999999995 110.859 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.65 130.81 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 71.329999999999998 110.818 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -161.27 171.07 19.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 110.908 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -175.96 73.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 72.239999999999995 110.848 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 66' ' ' ILE . 4.3 tp -95.74 111.03 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 64.5 111.109 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.45 104.7 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 54.539999999999999 112.447 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.6 t -160.74 151.18 18.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 65.299999999999997 111.196 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 154.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 72.430000000000007 110.821 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.99 -22.41 5.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 75.219999999999999 111.133 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -33.51 27.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 111.126 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.96 1.76 62.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 20.140000000000001 112.485 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.56 -78.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 72.239999999999995 110.869 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.73 HG22 ' ND2' ' A' ' 113' ' ' ASN . 23.3 mt 56.58 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.221 -0.445 . . . . 65.010000000000005 111.188 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.16 161.03 16.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 72.319999999999993 111.208 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' N ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -70.74 122.6 20.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 72.329999999999998 111.14 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 64' ' ' HIS . 7.4 p -125.34 127.25 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.176 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 179.35 123.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 72.109999999999999 110.87 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -151.27 161.31 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 64.200000000000003 110.815 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.887 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 8.1 mt -97.2 118.8 64.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.639 0.733 . . . . 72.019999999999996 110.982 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.945 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.6 Cg_endo -69.73 -25.75 28.43 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.74 2.293 . . . . 55.340000000000003 112.251 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.9 Cg_endo -69.67 97.32 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.667 2.244 . . . . 74.239999999999995 112.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 106' ' ' ASN . 14.8 p -118.15 156.5 28.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 75.099999999999994 111.121 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.42 118.87 37.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.901 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.26 113.4 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.815 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -103.7 144.08 31.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 55.310000000000002 111.12 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -127.66 148.03 50.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.982 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -139.53 112.56 8.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.883 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -79.78 149.08 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 72.450000000000003 110.953 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -51.03 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 62.409999999999997 110.903 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.66 173.19 23.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.673 -0.775 . . . . 63.43 112.426 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -95.78 61.79 2.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.879 0.371 . . . . 75.019999999999996 110.836 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.07 -165.53 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 60.350000000000001 111.094 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.6 -68.92 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.400000000000006 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.3 t 64.69 55.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 53.229999999999997 110.919 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.67 -34.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 75.140000000000001 110.971 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -163.82 134.32 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 72.099999999999994 110.951 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 156.82 21.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.74 0.781 . . . . 74.400000000000006 110.828 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 179.91 3.37 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 75.409999999999997 112.305 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.87 103.23 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.4 t -79.41 108.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 63.43 111.228 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.54 153.44 26.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 61.439999999999998 112.592 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -178.89 121.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 65.010000000000005 111.123 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -168.85 -166.02 27.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.811 -0.709 . . . . 45.329999999999998 112.537 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.507 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -148.67 141.91 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 63.200000000000003 111.04 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.633 ' OD1' HG23 ' A' ' 108' ' ' THR . 7.5 t30 -119.9 108.56 14.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 54.549999999999997 110.997 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -95.17 106.28 18.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 71.439999999999998 110.863 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.633 HG23 ' OD1' ' A' ' 106' ' ' ASN . 36.6 p -128.04 115.25 18.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 52.43 111.052 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -155.08 120.01 4.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.145 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.34 179.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.03 146.55 31.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 73.439999999999998 110.828 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.566 ' H ' HG22 ' A' ' 76' ' ' THR . 8.6 t70 -127.65 -68.62 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 62.5 110.851 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.73 ' ND2' HG22 ' A' ' 74' ' ' ILE . 16.1 t30 -72.51 -80.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.517 . . . . 73.030000000000001 110.917 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.706 ' N ' HG23 ' A' ' 76' ' ' THR . . . 54.22 -176.01 0.4 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.68 -0.772 . . . . 74.329999999999998 112.508 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 124' ' ' LEU . 2.6 m-85 -113.78 170.19 8.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 73.120000000000005 110.906 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 120' ' ' LYS . 7.9 t-20 -179.65 -145.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.838 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -44.94 -54.63 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 72.450000000000003 110.806 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 52.8 m80 -78.05 -51.29 10.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 74.340000000000003 110.809 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.66 -59.99 9.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 54.229999999999997 112.516 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 116' ' ' ASN . 16.5 ttpt -55.99 -49.81 72.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 74.109999999999999 110.959 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -67.76 -13.91 62.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.519999999999996 110.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' HIS . . . -85.49 -2.62 58.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 65.140000000000001 111.067 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.69 -7.45 6.53 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.677 -0.773 . . . . 64.200000000000003 112.425 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 115' ' ' PHE . 4.0 mm? -91.23 169.8 10.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 74.450000000000003 110.974 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.16 33.21 4.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 62.409999999999997 110.904 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.642 ' O ' HD22 ' A' ' 127' ' ' LEU . 5.1 t0 57.68 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 70.140000000000001 110.774 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.747 HD23 ' HB2' ' A' ' 167' ' ' LYS . 0.4 OUTLIER -144.63 -170.71 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.349999999999994 110.863 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 174.09 -168.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 61.310000000000002 110.864 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.68 151.48 33.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 62.130000000000003 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -65.5 152.42 44.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 63.219999999999999 110.86 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -51.04 154.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 62.450000000000003 110.789 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -107.38 104.08 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.439999999999998 110.834 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -105.62 118.43 36.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 75.120000000000005 110.99 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.55 148.4 18.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.83 -0.7 . . . . 42.25 112.476 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -178.02 103.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.721 0.296 . . . . 70.209999999999994 111.12 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -167.19 179.2 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.42 -172.86 13.33 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.778 -0.725 . . . . 74.519999999999996 112.46 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -168.16 110.68 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.803 0.335 . . . . 74.140000000000001 110.862 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.47 87.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 72.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.1 -168.3 37.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.793 -0.718 . . . . 75.400000000000006 112.602 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.0 p -123.07 143.51 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 70.319999999999993 111.121 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -122.08 135.63 54.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.400000000000006 110.927 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.18 133.98 43.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 75.420000000000002 110.97 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 147' ' ' ARG . 0.5 OUTLIER -59.9 135.24 57.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 110.956 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.667 HD11 ' CG1' ' A' ' 151' ' ' VAL . 41.3 mm -105.79 -47.3 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 62.130000000000003 111.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.88 25.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 75.219999999999999 110.845 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.567 ' HG2' HD21 ' A' ' 144' ' ' LEU . 0.6 OUTLIER 75.32 -55.13 0.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.777 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -73.2 -22.97 60.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.912 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.464 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -142.69 143.88 32.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 110.899 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -131.6 176.43 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 54.450000000000003 110.879 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 145' ' ' ILE . 4.7 p -125.95 113.55 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 72.409999999999997 111.119 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 153' ' ' MET . 6.4 p30 -121.85 132.08 54.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.529 ' HB2' ' O ' ' A' ' 152' ' ' ASN . 1.3 tpt 167.84 -166.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 61.409999999999997 110.839 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.74 -178.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 61.43 110.893 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.95 125.8 62.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 72.109999999999999 111.177 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -134.8 175.1 9.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.908 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -132.47 -170.67 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.937 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.89 179.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.019999999999996 110.889 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.51 178.2 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 70.310000000000002 110.815 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -53.44 151.38 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 111.126 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.25 116.56 31.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.976 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 m -141.5 119.11 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 74.120000000000005 111.194 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.7 t -86.08 150.75 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 74.439999999999998 111.135 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.18 124.37 27.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 65.010000000000005 111.062 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.32 128.32 53.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.137 -0.483 . . . . 74.030000000000001 110.956 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -134.85 129.86 35.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 75.010000000000005 110.908 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.747 ' HB2' HD23 ' A' ' 127' ' ' LEU . 1.9 mtpt -110.84 113.43 26.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 73.340000000000003 110.937 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 168' ' ' LEU . 8.0 tt -128.9 87.49 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 65.549999999999997 110.867 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.53 13.86 31.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 52.439999999999998 112.492 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 92.64 47.28 3.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 52.340000000000003 112.532 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.29 95.41 3.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.794 0.33 . . . . 64.430000000000007 111.153 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -67.75 98.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.430000000000007 110.878 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -89.26 169.03 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 54.130000000000003 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -172.64 113.73 0.27 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 73.329999999999998 110.821 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -155.27 143.08 19.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 m -79.56 128.4 33.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 64.200000000000003 110.877 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 177' ' ' VAL . 5.2 m -61.01 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 61.140000000000001 111.166 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.16 136.32 39.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 75.329999999999998 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 -74.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 64.319999999999993 110.884 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -49.53 108.02 0.9 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.591 0.71 . . . . 73.299999999999997 110.801 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.803 ' HG3' HG22 ' A' ' 19' ' ' THR . 54.3 Cg_endo -69.77 -48.71 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.65 2.234 . . . . 74.209999999999994 112.336 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -144.67 146.84 32.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.954 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 15' ' ' THR . 3.5 p -150.3 130.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 73.340000000000003 111.162 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.74 139.74 37.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 64.219999999999999 110.842 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 153' ' ' MET . 3.2 mtt -123.81 125.45 44.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 73.040000000000006 110.896 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 153' ' ' MET . 25.2 p90 -138.31 122.24 17.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 110.947 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.504 ' H ' ' HB2' ' A' ' 153' ' ' MET . 70.9 m -123.01 144.5 49.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.824 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 10' ' ' ARG . . . -122.78 109.63 14.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 44.43 111.126 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.77 120.45 5.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.748 . . . . 65.519999999999996 112.439 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -117.34 136.74 52.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 110.896 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -64.28 129.54 40.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 70.439999999999998 110.838 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 61.32 110.955 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.338 . . . . 73.049999999999997 110.808 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.42 23.93 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 74.140000000000001 110.888 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -174.0 154.44 2.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 110.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.56 102.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 34.409999999999997 111.127 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.57 11.32 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.769 -0.729 . . . . 75.239999999999995 112.558 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -76.95 156.79 31.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 70.340000000000003 110.889 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -134.13 118.79 18.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.540000000000006 110.816 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -122.62 139.55 53.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 70.310000000000002 110.791 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -104.42 139.1 39.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 62.299999999999997 110.783 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.9 ttp85 -148.03 152.81 38.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 65.409999999999997 110.867 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.0 147.89 27.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 55.549999999999997 111.029 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.56 90.56 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.748 . . . . 72.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 p -122.3 84.0 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 70.409999999999997 110.905 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.49 110.53 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 63.030000000000001 111.148 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 m -91.96 110.76 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.329999999999998 111.144 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 183' ' ' VAL . 12.1 p -78.95 135.08 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 111.103 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.41 74.13 2.08 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.583 0.706 . . . . 73.040000000000006 110.884 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD3' HG22 ' A' ' 16' ' ' VAL . 54.2 Cg_endo -69.76 138.64 38.31 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.667 2.245 . . . . 43.350000000000001 112.363 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.77 150.21 23.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 72.319999999999993 111.036 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -172.51 152.24 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 72.430000000000007 110.92 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.92 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.669 -0.777 . . . . 74.310000000000002 112.505 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.8 -67.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 62.200000000000003 111.039 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 152.84 57.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.744 . . . . 65.439999999999998 112.467 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.28 -126.24 30.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.808 -0.711 . . . . 71.230000000000004 112.43 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -48.53 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.319 . . . . 72.129999999999995 111.017 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.42 -60.82 1.87 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 74.219999999999999 110.933 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.07 63.48 3.61 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.486 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.2 t -174.44 158.68 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 63.140000000000001 110.932 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 tt 63.16 105.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.979 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 42.14 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 62.009999999999998 112.535 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.64 105.15 0.99 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.68 -0.771 . . . . 55.340000000000003 112.594 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.46 165.3 21.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.925 0.393 . . . . 62.299999999999997 110.897 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 m -151.5 84.78 1.31 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 42.119999999999997 110.899 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.98 123.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 61.109999999999999 111.159 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 139.72 36.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.176 -0.465 . . . . 73.549999999999997 111.033 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -129.26 136.41 50.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.956 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 179.49 173.81 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 70.219999999999999 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' THR . 4.5 t -79.97 116.8 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 74.299999999999997 111.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -88.56 -169.61 2.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.954 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.77 117.23 19.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.426 . . . . 65.439999999999998 110.903 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.18 170.88 23.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 53.210000000000001 112.454 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mt -113.27 143.22 44.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 72.340000000000003 110.928 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.526 HG22 ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -118.79 132.07 56.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 111.152 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -126.39 119.08 26.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 110.916 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -109.96 128.98 55.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 72.409999999999997 111.191 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -134.71 146.08 49.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 70.140000000000001 110.995 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -101.51 133.62 45.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.04 -0.527 . . . . 73.049999999999997 110.817 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.97 -65.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.069 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -177.09 37.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 71.25 111.127 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -178.55 -135.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.83 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.7 16.1 11.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 64.319999999999993 110.863 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.5 mt -106.55 116.04 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 71.239999999999995 111.16 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.85 159.71 14.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 65.120000000000005 112.436 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 54' ' ' VAL . 5.4 p -139.57 120.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.75 0.309 . . . . 65.099999999999994 111.134 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.733 ' HB2' HG23 ' A' ' 45' ' ' THR . 9.1 tt0 -105.09 144.5 31.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.409999999999997 110.866 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.73 124.0 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 61.340000000000003 110.925 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.48 127.02 53.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 64.120000000000005 110.863 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.75 166.91 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.146 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.94 -166.24 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 33.32 111.105 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -146.42 58.49 4.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.676 0.751 . . . . 73.230000000000004 111.244 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -172.63 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.734 2.289 . . . . 65.049999999999997 112.306 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -123.25 175.75 6.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 70.409999999999997 110.869 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.74 131.79 45.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 75.400000000000006 110.934 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -68.08 163.52 22.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 75.349999999999994 110.916 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.26 158.96 15.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.030000000000001 110.931 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.525 HG21 ' OG1' ' A' ' 71' ' ' THR . 1.2 tt -140.26 145.68 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.253 -0.431 . . . . 71.109999999999999 111.123 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -152.7 39.97 0.73 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.639 -0.791 . . . . 52.439999999999998 112.359 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 70' ' ' ALA . 11.6 t -133.46 171.11 14.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 72.409999999999997 111.216 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -62.22 -17.09 57.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 72.340000000000003 110.896 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 68' ' ' THR . . . -50.38 -51.81 42.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 54.329999999999998 111.022 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.525 ' OG1' HG21 ' A' ' 66' ' ' ILE . 17.6 p -128.91 -32.96 2.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 63.130000000000003 111.107 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.47 -98.61 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 34.210000000000001 112.437 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.8 p30 175.54 -175.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 73.230000000000004 110.884 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.0 mt 65.67 79.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.125 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.48 108.94 3.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 72.019999999999996 111.098 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.58 104.85 3.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 71.540000000000006 111.119 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 113' ' ' ASN . 6.6 m -154.29 -177.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 44.310000000000002 111.087 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -133.71 127.12 32.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.903 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 179.21 6.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.309 -0.405 . . . . 75.230000000000004 110.853 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 82' ' ' PRO . 1.3 pp -153.88 108.79 2.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.605 0.717 . . . . 73.530000000000001 110.969 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.4 Cg_endo -69.72 105.57 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.815 2.344 . . . . 63.140000000000001 112.343 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.72 118.77 5.88 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.642 2.228 . . . . 71.230000000000004 112.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -115.99 146.01 42.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 71.299999999999997 111.121 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -143.14 144.17 32.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 64.299999999999997 110.947 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.3 mtm -140.02 123.48 17.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 64.310000000000002 110.912 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -91.07 128.03 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 62.329999999999998 111.105 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 134.2 41.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.918 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.421 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 2.9 t-105 -143.19 154.47 43.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.943 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HB3' ' HG3' ' A' ' 99' ' ' PRO . 3.7 p90 -106.2 123.88 48.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.889 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' HG11 ' A' ' 101' ' ' VAL . 6.8 t80 -124.0 30.96 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.109999999999999 110.951 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.42 37.15 0.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.58 -0.819 . . . . 43.310000000000002 112.458 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.92 166.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 72.400000000000006 110.921 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.58 -165.94 2.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 111.112 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -126.87 23.67 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.210000000000001 110.871 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.18 29.73 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 63.229999999999997 110.835 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.712 ' HG2' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -152.89 -42.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 73.150000000000006 110.811 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.71 144.15 26.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 71.129999999999995 110.904 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 130.8 42.91 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.775 0.797 . . . . 72.540000000000006 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.1 Cg_endo -69.82 138.82 38.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 74.049999999999997 112.37 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.744 ' HB3' HG13 ' A' ' 141' ' ' VAL . 48.1 p90 -95.08 32.41 1.7 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 55.140000000000001 110.948 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 90' ' ' PHE . 1.4 t -112.6 82.48 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 65.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 86' ' ' ALA . . . -146.38 -168.22 13.34 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 71.040000000000006 112.456 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -138.49 126.11 22.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 53.32 111.024 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -102.95 135.01 12.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 63.310000000000002 112.55 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 105' ' ' ILE . 7.9 tt -123.99 120.66 60.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 73.420000000000002 111.142 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.741 ' HA ' HG22 ' A' ' 83' ' ' THR . 4.4 p30 -101.3 109.76 21.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.350000000000001 110.928 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.469 ' HE1' HG23 ' A' ' 105' ' ' ILE . 1.5 p90 -120.69 111.33 17.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 72.549999999999997 110.874 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -98.51 148.44 23.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 62.020000000000003 111.06 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.1 p -124.18 -172.77 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 111.149 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.33 -80.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 62.420000000000002 110.936 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 65.12 10.5 6.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 74.019999999999996 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.42 133.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 71.510000000000005 110.828 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 175.42 91.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 60.549999999999997 110.949 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.23 -60.61 2.72 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.767 . . . . 64.040000000000006 112.458 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -49.37 105.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.847 0.356 . . . . 73.329999999999998 110.929 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.446 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -164.01 -161.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 73.5 110.901 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.5 -59.45 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 75.0 110.84 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -79.27 -46.38 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 72.409999999999997 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.41 -58.72 12.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 62.43 112.485 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.9 OUTLIER -60.12 -45.75 91.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 75.450000000000003 110.881 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.5 -11.64 58.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.29 -0.414 . . . . 71.230000000000004 110.883 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.658 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -107.81 10.92 28.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.340000000000003 111.018 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.85 34.48 37.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.79 -0.719 . . . . 61.119999999999997 112.497 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 125' ' ' SER . 2.9 pp -120.75 149.22 42.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 73.109999999999999 110.974 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 124' ' ' LEU . 0.1 OUTLIER 65.8 113.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 65.209999999999994 110.872 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.52 13.91 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 71.549999999999997 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 130' ' ' LYS . 5.0 tp -176.92 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 35.049999999999997 110.967 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t 65.23 -148.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 75.349999999999994 110.867 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.683 HD22 ' HB2' ' A' ' 164' ' ' ALA . 2.8 mm? -52.75 115.85 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 63.210000000000001 110.885 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 127' ' ' LEU . 9.0 tttm -80.71 177.72 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 63.350000000000001 110.882 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -77.55 169.82 17.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.247 -0.433 . . . . 54.140000000000001 110.899 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 107' ' ' TYR . 0.3 OUTLIER -157.22 105.69 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 64.030000000000001 110.925 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' TYR . 59.9 p-90 -110.31 133.22 53.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 62.520000000000003 110.838 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -147.27 109.16 0.46 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.662 -0.78 . . . . 53.229999999999997 112.474 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -97.89 144.5 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 55.020000000000003 111.118 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -164.18 178.42 7.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 111.013 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.71 130.63 10.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.559 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -123.54 148.82 45.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 75.409999999999997 110.929 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.8 m -105.34 119.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 111.168 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -125.86 108.61 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.729 -0.748 . . . . 33.100000000000001 112.464 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -116.4 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.409999999999997 111.111 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.5 151.09 43.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 71.450000000000003 110.823 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -134.36 135.68 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.507 . . . . 75.5 110.965 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 96' ' ' LYS . 3.7 tt -81.1 110.61 16.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 75.030000000000001 110.882 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 77.0 mt -86.69 -71.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 111.191 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -95.66 -169.4 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 70.209999999999994 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.16 -28.75 48.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -131.78 22.9 4.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 64.219999999999999 110.818 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -144.04 129.59 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.510000000000005 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 144' ' ' LEU . 1.1 mp -140.15 -178.53 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 65.099999999999994 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.12 138.8 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.409999999999997 111.129 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -133.41 139.46 46.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.851 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 18.1 mtt -141.86 135.91 30.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 72.510000000000005 110.84 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 39.8 m -151.22 -178.4 6.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 110.829 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.6 p -165.53 149.08 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 43.130000000000003 111.169 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.585 ' HH2' HG21 ' A' ' 83' ' ' THR . 44.1 m0 -102.25 -179.05 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 70.120000000000005 110.826 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -179.68 127.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.918 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 51.84 -168.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.200000000000003 110.894 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HD13 ' A' ' 160' ' ' ILE . 1.6 m-20 66.09 55.22 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.878 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.858 HG21 HD22 ' A' ' 179' ' ' LEU . 37.4 mm -145.81 107.82 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.142 -0.481 . . . . 73.230000000000004 111.11 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.63 149.71 42.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 53.219999999999999 110.789 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.1 131.9 24.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 70.510000000000005 111.019 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -146.48 145.29 30.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 63.329999999999998 111.17 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.683 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -134.09 134.77 42.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.409999999999997 111.138 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -153.58 113.14 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.236 -0.438 . . . . 53.439999999999998 111.0 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.464 ' CZ ' HD22 ' A' ' 168' ' ' LEU . 4.8 p90 -148.89 166.51 28.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 110.94 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -116.48 113.2 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 72.349999999999994 110.911 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -98.24 86.84 3.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 72.0 110.818 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 76.53 6.67 84.71 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.803 -0.713 . . . . 62.409999999999997 112.456 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 119.59 43.68 0.49 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.78 -0.724 . . . . 72.010000000000005 112.505 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.467 ' HB3' ' HG ' ' A' ' 168' ' ' LEU . . . -137.49 92.82 2.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 43.109999999999999 111.095 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.56 108.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 110.901 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -91.44 164.18 13.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 63.530000000000001 110.857 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -173.97 113.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.872 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -142.2 133.0 25.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.848 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.39 102.6 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 61.340000000000003 110.916 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.22 146.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 71.420000000000002 111.146 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.42 136.32 54.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 110.954 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 160' ' ' ILE . 1.1 tp -81.76 -166.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.945 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -176.83 -61.59 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.546 0.688 . . . . 75.200000000000003 110.861 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.66 133.98 27.09 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.635 2.223 . . . . 73.129999999999995 112.39 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -81.64 -170.46 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 74.150000000000006 110.812 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.4 m -138.83 -179.69 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 41.130000000000003 111.162 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 136.86 54.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.941 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.3 tpt -135.92 107.62 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 60.210000000000001 110.842 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.49 148.78 27.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 62.310000000000002 110.845 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 m -172.58 174.22 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 72.310000000000002 110.786 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -91.81 168.9 11.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 64.209999999999994 111.164 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 150' ' ' LEU . . . -109.9 121.97 6.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 63.530000000000001 112.497 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.75 145.16 44.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.904 0.383 . . . . 75.530000000000001 110.883 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 126.54 28.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 64.409999999999997 110.898 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.873 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ttm . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.732 0.301 . . . . 75.099999999999994 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -95.33 25.6 4.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 74.530000000000001 110.846 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.68 154.05 46.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.549999999999997 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.01 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.299999999999997 111.09 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.01 -5.88 72.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 60.25 112.524 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -76.03 125.87 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 65.510000000000005 110.836 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.9 113.26 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.902 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -128.3 145.84 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.96 163.86 25.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.019 -0.537 . . . . 62.030000000000001 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 23.6 tpt180 -156.1 160.98 40.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 62.030000000000001 110.912 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.33 38.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 61.32 111.13 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.32 120.77 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 33.409999999999997 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -142.73 80.44 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 64.430000000000007 110.808 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HB1' ' CG2' ' A' ' 183' ' ' VAL . . . -106.71 137.71 44.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 61.5 111.145 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.631 ' C ' HG23 ' A' ' 183' ' ' VAL . 1.6 p -109.89 103.61 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 70.25 111.199 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB ' ' A' ' 183' ' ' VAL . 27.3 m -72.58 130.4 35.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.326 -0.397 . . . . 71.310000000000002 111.096 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 179.18 156.07 0.63 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.647 0.737 . . . . 72.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -14.42 36.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.625 2.216 . . . . 64.329999999999998 112.378 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 p 51.71 -171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 72.420000000000002 111.18 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.98 -174.47 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 70.219999999999999 110.91 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.66 -114.06 0.6 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.856 -0.688 . . . . 60.310000000000002 112.563 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.03 68.48 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.947 0.403 . . . . 31.039999999999999 111.091 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.58 88.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.81 -0.709 . . . . 62.240000000000002 112.527 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.61 133.05 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.78 -0.724 . . . . 72.349999999999994 112.529 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.8 p -115.85 24.87 11.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.73 0.3 . . . . 43.399999999999999 111.056 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.82 102.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.242 -0.435 . . . . 73.319999999999993 110.89 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 126.77 1.11 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.742 -0.742 . . . . 50.229999999999997 112.501 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.28 96.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 65.450000000000003 110.895 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.11 170.02 1.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.083 -0.508 . . . . 74.219999999999999 110.886 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.12 43.36 1.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 52.229999999999997 112.476 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.46 162.81 18.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.838 -0.696 . . . . 60.119999999999997 112.496 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.93 124.91 17.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.936 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.19 153.03 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 62.100000000000001 110.868 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 65' ' ' LYS . 7.9 p -137.88 154.36 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 72.140000000000001 111.124 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -173.9 61.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 71.129999999999995 111.081 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' A' ' 16' ' ' VAL . 4.6 m-20 -169.48 177.59 4.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 63.43 110.916 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.51 173.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.861 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -85.3 53.08 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.329999999999998 111.214 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -81.86 -169.28 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.919 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.64 172.7 12.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 61.399999999999999 110.961 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.32 -141.12 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 72.549999999999997 112.443 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.6 mt -150.48 141.2 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 75.010000000000005 110.964 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 m -134.95 134.0 40.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 65.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.5 146.37 49.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 110.773 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.6 m -137.83 136.88 37.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.005 -0.543 . . . . 70.329999999999998 111.181 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -141.7 134.92 29.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.277 -0.419 . . . . 64.209999999999994 110.866 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.2 mtp -97.7 138.3 35.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 64.540000000000006 110.858 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.34 -84.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.122 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 t 178.57 60.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 72.409999999999997 111.065 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 t0 179.79 39.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.852 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.23 15.84 8.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.905 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 tt -131.27 144.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.051 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.11 172.54 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.842 -0.694 . . . . 24.140000000000001 112.517 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.8 139.81 49.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 71.099999999999994 111.005 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.89 145.29 51.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.93 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.6 134.33 54.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.935 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.485 HD13 ' HE1' ' A' ' 156' ' ' TRP . 0.5 OUTLIER -107.5 134.61 50.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 55.509999999999998 110.917 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.56 136.21 44.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 63.539999999999999 111.205 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.34 -169.01 2.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.329999999999998 111.158 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.09 159.95 0.73 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 63.100000000000001 111.197 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -169.24 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 70.129999999999995 112.314 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -60.06 131.06 49.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.859 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.73 132.43 3.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.409999999999997 110.896 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' HB3' HG21 ' A' ' 77' ' ' VAL . 9.5 t60 -159.94 129.69 5.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.762 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -107.93 93.66 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 73.140000000000001 110.961 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.3 tt -74.91 147.08 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.123 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.51 40.03 0.1 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.661 -0.78 . . . . 71.329999999999998 112.428 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -104.76 157.09 17.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 71.329999999999998 111.144 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -19.17 58.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 73.530000000000001 110.827 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.99 -50.93 60.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 70.409999999999997 111.122 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -25.2 6.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 74.400000000000006 111.103 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.41 -94.01 0.56 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.751 -0.738 . . . . 72.129999999999995 112.506 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 p30 179.75 177.71 0.6 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.793 0.33 . . . . 62.520000000000003 110.817 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 64.35 87.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 71.340000000000003 111.016 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.92 157.45 44.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.094 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.06 131.62 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 60.130000000000003 111.143 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 64' ' ' HIS . 65.6 t -132.34 132.32 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 54.409999999999997 111.164 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -148.73 123.95 10.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 72.439999999999998 110.793 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -151.53 170.61 19.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 63.240000000000002 110.854 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.877 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 7.2 mt -96.86 120.08 62.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 64.439999999999998 110.928 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.934 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.1 Cg_endo -69.8 -25.9 27.93 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.677 2.252 . . . . 71.219999999999999 112.214 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.934 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.6 Cg_endo -69.74 110.39 2.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.703 2.269 . . . . 64.310000000000002 112.295 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 p -118.4 156.37 29.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 73.239999999999995 111.244 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.85 139.56 42.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.875 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 30.2 mtm -140.01 124.22 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.049999999999997 110.727 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.27 126.18 38.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 72.209999999999994 111.078 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.66 133.31 44.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.049999999999997 110.947 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' TYR . 3.9 t-105 -143.75 156.85 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 110.933 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -113.29 127.87 56.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 75.099999999999994 110.939 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.554 ' H ' HG21 ' A' ' 101' ' ' VAL . 27.7 t80 -60.09 137.23 58.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 110.821 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -52.6 113.06 2.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 75.519999999999996 112.514 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.37 -58.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.811 0.338 . . . . 74.109999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.67 140.04 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 61.219999999999999 111.141 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.64 91.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 70.120000000000005 110.887 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -176.71 5.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 73.549999999999997 110.867 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -117.03 40.37 3.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 71.549999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -148.19 157.65 43.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.914 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -68.35 116.35 38.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.658 0.742 . . . . 73.150000000000006 110.773 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 53.0 Cg_endo -69.69 137.99 36.98 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.697 2.265 . . . . 73.150000000000006 112.316 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 52.4 p90 -92.82 31.69 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 73.209999999999994 110.932 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 90' ' ' PHE . 1.4 t -113.77 79.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 61.25 111.111 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.42 14.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 23.239999999999998 112.43 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -130.31 124.75 33.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 72.219999999999999 111.159 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.46 7.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.893 -0.67 . . . . 72.150000000000006 112.533 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 9.9 tt -123.63 119.65 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 62.439999999999998 111.208 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.584 ' CG ' HD12 ' A' ' 160' ' ' ILE . 8.8 t-20 -94.43 110.04 21.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 65.209999999999994 110.916 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -100.96 124.07 46.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.985 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.0 m -122.82 140.37 53.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 111.107 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.566 ' H ' HD12 ' A' ' 80' ' ' LEU . 1.3 m -156.06 162.01 40.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 71.530000000000001 111.104 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -167.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.284 -0.416 . . . . 73.150000000000006 110.847 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 65.17 163.26 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 110.889 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -161.58 130.27 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 71.510000000000005 110.899 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -125.9 -167.31 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.77 -93.98 0.96 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -50.89 145.68 6.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 110.899 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.484 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.9 OUTLIER -162.3 -160.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.9 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -46.97 -61.0 2.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 64.409999999999997 110.854 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.94 -45.04 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 65.439999999999998 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.1 -57.96 16.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 64.329999999999998 112.459 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' H ' ' H ' ' A' ' 116' ' ' ASN . 12.1 tmtt? -60.65 -46.63 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 71.129999999999995 110.934 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.32 -10.98 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 60.240000000000002 110.939 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.549 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -107.04 3.32 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.129999999999995 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.38 41.49 52.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 72.230000000000004 112.439 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 168' ' ' LEU . 4.3 mm? -113.23 123.6 50.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.324 . . . . 73.140000000000001 111.012 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.81 110.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 74.129999999999995 110.921 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -111.88 25.47 11.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 65.140000000000001 110.952 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.34 -45.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 71.150000000000006 110.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t 65.5 -162.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 110.912 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.3 tt -52.81 122.92 10.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.272 -0.422 . . . . 63.5 110.88 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 160.78 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.905 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' CB ' HG23 ' A' ' 109' ' ' THR . 2.1 p-10 -58.04 142.22 47.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 71.430000000000007 110.814 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.25 166.69 7.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 71.319999999999993 110.887 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -131.97 134.64 45.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 73.310000000000002 110.922 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.12 99.76 0.59 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.748 -0.739 . . . . 51.350000000000001 112.494 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -89.04 147.95 23.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 65.099999999999994 111.139 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.98 9.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 74.219999999999999 110.97 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.9 130.66 9.97 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 43.140000000000001 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -130.03 142.94 50.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.894 0.378 . . . . 65.439999999999998 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.17 131.82 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.101 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' TYR . . . -146.13 112.92 0.65 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.729 . . . . 23.399999999999999 112.377 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.5 127.67 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 51.520000000000003 111.119 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.46 132.91 28.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 110.945 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.6 133.86 51.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 75.209999999999994 110.943 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.764 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -112.37 96.3 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.913 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 145' ' ' ILE . 3.7 tt -175.56 31.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 54.43 111.011 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.11 75.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 110.859 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.67 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.05 11.03 2.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 72.430000000000007 110.823 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.481 ' C ' HD23 ' A' ' 150' ' ' LEU . 8.1 p-90 -134.84 171.72 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -117.04 173.15 6.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.264 -0.425 . . . . 62.420000000000002 110.911 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.5 p -130.29 123.46 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 111.152 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -103.27 131.11 50.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.51 135.36 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 110.795 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 p -176.77 -170.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 62.539999999999999 110.919 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 184' ' ' PHE . 9.1 m -152.02 133.61 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.236 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.485 ' HE1' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -92.88 162.64 14.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 74.329999999999998 110.888 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -166.09 159.74 15.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 72.530000000000001 110.867 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.5 tmm? -52.31 150.66 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.044 -0.525 . . . . 64.019999999999996 110.87 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.3 -33.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.974 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 106' ' ' ASN . 13.1 tt -50.54 129.25 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.125 -0.489 . . . . 71.510000000000005 111.175 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.83 105.37 9.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.866 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.9 p -126.01 146.15 50.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 111.055 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.86 140.96 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.400000000000006 111.083 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.99 101.83 7.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 43.329999999999998 111.156 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.51 101.84 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 71.530000000000001 110.877 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -106.83 136.45 46.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.181 -0.463 . . . . 74.109999999999999 110.968 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.63 120.46 33.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.497 . . . . 73.230000000000004 110.928 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.715 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -124.95 87.69 2.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.912 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.56 14.69 63.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 65.340000000000003 112.527 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.78 48.22 1.41 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.793 -0.718 . . . . 61.049999999999997 112.439 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.39 90.95 2.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.772 0.32 . . . . 40.409999999999997 111.162 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.28 98.13 2.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 75.319999999999993 110.843 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.4 132.2 53.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.049999999999997 110.929 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -96.77 133.29 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.773 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.68 132.58 44.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 62.310000000000002 110.798 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -72.78 122.85 22.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 63.399999999999999 110.844 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.03 90.76 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.098 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -136.07 107.53 6.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 110.837 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -179.26 133.61 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.301 -0.409 . . . . 53.399999999999999 110.946 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.02 158.55 1.41 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.57 0.7 . . . . 73.040000000000006 110.961 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -169.77 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 75.219999999999999 112.422 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -95.92 172.43 8.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.314 -0.403 . . . . 72.209999999999994 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.631 HG23 ' C ' ' A' ' 15' ' ' THR . 4.2 p -164.28 133.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 70.200000000000003 111.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.479 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -85.96 140.68 30.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 65.510000000000005 110.854 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.89 114.69 26.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 64.329999999999998 110.933 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -135.81 120.78 18.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.299999999999997 110.858 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.6 176.57 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.808 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -106.97 -162.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 43.329999999999998 111.108 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -137.19 109.4 0.71 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 75.25 112.552 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.8 119.77 39.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.003 0.43 . . . . 75.209999999999994 110.921 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -64.7 134.45 54.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 62.119999999999997 110.778 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.329999999999998 110.913 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 mtm . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.671 0.272 . . . . 75.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 m170 55.22 70.73 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 73.409999999999997 110.867 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.5 139.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 75.349999999999994 110.947 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 64.46 92.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 111.08 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.73 72.23 0.49 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.699 -0.762 . . . . 64.430000000000007 112.519 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.29 92.11 1.99 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.904 0.383 . . . . 72.510000000000005 110.84 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.748 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -162.52 -161.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.510000000000005 110.951 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.64 165.03 23.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 63.399999999999999 110.837 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -114.83 169.47 9.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.085 -0.507 . . . . 75.030000000000001 110.794 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 155.73 38.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 110.843 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 187' ' ' SER . . . -79.77 149.94 30.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.200000000000003 111.155 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.07 108.03 3.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.709 -0.758 . . . . 73.420000000000002 112.451 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t -130.34 80.66 1.96 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.377 . . . . 73.140000000000001 110.881 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -73.35 88.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 42.520000000000003 111.052 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m -87.51 98.5 11.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 64.349999999999994 111.156 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 p -78.13 123.6 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 160.53 62.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.531 0.681 . . . . 75.430000000000007 110.864 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 157.81 59.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 72.540000000000006 112.385 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.78 HG23 ' CZ3' ' A' ' 182' ' ' TRP . 15.0 m -119.06 150.44 39.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 75.329999999999998 111.136 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 126.86 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.841 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.06 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.807 -0.711 . . . . 73.010000000000005 112.448 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.6 40.58 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 54.409999999999997 111.087 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.05 -105.65 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 61.119999999999997 112.527 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.37 -93.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 42.109999999999999 112.476 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -140.83 74.33 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.886 0.374 . . . . 72.109999999999999 111.125 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.22 40.14 9.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.129999999999995 110.946 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.6 138.22 3.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 63.100000000000001 112.482 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.476 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -94.38 80.66 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.887 0.375 . . . . 71.010000000000005 110.835 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.656 HD23 ' HG3' ' A' ' 69' ' ' ARG . 4.3 mp -144.69 126.84 15.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 64.510000000000005 110.912 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.25 43.56 1.16 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.742 -0.742 . . . . 62.539999999999999 112.47 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 -161.21 0.82 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.795 -0.716 . . . . 75.5 112.487 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 126.38 16.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.392 . . . . 72.230000000000004 110.863 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.26 -174.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 45.210000000000001 110.87 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.73 HG13 ' OD1' ' A' ' 159' ' ' ASP . 33.0 m -137.96 -176.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 111.122 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 p -78.7 120.47 23.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 71.5 111.14 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' OD1' ' HB1' ' A' ' 14' ' ' ALA . 29.0 m-80 -131.24 178.48 6.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.875 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.76 173.74 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 110.806 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 t -79.91 58.18 2.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 45.520000000000003 111.05 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.78 -169.83 1.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 63.299999999999997 110.861 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.973 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.12 165.02 12.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 62.43 112.413 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 44' ' ' PHE . 5.1 mt -142.3 132.42 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.934 0.397 . . . . 74.540000000000006 110.776 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 56' ' ' LEU . 3.3 m -136.84 146.1 45.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 72.209999999999994 111.151 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CE2' HD22 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -144.33 136.12 25.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 73.209999999999994 110.892 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.748 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 1.1 p -116.79 139.03 51.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 73.230000000000004 111.041 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.65 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 19.5 p90 -139.9 126.53 20.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 73.209999999999994 110.886 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 45.4 tpp -56.28 147.64 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 71.510000000000005 110.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.44 -80.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 52.25 111.094 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.3 t 179.1 43.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.113 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.61 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.828 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 t30 67.17 11.58 8.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 110.914 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.04 113.66 42.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 111.099 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.05 147.17 16.18 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.681 -0.771 . . . . 74.299999999999997 112.525 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 85' ' ' MET . 23.3 t -100.53 128.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 43.439999999999998 111.228 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER -105.46 118.73 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 74.310000000000002 110.831 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 43' ' ' THR . 32.6 mt -97.65 127.6 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 52.539999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.62 142.78 34.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.219 -0.446 . . . . 72.010000000000005 111.005 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.73 42.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 55.009999999999998 111.133 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.57 -168.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 34.210000000000001 111.083 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -51.37 159.06 1.22 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.493 0.663 . . . . 63.420000000000002 111.215 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.8 Cg_endo -69.67 -87.01 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.721 2.281 . . . . 64.129999999999995 112.36 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -67.56 148.52 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 70.109999999999999 110.945 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.6 132.12 3.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.150000000000006 110.829 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -160.01 106.69 1.61 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 63.25 110.774 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' O ' HD11 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -138.87 79.21 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 51.439999999999998 110.908 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.518 HG21 HG22 ' A' ' 71' ' ' THR . 3.6 mp -98.79 138.08 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 52.310000000000002 111.177 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.14 40.12 1.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 62.329999999999998 112.515 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -98.02 -178.74 4.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.706 0.289 . . . . 61.439999999999998 111.228 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HG3' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.44 -77.99 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 64.310000000000002 110.911 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.75 -9.26 59.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 52.009999999999998 111.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.518 HG22 HG21 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -98.57 -21.48 16.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 111.173 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 76.65 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 64.530000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.529 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.1 p30 -117.95 -15.57 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 74.340000000000003 110.896 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 73' ' ' ASP . 3.2 mp 64.55 86.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 111.027 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.55 163.29 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 64.219999999999999 111.101 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.1 p -111.24 105.14 13.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.319999999999993 111.169 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 113' ' ' ASN . 18.8 m -127.96 136.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.189 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -75.7 132.27 40.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.816 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 167.33 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 70.200000000000003 110.855 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.883 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -104.23 118.45 56.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.509 0.671 . . . . 74.25 110.889 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.939 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.0 Cg_endo -69.86 -25.64 27.94 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.7 2.267 . . . . 63.240000000000002 112.293 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.939 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.84 103.18 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.649 2.232 . . . . 71.030000000000001 112.34 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 149.75 40.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 111.074 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.41 129.66 46.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 53.25 111.013 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' VAL . 11.3 mtt -134.48 163.37 29.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 62.329999999999998 110.854 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.37 116.07 9.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 70.049999999999997 111.137 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.71 -177.43 5.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 60.219999999999999 110.875 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -151.03 161.06 43.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.853 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -107.82 131.95 53.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 75.430000000000007 111.021 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.99 101.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.203 -0.453 . . . . 62.140000000000001 110.852 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.18 24.89 22.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 72.319999999999993 112.505 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t0 57.72 43.4 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 73.340000000000003 110.876 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.56 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 61.420000000000002 111.073 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t 64.19 59.85 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 64.420000000000002 110.736 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.33 -166.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.219999999999999 110.78 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -54.8 -23.75 19.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.973 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -89.05 150.86 22.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 110.834 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 3.4 mtt180 -137.83 90.16 14.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.439999999999998 110.948 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 98' ' ' ARG . 53.2 Cg_endo -69.74 169.27 19.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.679 2.252 . . . . 62.140000000000001 112.345 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -135.85 98.22 3.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.927 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -111.82 141.49 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 75.420000000000002 111.132 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.33 -150.27 19.81 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.651 -0.785 . . . . 63.020000000000003 112.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.78 137.69 28.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 75.209999999999994 111.231 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.84 -178.05 28.08 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.642 -0.79 . . . . 65.109999999999999 112.53 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 31.6 mt -148.51 117.57 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.37 . . . . 54.539999999999999 111.103 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -107.67 109.49 21.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 72.439999999999998 110.93 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -118.03 105.95 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 72.209999999999994 110.905 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.7 p -126.41 145.14 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 111.162 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.76 -175.84 2.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 73.200000000000003 111.143 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -134.52 -170.02 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 110.896 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -173.18 -73.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.892 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.01 119.52 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.847 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.708 ' HB2' HG12 ' A' ' 77' ' ' VAL . 5.5 p30 -149.75 164.24 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 71.430000000000007 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.1 -170.82 36.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 71.140000000000001 112.428 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 65.81 147.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 74.329999999999998 110.884 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.531 ' H ' ' H ' ' A' ' 120' ' ' LYS . 1.0 OUTLIER -156.74 -173.1 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 63.329999999999998 110.864 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -62.17 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 63.109999999999999 110.886 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.42 -46.17 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.827 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.73 -57.32 19.38 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.763 -0.732 . . . . 64.109999999999999 112.435 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.531 ' H ' ' H ' ' A' ' 116' ' ' ASN . 2.9 ttpt -61.88 -46.3 89.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.793 0.33 . . . . 72.150000000000006 110.892 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.07 -11.13 56.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 73.120000000000005 110.873 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.13 -0.09 18.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 71.420000000000002 111.156 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.658 ' O ' HD23 ' A' ' 124' ' ' LEU . . . 64.94 28.21 73.19 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.707 -0.759 . . . . 73.200000000000003 112.486 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.748 HD22 ' H ' ' A' ' 169' ' ' GLY . 6.3 mt -127.01 121.92 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.939 0.399 . . . . 74.430000000000007 110.935 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 126' ' ' ASP . 0.4 OUTLIER 173.21 -173.66 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.100000000000001 110.908 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 125' ' ' SER . 44.6 m-20 -37.38 -79.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.010000000000005 110.894 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 172' ' ' GLN . 0.1 OUTLIER 74.41 -56.45 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.310000000000002 110.956 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.53 109.34 18.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 54.140000000000001 110.856 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.09 114.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 75.540000000000006 110.867 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -115.37 168.43 9.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 110.891 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' THR . 4.3 p30 -56.3 144.34 30.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 72.420000000000002 110.802 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.429 ' OG ' HD13 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -94.96 91.66 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.540000000000006 110.795 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -121.16 117.22 26.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.349999999999994 110.941 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.21 46.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 71.439999999999998 112.508 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -101.36 173.45 6.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 54.100000000000001 111.086 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.06 168.1 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 70.329999999999998 111.084 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -104.71 102.34 2.06 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.697 -0.763 . . . . 33.210000000000001 112.474 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -79.51 116.62 19.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.79 0.329 . . . . 73.540000000000006 110.973 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.844 HG23 HG11 ' A' ' 155' ' ' VAL . 4.9 m -153.42 61.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.194 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -105.8 -170.48 23.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.803 -0.713 . . . . 62.43 112.445 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.6 t -136.66 134.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.918 0.39 . . . . 74.530000000000001 111.128 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -125.04 114.9 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 72.400000000000006 110.931 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -124.19 140.13 53.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 71.450000000000003 110.823 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tt -81.06 132.32 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 71.409999999999997 110.867 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -112.69 -28.68 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 111.063 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.54 -170.87 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.897 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -73.69 -39.54 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 72.549999999999997 110.901 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -126.18 22.93 7.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 54.119999999999997 110.962 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.418 ' HZ3' ' HH ' ' A' ' 190' ' ' TYR . 30.8 m95 -139.31 130.76 27.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 110.928 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -126.76 -171.43 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.875 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.6 t -142.92 114.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.154 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -113.28 138.82 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 73.030000000000001 110.882 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 15.5 ptp -131.74 131.62 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 73.530000000000001 110.956 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -97.52 -169.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 52.109999999999999 110.876 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.844 HG11 HG23 ' A' ' 139' ' ' VAL . 35.3 m -125.83 -176.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 75.319999999999993 111.152 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -123.49 -176.58 3.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 69.88 -167.08 0.17 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.249 -0.432 . . . . 73.519999999999996 110.974 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.76 -78.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 74.219999999999999 110.853 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.73 ' OD1' HG13 ' A' ' 34' ' ' VAL . 5.5 m-20 49.14 -165.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.178 -0.465 . . . . 71.5 110.927 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 160' ' ' ILE . 1.2 pp -116.58 153.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.310000000000002 111.065 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -95.64 125.09 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 60.219999999999999 110.829 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 131' ' ' ASP . 5.3 m -142.74 147.54 35.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.16 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 174' ' ' HIS . 92.3 m -78.73 104.8 9.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 73.439999999999998 111.044 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.01 142.28 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.030000000000001 111.144 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.27 162.62 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 110.856 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 41.4 p90 -104.57 164.3 11.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.219999999999999 110.921 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.62 ' HD3' HD13 ' A' ' 127' ' ' LEU . 9.1 tttt -125.66 112.21 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.855 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.21 94.52 4.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 110.912 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.748 ' H ' HD22 ' A' ' 124' ' ' LEU . . . 105.5 8.65 34.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.099999999999994 112.56 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.69 36.94 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 60.149999999999999 112.445 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.22 89.73 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 72.019999999999996 111.087 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.765 ' HB3' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -82.2 97.48 8.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.430000000000007 110.955 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -70.38 -174.63 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 52.509999999999998 110.988 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 163' ' ' THR . 20.1 p-80 -160.67 113.72 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 72.310000000000002 110.808 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.58 167.24 22.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 64.319999999999993 110.916 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 p -74.1 126.47 30.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 70.319999999999993 110.786 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 177' ' ' VAL . 17.0 m -59.69 97.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 75.510000000000005 111.186 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.52 136.64 39.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 73.530000000000001 110.847 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.495 HD11 ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -101.01 153.98 19.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 70.040000000000006 110.908 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -68.36 -60.38 4.97 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.641 0.734 . . . . 50.439999999999998 110.877 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 53.6 Cg_endo -69.73 169.47 18.81 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.707 2.272 . . . . 74.349999999999994 112.352 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.78 ' CZ3' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -106.69 -175.93 2.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.908 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 183' ' ' VAL . 5.6 p -152.01 119.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 74.540000000000006 111.115 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -104.36 143.43 33.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.855 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 5.1 ttp -118.91 120.89 38.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.049999999999997 110.91 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.61 111.65 7.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.448 . . . . 74.519999999999996 110.903 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -146.04 174.1 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 62.409999999999997 110.735 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.88 172.16 14.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.004 -0.544 . . . . 54.539999999999999 111.081 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.21 156.27 21.45 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 62.520000000000003 112.38 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.418 ' HH ' ' HZ3' ' A' ' 149' ' ' TRP . 64.4 m-85 -138.95 157.43 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.863 0.363 . . . . 72.329999999999998 110.948 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -64.58 132.76 50.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 62.109999999999999 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 54.310000000000002 110.957 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.839 0.352 . . . . 53.039999999999999 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -160.25 105.98 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 52.210000000000001 110.861 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.41 -176.95 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.549999999999997 110.861 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -49.26 160.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 74.319999999999993 111.161 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.03 39.66 41.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 74.209999999999994 112.468 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 47' ' ' MET . 6.4 tp10 -139.23 95.73 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 64.5 110.942 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.819 ' HB3' ' O ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -167.16 -162.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.93 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -144.35 166.85 23.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 64.340000000000003 110.918 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 44' ' ' PHE . 2.4 ptm -123.7 149.11 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 72.299999999999997 110.919 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.14 -176.08 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 73.150000000000006 110.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.7 163.93 19.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 71.219999999999999 111.037 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.38 89.06 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 70.0 112.385 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 t -109.42 80.84 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 71.439999999999998 110.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.56 107.46 18.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 70.329999999999998 111.074 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -97.63 118.05 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 64.099999999999994 111.198 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 37' ' ' ASN . 90.2 t -83.5 134.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 60.299999999999997 111.128 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.77 160.47 66.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.632 0.729 . . . . 75.219999999999999 110.859 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -173.96 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.7 2.266 . . . . 54.039999999999999 112.352 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.4 p -136.47 -175.28 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.049999999999997 111.172 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -59.86 112.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 65.040000000000006 110.904 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.8 110.71 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 42.310000000000002 112.516 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -174.94 105.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 54.439999999999998 111.072 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.55 97.79 0.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.855 -0.688 . . . . 52.450000000000003 112.58 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 52.3 -171.27 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.85 -0.691 . . . . 53.5 112.418 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.738 HG22 ' H ' ' A' ' 27' ' ' GLY . 90.5 m -160.34 -72.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 72.140000000000001 111.094 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt 51.87 32.94 10.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 73.329999999999998 110.943 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.738 ' H ' HG22 ' A' ' 25' ' ' THR . . . 129.13 148.43 6.6 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.633 -0.794 . . . . 35.329999999999998 112.403 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.05 -73.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 75.150000000000006 110.82 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 61.92 175.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 74.439999999999998 110.962 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.71 43.35 84.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.7 -0.762 . . . . 70.25 112.572 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.89 75.39 0.33 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 22.120000000000001 112.54 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -103.42 101.21 11.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.373 . . . . 72.030000000000001 110.908 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 t -171.95 89.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 74.109999999999999 110.912 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG13 ' CG ' ' A' ' 64' ' ' HIS . 61.6 t -116.92 115.14 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 72.129999999999995 111.185 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.5 m -80.37 141.08 35.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.219999999999999 111.139 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -79.99 -168.09 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -101.29 140.1 36.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.849 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.98 107.23 12.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 60.530000000000001 111.139 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.82 47.18 1.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.909 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mp -133.27 41.01 3.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.200000000000003 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.76 -140.19 5.41 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.696 -0.764 . . . . 74.140000000000001 112.433 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.84 151.96 40.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 54.140000000000001 110.853 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -143.09 144.12 32.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.450000000000003 111.18 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' MET . 20.7 p90 -156.17 123.69 5.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 75.319999999999993 110.918 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.819 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 9.4 t -118.42 147.76 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 73.519999999999996 111.263 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.666 ' HA ' ' HB2' ' A' ' 7' ' ' PHE . 38.7 p90 -141.68 127.41 19.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 72.430000000000007 110.911 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.406 ' HB2' ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -57.3 141.09 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.791 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.44 -11.48 15.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 111.092 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.23 -166.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 51.100000000000001 111.256 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -88.2 39.32 0.9 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.339 -0.391 . . . . 71.409999999999997 110.87 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 175.55 -46.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.815 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 88' ' ' TRP . 23.9 mm -86.86 134.52 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 73.340000000000003 111.126 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.53 142.73 13.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.74 -0.743 . . . . 65.450000000000003 112.515 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.47 118.48 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 73.040000000000006 111.115 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.21 137.24 47.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.150000000000006 111.049 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.52 129.99 56.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 70.409999999999997 110.925 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 141.6 41.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 65.530000000000001 110.923 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.17 135.56 32.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 53.450000000000003 111.176 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -179.01 -165.85 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 111.094 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 77.37 1.81 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.04 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -7.11 20.2 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.7 2.267 . . . . 54.43 112.327 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -59.51 141.57 54.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.030000000000001 110.865 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -101.0 178.02 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 71.299999999999997 110.946 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.664 ' CG ' HG13 ' A' ' 34' ' ' VAL . 3.4 p-80 -64.31 -169.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.450000000000003 110.784 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.81 -169.32 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 72.230000000000004 110.78 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 73' ' ' ASP . 12.1 tt -123.15 140.63 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.077 -0.51 . . . . 65.040000000000006 111.153 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.9 68.9 0.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 61.140000000000001 112.487 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.13 152.79 18.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 53.549999999999997 111.114 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -80.66 -0.23 37.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.867 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.16 -51.77 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.520000000000003 111.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.91 0.05 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 63.340000000000003 111.218 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.46 -98.85 2.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 40.450000000000003 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.609 ' O ' HG23 ' A' ' 74' ' ' ILE . 1.4 m-20 66.4 143.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.787 0.327 . . . . 73.5 110.845 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 73' ' ' ASP . 1.1 pp -163.56 24.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.205 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . . . -139.05 163.42 32.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 111.188 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.524 HG21 ' O ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -147.82 -173.35 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 70.030000000000001 111.136 -179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 112' ' ' ASP . 87.2 t -110.4 131.07 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 111.235 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -99.59 134.32 42.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 110.812 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.87 178.25 5.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.845 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.2 tp -96.87 129.29 32.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.621 0.724 . . . . 73.420000000000002 110.84 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.919 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.7 Cg_endo -69.98 -26.29 26.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.663 2.242 . . . . 70.310000000000002 112.279 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.919 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 52.0 Cg_endo -69.94 101.3 0.92 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.692 2.261 . . . . 63.439999999999998 112.31 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 139.31 50.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 72.439999999999998 111.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.48 131.85 54.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.035 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.88 140.07 38.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 72.450000000000003 110.836 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.9 120.21 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 111.091 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -123.42 138.77 54.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 110.866 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.498 ' CG ' HD13 ' A' ' 52' ' ' ILE . 5.2 t90 -153.77 118.54 4.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 75.400000000000006 110.928 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.774 ' HB2' HG22 ' A' ' 101' ' ' VAL . 30.5 t80 177.79 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 72.5 110.94 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -51.82 -32.58 32.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.121 -0.491 . . . . 73.150000000000006 110.923 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.38 -128.41 8.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.749 . . . . 63.299999999999997 112.496 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -160.61 36.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 63.030000000000001 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.76 -58.66 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 64.409999999999997 111.102 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p 54.39 30.51 12.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.72 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -72.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 61.039999999999999 110.789 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.34 38.7 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 110.895 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -167.65 135.93 2.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 63.450000000000003 110.937 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.17 88.35 5.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.648 0.737 . . . . 75.219999999999999 110.891 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 141' ' ' VAL . 54.0 Cg_endo -69.77 168.86 20.35 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.727 2.285 . . . . 62.509999999999998 112.344 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.406 ' HA ' ' N ' ' A' ' 89' ' ' TYR . 14.6 p90 177.44 127.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.94 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 89' ' ' TYR . 3.6 m -136.91 141.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 70.230000000000004 111.153 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -174.19 -137.38 2.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.778 -0.725 . . . . 64.109999999999999 112.489 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -134.26 139.27 45.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 65.450000000000003 111.04 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.43 174.02 36.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.652 -0.785 . . . . 75.310000000000002 112.448 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -150.09 118.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 74.439999999999998 111.187 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.82 109.56 21.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 72.530000000000001 110.959 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.99 107.22 19.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.946 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -108.57 104.46 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 72.129999999999995 111.203 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.33 128.8 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.212 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -168.14 -73.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 73.430000000000007 110.884 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.89 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.916 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.803 ' HB2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER 67.37 137.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 75.140000000000001 110.844 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.92 -79.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 61.450000000000003 110.999 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.49 -87.68 0.12 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 63.520000000000003 112.45 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -51.23 169.06 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.94 0.4 . . . . 71.299999999999997 110.916 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.473 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -162.75 -161.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.905 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -46.34 -59.92 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 60.5 110.85 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -47.68 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 71.400000000000006 110.89 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.77 -58.37 13.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.817 -0.706 . . . . 43.25 112.502 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -59.77 -47.7 84.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 71.439999999999998 110.929 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -66.31 -11.66 52.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 73.430000000000007 110.946 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.411 ' CB ' HD23 ' A' ' 124' ' ' LEU . . . -108.42 13.56 25.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 72.230000000000004 110.988 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 57.92 32.84 66.98 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.711 -0.757 . . . . 72.25 112.491 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER -147.1 179.17 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 63.210000000000001 110.868 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -150.2 142.12 23.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 65.430000000000007 110.772 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -52.17 -36.11 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.858 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.61 134.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.874 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -119.6 159.27 24.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 60.25 110.776 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -134.56 128.08 32.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 60.25 110.962 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -176.82 6.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.271 -0.422 . . . . 75.409999999999997 110.792 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.29 113.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.129999999999995 110.879 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 162' ' ' THR . 0.8 OUTLIER -105.75 91.25 3.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 110.9 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -113.57 118.24 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.976 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.49 175.99 22.08 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.696 -0.764 . . . . 70.519999999999996 112.469 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.54 174.11 6.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 62.200000000000003 111.052 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 156' ' ' TRP . . . -147.5 176.85 9.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 41.539999999999999 111.106 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -106.26 102.4 1.92 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 65.439999999999998 112.651 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.98 145.3 27.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 64.340000000000003 110.868 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.5 p 179.38 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 62.100000000000001 111.109 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.58 -172.4 23.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 21.239999999999998 112.568 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 99' ' ' PRO . 6.1 m -143.58 160.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 55.210000000000001 111.146 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.89 111.02 17.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 64.409999999999997 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -91.32 141.27 28.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 110.898 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.756 ' CB ' HD22 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -121.37 80.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 71.450000000000003 110.976 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 144' ' ' LEU . 3.4 pt -154.93 32.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.4 . . . . 71.140000000000001 111.193 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.36 59.72 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.94 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 mmm-85 69.14 -74.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 110.848 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.91 12.66 3.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 64.439999999999998 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.401 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -136.46 173.86 11.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.475 . . . . 73.209999999999994 110.945 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.756 HD22 ' CB ' ' A' ' 144' ' ' LEU . 1.8 mt -108.49 -170.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 62.310000000000002 110.944 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 187' ' ' SER . 12.2 p -160.17 134.83 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 72.040000000000006 111.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.29 134.21 52.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 62.530000000000001 110.947 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -136.87 122.75 20.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 70.450000000000003 110.947 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.02 -170.31 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 54.439999999999998 110.889 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 30.9 m -139.87 -176.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 111.172 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CZ2' ' HB2' ' A' ' 136' ' ' ALA . 0.0 OUTLIER -150.59 146.13 26.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 110.945 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -178.21 108.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.95 -170.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.863 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 179' ' ' LEU . 5.7 m-20 -136.83 170.28 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 74.340000000000003 110.809 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.93 HG22 HD11 ' A' ' 179' ' ' LEU . 16.3 tt -154.93 146.48 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 70.129999999999995 111.16 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -92.53 107.33 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.483 . . . . 65.209999999999994 110.832 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.933 HG22 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -108.11 125.03 51.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 111.125 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 129' ' ' LEU . 2.7 m -94.8 116.44 28.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 65.239999999999995 111.147 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.754 ' HA ' HD22 ' A' ' 129' ' ' LEU . . . -109.2 112.48 24.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 44.039999999999999 111.148 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -99.44 113.33 25.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.932 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -84.83 105.35 15.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.428 . . . . 75.420000000000002 110.92 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -82.38 114.65 20.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 74.019999999999996 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.05 99.51 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 65.420000000000002 110.971 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.53 20.68 78.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.75 -0.738 . . . . 74.200000000000003 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.56 39.35 7.22 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.788 -0.72 . . . . 60.039999999999999 112.579 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -113.73 91.65 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.711 0.291 . . . . 75.299999999999997 111.111 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 97.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.420000000000002 110.995 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.99 -175.84 3.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.209999999999994 110.942 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -172.55 115.73 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.767 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -129.28 130.65 46.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 62.039999999999999 110.85 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.64 111.14 22.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.93 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.485 HG22 ' HB ' ' A' ' 162' ' ' THR . 18.0 m -95.2 146.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 63.43 111.134 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -113.82 136.44 52.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 63.32 110.838 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 160' ' ' ILE . 28.7 mt -61.41 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.474 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.4 OUTLIER -179.26 -61.35 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 73.030000000000001 110.816 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 54.0 Cg_endo -69.68 126.03 12.89 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.596 2.197 . . . . 72.519999999999996 112.311 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -80.05 -178.68 6.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 111.04 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.3 t -149.09 140.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.372 -0.377 . . . . 60.509999999999998 111.136 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -104.57 138.38 41.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 60.039999999999999 110.948 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.53 103.7 7.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.173 -0.467 . . . . 71.430000000000007 110.839 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -153.39 133.53 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.877 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 151' ' ' VAL . 0.1 OUTLIER -174.68 174.73 2.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 50.210000000000001 110.889 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.82 162.79 15.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 61.130000000000003 111.142 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.42 176.03 37.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 72.150000000000006 112.509 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.32 158.01 30.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 70.109999999999999 110.923 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.566 ' CG ' HD11 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -63.73 138.29 58.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 53.32 110.948 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.827 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.87 0.367 . . . . 75.439999999999998 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -174.29 37.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 62.420000000000002 110.749 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 174.3 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 71.010000000000005 110.945 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 47' ' ' MET . . . -49.01 145.16 4.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 70.209999999999994 111.157 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.722 ' H ' ' HE3' ' A' ' 47' ' ' MET . . . 87.97 -17.72 44.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 61.0 112.488 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 47' ' ' MET . 9.7 mm-40 -81.2 113.27 19.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 74.239999999999995 110.833 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -106.19 133.65 50.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 61.539999999999999 110.919 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 1.1 m-85 -112.01 144.32 41.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.499 . . . . 74.200000000000003 110.959 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 ptm -142.87 133.72 25.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 62.200000000000003 110.84 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 22.4 tpt180 -155.39 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 71.340000000000003 110.937 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 10' ' ' ARG . . . -77.28 178.19 7.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 64.140000000000001 111.027 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.94 126.98 5.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 30.41 112.443 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -141.28 79.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 74.230000000000004 110.834 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.57 120.34 40.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 64.140000000000001 111.086 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' THR . 0.6 OUTLIER -120.31 105.22 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.200000000000003 111.118 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG12 HG11 ' A' ' 183' ' ' VAL . 34.7 m -74.64 136.35 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 111.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.17 72.55 1.6 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.597 0.713 . . . . 74.239999999999995 110.942 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HA ' ' HG3' ' A' ' 181' ' ' PRO . 53.5 Cg_endo -69.62 -50.42 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 71.230000000000004 112.28 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 1.011 HG21 HD13 ' A' ' 127' ' ' LEU . 7.1 t -177.14 -172.07 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 54.219999999999999 111.155 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.24 52.64 2.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 64.140000000000001 110.892 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.1 133.83 2.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 52.229999999999997 112.489 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.26 88.01 2.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 61.100000000000001 111.087 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.82 95.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.649 -0.786 . . . . 71.25 112.486 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.82 127.65 9.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.675 -0.774 . . . . 54.25 112.428 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.561 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 1.8 t 178.45 78.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 74.349999999999994 111.064 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 172' ' ' GLN . 0.7 OUTLIER -111.9 19.65 17.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 74.120000000000005 110.853 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.82 157.57 26.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 53.43 112.439 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -115.14 -28.49 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 71.549999999999997 110.788 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 tp -151.14 39.61 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.834 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.12 40.07 0.84 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.762 -0.732 . . . . 53.25 112.46 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' HG21 ' A' ' 66' ' ' ILE . . . -69.51 -177.64 18.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 55.219999999999999 112.423 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -117.11 121.63 41.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 110.895 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.573 ' H ' HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -172.2 145.62 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 55.119999999999997 110.799 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 65' ' ' LYS . 3.3 m -143.53 168.34 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 75.329999999999998 111.071 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' HA2' ' A' ' 114' ' ' GLY . 5.7 t -137.79 134.91 35.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 65.099999999999994 111.218 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -178.41 6.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 174.69 174.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.894 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -79.88 175.5 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 41.030000000000001 111.212 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -179.21 -175.02 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.3 -0.409 . . . . 75.099999999999994 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.7 mt -126.44 90.27 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 53.299999999999997 110.963 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' ALA . . . -94.16 -157.26 32.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.714 . . . . 63.119999999999997 112.566 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.27 151.15 17.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 62.450000000000003 110.905 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -125.21 131.93 53.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 62.299999999999997 111.106 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -119.03 126.33 51.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.140000000000001 110.912 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.482 HG23 ' CG ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -114.47 131.52 56.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 75.209999999999994 111.178 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.67 109.08 10.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.013 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.722 ' HE3' ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -63.14 101.16 0.26 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.097 -0.502 . . . . 71.430000000000007 110.946 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.86 -84.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 44.210000000000001 111.166 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 t 176.27 59.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.349999999999994 111.157 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.9 43.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.864 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m120 65.4 13.09 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 60.100000000000001 110.906 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 HG22 ' HB3' ' A' ' 88' ' ' TRP . 1.0 OUTLIER -126.58 132.42 70.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.184 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -126.42 153.09 18.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 65.219999999999999 112.56 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 5.8 p -98.07 120.68 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 64.010000000000005 111.158 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' CG ' HG23 ' A' ' 45' ' ' THR . 4.3 tt0 -103.45 117.99 35.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 75.049999999999997 110.889 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.91 116.96 31.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.938 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.721 ' CB ' HG23 ' A' ' 83' ' ' THR . 3.5 mt -98.67 105.81 18.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.917 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.09 -173.86 3.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 54.539999999999999 111.138 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 80' ' ' LEU . . . -155.86 175.78 13.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 53.100000000000001 111.11 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.467 ' N ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -83.2 -61.1 0.33 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.642 0.734 . . . . 63.149999999999999 111.14 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 60' ' ' THR . 53.5 Cg_endo -69.79 95.07 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.654 2.236 . . . . 55.539999999999999 112.364 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 62' ' ' PHE . 4.6 p90 -125.63 112.09 15.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 62.25 110.89 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -166.79 -179.82 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.928 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -160.05 146.32 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 75.420000000000002 110.869 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 74' ' ' ILE . 38.2 mmtt -143.37 -175.92 4.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 72.129999999999995 110.901 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.68 HG21 ' O ' ' A' ' 31' ' ' GLY . 1.4 mp -140.23 164.42 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.271 -0.422 . . . . 64.540000000000006 111.166 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 66' ' ' ILE . . . -129.18 136.36 8.95 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.691 -0.766 . . . . 72.319999999999993 112.405 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.1 p -145.87 149.55 34.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 75.420000000000002 111.127 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.85 156.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 60.329999999999998 110.794 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.47 -17.58 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 72.540000000000006 111.014 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.96 -33.38 19.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 74.150000000000006 111.075 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.68 101.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.733 . . . . 62.539999999999999 112.519 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.97 -58.44 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 72.510000000000005 110.966 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -105.43 -164.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 64.129999999999995 111.172 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.608 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -138.9 168.09 20.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 111.187 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 16.5 m -62.11 118.39 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 75.120000000000005 111.045 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -108.84 -173.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 61.350000000000001 111.135 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 77' ' ' VAL . 35.6 m-70 -73.71 -175.0 1.92 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 62.210000000000001 110.822 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -174.13 142.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.477 . . . . 75.140000000000001 110.864 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -156.53 110.9 2.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.514 0.673 . . . . 70.209999999999994 110.95 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.698 ' HB3' HG23 ' A' ' 108' ' ' THR . 54.0 Cg_endo -69.77 108.88 2.18 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.717 2.278 . . . . 64.439999999999998 112.443 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 81' ' ' PRO . 54.3 Cg_endo -69.58 97.5 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.809 2.339 . . . . 62.119999999999997 112.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.721 HG23 ' CB ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -128.15 141.81 51.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 111.06 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.63 117.6 8.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 74.019999999999996 110.88 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.41 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -141.34 150.66 42.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.852 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -91.49 164.04 13.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 71.299999999999997 111.125 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 144.49 41.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 71.340000000000003 110.915 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' HB3' HG22 ' A' ' 52' ' ' ILE . 49.1 p90 -151.24 161.3 42.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 73.129999999999995 110.954 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -79.57 136.19 36.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 75.319999999999993 110.937 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HD1' HG21 ' A' ' 101' ' ' VAL . 7.2 t80 -73.87 -55.37 6.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 72.340000000000003 110.872 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.44 71.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.767 . . . . 71.450000000000003 112.48 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.55 -72.15 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 72.420000000000002 110.933 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.95 68.49 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.349999999999994 111.086 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.5 1.64 13.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 44.130000000000003 110.881 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.25 169.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 73.430000000000007 110.858 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 tttt 72.13 -68.7 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 110.883 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.73 140.35 18.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 71.510000000000005 110.803 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.43 157.11 32.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 73.319999999999993 110.921 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -175.58 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.684 2.256 . . . . 72.420000000000002 112.344 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -162.86 124.7 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 71.239999999999995 111.04 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.422 HG21 ' HD1' ' A' ' 90' ' ' PHE . 21.2 t -79.3 143.26 12.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 111.122 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.05 156.93 27.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.758 . . . . 73.230000000000004 112.504 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.38 152.05 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 71.319999999999993 111.146 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . 168.78 -139.17 5.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 74.109999999999999 112.522 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 118.43 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.071 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -104.42 107.61 18.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 72.209999999999994 110.903 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -119.66 134.85 55.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 110.947 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.698 HG23 ' HB3' ' A' ' 81' ' ' PRO . 32.5 m -113.22 134.68 54.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 61.119999999999997 111.107 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -91.24 160.04 15.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 64.420000000000002 111.221 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -43.77 126.63 4.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 65.049999999999997 110.766 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.421 ' CE1' HG21 ' A' ' 108' ' ' THR . 16.6 m-85 -71.08 -174.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.924 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -164.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.872 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 2.2 t30 -82.59 -79.46 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 110.806 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 35' ' ' THR . . . 151.93 -153.13 24.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 70.230000000000004 112.522 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 25' ' ' THR . 4.8 m-85 62.42 156.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 64.430000000000007 110.886 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.8 OUTLIER -162.34 -167.16 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.530000000000001 110.923 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -61.29 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 74.030000000000001 110.882 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -79.11 -45.18 20.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 110.874 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.75 -57.69 18.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.684 -0.77 . . . . 50.340000000000003 112.567 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' H ' ' H ' ' A' ' 116' ' ' ASN . 9.9 tmtt? -60.97 -46.72 89.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.698 0.285 . . . . 74.120000000000005 110.863 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -66.11 -14.57 62.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.909 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.15 6.73 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 54.329999999999998 111.13 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.4 31.2 27.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.646 -0.787 . . . . 42.350000000000001 112.505 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.448 HD11 ' HA2' ' A' ' 169' ' ' GLY . 1.6 mp -115.5 169.38 9.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 74.340000000000003 110.93 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -121.53 110.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.229999999999997 110.773 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -48.84 -44.7 39.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 110.854 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 19' ' ' THR . 0.0 OUTLIER 175.07 156.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.218 -0.446 . . . . 73.329999999999998 110.924 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.15 149.16 34.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 65.409999999999997 110.86 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.42 130.59 10.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 71.5 110.965 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -177.97 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.842 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.68 -176.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 75.310000000000002 110.885 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.02 145.14 39.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 75.219999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -139.69 120.0 13.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 74.010000000000005 110.991 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.12 -173.18 28.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.762 -0.732 . . . . 71.200000000000003 112.444 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.19 162.31 32.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 52.409999999999997 111.023 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.55 32.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 74.209999999999994 111.1 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.88 80.55 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 71.230000000000004 112.568 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.23 -175.15 3.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 53.32 110.904 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.9 p -122.26 118.46 55.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.122 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.64 -169.19 42.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 61.020000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.62 134.36 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 63.329999999999998 111.154 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.58 137.76 54.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.218 -0.446 . . . . 52.140000000000001 110.868 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -119.16 99.92 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.976 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.04 85.63 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 73.0 110.862 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 151' ' ' VAL . 61.9 mt -59.34 -51.08 76.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.5 . . . . 73.209999999999994 111.213 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -144.86 -170.62 3.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 110.889 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 5.72 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 54.340000000000003 110.87 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.41 -5.58 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.856 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -166.91 146.33 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.869 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.63 HD11 ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -138.24 -178.98 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 74.420000000000002 110.959 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 145' ' ' ILE . 12.9 t -127.0 155.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 62.140000000000001 111.135 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.401 ' N ' HG12 ' A' ' 151' ' ' VAL . 4.6 p30 -152.84 133.23 13.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 70.329999999999998 110.925 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.48 135.11 45.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 110.823 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.17 172.63 12.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 44.310000000000002 110.924 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.25 -175.98 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 111.064 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.492 ' CD2' HG22 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -104.46 -179.68 4.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.885 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -169.71 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.904 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -123.2 -169.74 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 73.239999999999995 110.869 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 29.6 t70 63.36 85.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 54.450000000000003 110.841 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 180' ' ' ASP . 1.1 pt -151.71 127.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 55.399999999999999 111.12 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.15 108.94 20.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 52.329999999999998 110.789 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 64.4 m -142.22 146.5 35.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.040000000000006 111.187 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.53 138.93 37.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 62.450000000000003 111.173 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.04 132.43 49.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 53.140000000000001 111.066 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -139.3 163.94 31.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 70.310000000000002 110.865 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -175.76 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 62.549999999999997 110.94 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.81 113.86 26.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.430000000000007 110.871 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.69 86.68 2.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 71.430000000000007 110.935 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 124' ' ' LEU . . . 82.07 18.34 67.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 75.540000000000006 112.487 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.76 47.5 1.77 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.668 -0.777 . . . . 53.32 112.463 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -132.64 98.28 4.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.295 . . . . 52.399999999999999 111.046 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.407 ' HB2' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.53 100.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 73.549999999999997 110.904 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -90.4 162.2 15.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 110.9 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -173.53 113.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 75.120000000000005 110.831 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -166.45 155.96 11.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 73.400000000000006 110.874 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 59.9 p -73.5 129.49 38.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 51.219999999999999 110.901 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 177' ' ' VAL . 5.6 p -72.22 120.2 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.209999999999994 111.227 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.14 135.89 40.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 110.872 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.11 47.42 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 34.009999999999998 110.856 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.526 ' CG ' HD11 ' A' ' 160' ' ' ILE . 0.5 OUTLIER -50.88 156.32 1.71 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.56 0.695 . . . . 73.329999999999998 110.933 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.449 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 54.2 Cg_endo -69.72 -165.35 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.759 2.306 . . . . 64.329999999999998 112.346 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -117.35 -172.91 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 63.039999999999999 110.984 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.594 HG11 HG12 ' A' ' 16' ' ' VAL . 3.6 m -139.59 147.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.239999999999995 111.113 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.25 115.66 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.808 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 104.28 6.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 74.409999999999997 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -148.57 144.91 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.885 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.14 174.99 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 61.530000000000001 110.858 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 10' ' ' ARG . . . -102.16 -162.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 50.509999999999998 111.1 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -142.56 110.71 0.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.75 -0.738 . . . . 63.030000000000001 112.481 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.96 128.67 56.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 110.893 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 129.59 39.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 71.340000000000003 110.948 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 60.240000000000002 110.872 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.834 0.35 . . . . 74.340000000000003 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -75.76 88.46 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 75.409999999999997 110.889 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -170.04 -172.72 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 63.32 110.915 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HB2' ' CA ' ' A' ' 49' ' ' THR . . . -48.47 103.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 111.161 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.02 -31.49 0.66 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.827 -0.701 . . . . 75.040000000000006 112.602 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.778 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 4.6 mm-40 -76.27 136.85 39.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.959 0.409 . . . . 51.520000000000003 110.834 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.58 ' HA ' ' HB2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -137.3 127.14 25.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 71.239999999999995 111.002 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' H ' ' HB2' ' A' ' 46' ' ' TYR . 19.4 t80 -112.01 118.86 36.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 61.210000000000001 110.853 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.9 ttp -99.57 147.09 25.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 65.099999999999994 110.838 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.25 147.08 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.109999999999999 110.81 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.29 140.13 52.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 72.209999999999994 111.105 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.66 -139.97 2.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.493 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 m -151.22 101.76 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 71.049999999999997 110.874 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.78 4.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 111.109 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -81.64 116.28 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 75.25 111.019 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 18' ' ' PRO . 21.8 t -101.53 116.59 45.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 62.140000000000001 111.081 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.61 73.71 2.15 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.632 0.73 . . . . 72.299999999999997 110.899 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 16' ' ' VAL . 54.5 Cg_endo -69.76 -19.31 36.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.755 2.304 . . . . 63.109999999999999 112.318 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 t -101.51 117.16 34.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.010000000000005 111.142 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -127.05 26.56 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.209999999999994 110.846 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.84 93.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 72.400000000000006 112.584 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.54 -75.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 73.329999999999998 111.181 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.76 -108.56 0.52 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 20.129999999999999 112.495 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.13 4.7 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.851 -0.69 . . . . 73.400000000000006 112.52 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -152.28 -60.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 53.329999999999998 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.03 26.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 110.952 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.32 -148.65 5.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.748 -0.739 . . . . 70.010000000000005 112.486 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.82 -35.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 54.310000000000002 110.853 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -51.95 166.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 62.399999999999999 110.849 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.09 43.52 2.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 71.400000000000006 112.466 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.51 129.69 5.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.785 -0.722 . . . . 62.409999999999997 112.509 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.782 ' CD2' HG21 ' A' ' 68' ' ' THR . 3.6 t80 -138.39 102.04 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 74.409999999999997 110.926 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.547 ' H ' HG23 ' A' ' 66' ' ' ILE . 40.3 t -167.69 161.91 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 63.210000000000001 110.867 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 34' ' ' VAL . 2.8 p -107.52 106.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.121 -0.491 . . . . 73.540000000000006 111.149 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.62 130.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 43.549999999999997 111.161 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.37 99.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.788 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -180.0 148.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 110.911 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t 178.35 76.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 72.430000000000007 111.197 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -176.16 38.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.835 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.037 HD22 HG23 ' A' ' 60' ' ' THR . 0.3 OUTLIER 179.96 39.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 63.130000000000003 110.871 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.35 145.99 25.83 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.709 -0.758 . . . . 72.430000000000007 112.593 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mp -141.23 136.79 32.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 74.549999999999997 110.911 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 57' ' ' LEU . 18.3 p -145.25 147.05 31.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 111.137 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.7 119.61 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 72.430000000000007 110.816 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 93.3 m -138.32 126.36 22.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 111.125 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.778 ' HB3' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -176.96 -170.58 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.5 mmt -59.42 121.64 11.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 40.140000000000001 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.807 ' HB2' HG12 ' A' ' 54' ' ' VAL . . . -121.2 -14.55 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 65.329999999999998 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.696 ' CA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -141.16 -170.45 3.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 61.329999999999998 111.194 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.7 t0 -88.38 33.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.927 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 1.8 m-20 163.27 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.895 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.15 148.39 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 111.119 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.02 158.99 13.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 74.230000000000004 112.524 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 48' ' ' ALA . 7.6 p -115.1 144.75 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.65 0.262 . . . . 72.430000000000007 111.219 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.16 118.55 16.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.224 -0.443 . . . . 75.430000000000007 110.947 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.95 126.8 53.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 72.129999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -110.29 114.36 27.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 75.319999999999993 110.945 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 82' ' ' PRO . . . -142.62 -179.72 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.119999999999997 111.071 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.08 -176.72 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 70.030000000000001 111.249 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 1.037 HG23 HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.23 159.76 1.03 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.551 0.691 . . . . 65.120000000000005 111.151 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' HG22 ' A' ' 60' ' ' THR . 54.4 Cg_endo -69.65 146.68 61.6 Favored 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.843 2.362 . . . . 62.539999999999999 112.319 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -110.22 172.58 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.968 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.55 178.46 7.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 63.130000000000003 110.915 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -61.0 127.53 32.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 75.510000000000005 110.825 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -169.77 65.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.547 HG23 ' H ' ' A' ' 33' ' ' SER . 3.5 mp -95.82 140.94 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 55.530000000000001 111.112 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -119.22 102.09 0.9 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.793 -0.717 . . . . 43.240000000000002 112.475 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.782 HG21 ' CD2' ' A' ' 32' ' ' PHE . 9.0 t -160.63 151.32 18.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 70.329999999999998 111.192 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.1 155.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 73.140000000000001 110.867 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.95 -22.39 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 51.009999999999998 111.055 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.5 p -82.51 -33.48 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 52.240000000000002 111.156 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.22 -74.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.643 -0.789 . . . . 50.039999999999999 112.471 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.409 ' C ' HD12 ' A' ' 74' ' ' ILE . 3.5 t70 178.64 -75.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 72.319999999999993 110.934 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' C ' ' A' ' 73' ' ' ASP . 2.0 mp 62.33 53.67 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 70.25 111.16 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -111.64 163.84 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 62.409999999999997 111.097 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.1 m -122.81 104.85 9.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.126 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 111' ' ' PHE . 6.2 p -157.26 144.23 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 72.140000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -94.28 158.95 15.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 61.229999999999997 110.884 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -90.9 174.2 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 75.049999999999997 110.754 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 109' ' ' THR . 3.8 mt -96.36 166.27 14.55 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.619 0.723 . . . . 73.430000000000007 110.905 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.75 173.89 10.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.642 2.228 . . . . 65.230000000000004 112.38 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 81' ' ' PRO . 54.9 Cg_endo -69.84 -172.16 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.109999999999999 112.399 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -116.17 156.34 26.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 72.549999999999997 111.132 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.84 133.74 51.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.932 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -139.89 167.0 23.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.909 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.97 135.7 53.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 45.539999999999999 111.133 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.38 141.31 32.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.899 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -139.21 133.77 31.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.984 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -79.23 130.07 35.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 72.310000000000002 110.897 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -153.68 57.17 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.875 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.65 164.73 10.03 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.741 -0.742 . . . . 52.229999999999997 112.547 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.8 -169.84 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.347 . . . . 73.450000000000003 110.872 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.05 -77.32 0.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 52.219999999999999 111.063 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.55 54.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 63.049999999999997 110.813 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.86 21.45 10.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 53.310000000000002 110.803 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -38.28 2.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 75.299999999999997 110.883 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -121.57 134.04 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 55.030000000000001 110.898 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 87.98 36.06 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.663 0.744 . . . . 75.120000000000005 110.886 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.4 Cg_endo -69.69 171.27 14.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.715 2.277 . . . . 71.010000000000005 112.304 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -171.76 122.02 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 75.450000000000003 110.876 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 139' ' ' VAL . 21.9 t -118.95 149.81 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 70.209999999999994 111.023 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.7 -147.18 6.66 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.706 -0.759 . . . . 72.129999999999995 112.523 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.95 164.29 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.062 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 85' ' ' MET . . . -156.87 -149.11 5.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.826 -0.702 . . . . 52.439999999999998 112.564 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -139.93 128.75 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 75.150000000000006 111.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -114.43 110.24 19.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.388 . . . . 64.010000000000005 110.996 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.34 109.86 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 64.019999999999996 110.879 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.81 116.43 21.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 111.139 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -156.59 -179.84 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.133 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 109' ' ' THR . 0.4 OUTLIER -114.74 179.59 3.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 71.450000000000003 110.879 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.681 ' HB3' HG23 ' A' ' 77' ' ' VAL . 17.1 t80 -103.87 -72.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 110.859 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -161.94 30.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 74.030000000000001 110.778 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' HG11 ' A' ' 77' ' ' VAL . 1.4 p-10 -50.53 144.21 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 65.209999999999994 110.911 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.45 -105.62 2.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 44.299999999999997 112.507 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -51.46 130.19 26.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 71.150000000000006 110.85 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -163.46 -161.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.934 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.83 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -79.11 -46.95 16.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.420000000000002 110.9 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.62 -58.16 15.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.757 -0.735 . . . . 52.109999999999999 112.548 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' H ' ' H ' ' A' ' 116' ' ' ASN . 2.0 tttp -59.56 -48.16 82.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.767 0.318 . . . . 74.420000000000002 110.956 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.35 -9.98 46.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 73.219999999999999 110.84 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.66 -6.84 45.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.450000000000003 111.07 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.34 3.23 31.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.686 -0.768 . . . . 54.409999999999997 112.5 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 168' ' ' LEU . 10.8 tp -80.24 122.4 26.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.806 0.336 . . . . 63.450000000000003 110.95 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.8 t -121.21 -81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 70.010000000000005 110.855 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.521 ' CG ' ' HA ' ' A' ' 166' ' ' TYR . 1.1 p-10 40.46 -100.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 71.099999999999994 110.924 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.7 OUTLIER 72.91 44.39 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.876 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.19 136.63 41.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.274 -0.421 . . . . 64.099999999999994 110.815 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 130' ' ' LYS . 5.6 tt -170.24 117.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 64.510000000000005 110.922 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.457 ' O ' HD23 ' A' ' 129' ' ' LEU . 9.0 tptp -67.19 135.99 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.894 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.714 ' HA ' HG23 ' A' ' 109' ' ' THR . 10.2 p30 -70.85 152.56 43.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.510000000000005 110.809 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.5 t -124.01 78.21 1.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.962 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -134.83 141.57 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 75.150000000000006 110.928 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -177.76 174.39 46.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.796 -0.716 . . . . 63.030000000000001 112.527 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -78.88 162.18 26.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.728 0.299 . . . . 63.5 111.111 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -155.73 134.62 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 72.049999999999997 111.146 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.7 134.23 12.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.698 -0.763 . . . . 70.0 112.477 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.41 110.8 22.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 75.510000000000005 110.988 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 101' ' ' VAL . 4.2 p -130.82 117.74 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.434 . . . . 64.030000000000001 111.13 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.84 -170.88 22.33 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.664 -0.779 . . . . 24.23 112.436 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 12.8 p -143.37 147.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.328 . . . . 63.140000000000001 111.151 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.41 144.64 51.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 61.409999999999997 110.808 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.67 130.82 56.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 72.209999999999994 110.878 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.922 HD12 HD21 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -101.86 81.57 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 75.25 110.904 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 145' ' ' ILE . 0.5 OUTLIER -174.33 31.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 111.042 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.19 56.91 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 110.904 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -72.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 62.219999999999999 110.892 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.38 13.35 2.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 110.835 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -143.91 -175.83 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.97 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.922 HD21 HD12 ' A' ' 144' ' ' LEU . 6.7 mp -116.45 166.7 11.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 73.519999999999996 110.917 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.19 141.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.188 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.75 132.86 45.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 111.007 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -135.77 132.25 36.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 73.239999999999995 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 85.3 p -155.79 -178.67 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.894 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.3 -176.08 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 63.25 111.191 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.402 ' HZ2' HD22 ' A' ' 57' ' ' LEU . 17.1 m95 -128.17 175.94 8.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.378 -0.374 . . . . 74.409999999999997 110.957 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -167.87 -169.36 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.04 167.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.310000000000002 110.837 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.69 -169.64 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 110.874 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.0 tp -156.16 147.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 52.530000000000001 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.74 121.43 28.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 53.329999999999998 110.832 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.22 147.6 36.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 70.299999999999997 111.084 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 m -139.02 152.19 47.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 54.409999999999997 111.184 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.24 130.09 42.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 111.132 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.26 106.9 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 110.878 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.521 ' HA ' ' CG ' ' A' ' 126' ' ' ASP . 10.6 p90 -144.17 111.72 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 75.099999999999994 110.912 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.2 OUTLIER -166.91 168.57 13.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 71.439999999999998 110.891 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -66.06 159.16 26.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 72.519999999999996 110.91 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.75 -15.6 4.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 32.140000000000001 112.499 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.45 -21.13 22.96 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.781 -0.723 . . . . 75.030000000000001 112.461 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 167' ' ' LYS . . . -113.59 143.02 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 75.109999999999999 111.048 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.06 93.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.946 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -70.21 168.26 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 63.340000000000003 110.873 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -174.54 112.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 62.409999999999997 110.805 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -122.03 129.82 52.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 71.239999999999995 110.949 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.03 103.81 13.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 63.140000000000001 110.892 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.5 91.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.077 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.06 124.03 22.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 110.787 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.7 -32.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.143 -0.48 . . . . 74.319999999999993 110.973 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 65.73 71.3 0.51 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 73.519999999999996 110.897 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.78 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.723 2.282 . . . . 73.129999999999995 112.365 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -144.31 168.73 19.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.295 -0.411 . . . . 75.329999999999998 111.049 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 16' ' ' VAL . 17.8 m -148.21 163.02 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 71.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.55 125.72 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.849 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.89 103.81 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.81 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -152.8 127.37 9.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 65.340000000000003 110.813 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.54 176.04 3.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 53.130000000000003 110.895 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -119.66 177.36 4.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 62.240000000000002 111.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.21 -159.98 21.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.871 -0.68 . . . . 61.200000000000003 112.631 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -141.96 157.56 44.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.925 0.393 . . . . 74.510000000000005 110.922 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -103.42 136.34 43.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 73.239999999999995 110.902 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 53.299999999999997 110.883 -179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.764 0.316 . . . . 65.540000000000006 110.79 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -176.8 61.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.781 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.06 -175.02 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.819 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 49' ' ' THR . . . -51.63 129.38 25.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 71.530000000000001 111.09 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.36 -12.93 23.56 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.771 -0.728 . . . . 63.240000000000002 112.448 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 139.64 41.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.867 0.365 . . . . 64.109999999999999 110.872 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.86 163.98 17.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.887 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -149.56 128.38 12.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 110.917 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -117.29 124.9 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 110.809 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -136.45 137.35 40.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.786 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.52 128.66 41.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 43.329999999999998 111.087 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.59 -139.63 2.9 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.685 -0.769 . . . . 73.010000000000005 112.413 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 109.57 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 74.239999999999995 110.803 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.24 136.62 46.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 111.162 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.415 ' HA ' HG23 ' A' ' 38' ' ' THR . 12.7 m -106.49 99.56 9.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.3 -0.409 . . . . 61.130000000000003 111.117 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 183' ' ' VAL . 33.6 m -87.87 131.31 35.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 73.25 111.103 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.76 160.37 33.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.617 0.723 . . . . 71.140000000000001 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 169.33 19.08 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.692 2.261 . . . . 72.409999999999997 112.315 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.35 -54.62 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 61.439999999999998 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 -64.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 71.25 110.866 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.5 138.02 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.664 -0.779 . . . . 61.409999999999997 112.468 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.47 -75.73 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.313 . . . . 74.400000000000006 111.032 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.02 -97.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 42.130000000000003 112.486 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.2 -159.39 32.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 64.409999999999997 112.466 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.8 p -117.03 27.5 9.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.33 . . . . 51.030000000000001 111.16 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.93 24.51 14.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 71.299999999999997 110.896 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.19 119.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 62.520000000000003 112.408 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 t -179.41 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.397 . . . . 73.299999999999997 110.839 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.9 mt -141.16 -176.36 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 73.010000000000005 110.903 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.59 44.18 7.46 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.696 -0.764 . . . . 61.109999999999999 112.47 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' HD11 ' A' ' 66' ' ' ILE . . . -51.28 118.78 7.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.77 . . . . 73.010000000000005 112.496 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -88.89 165.18 14.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 72.540000000000006 110.905 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.13 97.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 70.420000000000002 110.907 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.01 145.92 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 61.310000000000002 111.155 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.1 p -79.77 118.63 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 111.142 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -179.55 118.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.519999999999996 110.894 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 179.87 173.85 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 110.919 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 15' ' ' THR . 15.2 m -84.03 62.13 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 64.319999999999993 111.178 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.859 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.14 142.3 34.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.853 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.97 159.4 21.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.659 -0.782 . . . . 65.010000000000005 112.472 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.11 137.86 31.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 71.430000000000007 111.011 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 t -144.92 151.3 38.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 55.409999999999997 111.144 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 56' ' ' LEU . 25.8 p90 -140.71 168.61 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 73.209999999999994 110.857 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' NE2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -138.04 147.82 44.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 55.219999999999999 111.115 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -142.7 102.43 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 65.099999999999994 110.902 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 136.6 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 72.040000000000006 110.894 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.99 -6.51 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 45.310000000000002 111.155 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -161.76 -169.62 2.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.174 -0.466 . . . . 65.230000000000004 111.043 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.6 39.13 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 53.350000000000001 110.794 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 176.42 -32.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 53.299999999999997 110.989 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.06 131.43 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.040000000000006 111.098 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.78 173.4 20.94 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 63.020000000000003 112.474 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.9 t -121.36 113.53 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.731 0.3 . . . . 63.210000000000001 111.171 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 140.73 37.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 63.340000000000003 110.899 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 84' ' ' LEU . 8.2 tt -131.62 116.91 17.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 72.340000000000003 110.891 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.65 117.59 34.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 63.009999999999998 110.959 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -134.57 -174.56 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.140000000000001 111.059 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.69 -170.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 111.076 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.86 161.19 0.7 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.537 0.684 . . . . 55.200000000000003 111.167 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 137.2 34.83 Favored 'Trans proline' 0 C--O 1.23 0.12 0 C-N-CA 122.705 2.27 . . . . 74.340000000000003 112.271 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.89 174.71 6.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 63.229999999999997 110.849 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.15 131.88 5.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 65.310000000000002 110.822 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -107.26 75.48 1.03 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 64.030000000000001 110.953 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.67 ' HB3' HD13 ' A' ' 74' ' ' ILE . 3.8 mmtt -151.25 165.01 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 71.230000000000004 110.824 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.68 HD11 ' O ' ' A' ' 31' ' ' GLY . 9.3 tt -154.65 105.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.239999999999995 111.169 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.24 69.47 0.67 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.683 -0.77 . . . . 63.5 112.39 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.487 HG22 ' CG1' ' A' ' 66' ' ' ILE . 13.8 t -160.56 157.55 27.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.77 0.319 . . . . 71.120000000000005 111.256 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.83 157.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.129999999999995 110.862 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -14.75 24.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 111.083 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 69.8 p -82.14 -31.22 30.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 75.129999999999995 111.126 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.65 -91.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 64.239999999999995 112.39 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.86 36.05 2.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.72 0.295 . . . . 73.409999999999997 110.85 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 65' ' ' LYS . 2.5 pp -82.6 -165.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 70.430000000000007 111.142 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 74' ' ' ILE . . . -133.81 163.24 29.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 111.096 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 76' ' ' THR . 2.9 t -75.92 105.18 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 111.099 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.7 p -155.96 161.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 74.120000000000005 111.219 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -106.41 -175.13 2.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 54.439999999999998 110.755 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.29 -173.98 3.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 71.349999999999994 110.891 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.805 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -88.68 162.31 39.26 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.658 0.742 . . . . 62.32 110.941 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 80' ' ' LEU . 53.2 Cg_endo -69.77 171.19 14.92 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.737 2.291 . . . . 73.019999999999996 112.347 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -169.13 0.31 Allowed 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.621 2.214 . . . . 70.340000000000003 112.273 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' ILE . 0.7 OUTLIER -117.89 133.69 55.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.179 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 56' ' ' LEU . 2.2 pt? -148.84 131.15 15.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 52.149999999999999 110.911 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -153.18 -158.82 0.92 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.943 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.63 160.1 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 44.299999999999997 111.06 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -152.28 148.07 27.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.120000000000005 110.975 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -144.58 105.85 4.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.421 . . . . 72.200000000000003 111.004 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -95.04 153.67 17.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 111.0 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -140.4 123.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 71.439999999999998 110.901 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -167.48 -150.9 6.69 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.721 -0.752 . . . . 60.119999999999997 112.487 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -152.66 -72.6 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 75.430000000000007 110.919 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.64 -52.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.319999999999993 111.093 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 t -144.06 70.54 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.744 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.83 -172.65 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 110.869 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.33 -19.92 16.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.916 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -130.93 134.12 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 65.400000000000006 110.795 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 144' ' ' LEU . 3.0 ttt180 -127.87 88.17 53.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 72.209999999999994 110.904 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.572 ' HA ' HG23 ' A' ' 141' ' ' VAL . 53.3 Cg_endo -69.75 174.29 9.71 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.701 2.268 . . . . 52.200000000000003 112.316 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -168.59 114.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.955 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 101' ' ' VAL . 4.6 p -124.28 115.88 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.004 -0.544 . . . . 61.25 111.091 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.26 -154.68 6.43 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.702 -0.761 . . . . 73.140000000000001 112.459 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -165.21 135.26 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 44.310000000000002 111.108 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 85' ' ' MET . . . -116.72 148.17 18.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.801 -0.714 . . . . 72.319999999999993 112.474 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -102.11 125.45 56.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.751 0.31 . . . . 73.25 111.161 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.32 109.4 20.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.952 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.64 ' CZ ' HG22 ' A' ' 109' ' ' THR . 5.3 t80 -108.5 106.27 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 64.340000000000003 110.882 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.485 HG23 ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -99.7 125.61 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 62.229999999999997 111.05 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 107' ' ' TYR . 44.9 p -97.8 -175.19 3.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 111.162 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -149.41 31.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 64.140000000000001 110.865 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -52.42 173.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 110.903 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.52 138.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 75.219999999999999 110.864 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.03 -28.96 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.923 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA3' ' HB1' ' A' ' 75' ' ' ALA . . . -63.55 -49.76 67.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 65.239999999999995 112.591 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.87 121.92 26.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 64.329999999999998 110.811 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -172.11 -152.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 52.240000000000002 110.865 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -46.08 -57.83 4.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 55.240000000000002 110.901 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -48.35 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 72.530000000000001 110.767 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.26 -59.13 10.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 54.210000000000001 112.462 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -48.96 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 64.239999999999995 110.857 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -11.3 57.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 72.299999999999997 110.881 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.55 -1.96 57.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 61.119999999999997 111.077 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.4 7.45 55.88 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 62.549999999999997 112.522 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mp -115.55 102.85 10.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.949 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.82 46.23 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.883 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 166' ' ' TYR . 0.3 OUTLIER -66.86 -21.13 66.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.549999999999997 110.906 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 46.68 -99.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 64.040000000000006 110.862 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 167.5 -169.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.239999999999995 110.798 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 162' ' ' THR . 9.0 mp -59.52 167.36 2.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 74.219999999999999 110.921 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.75 37.96 0.98 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.905 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 62.85 160.03 0.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.285 -0.416 . . . . 63.43 110.848 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 138.83 17.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 43.450000000000003 110.83 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -136.66 117.95 14.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 74.209999999999994 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -165.66 125.08 1.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.768 . . . . 74.049999999999997 112.434 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 105' ' ' ILE . . . -97.89 176.05 5.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.746 0.308 . . . . 72.140000000000001 111.177 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.63 138.37 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 74.109999999999999 111.067 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.89 121.9 5.62 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.764 -0.731 . . . . 75.340000000000003 112.503 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -101.96 111.09 23.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.874 0.368 . . . . 75.040000000000006 110.933 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.34 126.43 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 111.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.11 -174.06 24.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 70.329999999999998 112.5 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 99' ' ' PRO . 10.0 p -152.33 158.66 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.200000000000003 111.11 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.725 ' HB3' ' O ' ' A' ' 151' ' ' VAL . 7.0 t0 -166.77 -165.49 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 60.310000000000002 110.874 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 151' ' ' VAL . 13.1 m-85 -130.44 145.3 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 110.855 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' A' ' 98' ' ' ARG . 1.8 pp -105.37 111.67 24.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 62.240000000000002 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -49.28 -35.54 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.147 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.39 -169.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.485 . . . . 73.450000000000003 110.855 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -81.6 -1.34 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.879 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -113.73 -7.72 13.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 73.140000000000001 110.908 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.28 142.5 7.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.85 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.649 ' C ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -157.45 168.17 28.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 71.519999999999996 110.982 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.833 HG23 ' HB2' ' A' ' 188' ' ' ALA . 7.1 p -135.86 139.31 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 111.156 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.6 t30 -117.58 144.52 45.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 63.200000000000003 110.868 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -133.07 122.9 24.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.871 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.7 -171.28 3.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 75.439999999999998 110.812 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.8 t -142.57 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.210000000000001 111.067 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.05 165.3 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.967 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -175.16 176.66 2.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 61.140000000000001 110.91 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 60.4 173.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.129999999999995 110.935 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.21 -169.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 75.310000000000002 110.822 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 tp -137.48 145.95 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.13 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.96 133.35 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 73.030000000000001 110.798 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.511 ' CG2' HD23 ' A' ' 129' ' ' LEU . 1.6 t -142.0 147.83 37.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.102 -0.499 . . . . 70.420000000000002 111.062 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 24.3 p -79.74 170.23 16.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.065 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . . . -111.07 122.08 46.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 55.109999999999999 111.088 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.08 101.45 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 110.861 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 126' ' ' ASP . 22.5 p90 -136.17 169.1 18.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 74.099999999999994 110.933 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -163.26 122.67 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 72.209999999999994 110.909 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.52 96.45 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.893 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.0 18.63 26.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.755 -0.736 . . . . 42.43 112.527 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.08 42.42 9.52 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.671 -0.775 . . . . 54.549999999999997 112.47 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -124.15 95.54 4.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.69 0.281 . . . . 64.530000000000001 111.162 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -57.05 99.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.943 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.97 -175.63 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 110.944 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -172.18 113.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.929 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -107.95 173.66 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 110.883 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.5 101.09 6.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 54.329999999999998 110.824 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.95 116.63 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 64.340000000000003 111.11 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.91 130.7 34.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 110.84 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.79 138.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.349999999999994 111.006 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -149.01 68.12 9.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.517 0.675 . . . . 73.200000000000003 110.948 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.59 -172.91 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.768 2.312 . . . . 73.319999999999993 112.375 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 20.5 m95 -104.58 149.74 25.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.897 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 16' ' ' VAL . 80.1 t -149.66 138.81 15.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.217 -0.447 . . . . 44.32 111.095 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.37 124.56 40.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.907 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 33.2 mmm -112.93 107.1 15.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 74.239999999999995 110.957 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -152.12 144.23 23.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 110.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.2 p -172.76 170.59 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.0 110.808 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -141.1 156.16 46.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 73.420000000000002 111.067 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.06 -140.05 3.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.754 -0.736 . . . . 73.239999999999995 112.522 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -141.74 144.93 34.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.356 . . . . 72.099999999999994 111.01 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -74.59 134.06 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 70.400000000000006 110.857 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.010000000000005 110.857 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 72.5 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.8 m80 58.31 25.53 12.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 73.329999999999998 110.845 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -178.52 154.27 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 72.349999999999994 110.887 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 61.46 71.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 71.019999999999996 111.133 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.8 49.27 2.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 63.399999999999999 112.481 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -137.37 147.97 45.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.409 . . . . 61.409999999999997 110.901 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 191' ' ' ARG . 11.4 m-85 -117.03 127.83 54.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.409999999999997 110.876 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CA ' ' HB2' ' A' ' 191' ' ' ARG . 3.3 m-85 -122.21 127.61 50.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 71.319999999999993 110.87 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.505 ' N ' ' HB2' ' A' ' 191' ' ' ARG . 11.4 ttt -100.51 122.77 43.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.909 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ptt85 -132.57 114.99 14.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.8 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -103.56 154.07 19.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 55.130000000000003 111.108 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -151.21 8.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.696 -0.764 . . . . 54.130000000000003 112.454 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -142.43 117.12 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 73.340000000000003 110.802 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.0 46.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.087 -0.506 . . . . 74.209999999999994 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -108.59 98.4 7.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 53.350000000000001 111.14 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 183' ' ' VAL . 34.2 m -97.33 131.08 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.236 -0.438 . . . . 65.019999999999996 111.174 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -130.91 73.57 80.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.676 0.75 . . . . 73.420000000000002 110.898 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -25.06 29.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 62.350000000000001 112.342 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m 61.47 74.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 111.176 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.83 134.39 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.856 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.86 22.69 52.29 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.808 -0.711 . . . . 73.049999999999997 112.518 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.64 44.42 2.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 24.23 111.061 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.09 27.99 6.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.784 -0.722 . . . . 53.219999999999999 112.498 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.03 -97.56 1.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.78 -0.724 . . . . 64.140000000000001 112.523 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 t -114.39 25.64 10.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.86 0.362 . . . . 64.040000000000006 111.174 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.8 mt -139.43 71.79 1.39 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 63.310000000000002 110.887 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.53 -37.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 54.200000000000003 112.403 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 t -95.93 50.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 62.119999999999997 110.881 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD13 ' OG1' ' A' ' 68' ' ' THR . 7.6 mt -143.11 -62.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 71.219999999999999 110.829 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.36 -18.13 49.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.75 . . . . 60.520000000000003 112.467 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.45 117.39 4.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.754 -0.736 . . . . 72.129999999999995 112.486 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.92 123.96 41.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 74.430000000000007 110.787 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 t -170.84 98.46 0.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 73.030000000000001 110.859 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.687 HG13 ' OD1' ' A' ' 36' ' ' ASN . 6.6 p -160.25 143.66 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 111.129 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.628 HG21 ' HB3' ' A' ' 63' ' ' ARG . 18.0 p -80.23 121.31 25.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 72.140000000000001 111.147 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.687 ' OD1' HG13 ' A' ' 34' ' ' VAL . 4.6 p-10 -179.22 103.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 63.210000000000001 110.836 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.73 173.68 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 73.430000000000007 110.929 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 38' ' ' THR . 4.6 t -79.86 118.55 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 54.210000000000001 111.1 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.38 -170.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.18 140.51 52.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 52.030000000000001 110.916 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.73 179.68 36.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 70.040000000000006 112.535 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 11' ' ' ALA . 1.2 mp -135.87 151.42 50.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 61.25 110.809 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 57' ' ' LEU . 26.8 p -135.32 152.19 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.349999999999994 111.124 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -135.27 130.57 35.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 110.866 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -109.4 144.97 36.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 70.310000000000002 111.228 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -133.71 118.24 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.430000000000007 110.978 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 32.5 mmm -90.64 139.9 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.25 110.849 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.56 -80.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.329999999999998 111.07 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.4 t 179.31 54.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 63.520000000000003 111.142 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -179.3 42.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 110.864 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.07 22.54 9.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.825 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.603 HG22 ' CE3' ' A' ' 88' ' ' TRP . 2.1 pp -124.31 132.99 70.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.095 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.24 151.87 24.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 74.430000000000007 112.423 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.08 128.33 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.888 0.375 . . . . 72.340000000000003 111.113 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -108.16 118.94 38.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 64.430000000000007 110.874 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.88 117.11 34.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.040000000000006 110.873 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HA ' HG22 ' A' ' 43' ' ' THR . 2.2 tt -101.5 129.14 47.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 74.019999999999996 110.928 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.84 136.25 48.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 43.229999999999997 111.075 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 -168.22 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 63.210000000000001 111.129 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.59 160.28 0.61 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 74.340000000000003 111.103 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 170.12 17.23 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.791 2.327 . . . . 74.299999999999997 112.319 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -61.12 160.54 9.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.909 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.4 OUTLIER -163.7 132.42 3.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 75.120000000000005 110.836 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.405 ' CB ' HG22 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -157.06 145.62 19.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 64.510000000000005 110.863 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 75' ' ' ALA . 5.3 mttt -179.22 126.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 74.049999999999997 110.898 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' HB2' ' A' ' 75' ' ' ALA . 14.7 tt -118.3 143.5 28.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 64.040000000000006 111.178 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -140.52 48.82 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 74.219999999999999 112.541 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HD13 ' A' ' 29' ' ' LEU . 8.9 t -148.21 148.74 30.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 74.420000000000002 111.143 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 71' ' ' THR . 17.2 ttm180 62.15 157.34 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.329999999999998 110.929 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.16 24.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 65.409999999999997 111.092 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 69' ' ' ARG . 15.2 t -86.08 -32.05 21.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 74.019999999999996 111.237 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.509 ' HA2' HD13 ' A' ' 66' ' ' ILE . . . -59.8 -101.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 53.039999999999999 112.432 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.81 -75.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 74.209999999999994 110.811 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 pt -153.97 138.35 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.123 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -114.37 117.5 31.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.549999999999997 111.126 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -116.96 105.67 12.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.409 . . . . 65.230000000000004 111.192 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 64' ' ' HIS . 32.6 m -148.44 133.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 111.096 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -107.16 125.11 50.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -129.3 163.57 25.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.833 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.865 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 42.9 mt -98.37 119.23 62.12 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 51.340000000000003 110.927 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.936 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.7 Cg_endo -69.73 -25.87 28.31 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.758 2.305 . . . . 72.329999999999998 112.398 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.936 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.71 116.45 4.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 75.540000000000006 112.382 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.543 ' OG1' HD22 ' A' ' 57' ' ' LEU . 20.8 p -118.63 156.49 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 72.150000000000006 111.176 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.87 145.16 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.010000000000005 110.875 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.9 mtp -139.76 106.17 5.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 110.802 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.03 138.85 54.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.420000000000002 111.126 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -123.23 134.29 54.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.947 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.603 ' CE3' HG22 ' A' ' 52' ' ' ILE . 14.0 t-105 -138.09 124.33 20.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 110.889 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -83.05 112.78 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -104.12 110.62 22.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 74.420000000000002 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.58 -157.47 27.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.498 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -117.34 -65.23 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 71.329999999999998 110.912 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -179.07 -77.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 61.329999999999998 111.112 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 73.05 -61.2 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 73.030000000000001 110.796 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 m -142.32 -173.18 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.876 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -56.01 -73.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.030000000000001 110.93 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 143' ' ' TYR . 7.5 m-85 -94.99 159.81 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.329999999999998 110.845 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -168.65 167.13 6.28 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.618 0.723 . . . . 71.099999999999994 110.856 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.1 Cg_endo -69.73 169.72 18.22 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.668 2.245 . . . . 75.299999999999997 112.347 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -158.18 -163.83 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.420000000000002 110.863 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 139' ' ' VAL . 5.1 p -155.68 144.85 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 71.230000000000004 111.102 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.97 -155.57 6.98 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.66 -0.781 . . . . 75.019999999999996 112.441 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.98 125.6 7.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.647 0.26 . . . . 73.129999999999995 111.112 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.17 122.22 5.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.807 -0.711 . . . . 61.310000000000002 112.473 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 105' ' ' ILE . 12.2 tt -120.14 120.26 62.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.871 0.367 . . . . 50.409999999999997 111.202 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -91.16 109.16 20.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.952 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -95.79 107.41 19.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 74.230000000000004 110.985 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.8 m -125.32 132.74 52.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 71.219999999999999 111.144 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.9 p -94.79 170.73 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 111.121 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -67.41 127.54 33.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.954 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.74 115.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 70.019999999999996 110.884 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -178.73 136.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.811 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.65 -58.08 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 64.049999999999997 110.926 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.71 -131.34 18.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 63.119999999999997 112.481 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 63.45 149.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 74.299999999999997 110.839 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.8 OUTLIER -161.75 -164.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.549999999999997 110.872 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.53 -60.99 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 61.340000000000003 110.907 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -45.56 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 72.349999999999994 110.859 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.96 16.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.759 . . . . 64.540000000000006 112.502 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' H ' ' H ' ' A' ' 116' ' ' ASN . 12.1 tmtt? -60.53 -47.02 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.289 . . . . 74.530000000000001 110.846 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.22 -13.61 60.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.273 -0.421 . . . . 74.430000000000007 110.861 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.71 9.95 20.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 75.230000000000004 111.089 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 124' ' ' LEU . . . 53.52 31.34 43.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.668 -0.777 . . . . 74.030000000000001 112.607 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER -136.54 -172.99 3.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.788 0.327 . . . . 61.130000000000003 110.918 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.28 37.0 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 62.130000000000003 110.906 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -24.17 60.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 63.409999999999997 110.861 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.1 152.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 110.876 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.4 p -176.89 110.9 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 62.140000000000001 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.31 164.04 25.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 64.150000000000006 110.944 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -138.9 97.82 3.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 65.200000000000003 110.879 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.47 87.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 73.340000000000003 110.909 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -97.34 93.88 6.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 110.813 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 47.7 p-90 -108.51 118.13 35.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.099 -0.5 . . . . 75.239999999999995 110.771 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.67 76.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 55.420000000000002 112.46 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -83.4 137.08 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 45.299999999999997 111.156 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 157' ' ' TYR . . . -148.56 135.23 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 71.310000000000002 111.122 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.93 116.99 4.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.764 -0.731 . . . . 75.019999999999996 112.466 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.49 133.42 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 75.329999999999998 110.806 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.523 ' HA ' HG23 ' A' ' 101' ' ' VAL . 22.1 m -79.71 157.3 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 111.138 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -137.42 -176.23 14.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.786 -0.721 . . . . 75.099999999999994 112.532 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 23.8 m -151.33 134.08 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.326 . . . . 72.299999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.81 101.85 7.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 62.310000000000002 110.87 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.433 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 7.7 t80 -127.51 120.39 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.854 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -75.2 107.61 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 72.540000000000006 110.994 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -31.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 111.056 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.14 162.26 30.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.319999999999993 110.827 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.28 -0.09 39.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 74.030000000000001 110.83 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -122.12 -5.77 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 33.049999999999997 110.889 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -166.49 144.67 5.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.888 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 151' ' ' VAL . 0.8 OUTLIER -106.28 -171.89 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 71.319999999999993 110.875 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' N ' HD12 ' A' ' 150' ' ' LEU . 59.5 t -130.01 114.0 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.141 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.39 131.43 55.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.9 ttm -133.57 151.56 51.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.206 -0.452 . . . . 55.109999999999999 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.33 147.61 32.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 62.420000000000002 110.896 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 156' ' ' TRP . 9.1 p -87.92 159.64 2.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 111.028 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.41 ' N ' HG22 ' A' ' 155' ' ' VAL . 41.4 p-90 -92.98 155.13 17.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 73.030000000000001 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.646 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -137.63 -169.83 2.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 62.520000000000003 110.927 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.0 -169.15 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.911 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 64.61 109.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 74.109999999999999 110.862 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.6 ' CD1' HD12 ' A' ' 179' ' ' LEU . 4.3 pt -136.32 150.95 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.192 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -109.13 106.12 15.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 70.120000000000005 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.09 97.83 3.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 64.349999999999994 111.133 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.3 123.77 28.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 53.219999999999999 111.135 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.6 ' HB2' ' CG2' ' A' ' 177' ' ' VAL . . . -120.82 104.53 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 64.530000000000001 111.031 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -77.07 125.61 29.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.944 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -134.76 127.34 30.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 74.150000000000006 110.875 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -108.13 114.32 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 74.400000000000006 110.868 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 56.2 tp -114.02 87.31 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.329999999999998 110.84 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.6 -12.86 68.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 53.219999999999999 112.531 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.86 41.92 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.68 -0.771 . . . . 74.329999999999998 112.444 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -136.86 92.2 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 53.409999999999997 111.105 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 98.34 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.971 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.1 53.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.926 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -104.1 116.38 32.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 55.350000000000001 110.828 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.05 153.37 28.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 73.540000000000006 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 115.45 13.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 55.149999999999999 110.735 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.6 ' CG2' ' HB2' ' A' ' 164' ' ' ALA . 21.5 t -64.07 146.73 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.008 -0.542 . . . . 63.119999999999997 111.212 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.1 102.28 14.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.230000000000004 110.925 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 160' ' ' ILE . 19.0 mt -109.22 154.96 21.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.420000000000002 110.949 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.42 108.54 1.04 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.646 0.736 . . . . 63.240000000000002 110.816 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -48.3 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.639 2.226 . . . . 72.549999999999997 112.356 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -83.77 119.26 24.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.120000000000005 110.972 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 16' ' ' VAL . 57.5 t -146.97 107.72 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 64.530000000000001 111.217 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 133.46 35.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.519999999999996 110.99 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.09 116.99 23.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 43.409999999999997 110.936 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.28 125.79 8.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 61.130000000000003 110.834 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.6 m -148.14 172.1 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 62.109999999999999 110.827 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -147.12 140.28 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 111.085 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.16 35.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 12.199999999999999 112.493 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -165.92 158.91 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 73.239999999999995 110.872 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.522 ' HB2' ' CA ' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -143.03 173.24 11.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.51 . . . . 72.109999999999999 110.921 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 65.120000000000005 110.936 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.839 0.352 . . . . 65.019999999999996 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -175.48 77.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 72.109999999999999 110.803 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -151.44 -175.93 5.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 62.210000000000001 110.917 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.409 ' HB2' ' C ' ' A' ' 48' ' ' ALA . . . -51.71 147.88 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.319999999999993 111.048 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.06 -24.5 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 65.5 112.402 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.61 121.42 23.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.929 0.395 . . . . 65.150000000000006 110.841 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -114.06 147.51 38.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.901 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -113.06 149.13 33.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 110.932 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 ttt -124.07 124.52 42.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.878 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 43' ' ' THR . 23.6 mtm180 -147.27 160.34 42.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 70.010000000000005 110.837 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' O ' HG22 ' A' ' 43' ' ' THR . . . -80.05 176.17 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 53.399999999999999 111.089 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.19 96.48 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.677 -0.773 . . . . 72.400000000000006 112.45 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.0 m -121.43 80.35 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.885 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.07 138.56 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 42.039999999999999 111.084 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.456 ' C ' HG21 ' A' ' 183' ' ' VAL . 0.1 OUTLIER -110.89 147.97 33.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 64.450000000000003 111.071 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.679 ' HA ' HG11 ' A' ' 183' ' ' VAL . 16.0 m -125.37 132.57 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 71.120000000000005 111.111 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' H ' ' HB ' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -137.11 73.72 50.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 72.340000000000003 110.857 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' CB ' HD13 ' A' ' 179' ' ' LEU . 53.3 Cg_endo -69.8 114.4 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.737 2.291 . . . . 74.519999999999996 112.247 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 19' ' ' THR . 4.9 t -51.71 119.83 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 111.151 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -117.89 162.83 17.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.859 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.15 84.3 0.12 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.688 -0.768 . . . . 74.430000000000007 112.464 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.7 -36.87 48.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 74.409999999999997 111.113 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.32 -54.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.485 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.23 -41.43 1.5 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.687 -0.768 . . . . 71.510000000000005 112.534 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -115.36 -27.14 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 64.129999999999995 111.127 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.45 68.89 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.855 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.01 107.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.688 . . . . 53.229999999999997 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.86 -170.16 2.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.899 0.381 . . . . 52.329999999999998 110.841 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.5 177.94 5.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 110.95 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.33 43.49 0.91 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 62.039999999999999 112.459 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.684 ' C ' HG22 ' A' ' 68' ' ' THR . . . 110.77 -20.42 24.6 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.802 -0.713 . . . . 63.030000000000001 112.591 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.94 117.68 23.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 65.420000000000002 111.0 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.2 t -169.24 83.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.825 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' CG1' HD12 ' A' ' 66' ' ' ILE . 35.1 m -77.16 139.41 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.340000000000003 111.219 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 130.93 35.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 75.450000000000003 111.102 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -85.15 -173.77 4.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 55.229999999999997 110.894 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.6 m-20 -106.44 125.78 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.349999999999994 110.93 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.5 178.15 7.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 70.310000000000002 111.071 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -104.64 81.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 72.010000000000005 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.7 mt -143.85 44.64 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 62.539999999999999 110.93 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -111.03 -153.09 12.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 44.329999999999998 112.552 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -159.98 141.54 12.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 73.040000000000006 110.942 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 11' ' ' ALA . 5.3 t -128.73 140.52 51.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 111.15 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -127.61 158.34 37.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 74.340000000000003 110.896 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 m -136.43 146.65 46.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 70.549999999999997 111.246 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -142.37 101.68 3.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.929 0.395 . . . . 65.340000000000003 110.986 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.78 140.84 58.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 65.109999999999999 110.942 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' C ' ' HB2' ' A' ' 4' ' ' ALA . . . -116.13 -3.04 12.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.098 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -164.27 -170.15 2.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 61.219999999999999 111.21 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.52 39.19 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 110.878 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 p30 177.41 -33.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 72.329999999999998 110.935 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.11 142.27 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 71.239999999999995 111.215 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 86' ' ' ALA . . . -151.71 166.76 30.88 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.762 -0.732 . . . . 64.439999999999998 112.468 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -99.7 142.72 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.768 0.318 . . . . 72.209999999999994 111.096 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -127.65 130.19 48.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.909 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -126.12 117.04 22.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.783 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.05 108.59 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 71.349999999999994 110.887 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -107.56 151.69 25.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.124 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.46 -172.85 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 75.450000000000003 111.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 t -50.93 145.87 11.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.658 0.742 . . . . 63.329999999999998 111.068 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.658 2.239 . . . . 64.200000000000003 112.327 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -60.23 143.43 52.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.928 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -163.59 132.3 3.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.895 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 158.99 32.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 35.240000000000002 110.834 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -179.14 106.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 75.329999999999998 110.862 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.481 HD12 ' CG1' ' A' ' 34' ' ' VAL . 15.4 tt -152.69 145.1 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 73.430000000000007 111.123 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.9 96.83 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 64.25 112.457 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 31' ' ' GLY . 35.4 p -61.78 171.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 64.099999999999994 111.088 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -16.97 52.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 73.030000000000001 110.799 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.04 -50.96 14.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 70.120000000000005 111.154 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 -32.68 13.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 65.150000000000006 111.168 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.75 53.93 42.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 44.0 112.449 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.41 -73.81 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.79 0.328 . . . . 72.25 110.856 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm 65.0 56.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 70.209999999999994 111.087 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HB1' ' OD2' ' A' ' 126' ' ' ASP . . . -115.09 147.02 40.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 55.020000000000003 111.09 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.67 177.31 5.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.519999999999996 111.146 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.57 141.51 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 111.114 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -114.72 123.03 48.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.924 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -171.88 143.44 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 64.549999999999997 110.872 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 1.1 mp -98.0 117.06 65.52 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.627 0.727 . . . . 71.420000000000002 110.858 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.944 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.8 Cg_endo -69.88 -25.49 28.0 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.634 2.223 . . . . 63.009999999999998 112.306 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.944 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 54.1 Cg_endo -69.71 167.04 25.51 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.621 2.214 . . . . 74.25 112.422 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' CG ' ' A' ' 106' ' ' ASN . 21.5 p -145.3 156.4 43.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.403 . . . . 75.430000000000007 111.243 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -131.61 124.67 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.402 . . . . 64.219999999999999 110.981 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -167.09 -161.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.931 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' GLY . . . -144.83 162.13 37.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 53.210000000000001 111.016 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HA ' ' HA3' ' A' ' 102' ' ' GLY . 44.8 mt-30 -149.78 169.97 19.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 110.993 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.87 161.09 43.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.971 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.705 ' CD2' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER 176.43 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.415 . . . . 72.040000000000006 110.935 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.89 134.78 42.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.010000000000005 110.828 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.28 112.9 0.73 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 70.209999999999994 112.357 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.7 t70 53.51 80.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.747 0.308 . . . . 72.450000000000003 110.882 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.95 -35.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 62.030000000000001 111.057 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.31 -36.92 9.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 62.240000000000002 110.744 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t 63.23 165.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.876 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm 71.57 -69.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 54.229999999999997 110.925 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -101.74 134.14 45.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 63.049999999999997 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HE ' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -124.84 90.11 51.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.647 0.737 . . . . 72.349999999999994 110.984 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . 53.5 Cg_endo -69.77 -176.56 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.647 2.231 . . . . 75.239999999999995 112.283 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -178.55 113.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 110.93 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.705 HG22 ' CD2' ' A' ' 89' ' ' TYR . 28.4 m -131.66 132.58 62.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.461 . . . . 71.239999999999995 111.139 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 87' ' ' GLN . . . -162.45 -138.86 2.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.59 -0.814 . . . . 65.349999999999994 112.437 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 85' ' ' MET . . . -126.78 149.16 49.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 70.349999999999994 111.13 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA2' ' CB ' ' A' ' 85' ' ' MET . . . -123.51 132.43 8.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.68 -0.771 . . . . 74.010000000000005 112.463 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.573 HG12 ' HB2' ' A' ' 135' ' ' ALA . 24.7 mt -111.09 118.36 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.087 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' CG ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -96.91 109.36 22.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 72.439999999999998 110.881 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.105 -0.498 . . . . 74.5 111.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 80' ' ' LEU . 63.5 p -125.27 99.72 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 111.194 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -139.7 -173.2 3.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.078 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.38 -176.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 63.539999999999999 110.927 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 59.84 169.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.209999999999994 110.876 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.56 136.68 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 71.450000000000003 110.91 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -117.56 -169.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.439999999999998 110.878 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.47 159.19 28.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 71.099999999999994 112.504 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -50.58 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 75.430000000000007 110.858 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.535 ' H ' ' H ' ' A' ' 120' ' ' LYS . 10.9 t30 -174.12 -168.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.409999999999997 110.894 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -47.85 -61.54 1.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 70.430000000000007 110.905 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -79.62 -48.07 14.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 72.129999999999995 110.83 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.614 ' CA ' HD12 ' A' ' 124' ' ' LEU . . . -54.8 -56.73 21.23 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.688 -0.768 . . . . 75.439999999999998 112.534 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.535 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -61.49 -48.34 81.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.627 0.251 . . . . 73.519999999999996 110.813 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.77 -8.04 32.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 110.913 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.27 -4.94 47.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.141 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.75 -0.25 32.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 54.119999999999997 112.425 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.614 HD12 ' CA ' ' A' ' 119' ' ' GLY . 8.9 mt -86.8 93.35 9.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 71.209999999999994 110.967 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.2 t -70.63 -15.34 62.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.844 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' OD2' ' HB1' ' A' ' 75' ' ' ALA . 17.9 t0 72.39 -67.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 70.120000000000005 110.846 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.428 HD12 ' HE2' ' A' ' 130' ' ' LYS . 0.7 OUTLIER 67.54 -76.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 73.400000000000006 111.019 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 t 64.34 -166.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 74.209999999999994 110.807 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 mp -53.88 120.72 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 74.519999999999996 110.907 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.428 ' HE2' HD12 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -172.82 171.69 4.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 65.329999999999998 110.873 179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' HA ' HG23 ' A' ' 109' ' ' THR . 6.0 m-20 50.46 51.1 17.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.821 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.63 107.89 16.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 64.109999999999999 110.885 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -125.61 117.52 23.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.939 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.98 164.33 32.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.48 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -108.08 164.99 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 61.020000000000003 111.149 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.07 178.59 9.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.104 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -101.13 113.05 4.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 72.519999999999996 112.506 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.1 153.2 21.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 73.310000000000002 110.944 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.65 HG23 HG22 ' A' ' 155' ' ' VAL . 15.9 m -151.95 137.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 55.32 111.124 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -169.52 178.4 42.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 41.039999999999999 112.461 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 26.1 m -150.62 153.42 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.938 0.399 . . . . 71.239999999999995 111.113 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.666 ' OD2' HD13 ' A' ' 150' ' ' LEU . 16.2 t0 -125.34 134.51 52.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.329999999999998 110.927 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -136.42 140.69 43.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 110.902 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.04 130.65 44.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 45.520000000000003 110.837 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 tt -108.57 -33.48 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 51.229999999999997 111.1 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.87 -169.23 1.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.741 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -59.2 4.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 75.540000000000006 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.92 23.01 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.301 -0.409 . . . . 62.530000000000001 110.876 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -119.15 132.98 56.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.916 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.666 HD13 ' OD2' ' A' ' 142' ' ' ASP . 2.3 pp -124.66 171.76 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 110.903 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 188' ' ' ALA . 14.2 p -140.51 133.86 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.040000000000006 111.032 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -110.54 153.77 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 75.099999999999994 110.908 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 10.5 mtt -145.14 141.07 28.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 63.409999999999997 110.923 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 62.140000000000001 110.88 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.656 HG12 ' CZ ' ' A' ' 184' ' ' PHE . 16.9 m -95.17 -175.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.073 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -92.55 164.23 13.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.918 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -149.89 159.32 44.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.868 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 10.2 ttt -117.37 117.33 29.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 74.239999999999995 110.923 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.69 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.326 -0.397 . . . . 74.099999999999994 110.929 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -56.34 144.61 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 53.310000000000002 111.201 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.03 149.09 29.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 61.109999999999999 110.961 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.13 123.53 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.096 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.3 p -120.41 136.53 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.430000000000007 111.204 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.35 130.85 56.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.350000000000001 111.107 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -105.4 170.42 7.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 62.240000000000002 110.859 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -162.35 102.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 73.209999999999994 110.959 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.78 113.43 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 64.409999999999997 110.886 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 5.6 mp -126.6 86.6 2.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.806 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.51 76.95 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.838 -0.696 . . . . 62.350000000000001 112.496 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.53 49.28 1.21 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.72 -0.753 . . . . 74.109999999999999 112.375 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -137.59 106.48 5.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 54.409999999999997 111.128 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 101.72 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 62.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.96 -178.3 6.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.137 -0.483 . . . . 70.140000000000001 110.951 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -172.39 121.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 74.5 110.881 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -130.51 136.53 49.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 63.5 110.915 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.5 113.08 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 110.93 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.79 146.38 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 74.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.75 93.3 4.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.918 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.619 ' O ' HD12 ' A' ' 179' ' ' LEU . 4.6 pp -175.74 141.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.239999999999995 110.831 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' HD2' ' A' ' 181' ' ' PRO . 0.3 OUTLIER 179.95 -61.17 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.675 0.75 . . . . 65.329999999999998 110.87 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 180' ' ' ASP . 55.1 Cg_endo -69.62 60.17 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.719 2.279 . . . . 74.0 112.36 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.634 ' O ' ' HB ' ' A' ' 183' ' ' VAL . 32.8 m95 -138.66 63.34 1.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 75.409999999999997 110.871 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.773 HG13 ' N ' ' A' ' 184' ' ' PHE . 0.5 OUTLIER 168.28 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.389 . . . . 55.020000000000003 111.233 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.773 ' N ' HG13 ' A' ' 183' ' ' VAL . 0.2 OUTLIER -145.54 148.79 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 65.549999999999997 110.816 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.2 mtm -132.07 141.7 49.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 33.149999999999999 110.848 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.33 -175.58 5.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 63.109999999999999 110.878 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.3 p -168.42 174.44 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 53.530000000000001 110.879 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 151' ' ' VAL . . . -158.88 145.85 17.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 65.349999999999994 111.039 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.62 -139.68 5.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.76 -0.733 . . . . 51.240000000000002 112.514 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -153.94 157.57 39.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.962 0.41 . . . . 75.099999999999994 110.925 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -72.54 144.04 48.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 71.209999999999994 110.85 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.549999999999997 110.897 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.735 0.303 . . . . 65.329999999999998 110.924 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -94.93 52.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 74.430000000000007 110.877 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -171.43 -169.88 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 61.43 110.797 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.77 151.0 2.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.506 . . . . 72.439999999999998 111.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.04 -3.22 55.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.709 -0.758 . . . . 73.230000000000004 112.501 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.03 155.18 16.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 71.310000000000002 110.85 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -138.38 127.65 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 110.907 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.94 139.93 15.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.89 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -179.67 -162.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.129999999999995 110.893 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.81 -173.66 4.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.340000000000003 110.915 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -152.07 115.76 4.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.167 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.69 -137.52 3.86 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.722 . . . . 63.149999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -142.48 112.82 7.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 75.239999999999995 110.888 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 38' ' ' THR . . . -72.23 136.84 46.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 74.120000000000005 111.117 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.03 112.32 22.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 53.329999999999998 111.164 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' VAL . 16.8 m -78.42 119.53 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 74.230000000000004 111.105 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -130.86 160.61 65.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.62 0.724 . . . . 71.310000000000002 110.879 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 -171.16 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.725 2.283 . . . . 75.310000000000002 112.364 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -54.75 -28.5 49.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 73.25 111.017 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 62.88 164.04 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.013 0.435 . . . . 74.200000000000003 110.836 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.14 77.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.702 -0.761 . . . . 44.140000000000001 112.435 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -177.83 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 54.340000000000003 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.71 105.9 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 61.039999999999999 112.487 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.62 169.03 30.49 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.734 -0.746 . . . . 61.240000000000002 112.496 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.63 -25.43 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 60.310000000000002 111.108 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.37 -73.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 72.430000000000007 110.926 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.01 177.52 39.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.698 . . . . 65.239999999999995 112.518 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.522 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -178.31 160.65 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 73.230000000000004 110.943 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 28' ' ' SER . 15.5 mt -144.31 -169.48 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 72.409999999999997 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.11 43.14 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.783 -0.723 . . . . 53.310000000000002 112.562 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.03 -177.84 15.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 71.409999999999997 112.409 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -113.01 115.46 28.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 63.049999999999997 110.879 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 p -172.16 129.76 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 54.549999999999997 110.802 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' VAL . 6.0 m -109.98 106.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.51 . . . . 73.099999999999994 111.074 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t 176.9 99.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 54.020000000000003 111.132 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -175.12 56.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.303 -0.408 . . . . 73.129999999999995 110.908 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.9 110.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' ALA . 1.6 t 178.32 74.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 72.540000000000006 111.045 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -93.75 40.22 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.967 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 tp -161.6 137.0 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 110.985 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.78 91.91 0.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.758 -0.734 . . . . 71.099999999999994 112.457 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 ' HB2' ' A' ' 11' ' ' ALA . 25.4 tp -98.53 131.56 44.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 64.400000000000006 110.878 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.691 ' O ' ' HB3' ' A' ' 9' ' ' MET . 1.2 p -136.8 140.68 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 74.239999999999995 111.139 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' ' CB ' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.54 123.43 27.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 72.010000000000005 110.942 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 9' ' ' MET . 0.3 OUTLIER -101.98 145.99 28.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 74.25 111.163 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -140.43 117.39 11.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 72.150000000000006 110.92 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.6 mmt -57.76 118.29 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 53.219999999999999 110.931 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.04 -42.01 11.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 74.319999999999993 111.035 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.827 HG22 ' HB ' ' A' ' 52' ' ' ILE . 5.3 t -141.06 -162.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 53.109999999999999 111.139 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 49' ' ' THR . 8.0 p-10 -93.98 36.27 1.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 75.019999999999996 110.877 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' N ' HG23 ' A' ' 49' ' ' THR . 1.0 OUTLIER 169.69 23.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 74.349999999999994 110.813 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.827 ' HB ' HG22 ' A' ' 49' ' ' THR . 48.7 mt -151.01 130.17 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.431 . . . . 75.430000000000007 111.256 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.79 143.42 18.04 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 32.420000000000002 112.387 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.4 t -127.0 112.21 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 70.510000000000005 111.057 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -119.17 165.46 14.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.055 -0.52 . . . . 75.120000000000005 110.882 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.64 133.08 37.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.420000000000002 110.878 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.6 tt -106.25 142.25 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 44.119999999999997 110.944 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -160.0 138.24 10.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 53.109999999999999 111.185 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ALA . . . 175.55 -165.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 70.409999999999997 111.096 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 37.0 83.31 0.21 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.549 0.69 . . . . 62.32 111.103 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 79' ' ' HIS . 53.8 Cg_endo -69.82 -0.98 7.76 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.622 2.215 . . . . 74.420000000000002 112.41 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.6 175.12 6.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 110.95 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -99.67 175.65 5.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.946 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -64.53 -170.6 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.898 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -147.21 124.2 11.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 70.230000000000004 110.929 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 74' ' ' ILE . 2.0 mp -81.28 136.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 65.329999999999998 111.141 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.9 63.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.604 -0.808 . . . . 74.099999999999994 112.494 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 71' ' ' THR . 14.6 t -160.32 151.37 19.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.727 0.299 . . . . 53.32 111.184 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.59 -2.95 38.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 73.140000000000001 110.891 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.92 -51.56 9.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.451 . . . . 54.229999999999997 111.141 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.568 ' H ' HG23 ' A' ' 68' ' ' THR . 0.8 OUTLIER -129.66 17.66 5.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 62.439999999999998 111.2 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.98 100.25 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.7 -0.762 . . . . 72.400000000000006 112.55 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.99 -36.4 2.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 72.310000000000002 110.79 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 66' ' ' ILE . 28.8 mt 64.37 97.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 71.209999999999994 111.175 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 114' ' ' GLY . . . -113.67 161.89 16.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 72.430000000000007 111.006 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 105.24 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 75.120000000000005 111.14 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 112' ' ' ASP . 10.5 m -153.34 151.15 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 60.130000000000003 111.142 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -79.99 -173.35 3.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.956 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 8.5 p-80 -88.33 174.58 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.885 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -96.21 163.01 21.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.549 0.69 . . . . 63.399999999999999 110.935 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 55.2 Cg_endo -69.77 175.15 8.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 52.509999999999998 112.313 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 54.3 Cg_endo -69.78 150.51 68.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.784 2.323 . . . . 75.510000000000005 112.3 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 107' ' ' TYR . 10.9 p -113.47 158.71 20.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 75.519999999999996 111.076 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mp -92.05 139.63 30.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 70.299999999999997 110.87 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.416 ' HE1' HD13 ' A' ' 57' ' ' LEU . 3.2 ttm -141.97 99.07 3.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 75.129999999999995 110.781 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -75.34 141.05 43.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 35.32 111.147 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.12 134.01 41.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.961 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.434 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 6.0 t-105 -129.12 133.63 47.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 73.200000000000003 110.848 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -137.25 106.15 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.944 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.5 48.01 1.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 75.540000000000006 110.896 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.92 -152.97 27.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.675 -0.774 . . . . 42.530000000000001 112.496 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.17 -25.29 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 53.32 110.875 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.68 113.52 11.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 62.340000000000003 111.119 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.9 t -77.9 59.52 2.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 51.219999999999999 110.789 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.41 -74.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.781 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.08 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 74.310000000000002 110.855 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 144' ' ' LEU . 47.1 p90 -129.79 155.03 46.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.442 . . . . 63.450000000000003 110.954 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.7 mmt85 -129.29 140.1 37.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 71.299999999999997 110.906 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HG2' HG23 ' A' ' 101' ' ' VAL . 53.7 Cg_endo -69.68 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.734 2.289 . . . . 72.420000000000002 112.357 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.672 ' HB2' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER 163.09 34.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 72.409999999999997 110.86 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 99' ' ' PRO . 3.0 t -112.35 132.05 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 52.340000000000003 111.067 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.34 163.0 33.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 72.209999999999994 112.519 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -175.38 129.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.919 0.39 . . . . 62.409999999999997 111.113 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . -145.24 -140.45 3.55 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.677 -0.773 . . . . 74.340000000000003 112.39 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.74 125.22 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 62.399999999999999 111.209 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -90.23 121.0 31.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 63.049999999999997 110.857 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' H ' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -118.56 116.86 27.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.923 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.3 p -112.51 135.3 53.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 70.030000000000001 111.179 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.88 -171.82 3.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 70.109999999999999 111.205 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.34 122.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.32 -0.4 . . . . 54.399999999999999 110.893 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -169.63 109.0 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.519999999999996 110.864 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.518 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -51.3 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 73.030000000000001 110.797 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.75 -67.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.219999999999999 110.914 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 75' ' ' ALA . . . 136.57 -54.67 0.72 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.457 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -49.25 152.73 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.844 0.354 . . . . 71.340000000000003 110.835 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.455 ' H ' ' H ' ' A' ' 120' ' ' LYS . 9.6 p-10 -166.37 -158.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.859 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -46.47 -59.16 3.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.173 -0.467 . . . . 71.209999999999994 110.906 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -78.32 -47.3 18.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 73.5 110.921 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.81 -59.6 10.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 75.219999999999999 112.469 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -57.62 -47.94 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.67 0.271 . . . . 63.43 110.859 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.46 -11.02 56.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 75.319999999999993 110.797 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.755 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -96.35 -6.97 36.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 55.310000000000002 111.126 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.67 18.8 43.17 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.717 -0.754 . . . . 73.329999999999998 112.403 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 122' ' ' ALA . 4.4 mm? -78.86 130.78 36.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.749 0.309 . . . . 73.329999999999998 110.997 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 58.3 m -96.94 142.11 29.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.217 -0.447 . . . . 71.409999999999997 110.759 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.81 86.16 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 73.030000000000001 110.835 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.48 -83.25 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.835 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.58 177.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 75.530000000000001 110.917 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -170.99 157.83 5.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 64.230000000000004 110.952 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.513 ' H ' HD23 ' A' ' 129' ' ' LEU . 8.2 mttm 66.34 -155.08 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.896 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 t0 74.68 75.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.129999999999995 110.753 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 146.83 20.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 53.340000000000003 110.837 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.23 128.63 22.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 75.049999999999997 110.873 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -159.66 148.72 17.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.69 -0.767 . . . . 64.409999999999997 112.466 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -79.82 156.87 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 111.132 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -160.76 135.84 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.439999999999998 111.063 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -90.66 118.75 5.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 34.039999999999999 112.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 -177.11 3.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 75.129999999999995 110.912 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 100' ' ' TYR . 3.4 t -101.74 132.47 47.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 50.140000000000001 111.124 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 100' ' ' TYR . . . -128.8 107.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 70.319999999999993 112.443 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.783 HG22 ' OD1' ' A' ' 152' ' ' ASN . 7.5 p -126.33 133.14 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 72.200000000000003 111.167 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.584 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 7.0 t0 -135.52 130.54 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 61.100000000000001 110.888 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.449 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 1.4 t80 -117.92 106.8 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.922 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -70.29 81.3 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.476 . . . . 63.539999999999999 110.923 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.468 ' HB ' HG12 ' A' ' 151' ' ' VAL . 13.7 tt -53.61 -37.11 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 111.07 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -141.99 -169.37 2.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 70.219999999999999 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 3.18 47.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.936 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 -7.65 8.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 110.904 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.565 ' C ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -167.29 161.78 14.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.84 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -127.21 -168.98 1.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.918 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.468 HG12 ' HB ' ' A' ' 145' ' ' ILE . 7.7 p -168.01 123.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 71.420000000000002 111.24 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -179.47 -163.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 53.32 110.881 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.55 -176.58 5.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 73.019999999999996 110.886 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 99.0 p -165.9 82.97 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 63.450000000000003 110.86 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 183' ' ' VAL . 8.2 p -86.49 160.43 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 75.329999999999998 111.117 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.422 ' N ' HG22 ' A' ' 155' ' ' VAL . 16.4 m95 -92.76 -179.43 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.85 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -147.99 -42.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.861 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.623 ' O ' HD22 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -74.45 -169.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 72.299999999999997 110.867 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.61 ' HA ' HD13 ' A' ' 179' ' ' LEU . 1.2 p30 -118.11 -179.09 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.838 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -135.41 151.7 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 62.240000000000002 111.235 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.06 120.45 25.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.85 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 51.7 m -142.66 118.93 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.530000000000001 111.166 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.46 151.93 26.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.45 . . . . 65.430000000000007 111.111 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -136.09 119.68 17.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 41.310000000000002 111.148 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -101.53 102.56 13.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.894 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -146.06 114.52 6.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.958 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.656 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -148.22 167.41 25.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 73.099999999999994 110.835 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.7 155.29 46.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 32.329999999999998 110.909 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.91 -15.13 56.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.798 -0.715 . . . . 73.019999999999996 112.425 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 112.14 27.17 4.06 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 52.420000000000002 112.477 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.656 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.51 167.01 10.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 60.530000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -115.58 96.33 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 75.319999999999993 110.911 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 167' ' ' LYS . 1.3 tt0 -80.37 -175.85 5.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 73.450000000000003 110.818 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -174.25 112.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 72.150000000000006 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.74 130.18 55.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 110.879 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 100.24 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 61.43 110.825 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.41 89.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 64.209999999999994 111.129 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -80.75 137.14 36.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 110.803 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.623 HD22 ' O ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.59 168.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.872 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.468 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -179.84 -60.99 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.618 0.723 . . . . 71.310000000000002 110.897 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 180' ' ' ASP . 54.4 Cg_endo -69.7 127.04 14.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 74.310000000000002 112.385 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -79.75 131.62 35.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 155' ' ' VAL . 6.0 p -106.36 121.75 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 111.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -79.72 126.26 30.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 65.319999999999993 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.53 102.77 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 63.310000000000002 110.893 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -132.94 155.91 48.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 110.85 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 179.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 73.310000000000002 110.882 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.71 -160.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.041 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -134.6 124.33 3.45 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 72.319999999999993 112.495 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.97 146.51 30.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 72.329999999999998 110.834 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -64.57 144.12 57.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 72.329999999999998 110.856 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.832 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.872 0.367 . . . . 73.219999999999999 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -159.34 140.31 12.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.774 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' O ' ' C ' ' A' ' 4' ' ' ALA . 11.3 tp10 -151.87 -132.77 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.209999999999994 110.99 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 47' ' ' MET . . . -19.17 -70.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 111.078 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 48' ' ' ALA . . . 106.77 46.87 1.07 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.688 -0.768 . . . . 74.219999999999999 112.461 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.2 100.64 4.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 73.420000000000002 110.824 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -125.66 109.64 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.439999999999998 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -144.43 163.42 33.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.093 -0.503 . . . . 64.109999999999999 110.848 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptm -147.51 139.16 23.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.923 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.736 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -157.19 -172.12 3.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 70.439999999999998 110.847 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.68 156.16 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 52.329999999999998 111.105 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.26 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 75.140000000000001 112.4 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -151.0 97.23 2.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.969 0.414 . . . . 44.049999999999997 110.79 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 38' ' ' THR . . . -85.66 120.45 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.040000000000006 111.134 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.8 m -91.43 127.09 36.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.452 . . . . 55.439999999999998 111.164 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.33 127.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.43 . . . . 61.509999999999998 111.126 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 160.71 67.47 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.572 0.701 . . . . 55.240000000000002 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 152.7 69.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.633 2.222 . . . . 72.310000000000002 112.344 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.507 ' OG1' HD22 ' A' ' 179' ' ' LEU . 14.6 t -175.51 173.39 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 72.239999999999995 111.105 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.93 166.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 61.340000000000003 110.92 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.13 41.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.669 -0.777 . . . . 75.109999999999999 112.46 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.09 76.58 1.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.384 . . . . 70.349999999999994 111.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.75 -37.78 0.23 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 72.120000000000005 112.547 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.36 178.49 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 61.439999999999998 112.473 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.8 m -132.39 -43.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 70.349999999999994 111.145 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.11 108.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.219999999999999 110.876 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.97 176.08 19.49 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.699 -0.762 . . . . 51.130000000000003 112.436 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -53.85 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 73.340000000000003 110.907 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.8 -171.45 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 54.100000000000001 110.879 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.24 -17.74 23.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 63.43 112.458 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 146.46 4.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 63.109999999999999 112.503 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.35 165.29 27.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 75.140000000000001 110.888 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -71.49 -171.41 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.95 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.44 ' HA ' HG22 ' A' ' 66' ' ' ILE . 35.8 m -76.98 154.39 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 73.129999999999995 111.202 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.2 25.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 60.32 111.116 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.97 128.12 33.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 42.020000000000003 110.832 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -174.89 173.48 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 64.540000000000006 110.927 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' ALA . 60.4 m -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 111.147 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -170.49 2.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 72.400000000000006 110.848 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.31 121.8 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 65.510000000000005 110.925 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -157.62 -152.57 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 73.340000000000003 112.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.62 153.31 18.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.903 0.382 . . . . 75.099999999999994 110.941 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -148.32 132.07 16.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 111.061 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -106.22 157.64 17.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.798 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.3 m -139.23 123.86 18.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 62.43 111.122 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.63 119.24 10.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 55.149999999999999 110.902 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.722 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.2 ttm -124.66 107.86 11.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.072 -0.513 . . . . 70.510000000000005 110.822 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 47' ' ' MET . . . 161.77 -19.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 50' ' ' ASP . 13.2 t -78.93 28.99 0.21 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 111.069 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.0 m-20 157.55 37.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 74.430000000000007 110.888 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 48.73 25.43 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 74.420000000000002 110.983 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 pt -147.54 159.79 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 74.540000000000006 111.058 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 47' ' ' MET . . . -93.12 134.73 12.29 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 62.210000000000001 112.614 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.44 123.61 43.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 65.530000000000001 111.146 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 45' ' ' THR . 3.3 mt-10 -111.26 150.35 29.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 45.100000000000001 110.822 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.51 117.21 28.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 72.25 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' HG22 ' A' ' 43' ' ' THR . 0.5 OUTLIER -87.0 138.14 31.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.100000000000001 110.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -143.9 135.26 25.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 54.530000000000001 111.058 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.32 -165.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 62.329999999999998 111.062 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 p -50.44 156.87 1.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.593 0.711 . . . . 64.409999999999997 111.099 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -49.61 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 63.5 112.373 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -97.75 173.65 7.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 75.319999999999993 110.895 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.28 178.81 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 110.909 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -60.26 128.91 39.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 71.349999999999994 110.945 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -169.18 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 74.340000000000003 110.851 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -97.36 163.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.109 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.29 169.78 31.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.699 -0.762 . . . . 71.450000000000003 112.442 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 70' ' ' ALA . 8.7 t -72.4 162.75 29.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 44.439999999999998 111.167 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -11.63 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 74.540000000000006 110.825 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' A' ' 68' ' ' THR . . . -59.49 -51.07 71.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.167 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -121.45 -32.74 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 75.0 111.204 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.67 22.4 14.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.876 -0.678 . . . . 62.329999999999998 112.496 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -177.2 132.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 75.239999999999995 110.859 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -123.24 -35.21 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 111.081 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.95 130.15 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 52.229999999999997 111.141 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -97.35 105.41 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 43.100000000000001 111.126 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG21 HD12 ' A' ' 129' ' ' LEU . 14.6 p -111.5 132.69 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 111.107 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -101.78 140.4 36.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 71.040000000000006 110.895 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -124.89 178.22 5.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.200000000000003 110.89 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 12.3 mt -97.81 117.88 64.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 64.140000000000001 110.916 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.925 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.81 -25.54 28.26 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.54 2.16 . . . . 63.049999999999997 112.449 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.925 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.77 107.83 1.95 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.725 2.283 . . . . 64.140000000000001 112.302 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 144.45 45.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 111.119 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.6 tp -119.66 119.79 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.039999999999999 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.488 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 0.8 OUTLIER -126.5 145.36 50.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 62.409999999999997 110.857 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.62 113.99 14.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.340000000000003 111.105 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA2' ' A' ' 102' ' ' GLY . 5.4 pt20 -128.73 174.26 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.9 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -143.26 105.64 4.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.826 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 100' ' ' TYR . 28.4 p90 -122.07 156.03 34.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.964 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.66 175.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.430000000000007 110.973 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.16 -139.0 2.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.340000000000003 112.474 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.93 -75.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.299999999999997 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.36 -54.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 70.519999999999996 111.116 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.11 105.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 62.229999999999997 110.78 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -127.72 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 110.92 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 176.97 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 110.841 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -138.0 134.84 35.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.898 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.468 ' C ' HG23 ' A' ' 141' ' ' VAL . 1.4 mmt-85 -127.7 87.7 55.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.655 0.74 . . . . 71.219999999999999 110.899 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.573 ' N ' HG23 ' A' ' 141' ' ' VAL . 55.0 Cg_endo -69.74 143.02 49.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 74.109999999999999 112.346 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CB ' ' HA ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -167.5 -161.29 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 61.219999999999999 110.918 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 m -115.26 164.22 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 75.030000000000001 111.179 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 87' ' ' GLN . . . -166.97 146.36 10.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.831 -0.7 . . . . 63.310000000000002 112.549 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -143.19 160.54 40.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.787 0.327 . . . . 44.509999999999998 111.086 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 85' ' ' MET . . . -141.65 169.77 25.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.665 -0.779 . . . . 72.010000000000005 112.411 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.17 118.57 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 63.399999999999999 111.219 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -101.49 109.59 21.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.931 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.52 106.83 18.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 71.549999999999997 110.989 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 121.57 34.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 111.171 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 80' ' ' LEU . 15.3 t -112.09 149.7 31.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.13 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -54.09 151.03 7.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.829 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.95 -74.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.219999999999999 110.866 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 135.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 75.129999999999995 110.867 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -141.52 126.78 18.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.974 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.21 -160.59 1.73 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 73.239999999999995 112.505 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.725 ' H ' HD23 ' A' ' 124' ' ' LEU . 61.6 t80 59.56 98.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 73.219999999999999 110.948 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.442 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.3 t30 -163.42 -159.0 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 64.340000000000003 110.878 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.86 -60.33 2.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 63.119999999999997 110.805 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -79.42 -45.87 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 71.150000000000006 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.76 -58.26 14.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.731 -0.747 . . . . 61.210000000000001 112.437 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -60.26 -47.36 86.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.299999999999997 110.913 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.19 -10.4 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.975 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.6 -6.84 39.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 111.188 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.09 18.86 30.22 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.761 -0.733 . . . . 52.140000000000001 112.492 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 115' ' ' PHE . 13.3 tp -79.92 134.68 36.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 73.219999999999999 110.94 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -74.08 -169.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.86 69.26 7.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.851 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 124' ' ' LEU . 8.4 mp -53.41 129.77 33.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.349999999999994 110.882 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 p 179.39 148.12 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.858 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.597 HD12 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -91.11 162.4 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.15 -0.477 . . . . 75.150000000000006 110.966 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 49.4 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 65.420000000000002 110.897 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 65.49 148.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 110.95 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.43 129.53 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.549999999999997 110.88 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -138.66 118.38 13.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 64.420000000000002 110.902 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.12 -177.46 15.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.762 -0.732 . . . . 74.230000000000004 112.526 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -178.83 158.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 111.017 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.517 ' HB2' ' NE1' ' A' ' 156' ' ' TRP . . . -122.46 154.85 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 111.011 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -168.71 91.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 74.219999999999999 112.516 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.14 -174.9 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 75.109999999999999 110.938 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 139' ' ' VAL . 16.1 m -96.95 119.31 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.02 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.79 -176.1 32.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 71.120000000000005 112.377 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 99' ' ' PRO . 12.3 p -176.79 134.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 65.200000000000003 111.127 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.613 ' CB ' ' HA ' ' A' ' 152' ' ' ASN . 1.4 t70 -169.88 -170.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 73.140000000000001 110.897 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.79 126.35 40.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.012 0.434 . . . . 73.430000000000007 110.951 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -106.9 117.83 35.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 73.040000000000006 110.953 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 58.3 mt 56.37 94.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 72.319999999999993 111.161 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -100.29 -30.96 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 72.150000000000006 110.951 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.63 -58.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 43.350000000000001 110.912 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 4.96 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 71.040000000000006 110.952 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -166.65 -174.62 2.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 110.889 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 151' ' ' VAL . 2.7 pp -152.67 179.12 8.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.399999999999999 110.982 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.612 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -148.76 150.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.473 . . . . 62.109999999999999 111.087 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.613 ' HA ' ' CB ' ' A' ' 142' ' ' ASP . 7.3 t-20 -130.71 136.46 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 64.409999999999997 110.886 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.506 ' H ' ' HB2' ' A' ' 142' ' ' ASP . 8.9 mtm -129.21 124.07 33.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 72.219999999999999 110.822 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.8 m -142.05 -175.16 4.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 61.219999999999999 110.805 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.99 177.75 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.136 -0.484 . . . . 64.129999999999995 111.186 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.517 ' NE1' ' HB2' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -140.44 176.42 8.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.519999999999996 110.956 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 -38.46 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 51.32 110.803 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' VAL . 0.0 OUTLIER 62.72 24.81 14.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 73.420000000000002 110.852 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.98 89.77 6.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 63.210000000000001 110.8 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.43 144.27 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 73.400000000000006 111.097 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -124.16 111.28 15.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.450000000000003 110.85 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.6 m -141.38 144.2 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 53.219999999999999 111.225 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.8 p -95.66 141.14 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 111.093 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -117.77 99.56 7.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 15.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -59.03 118.45 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.839 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.95 108.85 2.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 62.109999999999999 110.962 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.608 ' CG ' ' HB3' ' A' ' 171' ' ' ALA . 6.9 tptp -164.14 164.45 22.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 65.549999999999997 110.996 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.446 ' HB3' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -146.69 160.36 42.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.291 -0.413 . . . . 75.120000000000005 110.84 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.8 -6.82 82.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 73.340000000000003 112.469 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.1 23.24 7.81 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.617 -0.801 . . . . 64.319999999999993 112.457 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 167' ' ' LYS . . . -106.11 157.89 17.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 75.530000000000001 111.017 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.93 94.02 4.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.879 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -125.2 141.55 52.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 110.882 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -145.34 152.18 39.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.942 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.0 130.57 46.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.8 p -95.1 100.99 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 50.100000000000001 110.812 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.19 90.18 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.400000000000006 111.125 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -136.04 108.67 7.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 65.200000000000003 110.985 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.507 HD22 ' OG1' ' A' ' 19' ' ' THR . 0.6 OUTLIER -178.32 140.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 64.129999999999995 110.974 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.72 72.91 2.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.522 0.677 . . . . 70.540000000000006 110.833 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.684 2.256 . . . . 74.349999999999994 112.336 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -80.74 119.27 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.43 . . . . 73.540000000000006 110.907 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.58 HG21 ' HB2' ' A' ' 158' ' ' MET . 28.3 t -117.6 143.05 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 111.136 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 102.04 7.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 110.892 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -105.18 108.11 19.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 64.230000000000004 110.894 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -152.37 153.0 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.922 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 p -168.48 174.6 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 110.916 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.736 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -105.37 -173.02 2.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 73.319999999999993 111.042 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.35 129.31 2.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 54.43 112.481 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -110.67 157.32 19.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.389 . . . . 55.399999999999999 110.895 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -60.58 112.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 71.420000000000002 110.869 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 60.229999999999997 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -85.79 55.28 3.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.871 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.74 162.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 62.149999999999999 110.942 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.883 ' HB1' HG23 ' A' ' 49' ' ' THR . . . 58.6 96.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.128 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.95 55.6 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 74.209999999999994 112.472 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.06 130.31 38.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.843 0.354 . . . . 72.239999999999995 110.945 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -107.46 112.74 25.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 61.009999999999998 110.781 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.2 153.64 30.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.873 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.3 ttp -119.7 143.19 47.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.150000000000006 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.836 ' HB2' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER -140.53 145.89 37.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 65.439999999999998 110.855 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.94 163.13 40.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.8 -154.45 25.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 71.549999999999997 112.403 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.2 p -151.74 118.01 5.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 110.863 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.7 137.54 46.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 111.108 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.73 129.37 56.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 61.310000000000002 111.194 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG22 ' CG2' ' A' ' 183' ' ' VAL . 84.0 t -122.74 131.65 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.401 . . . . 65.409999999999997 111.119 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 160.1 50.36 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 121.518 0.675 . . . . 74.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -170.69 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.636 2.224 . . . . 70.310000000000002 112.405 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.52 -171.54 2.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 62.25 111.082 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -51.76 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 110.902 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' HB2' ' A' ' 70' ' ' ALA . . . 68.27 132.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 34.340000000000003 112.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.8 -75.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.306 . . . . 70.030000000000001 111.076 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.17 -94.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.711 -0.757 . . . . 71.150000000000006 112.499 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.01 -150.57 13.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.808 -0.71 . . . . 73.120000000000005 112.544 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.46 -74.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.779 0.323 . . . . 64.209999999999994 111.163 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -179.44 -69.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 70.040000000000006 110.937 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.29 19.59 48.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 70.299999999999997 112.443 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.4 ' C ' HD12 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -145.11 155.5 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 72.219999999999999 110.855 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER 62.74 -177.57 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.91 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.611 ' HA2' HG21 ' A' ' 71' ' ' THR . . . 119.47 41.46 0.58 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.644 -0.788 . . . . 34.100000000000001 112.487 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 71' ' ' THR . . . -72.44 143.1 33.64 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.733 -0.746 . . . . 71.530000000000001 112.426 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -50.7 165.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 71.510000000000005 110.889 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.27 165.63 23.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.150000000000006 110.799 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -140.57 -178.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 111.112 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t 175.75 123.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 111.184 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' OD1' HG21 ' A' ' 16' ' ' VAL . 10.0 t-20 -93.22 39.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.908 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' THR . 14.0 p-10 -163.07 102.24 0.98 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 75.230000000000004 110.941 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 179.49 83.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 111.226 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.63 -168.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.442 . . . . 72.319999999999993 110.944 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.01 120.49 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 64.319999999999993 110.932 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.71 123.71 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.861 -0.685 . . . . 63.539999999999999 112.499 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 1.1 pp -136.94 130.32 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.931 0.396 . . . . 74.420000000000002 110.943 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.836 HG23 ' HB2' ' A' ' 10' ' ' ARG . 1.8 t -146.92 144.3 29.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 61.450000000000003 111.076 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 45.6 m-85 -120.66 148.35 44.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.299999999999997 110.928 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 55' ' ' GLU . 93.5 m -127.1 132.34 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 62.219999999999999 111.177 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.79 119.33 18.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 64.510000000000005 110.84 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.56 140.41 37.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 61.329999999999998 110.845 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.12 -95.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.010000000000005 111.141 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.883 HG23 ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -166.96 50.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.126 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -177.7 45.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 71.120000000000005 110.819 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.5 21.03 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 63.420000000000002 110.895 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.24 130.98 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 111.082 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.92 134.92 12.06 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.497 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.22 113.73 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 111.147 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -164.26 -167.4 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.913 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 83' ' ' THR . 1.7 mp -126.64 141.03 51.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.85 146.85 41.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 71.120000000000005 110.948 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -138.04 138.53 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 73.340000000000003 111.059 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 60' ' ' THR . . . 178.69 144.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 111.119 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 59' ' ' ALA . 1.3 t 36.27 80.7 0.26 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 72.109999999999999 111.136 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 62' ' ' PHE . 54.5 Cg_endo -69.68 -84.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.633 2.222 . . . . 64.239999999999995 112.455 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 29.7 p90 -59.25 146.42 39.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.965 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.515 ' O ' HG21 ' A' ' 76' ' ' THR . 40.7 ttm-85 -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.92 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -149.92 94.91 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.319999999999993 110.849 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER 178.64 45.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 64.140000000000001 110.811 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 65' ' ' LYS . 19.1 mm -135.05 133.72 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 74.310000000000002 111.189 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.31 -138.79 5.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 32.219999999999999 112.541 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.16 -179.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 111.205 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -51.32 -97.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 63.109999999999999 110.847 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 21' ' ' GLY . . . -83.13 -12.09 57.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 64.439999999999998 111.076 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.611 HG21 ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -82.69 -36.05 26.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 73.030000000000001 111.139 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 33.7 83.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.736 -0.745 . . . . 74.030000000000001 112.465 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' O ' HG13 ' A' ' 34' ' ' VAL . 9.1 t0 -49.81 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 73.140000000000001 110.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG22 ' OD1' ' A' ' 73' ' ' ASP . 4.3 tt 171.71 113.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 72.230000000000004 111.088 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -151.88 106.62 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 70.310000000000002 111.104 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 63' ' ' ARG . 56.1 p -149.06 -175.54 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 111.085 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.17 167.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 62.530000000000001 111.033 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -66.03 124.5 22.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 71.400000000000006 110.945 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -124.65 147.83 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.253 -0.431 . . . . 75.140000000000001 110.8 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 9.0 mp -97.44 118.82 63.96 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.605 0.717 . . . . 73.25 110.845 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.929 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.8 Cg_endo -69.75 -25.87 28.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.34 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.929 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.2 Cg_endo -69.8 92.72 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.676 2.25 . . . . 62.219999999999999 112.292 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.403 ' C ' HD23 ' A' ' 56' ' ' LEU . 1.6 t -118.58 149.62 41.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 111.084 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 126.58 36.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 74.329999999999998 110.931 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -139.61 145.88 39.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.409999999999997 110.992 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -119.87 145.54 46.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 72.400000000000006 111.131 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -98.58 134.43 41.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 63.439999999999998 110.916 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.29 -0.414 . . . . 75.549999999999997 110.946 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -100.9 126.86 47.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 63.140000000000001 110.907 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.785 ' HB2' HG21 ' A' ' 101' ' ' VAL . 38.6 t80 -120.75 59.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.059 -0.519 . . . . 73.439999999999998 111.032 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.45 -130.22 1.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.712 -0.756 . . . . 65.319999999999993 112.428 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 30.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 74.140000000000001 110.94 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.85 37.3 23.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 63.32 111.077 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -26.12 41.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 61.310000000000002 110.928 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.75 -179.94 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 110.841 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.08 -47.38 68.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 75.329999999999998 110.871 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -89.87 165.62 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.349999999999994 110.814 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -124.04 160.6 51.31 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.667 0.746 . . . . 53.039999999999999 110.787 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 145.88 58.17 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.733 2.289 . . . . 54.520000000000003 112.248 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -116.13 86.14 2.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 110.966 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 90' ' ' PHE . 21.2 t -90.42 110.02 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 71.319999999999993 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.14 150.78 19.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 34.439999999999998 112.522 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 86' ' ' ALA . . . -173.61 123.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.795 0.331 . . . . 64.219999999999999 111.105 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.55 -139.59 2.67 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.734 -0.746 . . . . 71.209999999999994 112.522 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 134' ' ' GLY . 50.8 mt -135.43 124.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 72.409999999999997 111.07 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.67 110.0 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.893 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.53 110.31 22.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 61.109999999999999 110.924 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 m -125.31 132.4 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 111.097 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.1 t -153.55 -174.57 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 111.194 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.58 152.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.894 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -152.83 139.01 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 64.140000000000001 110.817 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -174.48 72.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -164.79 -178.97 5.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 110.982 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.14 -100.4 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.150000000000006 112.486 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -53.77 168.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 71.030000000000001 110.799 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.47 ' H ' ' H ' ' A' ' 120' ' ' LYS . 8.3 t30 -162.54 -160.56 0.66 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 74.239999999999995 110.905 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -60.22 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 75.510000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -79.36 -46.48 17.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 70.209999999999994 110.897 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.765 ' HA2' HD12 ' A' ' 124' ' ' LEU . . . -55.34 -58.32 14.4 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.754 . . . . 71.329999999999998 112.435 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' H ' ' H ' ' A' ' 116' ' ' ASN . 1.6 ttpm? -60.21 -47.36 86.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.6 0.238 . . . . 71.319999999999993 110.874 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -66.75 -11.11 53.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 75.030000000000001 110.873 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.09 10.67 28.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 75.209999999999994 111.171 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.25 34.08 88.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.691 -0.766 . . . . 65.230000000000004 112.502 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.765 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.5 mt -90.94 80.75 5.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 53.210000000000001 110.968 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.6 m 53.11 90.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.851 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.18 36.39 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.853 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.41 -57.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 70.019999999999996 110.916 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.659 ' O ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER 69.72 -75.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 110.811 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 163' ' ' THR . 3.4 mm? -129.67 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.209999999999994 110.915 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -97.05 -179.66 4.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 110.914 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -52.03 164.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 64.519999999999996 110.959 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.23 98.37 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.2 -0.454 . . . . 64.5 110.842 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -123.92 118.24 26.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 74.340000000000003 110.914 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -167.64 -156.26 9.88 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.73 -0.748 . . . . 74.120000000000005 112.504 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' ILE . . . -95.29 156.21 16.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 51.240000000000002 111.053 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' ALA . . . -115.06 164.58 13.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.100000000000001 111.129 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.17 151.18 21.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 74.120000000000005 112.545 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.71 155.95 42.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.833 0.349 . . . . 75.549999999999997 110.907 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -150.25 85.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 64.319999999999993 111.166 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.56 6.1 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 73.219999999999999 112.484 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 4.0 t -122.62 149.86 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 61.530000000000001 111.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.573 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 2.1 t70 -140.57 119.41 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.287 -0.415 . . . . 71.040000000000006 110.81 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 152' ' ' ASN . 2.5 t80 -102.13 140.28 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 73.420000000000002 110.933 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 tp -101.49 80.98 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.937 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.8 mm -60.46 -44.4 96.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 71.409999999999997 111.139 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -134.38 -169.88 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 64.25 110.858 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -36.62 63.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.914 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.36 23.48 8.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -133.84 128.88 35.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 63.420000000000002 110.923 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 150' ' ' LEU . 2.6 mm? -121.44 157.43 30.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.41 . . . . 53.219999999999999 110.909 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.9 t -152.49 113.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.148 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 141' ' ' VAL . 0.1 OUTLIER 179.61 -166.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 42.420000000000002 110.918 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.78 173.01 12.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.420000000000002 110.932 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 40.3 t -167.76 122.43 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 110.929 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 184' ' ' PHE . 23.3 m -90.64 -176.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.439999999999998 111.083 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.98 171.44 8.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -174.59 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 64.030000000000001 110.914 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -56.26 145.91 25.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.863 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.77 157.79 16.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 73.120000000000005 110.859 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 35.7 mt -142.9 149.42 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 111.211 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.11 116.5 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.917 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.15 104.49 5.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 63.030000000000001 111.207 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.664 ' O ' HD13 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -79.78 145.7 32.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 34.240000000000002 111.145 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.97 127.97 50.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.305 -0.407 . . . . 72.400000000000006 111.12 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -133.79 101.33 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 74.409999999999997 110.954 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -122.69 116.54 23.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.340000000000003 110.944 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -82.32 123.72 29.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 110.846 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.44 87.51 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 65.420000000000002 110.871 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.19 18.82 54.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.748 . . . . 53.439999999999998 112.574 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.84 53.63 1.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.762 -0.732 . . . . 64.200000000000003 112.462 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.76 151.72 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 62.109999999999999 111.055 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -99.25 98.02 9.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.892 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 165.22 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.892 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -172.97 113.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 75.109999999999999 110.892 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -165.19 130.49 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 71.109999999999999 110.908 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.13 129.54 38.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.887 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.76 137.99 55.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 74.549999999999997 111.121 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -135.74 93.88 3.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.510000000000005 110.871 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.52 137.6 32.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.821 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.44 67.84 0.17 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 53.219999999999999 110.929 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -86.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.646 2.231 . . . . 53.509999999999998 112.382 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -124.66 123.27 39.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.284 -0.416 . . . . 65.239999999999995 110.989 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.621 ' CG2' HG22 ' A' ' 16' ' ' VAL . 5.0 p -155.1 143.32 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 35.119999999999997 111.162 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.758 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.5 p90 -144.66 138.7 27.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.936 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.4 ttp -136.12 142.24 44.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 73.140000000000001 110.938 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.02 161.87 13.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.310000000000002 110.962 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.97 134.92 23.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 62.210000000000001 110.765 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.39 114.91 16.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 72.340000000000003 111.068 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -79.47 122.56 5.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.689 -0.767 . . . . 22.030000000000001 112.465 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -121.3 129.49 53.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 72.109999999999999 110.965 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.87 122.54 16.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 55.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.2 p90 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 63.43 110.936 180.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.8 0.333 . . . . 53.030000000000001 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -82.25 68.33 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.865 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -173.94 -169.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 53.329999999999998 110.838 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.98 91.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 51.240000000000002 111.053 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.19 80.01 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.708 -0.758 . . . . 70.400000000000006 112.485 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -76.33 151.13 36.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.853 0.358 . . . . 63.25 110.949 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.03 113.17 11.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.450000000000003 110.814 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -116.17 161.67 18.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.340000000000003 110.859 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -159.42 137.28 10.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 63.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.793 ' HG2' ' HB3' ' A' ' 188' ' ' ALA . 0.5 OUTLIER -155.08 -174.69 5.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.924 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.86 134.21 33.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.092 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.77 103.06 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.676 -0.773 . . . . 45.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 m -96.49 126.65 41.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 71.209999999999994 110.823 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.32 128.17 52.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 55.409999999999997 111.168 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.597 ' C ' HG23 ' A' ' 183' ' ' VAL . 94.4 m -99.08 98.64 9.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.116 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 180' ' ' ASP . 12.5 p -75.48 134.82 28.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -120.0 73.42 18.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.623 0.725 . . . . 70.439999999999998 110.882 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 16' ' ' VAL . 53.9 Cg_endo -69.74 -17.23 37.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.58 2.186 . . . . 74.450000000000003 112.387 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.4 p -58.19 108.08 0.56 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 111.104 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.05 -170.51 1.85 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 110.865 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.9 -73.69 1.26 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.728 -0.748 . . . . 43.530000000000001 112.364 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.63 106.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 71.530000000000001 111.074 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.97 -28.06 7.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 52.32 112.52 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.68 154.98 11.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 64.439999999999998 112.483 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.5 t -55.41 -32.04 62.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.36 . . . . 42.229999999999997 111.131 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 59.72 98.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.977 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.84 -116.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.79 . . . . 44.240000000000002 112.486 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 -39.2 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 71.329999999999998 110.82 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.06 152.5 23.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 70.450000000000003 110.979 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.91 24.25 5.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.776 -0.726 . . . . 72.150000000000006 112.523 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' THR . . . -63.15 107.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.7 -0.762 . . . . 63.439999999999998 112.552 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -108.7 154.25 22.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 71.5 110.898 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 m -154.12 114.08 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 62.210000000000001 110.894 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.2 176.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 65.310000000000002 111.208 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.82 139.75 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.5 111.13 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.09 121.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.484 . . . . 71.430000000000007 110.882 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -179.65 173.85 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 64.129999999999995 110.916 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -79.96 61.16 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 111.158 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -170.13 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 110.899 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.28 169.92 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.109999999999999 110.919 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.74 -140.25 3.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.66 -0.781 . . . . 55.149999999999999 112.404 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.46 155.06 27.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 43.039999999999999 110.911 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.0 p -145.55 131.92 19.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 61.32 111.204 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -119.25 140.36 50.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.953 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 55' ' ' GLU . 7.4 p -132.41 137.95 47.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 70.450000000000003 111.058 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -141.21 132.38 26.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 65.540000000000006 110.948 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.3 mmt -105.41 146.66 29.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.941 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.28 -81.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 63.240000000000002 111.195 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 t 178.87 57.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 61.439999999999998 111.281 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.5 40.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 110.877 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.03 18.92 9.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 54.409999999999997 110.88 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 tt -128.7 133.19 66.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 111.139 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.47 161.91 29.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 73.200000000000003 112.451 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.8 t -112.98 139.47 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.329 . . . . 74.019999999999996 111.142 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HB2' HG22 ' A' ' 45' ' ' THR . 9.4 pt-20 -131.59 146.54 52.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 110.826 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mp -114.62 136.81 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.409999999999997 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.61 122.74 47.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 54.409999999999997 110.862 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.42 135.54 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 111.04 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.91 -168.67 1.83 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 73.019999999999996 111.114 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.12 159.41 0.81 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 42.240000000000002 111.103 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.75 -174.0 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.287 . . . . 73.409999999999997 112.31 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -61.17 129.3 40.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 74.439999999999998 110.837 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -163.37 132.18 3.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.842 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.692 ' CB ' HG21 ' A' ' 77' ' ' VAL . 6.5 t60 -160.0 161.94 34.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.439999999999998 110.842 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -151.56 112.79 4.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 110.902 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.91 106.09 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 71.120000000000005 111.192 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -133.41 42.63 1.35 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.788 -0.72 . . . . 32.420000000000002 112.574 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.722 HG22 ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -90.54 -178.33 5.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 73.540000000000006 111.23 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.722 ' HD3' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -48.6 -93.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 72.430000000000007 110.821 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.71 -8.63 59.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 65.140000000000001 111.071 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.94 -5.36 30.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 72.5 111.111 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.97 71.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.785 -0.722 . . . . 74.430000000000007 112.513 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.63 -12.9 18.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.772 0.32 . . . . 74.030000000000001 110.856 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 64.43 87.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 72.219999999999999 111.064 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -121.62 163.48 18.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 54.43 111.14 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.51 156.04 39.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 64.430000000000007 111.242 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 64' ' ' HIS . 7.7 m -144.15 141.01 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 64.030000000000001 111.128 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -156.04 124.06 5.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 108' ' ' THR . 8.7 p80 -141.65 171.29 14.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.874 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 6.6 mp -98.05 118.5 63.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 71.049999999999997 110.951 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.931 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.4 Cg_endo -69.79 -25.68 28.19 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.64 2.226 . . . . 72.420000000000002 112.337 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.931 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.7 Cg_endo -69.67 133.02 24.71 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.638 2.225 . . . . 62.43 112.453 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 107' ' ' TYR . 4.6 p -130.03 146.73 51.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.323 -0.398 . . . . 52.310000000000002 111.085 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.3 121.57 33.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.299999999999997 110.966 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.1 mmm -139.23 112.64 8.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.481 . . . . 75.25 110.87 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 103' ' ' ALA . . . -94.74 129.55 41.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 73.010000000000005 111.079 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -122.73 136.64 54.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 75.349999999999994 110.805 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.562 ' CH2' ' HB3' ' A' ' 103' ' ' ALA . 7.0 p90 -150.81 160.98 43.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -80.14 146.59 31.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 60.329999999999998 110.95 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -172.33 94.64 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 54.210000000000001 110.89 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.98 -135.54 4.49 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.617 -0.802 . . . . 45.0 112.475 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.98 122.85 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 61.329999999999998 110.804 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.18 -63.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.164 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.48 26.33 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.049999999999997 110.918 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.89 80.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 71.25 110.9 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.16 -75.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 70.430000000000007 110.949 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -91.03 150.69 21.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 65.329999999999998 110.813 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -126.32 159.52 62.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.552 0.692 . . . . 53.109999999999999 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.86 146.87 60.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 75.349999999999994 112.334 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.76 95.41 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 74.209999999999994 110.95 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 139' ' ' VAL . 40.1 t -79.16 126.8 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.051 -0.522 . . . . 71.019999999999996 111.059 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.94 154.03 17.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 62.509999999999998 112.443 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.562 ' HB3' ' CH2' ' A' ' 88' ' ' TRP . . . -173.98 134.63 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 51.509999999999998 111.073 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.524 ' C ' HD12 ' A' ' 105' ' ' ILE . . . 163.37 -139.64 6.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.726 -0.75 . . . . 35.119999999999997 112.442 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 104' ' ' GLY . 5.3 mp -145.09 118.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.961 0.41 . . . . 62.329999999999998 111.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.19 101.54 8.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 62.420000000000002 110.911 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 132' ' ' SER . 0.0 OUTLIER 175.39 176.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.929 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 79' ' ' HIS . 2.4 t -111.28 140.71 45.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 72.109999999999999 111.093 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.3 t -137.56 170.45 16.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 74.120000000000005 111.192 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.51 -169.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 61.340000000000003 110.775 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.62 159.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 73.349999999999994 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -153.74 124.84 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 71.340000000000003 110.847 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.05 -169.8 1.92 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.873 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 169.86 22.33 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.851 -0.69 . . . . 73.129999999999995 112.453 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 66.27 124.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 63.0 110.786 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 120' ' ' LYS . 0.7 OUTLIER -169.11 -161.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 65.109999999999999 110.826 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.54 -60.1 2.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 72.230000000000004 110.876 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -78.44 -46.48 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 71.349999999999994 110.755 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.11 -57.79 16.72 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.743 -0.741 . . . . 72.010000000000005 112.437 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -59.6 -47.52 85.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.682 0.277 . . . . 74.230000000000004 110.852 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -67.42 -11.11 56.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.439999999999998 111.0 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.04 13.35 29.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 75.340000000000003 111.204 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.26 28.58 19.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 64.340000000000003 112.545 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 125' ' ' SER . 1.1 pp -144.74 -175.98 4.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 63.43 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 124' ' ' LEU . 14.4 m 64.81 111.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.019999999999996 110.83 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -170.58 28.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 71.349999999999994 110.822 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 165' ' ' ASN . 1.9 tp -153.72 -160.05 1.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.897 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.69 -163.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.846 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 0.5 OUTLIER -54.29 160.62 1.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 61.530000000000001 110.884 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -89.73 160.41 16.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.409999999999997 110.799 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.47 114.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 64.5 110.909 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 107' ' ' TYR . 1.1 m -104.11 134.59 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.888 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.495 ' HA ' ' CB ' ' A' ' 107' ' ' TYR . 59.9 p-90 -141.18 122.42 14.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 75.030000000000001 110.916 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 107' ' ' TYR . . . -105.05 98.62 1.5 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 70.099999999999994 112.625 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.46 120.64 22.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.328 . . . . 74.519999999999996 111.033 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.39 157.52 18.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 71.129999999999995 111.09 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 178.74 85.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 62.530000000000001 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -153.88 -178.3 6.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 63.049999999999997 110.943 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.575 HG12 HG22 ' A' ' 101' ' ' VAL . 26.5 m -96.22 131.46 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 55.509999999999998 111.152 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -119.31 -171.26 14.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.671 -0.775 . . . . 54.43 112.414 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.7 t -123.14 140.89 45.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 111.143 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -140.26 103.29 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 71.310000000000002 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 151' ' ' VAL . 9.4 t80 -102.07 131.17 48.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 70.329999999999998 110.938 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.52 140.19 41.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 110.907 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.27 -64.8 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 111.083 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.22 151.67 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 72.299999999999997 110.886 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.8 mmt-85 61.09 -89.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 63.229999999999997 110.817 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -138.7 9.36 2.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.85 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -97.2 138.8 34.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.977 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -144.97 173.3 12.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.336 -0.393 . . . . 72.129999999999995 111.009 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' TYR . 6.6 m -133.96 132.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -125.02 140.39 52.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 74.129999999999995 110.837 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -142.48 143.32 32.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.953 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.55 -170.06 2.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.149999999999999 110.819 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.2 155.94 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 72.019999999999996 111.035 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -92.64 149.22 21.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 73.299999999999997 111.005 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -170.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 110.896 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 63.27 164.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 61.340000000000003 110.872 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.86 161.22 18.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.18 -0.464 . . . . 65.299999999999997 110.882 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.91 150.42 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 73.109999999999999 111.224 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -79.2 149.3 31.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 110.845 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.1 p -128.76 78.43 1.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 70.439999999999998 111.13 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.484 ' C ' HG23 ' A' ' 177' ' ' VAL . 0.2 OUTLIER -103.53 118.91 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 52.210000000000001 111.236 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.711 ' HB3' ' CB ' ' A' ' 175' ' ' ASP . . . -109.32 137.29 47.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.099 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.726 ' HB3' HD23 ' A' ' 127' ' ' LEU . 73.8 m-20 -129.62 145.68 51.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.923 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 6.8 p90 -148.63 -163.95 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.966 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.94 117.52 21.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 72.230000000000004 110.9 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.8 tt -144.08 85.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 65.019999999999996 110.875 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.7 13.6 40.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 62.009999999999998 112.459 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.42 -54.42 0.79 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.729 -0.748 . . . . 74.319999999999993 112.494 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -156.3 87.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 74.310000000000002 111.062 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -112.68 85.88 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 43.229999999999997 110.978 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.1 99.88 8.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 71.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.35 105.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 75.109999999999999 110.869 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.711 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 1.6 m-20 -171.26 177.95 3.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 71.109999999999999 110.898 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 128.64 55.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.040000000000006 110.837 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 163' ' ' THR . 94.7 t -76.77 144.77 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.235 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.54 136.45 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 60.140000000000001 110.823 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.531 HD13 ' OH ' ' A' ' 107' ' ' TYR . 0.6 OUTLIER -156.0 -173.08 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 72.530000000000001 110.859 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 16' ' ' VAL . 27.2 m-20 -130.64 76.79 76.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.635 0.731 . . . . 75.049999999999997 110.8 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -21.2 34.19 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.727 2.284 . . . . 64.310000000000002 112.43 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -96.81 65.6 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 110.89 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.597 HG23 ' C ' ' A' ' 15' ' ' THR . 11.6 p -129.2 135.1 62.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 62.140000000000001 111.231 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.61 122.02 26.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.953 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 6.8 tpp -97.13 113.8 25.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 70.400000000000006 110.772 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -151.6 134.65 15.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 71.409999999999997 110.86 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 p -158.11 174.31 15.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.048 -0.524 . . . . 75.109999999999999 110.916 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.793 ' HB3' ' HG2' ' A' ' 10' ' ' ARG . . . -112.84 -171.54 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 63.310000000000002 111.11 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.75 123.29 1.51 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 60.420000000000002 112.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 119.89 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 61.530000000000001 110.916 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -63.79 125.81 25.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 53.509999999999998 110.815 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 70.510000000000005 110.884 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.767 0.317 . . . . 62.119999999999997 110.844 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -174.99 91.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 74.140000000000001 110.849 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -178.78 173.38 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.099999999999994 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 58.92 97.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.475 . . . . 74.540000000000006 111.066 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.85 3.36 83.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.706 -0.759 . . . . 63.299999999999997 112.48 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -76.72 128.46 34.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 75.540000000000006 110.824 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -108.03 119.87 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.400000000000006 110.845 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 150' ' ' LEU . 2.9 m-85 -119.07 155.85 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 75.340000000000003 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mtp -122.5 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 65.549999999999997 110.877 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -149.12 117.35 6.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 75.549999999999997 110.843 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.63 148.21 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 111.072 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.44 -163.88 36.41 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.836 -0.697 . . . . 75.439999999999998 112.556 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -151.44 167.53 27.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.896 0.379 . . . . 45.32 110.888 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.18 123.13 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.209999999999994 111.123 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.4 m -94.59 134.61 36.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.210000000000001 111.115 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.664 ' HA ' HG12 ' A' ' 183' ' ' VAL . 91.3 t -94.95 134.81 31.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.087 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -80.91 160.59 65.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 75.439999999999998 110.89 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 133.58 25.91 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.688 2.259 . . . . 62.109999999999999 112.306 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.2 p -128.77 -173.0 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 55.409999999999997 111.113 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.63 139.14 26.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 73.049999999999997 110.882 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.54 109.69 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.219999999999999 112.486 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.17 106.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 71.430000000000007 111.162 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.41 -110.34 1.3 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 120.742 -0.742 . . . . 63.539999999999999 112.498 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.55 171.91 55.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 72.230000000000004 112.425 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.9 t -105.69 -31.66 8.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.867 0.365 . . . . 72.340000000000003 111.169 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 29' ' ' LEU . 2.8 mm? 52.11 88.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 71.120000000000005 110.859 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.46 39.55 2.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 22.039999999999999 112.457 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.28 -73.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 72.340000000000003 110.793 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.9 pp -174.34 172.08 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.516 . . . . 70.310000000000002 110.934 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.67 43.68 35.12 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.755 -0.736 . . . . 63.420000000000002 112.487 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.58 94.88 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 44.240000000000002 112.572 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -142.64 160.26 40.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 74.239999999999995 110.9 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -111.95 -171.57 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 43.340000000000003 110.821 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.11 163.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 74.25 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -80.26 123.38 27.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 44.240000000000002 111.086 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -130.97 112.92 13.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.136 -0.484 . . . . 75.209999999999994 110.831 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -175.53 173.59 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.967 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.13 107.61 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 65.25 111.109 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -80.45 -169.43 2.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.851 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.83 92.28 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.971 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.24 127.68 8.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 63.310000000000002 112.57 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -97.1 132.33 42.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.942 0.401 . . . . 50.340000000000003 110.895 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 57' ' ' LEU . 4.9 m -128.24 132.76 48.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 65.010000000000005 111.188 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.506 ' CE2' HD12 ' A' ' 42' ' ' LEU . 69.8 m-85 -120.71 140.3 51.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 73.430000000000007 110.793 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.65 HG23 ' HG2' ' A' ' 55' ' ' GLU . 98.2 m -118.33 137.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 53.25 111.147 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -142.5 105.97 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 74.439999999999998 110.971 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.0 mmt -61.84 138.97 58.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 64.209999999999994 110.852 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.01 -82.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.083 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t 179.44 39.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 71.510000000000005 111.068 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 51' ' ' ASN . 4.5 t0 -177.84 51.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 61.149999999999999 110.818 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 50' ' ' ASP . 13.6 t-20 76.67 -49.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 71.140000000000001 110.923 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 tt -70.3 138.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.423 . . . . 62.43 111.09 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.0 156.1 23.09 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.719 -0.753 . . . . 61.119999999999997 112.493 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.3 t -102.39 131.44 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 74.109999999999999 111.087 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' HG23 ' A' ' 45' ' ' THR . 19.6 mt-10 -125.24 141.15 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.854 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 125.61 54.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.94 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -106.56 134.79 49.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 61.210000000000001 111.03 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -139.59 138.16 35.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 51.240000000000002 111.149 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.34 146.24 13.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.292 -0.413 . . . . 70.109999999999999 111.104 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.5 p -48.51 107.06 0.69 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.491 0.663 . . . . 75.230000000000004 111.156 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -48.88 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.633 2.222 . . . . 62.5 112.352 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.44 117.08 6.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 73.340000000000003 110.937 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' VAL . 15.9 mtm-85 -160.31 131.65 5.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.150000000000006 110.85 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.819 ' CG ' HD13 ' A' ' 74' ' ' ILE . 7.9 p80 -160.1 156.91 27.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 110.861 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' O ' HD13 ' A' ' 66' ' ' ILE . 1.3 mttt -179.99 84.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.400000000000006 110.92 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.606 ' H ' HG22 ' A' ' 74' ' ' ILE . 24.4 mm -129.17 151.39 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 111.178 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.57 96.28 0.38 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.762 -0.733 . . . . 72.040000000000006 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.02 151.53 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 71.010000000000005 111.132 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.27 159.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.867 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -21.32 6.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.010000000000005 111.077 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -33.3 31.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 111.155 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.87 90.18 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.786 -0.721 . . . . 54.43 112.529 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.76 173.47 10.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 74.239999999999995 110.837 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.819 HD13 ' CG ' ' A' ' 64' ' ' HIS . 1.1 pp -95.55 -171.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 111.096 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -122.03 163.4 19.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.112 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 76' ' ' THR . 4.6 t -74.7 117.5 16.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 111.063 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 63' ' ' ARG . 27.1 m -138.74 167.05 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 62.329999999999998 111.151 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -178.21 124.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 70.319999999999993 110.894 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.42 172.1 8.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 70.230000000000004 110.851 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.88 ' C ' ' HD2' ' A' ' 82' ' ' PRO . 71.1 mt -110.42 117.96 50.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.619 0.724 . . . . 64.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.921 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.1 Cg_endo -69.67 -25.77 28.67 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.672 2.248 . . . . 71.319999999999993 112.348 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.921 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 53.8 Cg_endo -69.71 99.3 0.73 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.646 2.23 . . . . 64.420000000000002 112.338 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 130.26 55.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 111.128 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mp -101.35 128.19 47.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 110.817 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ttt -141.71 96.33 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.907 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 103' ' ' ALA . . . -113.98 121.57 44.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 74.310000000000002 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.746 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 tp60 -173.53 -163.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 111.019 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 15.5 p90 -153.22 168.77 24.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 64.329999999999998 110.88 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 39.9 p90 -99.67 131.13 45.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 73.430000000000007 110.998 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.87 -70.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 74.230000000000004 110.836 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 98.37 0.86 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.803 -0.713 . . . . 60.240000000000002 112.476 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.29 108.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 63.43 110.996 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.95 -76.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 71.010000000000005 111.045 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -179.77 42.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 71.349999999999994 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m 55.75 73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 64.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -179.15 -74.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 64.400000000000006 110.878 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -114.55 134.79 54.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.881 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -147.43 156.8 45.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.583 0.706 . . . . 62.149999999999999 110.841 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -175.96 1.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.751 2.3 . . . . 73.319999999999993 112.358 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -164.78 118.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 74.219999999999999 110.847 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' GLN . 3.4 p -103.76 138.08 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.09 -0.504 . . . . 54.020000000000003 111.126 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.676 ' HA2' ' CB ' ' A' ' 87' ' ' GLN . . . -126.48 150.32 17.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 51.219999999999999 112.507 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.746 ' HB3' ' OE1' ' A' ' 87' ' ' GLN . . . -160.27 123.58 3.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 64.420000000000002 111.154 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -163.24 -144.62 4.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 63.229999999999997 112.441 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 134' ' ' GLY . 53.4 mt -121.93 119.15 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.85 0.357 . . . . 62.020000000000003 111.12 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -96.16 109.09 21.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 74.129999999999995 110.799 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -92.62 106.82 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 73.230000000000004 110.901 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.9 151.02 47.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 72.120000000000005 111.099 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.2 177.56 7.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 111.118 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -52.27 149.44 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 64.120000000000005 110.875 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -171.0 36.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB2' HD23 ' A' ' 129' ' ' LEU . 1.0 OUTLIER -140.95 39.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.494 . . . . 65.430000000000007 110.812 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.486 ' CB ' ' HB1' ' A' ' 75' ' ' ALA . 29.5 t-20 66.5 141.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 73.109999999999999 110.853 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.0 164.04 29.9 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.724 -0.75 . . . . 64.519999999999996 112.5 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CE1' HD13 ' A' ' 127' ' ' LEU . 29.8 p90 -47.46 105.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 72.310000000000002 110.906 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -179.09 -148.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.096 -0.502 . . . . 73.430000000000007 110.866 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -45.68 -57.09 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.010000000000005 110.802 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -79.36 -48.81 13.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 72.310000000000002 110.801 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.33 -59.52 10.33 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 73.450000000000003 112.431 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -46.61 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 50.439999999999998 110.837 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.45 -15.4 63.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 71.040000000000006 110.917 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.82 -5.17 58.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 72.519999999999996 111.123 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 124' ' ' LEU . . . 115.56 -25.12 9.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.797 -0.716 . . . . 50.119999999999997 112.485 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.599 ' O ' ' CB ' ' A' ' 125' ' ' SER . 0.1 OUTLIER 164.99 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 60.039999999999999 110.825 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 1.9 t 153.06 161.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 63.310000000000002 110.854 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 127' ' ' LEU . 14.0 t70 -134.47 38.88 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 53.310000000000002 110.906 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.526 HD13 ' CE1' ' A' ' 115' ' ' PHE . 7.3 tp 81.45 -32.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 t 73.14 -69.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 65.129999999999995 110.808 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.557 HD23 ' HB2' ' A' ' 112' ' ' ASP . 1.8 mm? -107.87 125.22 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 52.43 111.019 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.4 160.66 15.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.934 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -51.77 125.24 14.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.150000000000006 110.827 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.88 81.07 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.0 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -117.35 118.9 33.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 75.120000000000005 110.915 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' ILE . . . -166.66 -143.78 3.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.445 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.47 158.25 15.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 62.439999999999998 111.092 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.719 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . . . -145.97 133.12 20.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 52.119999999999997 111.123 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.98 161.54 30.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 51.409999999999997 112.368 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -169.36 158.34 8.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 64.109999999999999 110.964 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.4 p -120.46 91.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 75.150000000000006 111.011 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.44 -161.99 27.19 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.759 . . . . 72.420000000000002 112.39 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.521 ' O ' ' HB3' ' A' ' 152' ' ' ASN . 15.8 t -122.83 154.0 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.825 0.345 . . . . 71.25 111.084 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 18.8 t70 -138.18 132.23 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.549999999999997 110.928 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.533 ' N ' HD22 ' A' ' 152' ' ' ASN . 10.5 t80 -124.51 113.47 18.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.268 -0.424 . . . . 72.140000000000001 110.983 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.2 88.89 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 75.420000000000002 110.858 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.2 tt -55.65 -29.92 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.037 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.4 -170.36 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.519999999999996 110.802 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -42.75 70.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 73.019999999999996 110.866 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -119.16 23.43 11.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.984 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -136.71 131.34 33.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 74.329999999999998 110.996 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.548 ' O ' ' HB1' ' A' ' 188' ' ' ALA . 11.9 mt -123.01 171.25 9.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.795 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 151' ' ' VAL . 5.1 p -170.56 118.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.120000000000005 111.121 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.652 ' CB ' ' HA ' ' A' ' 142' ' ' ASP . 1.4 t-20 -179.98 -166.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 74.409999999999997 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -158.45 -176.51 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.020000000000003 110.834 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -126.85 -173.95 3.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.895 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.1 m -106.62 -179.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 65.209999999999994 111.134 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -102.35 156.77 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.519999999999996 110.916 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -179.94 -169.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 62.210000000000001 110.91 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.43 133.38 45.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 72.200000000000003 110.835 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -150.26 19.29 0.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.85 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -144.38 151.52 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.193 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.49 133.61 36.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.109999999999999 110.884 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.1 m -123.31 113.6 19.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 60.329999999999998 111.175 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 176' ' ' SER . 99.6 m -105.65 130.65 53.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 60.509999999999998 111.235 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 174' ' ' HIS . . . -125.72 142.33 51.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 70.230000000000004 111.074 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -167.08 120.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 45.420000000000002 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -142.5 119.73 11.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.046 0.451 . . . . 71.200000000000003 110.884 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 17.5 tttt -108.97 111.55 23.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 71.319999999999993 110.945 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 171' ' ' ALA . 1.9 mt -114.56 109.41 18.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 74.150000000000006 110.932 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 124' ' ' LEU . . . 51.71 26.3 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 74.049999999999997 112.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 29.67 9.27 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.706 -0.759 . . . . 65.239999999999995 112.453 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 168' ' ' LEU . . . -81.35 173.68 12.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 52.420000000000002 111.017 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.92 96.02 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.5 161.36 29.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.417 . . . . 72.109999999999999 110.942 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -78.73 -174.36 3.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 74.329999999999998 110.878 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.52 -179.36 5.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 70.400000000000006 110.803 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 163' ' ' THR . 3.2 m -73.49 128.66 36.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 70.439999999999998 110.904 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.4 t -131.11 147.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.230000000000004 111.111 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -103.41 92.85 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.837 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER 178.99 -169.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.903 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.09 157.2 29.13 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.678 0.751 . . . . 71.530000000000001 110.831 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -170.32 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 63.229999999999997 112.394 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -111.07 114.04 27.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 64.420000000000002 110.961 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.664 HG12 ' HA ' ' A' ' 16' ' ' VAL . 18.1 m -139.3 149.5 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.351 -0.386 . . . . 63.240000000000002 111.172 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.5 150.4 26.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.893 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.7 ttp -132.4 109.28 9.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 71.400000000000006 110.879 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -121.39 149.24 43.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 71.25 110.776 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 p -175.28 175.1 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 71.340000000000003 110.91 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 150' ' ' LEU . . . -117.73 -179.98 3.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 111.093 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.33 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.87 -0.681 . . . . 63.100000000000001 112.6 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -143.78 157.27 44.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.959 0.409 . . . . 74.140000000000001 110.894 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.33 121.7 15.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.806 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 71.319999999999993 110.945 -179.932 . . . . . . . . 1 1 . 1 stop_ save_